variant_id	variant_civic_url	gene	entrez_id	variant	summary	variant_groups	chromosome	start	stop	reference_bases	variant_bases	representative_transcript	ensembl_version	reference_build	chromosome2	start2	stop2	representative_transcript2	variant_types	hgvs_expressions	last_review_date	civic_variant_evidence_score	allele_registry_id	clinvar_ids	variant_aliases	assertion_ids	assertion_civic_urls
1	https://civic.genome.wustl.edu/links/variants/1	ABL1	25	BCR-ABL	The BCR-ABL fusion protein, commonly referred to as the Philadelphia chromosome, is one of the most studied fusion genes in cancer. It has widely been considered the initiating event in chronic myelogenous leukemia (CML). However, despite its ability to initiate disease in mice, its status as an initiating mutation is in dispute. In what is commonly used as the poster-child for targeted therapeutics, the development and use of imatinib in the clinic has led to profound improvements in the prognosis of the disease. However, imatinib resistance is still seen in patients with mutations in the ABL kinase domain of the fusion, most notably the T315I variant. In patients resistant to imatinib, either acquired or otherwise, second generation BCR-ABL TKI's (dasatinib and nilotinib) have seen some success in delivering a tumor response. Third generation ABL1 inhibitor ponatinib is the only FDA approved drug with activity against T315I . However due to risk of life-threatening blood clots and severe narrowing of blood vessels ponatinib is ONLY approved for T315I-positive CML or T315I-positive Ph+ ALL or in cases of CML, Ph+ ALL with resistance or intolerance to other approved ABL1 inhibitors.		22	23522397	23632600			ENST00000305877.8	75	GRCh37	9	133729451	133763063	ENST00000318560.5	transcript_fusion	N/A	2020-02-08 03:53:21 UTC	255.5		N/A	T(9;22)(Q34;Q11),BCR-ABL1		
2	https://civic.genome.wustl.edu/links/variants/2	ABL1	25	BCR-ABL T315I	While the efficacy of imatinib has revolutionized chronic myelogenous leukemia (CML) treatment, it is still not a cure-all. Both initial resistance and acquired resistance as a result of selection have been seen in a small subset of CML patients. The ABL kinase domain mutation T315I (aka T334I) has been shown to be one such mutation that confers resistance to imatinib. Second generation TKI's (dasatinib and ponatinib) specific to BCR-ABL have shown efficacy in treating resistant cases.	Imatinib Resistance	9	133748283	133748283	C	T	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_007313.2:c.1001C>T,NP_005148.2:p.Thr315Ile,ENST00000372348.2:c.1001C>T,NC_000009.11:g.133748283C>T	2020-08-29 00:06:08 UTC	146.0	CA122575	12624	THR334ILE,RS121913459,BCR-ABL THR315ILE,BCR-ABL1 T315I,BCR-ABL1 THR315ILE		
3	https://civic.genome.wustl.edu/links/variants/3	ABL1	25	BCR-ABL E255K	While the efficacy of imatinib has revolutionized chronic myelogenous leukemia (CML) treatment, it is still not a cure-all. Both initial resistance and acquired resistance as a result of selection have been seen in a small subset of CML patients. The ABL kinase domain mutation E255K has been shown to be one such mutation that confers resistance to imatinib. Second generation TKI's (dasatinib and nilotinib) specific to BCR-ABL have shown efficacy in treating resistant cases.	Imatinib Resistance	9	133738363	133738363	G	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NC_000009.11:g.133738363G>A,NM_005157.5:c.763G>A,NP_005148.2:p.Glu255Lys,ENST00000318560.5:c.763G>A	2020-07-10 23:36:50 UTC	73.0	CA16602551	376090	E274K,RS121913448,BCR-ABL GLU255LYS,BCR-ABL1 E255K,BCR-ABL1 GLU255LYS		
4	https://civic.genome.wustl.edu/links/variants/4	AKT1	207	E17K	AKT1 E17K is a recurrent mutation that has been observed in breast, colorectal, lung, and ovarian cancer. It has been convincingly shown to be an activating mutation resulting in PI3K/AKT/mTOR pathway activity. It has been suggested that this mutation decreases the cell's sensitivity to AKT1 allosteric kinase inhibitors. This, and other AKT1 mutations, are the subject of much research and development for therapeutics.		14	105246551	105246551	C	T	ENST00000407796.2	75	GRCh37					missense_variant	NC_000014.8:g.105246551C>T,NM_001014432.1:c.49G>A,NP_001014432.1:p.Glu17Lys,ENST00000407796.2:c.49G>A	2018-11-30 14:44:59 UTC	32.5	CA123660	13983	GLU17LYS,RS34409589		
5	https://civic.genome.wustl.edu/links/variants/5	ALK	238	EML4-ALK	The EML4-ALK fusion variant 1 consisting of ALK kinase domain (exons 20-29) fused to EML4 exons 1-13 is the most common EML4-ALK variant, and was discovered in non-small cell lung cancer. Multiple EML4 breakpoint shave been described with differential sensitivity to inhibitors with variant 1 showing greater sensitivity than 3a in cell lines. EML4-ALK is crizotinib sensitive; however, several mutations that confer resistance mutations have been described in case studies. In the only clinical trial for crizotinib that included determination of EML4-ALK variant type in a subset of its participants, a very high response rate was observed, although the numbers were insufficient to validate correlation of variant type to outcome. Preclinical studies with this variant have indicated sensitivity to Hsp90 inhibitors.	ALK Fusions	2	42396490	42522656			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2020-08-29 19:17:30 UTC	38.0		N/A			
6	https://civic.genome.wustl.edu/links/variants/6	ALK	238	EML4-ALK C1156Y	In patients with non-small cell lung cancer exhibiting EML4-ALK fusion, C1156Y has been shown to confer resistance to crizotinib. Case reports indicate that secondary mutations can modulate drug sensitivity. EML4-ALK C1156Y/L1196M maintained crizotinib resistance while the lorlatinib resistant combination EML4-ALK C1156Y/L1198F re-sensitized the tumor to crizotinib treatment.	Crizotinib Resistance,ALK Fusions	2	29445258	29445258	C	T	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3467G>A,NC_000002.11:g.29445258C>T,NM_004304.4:c.3467G>A,NP_004295.2:p.Cys1156Tyr	2020-09-04 15:14:49 UTC	29.0	CA16602783	376340	EML4-ALK CYS1156TYR,RS1057519859		
7	https://civic.genome.wustl.edu/links/variants/7	ALK	238	EML4-ALK L1196M	In patients with non-small cell lung cancer exhibiting EML4-ALK fusion, L1196M has been shown to confer resistance to crizotinib. This was also true in a patient with both EML4-ALK C1156Y & L1196M.	Crizotinib Resistance,ALK Fusions	2	29443631	29443631	G	T	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3586C>A,NC_000002.11:g.29443631G>T,NM_004304.4:c.3586C>A,NP_004295.2:p.Leu1196Met	2020-08-29 21:04:18 UTC	21.0	CA16602593	376135	EML4-ALK LEU1196MET,RS1057519784		
8	https://civic.genome.wustl.edu/links/variants/8	ALK	238	F1174L	ALK F1174L has been observed as recurrent in neuroblastoma, non-small cell lung cancer (NSCLC), and other cancer types. Neuroblastoma cells containing this mutation have shown resistance to low doses of criztonib. However, increased dosage can overcome this resistance in cell lines studies. TAE684 has also proven effective in both NSCLC and neuroblastoma F1174L containing cells.	Crizotinib Resistance	2	29443695	29443695	G	T	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3522C>A,NP_004295.2:p.Phe1174Leu,NC_000002.11:g.29443695G>T,ENST00000389048.3:c.3522C>A	2018-11-30 14:45:01 UTC	33.5	CA279586	217851	PHE1174LEU,RS863225281		
9	https://civic.genome.wustl.edu/links/variants/9	ALK	238	R1275Q	ALK R1275Q has been observed as a recurrent mutation in  neuroblastoma, non-small cell lung cancer (NSCLC), as well as other cancer types. Neuroblastoma cells with this mutation have shown sensitivity to the ALK-inhibitor TAE684. This and the geldanamycin deriviative 17-DMAG have been shown to be effective in NSCLC cell lines.		2	29432664	29432664	C	T	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3824G>A,NP_004295.2:p.Arg1275Gln,NC_000002.11:g.29432664C>T,ENST00000389048.3:c.3824G>A	2018-11-30 14:44:59 UTC	23.0	CA341482	18083	ARG1275GLN,RS113994087		
10	https://civic.genome.wustl.edu/links/variants/10	ARAF	369	S214C	ARAF S214C has been found to be a recurrent oncogenic mutation in non-small cell lung cancer. It has been shown to confer sensitivity to sorafenib and trametenib in cell lines. In a case study of advanced stage lung adenocarcinoma harboring this mutation, sorafenib also acheived near-complete clinical remission. This case has brought more interest to the variant from a research and clinical perspective.		X	47426121	47426121	C	G	ENST00000377045.4	75	GRCh37					missense_variant	NC_000023.10:g.47426121C>G,NM_001654.4:c.641C>G,NP_001645.1:p.Ser214Cys,ENST00000377045.4:c.641C>G	2018-11-30 14:43:04 UTC	11.0	CA16602595	376137	SER214CYS,RS1057519786		
11	https://civic.genome.wustl.edu/links/variants/11	BRAF	673	V600D	Patients harboring mutations in valine 600 residue of BRAF have been shown to be sensitive to dabrafenib. For more information on the V600 locus, see the V600E entry.	Other V600's	7	140453135	140453136	CA	AT	ENST00000288602.6	75	GRCh37					missense_variant	NC_000007.13:g.140453135_140453136delinsAT,NM_004333.4:c.1799_1800delTGinsAT,NP_004324.2:p.Val600Asp,ENST00000288602.6:c.1799_1800delTGinsAT	2020-11-21 22:43:17 UTC	47.0	CA16602419	375939	RS121913377,VAL600ASP		
12	https://civic.genome.wustl.edu/links/variants/12	BRAF	673	V600E	BRAF V600E has been shown to be recurrent in many cancer types. It is one of the most widely studied variants in cancer. This variant is correlated with poor prognosis in certain cancer types, including colorectal cancer and papillary thyroid cancer. The targeted therapeutic dabrafenib has been shown to be effective in clinical trials with an array of BRAF mutations and cancer types. Dabrafenib has also shown to be effective when combined with the MEK inhibitor trametinib in colorectal cancer and melanoma. However, in patients with TP53, CDKN2A and KRAS mutations, dabrafenib resistance has been reported. Ipilimumab, regorafenib, vemurafenib, and a number of combination therapies have been successful in treating V600E mutations. However, cetuximab and panitumumab have been largely shown to be ineffective without supplementary treatment.		7	140453136	140453136	A	T	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1799T>A,NP_004324.2:p.Val600Glu,NC_000007.13:g.140453136A>T,ENST00000288602.6:c.1799T>A	2021-01-26 23:27:09 UTC	1203.5	CA123643	13961,376069	RS113488022,VAL600GLU	20,10,12,7,23	https://civic.genome.wustl.edu/links/assertions/20	https://civic.genome.wustl.edu/links/assertions/10	https://civic.genome.wustl.edu/links/assertions/12	https://civic.genome.wustl.edu/links/assertions/7	https://civic.genome.wustl.edu/links/assertions/23
13	https://civic.genome.wustl.edu/links/variants/13	BRAF	673	V600E and V600M	A case study of a single patient harboring both a V600E and a V600M mutation, dabrafenib was shown to acheive clinical response.	Other V600's	7	140453135	140453137			ENST00000288602.6	75	GRCh37					missense_variant		2020-05-28 20:11:12 UTC	7.5		13961,44815			
14	https://civic.genome.wustl.edu/links/variants/14	BRAF	673	V600E and AMPLIFICATION	Amplification of BRAF V600E has been shown to confer resistance to MEK inhibitors. For more information on the V600 locus, see the V600E entry.		7	140434279	140624564			ENST00000288602.6	75	GRCh37					missense_variant,transcript_amplification		2020-05-28 21:34:17 UTC	1.0					
17	https://civic.genome.wustl.edu/links/variants/17	BRAF	673	V600	BRAF mutations of the valine 600 residue have been shown to be recurrent in many cancer types. Of the V600 mutations, V600E is the most widely researched. V600 mutations as a whole have been correlated to poorer prognosis in colorectal and papilarry thyroid cancers. V600 mutations have also been shown to confer sensitivity to the BRAF inhibitor dabrafenib. For a more detailed summary, click the individual mutations.	Other V600's	7	140453136	140453137			ENST00000288602.6	75	GRCh37					protein_altering_variant		2020-12-10 20:13:06 UTC	460.0		13961,44815,376288,40389,376289,44816	VAL600		
18	https://civic.genome.wustl.edu/links/variants/18	CCND1	595	AMPLIFICATION	CCND1 amplification has been implicated in poorer prognosis in non-small cell lung cancer.		11	69455855	69469242			ENST00000227507.2	75	GRCh37					transcript_amplification	N/A	2017-12-01 14:40:28 UTC	47.0		N/A		1,2	https://civic.genome.wustl.edu/links/assertions/1	https://civic.genome.wustl.edu/links/assertions/2
19	https://civic.genome.wustl.edu/links/variants/19	CCND1	595	EXPRESSION	CCND1 expression, and its prognositc impact, is still in dispute. Three experiments in non-small cell lung cancer have shown it to have no impact on survival, but three additional studies have shown it results in poorer prognosis. There is also some ambiguity in how the boundaries between expression and overexpression are defined.		11	69455855	69469242			ENST00000227507.2	75	GRCh37					N/A		2017-12-01 14:40:28 UTC	30.0		N/A			
20	https://civic.genome.wustl.edu/links/variants/20	CCND1	595	OVEREXPRESSION	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.		11	69455855	69469242			ENST00000227507.2	75	GRCh37					N/A		2020-06-08 17:36:07 UTC	116.0		N/A			
21	https://civic.genome.wustl.edu/links/variants/21	CCND2	894	OVEREXPRESSION	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.		12	4382938	4414516			ENST00000261254.3	75	GRCh37					N/A		2017-12-01 14:40:28 UTC	16.0		N/A			
22	https://civic.genome.wustl.edu/links/variants/22	CCND2	894	PROMOTER DEMETHYLATION	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are misregulated are widely variable, and range from genomic amplification to promoter methylation changes. While Cyclin D2 has only been found to be significantly misregulated in glioma, Cyclin D1 in particular seems to be a pan-cancer actor. Cyclin D misregulation has been shown to lead to poorer outcomes in a number of studies, and currently there are no FDA-approved targeted therapies.		12	4381437	4382937			ENST00000261254.3	75	GRCh37					N/A		2017-12-01 14:40:28 UTC	3.0					
23	https://civic.genome.wustl.edu/links/variants/23	CCND3	896	LOSS	Cyclin D has been shown in many cancer types to be misregulated. Well established for their oncogenic properties, the cyclins and the cyclin-dependent kinases (CDK's) they activate have been the focus of major research and development efforts over the past decade. The methods by which the cyclins are deregulated are widely variable, and range from genomic amplification to promoter methylation changes. Cyclin D3 loss has been reported in T-cell acute lymphoblastic leukemia (T-ALL), a seemingly unique trend when compared to the amplifcations and overexpressions of the other cyclin D's. Treating cyclin D3 knockout mice with the targeted therapeutic palbociclib significantly increased the median survival of a Notch-driven model of T-ALL.		6	41902671	41909586			ENST00000372991.4	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:28 UTC	3.0		N/A			
24	https://civic.genome.wustl.edu/links/variants/24	CCNE1	898	OVEREXPRESSION	Cyclin E, while currenly not as widely implicated as its counterpart, cyclin D, has been implicated in various carcinomas, including breast, gastric, stomach and colorectal. High levels of cyclin E, either by gene amplification or overexpression, are correlated with later stage disease and have been shown to lead to poorer prognosis in gastic carcinoma. It has also been shown, in lung cancer specifically, that neoplastic cells with higher levels of the cyclin E/CDK2 complex are more radiosensitive than their lowly expressed counterparts.		19	30302805	30315215			ENST00000262643.3	75	GRCh37					N/A		2017-12-01 14:40:28 UTC	62.0		N/A			
25	https://civic.genome.wustl.edu/links/variants/25	CDK4	1019	EXPRESSION	CDK4, along with its partner CDK6, are key players in cell cycle progression. The complex has been implicated in a number of cancer types, and is the focus of therapeutic research and development. One targeted therapy for CDK inhibition is palbociclib, which may slow the growth of advanced stage breast cancers. It has also been shown, in mouse, that CDK inhibition may sensitize mutant PIK3CA tumors to PI3K inhibitors.		12	58141510	58146304			ENST00000257904.6	75	GRCh37					N/A		2017-12-01 14:40:28 UTC	8.0		N/A			
27	https://civic.genome.wustl.edu/links/variants/27	CDKN2A	1029	PROMOTER HYPERMETHYLATION	CDKN2A loss has been shown to be a significant event in a number of cancer types. One mechanism by which this can occur is by hypermethylation of the CDKN2A promoter region. While no targeted therapeutic has been engaged in clinical trials, the prognostic impact has been studied by a number of meta-analyses. The prognostic impact of promoter hypermethylation has been relatively ambiguous. Many studies have shown significant p-values suggesting poorer prognostic outcomes for patients with hypermethylation in colorectal, liver, and younger lung cancer patients. This being said, there is still research to be done before this becomes a widely-accepted prognostic indicator.		9	21974827	21994591			ENST00000498124.1	75	GRCh37					N/A		2017-12-01 14:40:28 UTC	15.0					
28	https://civic.genome.wustl.edu/links/variants/28	CEBPA	1050	N-TERMINAL FRAME SHIFT	CEBPA N-terminal frame shift mutations that result in a premature stop codon are associated with cytogenetically normal acute myeloid leukemia (CN-AML). CEBPA mutations are associated with a favorable prognosis; however, NPM1 and FLT3 mutations should also be assessed in CN-AML patients as concurrent mutations may have prognostic implications. N-terminal frame shift mutations within amino acids 1-120 have been shown to disrupt expression of the full-length 42kDa isoform while maintaining expression of a 30kDa isoform (translated from the AUG at full-length protein isoform amino acid M120). This 30kDa isoform exhibits dominant negative activity.		19	33792961	33793470			ENST00000498907.2	75	GRCh37					frameshift_truncation,dominant_negative_variant		2017-12-01 14:40:28 UTC	3.0					
29	https://civic.genome.wustl.edu/links/variants/29	CEBPA	1050	MUTATION	CEBPA mutations are associated with cytogenetically normal acute myeloid leukemia (CN-AML) and a favorable prognosis. However, NPM1 and FLT3 mutations should also be assessed in CN-AML patients as concurrent mutations may have prognostic implications.		19	33790840	33793470			ENST00000498907.2	75	GRCh37					transcript_variant,loss_of_function_variant		2017-12-01 14:40:28 UTC	105.0		N/A			
30	https://civic.genome.wustl.edu/links/variants/30	CSF1R	1436	MEF2D-CSF1R	MEF2D-CSF1R is a fusion that has been observed in acute lymphocytic leukemia. In cell lines harboring this event, treatment with imatinib has shown notable sensitivity.		1	156446804	156470620			ENST00000348159.4	75	GRCh37	5	149433787	149441412	ENST00000286301.3	transcript_fusion		2017-12-01 14:40:28 UTC	3.0		N/A			
31	https://civic.genome.wustl.edu/links/variants/31	PRKACA	5566	DNAJB1-PRKACA	This fusion has been found to be very recurrent in the rare form of adolescent liver cancer, fibrolamellar hepatocellular carcinoma. In one study, this fusion was observed in 15/15 FL-HCC cases examined and functional studies found that the fusion retained kinase activity. The presence of this fusion may be used as a diagnostic marker for this rare tumor type.		19	14628951	14629232			ENST00000254322.2	75	GRCh37	19	14202500	14218221	ENST00000308677.4	transcript_fusion		2017-12-01 14:40:28 UTC	75.0				24	https://civic.genome.wustl.edu/links/assertions/24
32	https://civic.genome.wustl.edu/links/variants/32	DNMT3A	1788	R882	DNMT3A R882 mutations are associated with cytogenetically normal acute myeloid leukemia (CN-AML) with R882H as the most common form. Mutations in DNMT3A have largely been associated with poorer prognosis, however this is not consistent across all studies. This may be a result of patient age or combining R882 and non-R882 mutations during analysis as studies have indicated independent mechanisms of action and differential prognostic implications for these mutation types. One study that independently analyzed R882 and non-R882 mutations showed R882 mutations were associated with poorer prognosis than patients with wildtype and non-R882 mutations, but only in older patients with AML.		2	25457241	25457243			ENST00000264709.3	75	GRCh37					missense_variant		2017-12-01 14:40:28 UTC	525.0		375881,375880,375879,375884,375883,375882	R693		
33	https://civic.genome.wustl.edu/links/variants/33	EGFR	1956	L858R	EGFR L858R has long been recognized as a functionally significant mutation in cancer, and is one of the most prevalent single mutations in lung cancer. Best described in non-small cell lung cancer (NSCLC), the mutation seems to confer sensitivity to first and second generation TKI's like gefitinib and neratinib. NSCLC patients with this mutation treated with TKI's show increased overall and progression-free survival, as compared to chemotherapy alone. Third generation TKI's are currently in clinical trials that specifically focus on mutant forms of EGFR, a few of which have shown efficacy in treating patients that failed to respond to earlier generation TKI therapies.		7	55259515	55259515	T	G	ENST00000275493.2	75	GRCh37					missense_variant	NC_000007.13:g.55259515T>G,NM_005228.4:c.2573T>G,ENST00000275493.2:c.2573T>G,NP_005219.2:p.Leu858Arg	2021-02-03 23:40:53 UTC	367.5	CA126713	16609,376282,376280	LEU858ARG,RS121434568	5,6	https://civic.genome.wustl.edu/links/assertions/5	https://civic.genome.wustl.edu/links/assertions/6
34	https://civic.genome.wustl.edu/links/variants/34	EGFR	1956	T790M	EGFR T790M was one of the very first mutations recognized to confer resistance to targeted therapies in non-small cell lung cancer. While successful in amplified EGFR, the efficacy of the first and second generation TKI's (erlotinib, gefitinib, neratinib) in treating patients harboring this mutation before treatment is notably lower. This lack of efficacy can likely be to blame for the poorer prognosis for patients with this mutation as compared to patients with wildtype EGFR or other types of EGFR mutations. Approximately half of EGFR mutant tumors with acquired resistance to TKI inhibition have been shown to harbor this mutation, implicating it as a mechanism of acquired therapy resistence. A third generation TKI (osimertinib) has been approved for the treatment of EGFR T790M mutant NSCLC. Patients positive for T790M in a plasma-based test have similar outcomes like those with tumor biopsy testing.	EGFR TKI Resistance	7	55249071	55249071	C	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2369C>T,NM_005228.4:c.2369C>T,NP_005219.2:p.Thr790Met,NC_000007.13:g.55249071C>T	2020-12-16 20:31:40 UTC	386.25	CA090928	16613	THR790MET,RS121434569		
35	https://civic.genome.wustl.edu/links/variants/35	ERBB2	2064	D769H	ERBB2 D769H was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines were shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 activating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37880261	37880261	G	C	ENST00000269571.5	75	GRCh37					missense_variant	NM_001289937.1:c.2305G>C,NP_001276866.1:p.Asp769His,ENST00000269571.5:c.2305G>C,NC_000017.10:g.37880261G>C	2018-11-30 14:44:12 UTC	4.0	CA16602465	375991	ASP769HIS,D739H,D754H,ASP739HIS,ASP754HIS,D769H,RS121913468		
36	https://civic.genome.wustl.edu/links/variants/36	ERBB2	2064	D769Y	ERBB2 D769Y was one of the first ERBB2 variants to be functionally classified (Bose et al., 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37880261	37880261	G	T	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2305G>T,NC_000017.10:g.37880261G>T,NM_004448.3:c.2305G>T,NP_004439.2:p.Asp769Tyr	2018-11-30 14:44:52 UTC	4.0	CA16602466	375992	D739Y,D754Y,RS121913468,ASP769TYR,D769Y,ASP754TYR,ASP739TYR		
37	https://civic.genome.wustl.edu/links/variants/37	ERBB2	2064	L755_T759del	ERBB2 in-frame deletion of 755-759 was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.		17	37880219	37880233	TTGAGGGAAAACACA		ENST00000269571.5	75	GRCh37					inframe_deletion	ENST00000269571.5:c.2263_2277del,NC_000017.10:g.37880219_37880233del,NP_004439.2:p.Leu755_Thr759del,NM_004448.3:c.2263_2277delTTGAGGGAAAACACA	2020-07-24 18:54:58 UTC	5.0	CA645372623	375990	RS1131692241,LEU755_THR759DEL		
38	https://civic.genome.wustl.edu/links/variants/38	ERBB2	2064	G309A	ERBB2 G309A was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37868205	37868205	G	C	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.926G>C,NC_000017.10:g.37868205G>C,NM_004448.3:c.926G>C,NP_004439.2:p.Gly309Ala	2018-11-30 14:43:04 UTC	5.0	CA16602660	376205	GLY309ALA,GLY279ALA,GLY294ALA,G294A,G279A,RS1057519787		
39	https://civic.genome.wustl.edu/links/variants/39	ERBB2	2064	L755S	ERBB2 L755S was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was not shown to be an activating mutation, unlike many of the other variants queried. This mutation was also shown to confer resistance to the tyrosine kinase inhibitor lapatinib in MCF10A cell lines.		17	37880220	37880220	T	C	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2264T>C,NC_000017.10:g.37880220T>C,NM_004448.3:c.2264T>C,NP_004439.2:p.Leu755Ser	2019-10-11 18:55:54 UTC	21.5	CA16602502	376035	LEU755SER,L725S,L740S		
40	https://civic.genome.wustl.edu/links/variants/40	ERBB2	2064	L755W	ERBB2 L755W was one of the first ERBB2 variants to be functionally classified (Bose et al., 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.		17	37880220	37880220	T	G	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2264T>G,NC_000017.10:g.37880220T>G,NM_004448.3:c.2264T>G,NP_004439.2:p.Leu755Trp	2018-11-30 14:43:24 UTC	5.0	CA16602786	376343	LEU755TRP,L725W,L740W,RS121913470		
41	https://civic.genome.wustl.edu/links/variants/41	ERBB2	2064	P780INS	ERBB2 P780 insertion was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 activating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881011	37881012		GGCTCCCCA	ENST00000269571.5	75	GRCh37					inframe_insertion	ENST00000269571.5:c.2340_2341insGGCTCCCCA,NC_000017.10:g.37881011_37881012insGGCTCCCCA	2020-12-03 18:33:03 UTC	12.5	CA135401	NONE FOUND	PRO780INS		
42	https://civic.genome.wustl.edu/links/variants/42	ERBB2	2064	R678Q	ERBB2 R678Q was shown to have NO functional effect in tissue culture assay (Bose et al 2013). This conclusion was confirmed by a second, independent lab.		17	37879658	37879658	G	A	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2033G>A,NC_000017.10:g.37879658G>A,NM_004448.3:c.2033G>A,NP_004439.2:p.Arg678Gln	2018-11-30 14:43:31 UTC	5.0	CA16602787	376344	ARG678GLN,R648Q,R663Q,RS1057519862		
43	https://civic.genome.wustl.edu/links/variants/43	ERBB2	2064	R896C	ERBB2 R896C was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881616	37881616	C	T	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2686C>T,NC_000017.10:g.37881616C>T,NM_004448.3:c.2686C>T,NP_004439.2:p.Arg896Cys	2018-11-30 14:43:04 UTC	5.0	CA8534359	375995	ARG896CYS,R866C,R881C,RS758222990		
44	https://civic.genome.wustl.edu/links/variants/44	ERBB2	2064	V777L	ERBB2 V777L was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881000	37881000	G	T	ENST00000269571.5	75	GRCh37					missense_variant	NM_004448.3:c.2329G>T,NP_004439.2:p.Val777Leu,ENST00000269571.5:c.2329G>T,NC_000017.10:g.37881000G>T	2018-11-30 14:43:13 UTC	9.0	CA135387	44991	V747L,V762L,VAL777LEU,RS121913471		
45	https://civic.genome.wustl.edu/links/variants/45	ERBB2	2064	V842I	ERBB2 V842I was one of the first ERBB2 variants to be functionally classified (Bose et al. 2013). This mutation was shown to be an activating mutation in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in MCF10A breast cancer cell lines have been shown to be sensitive to the kinase inhibitor neratinib. More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.	HER2 Activating	17	37881332	37881332	G	A	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2524G>A,NM_004448.3:c.2524G>A,NP_004439.2:p.Val842Ile,NC_000017.10:g.37881332G>A	2018-11-30 14:43:19 UTC	9.0	CA16602468	375994	VAL842ILE,V812I,V827I,VAL812ILE,VAL827ILE,RS1057519738		
46	https://civic.genome.wustl.edu/links/variants/46	ESR1	2099	L536Q	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y536Q is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419920	152419921	TC	AG	ENST00000440973.1	75	GRCh37					missense_variant	NC_000006.11:g.152419920_152419921delinsAG	2018-11-30 14:45:01 UTC	8.0	CA645542628	NONE FOUND	LEU536GLN		
47	https://civic.genome.wustl.edu/links/variants/47	ESR1	2099	D538G	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. D538G is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419926	152419926	A	G	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1613A>G,NC_000006.11:g.152419926A>G	2018-11-30 14:45:02 UTC	18.0	CA366085705	NONE FOUND	ASP538GLY		
48	https://civic.genome.wustl.edu/links/variants/48	ESR1	2099	Y537C	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537C is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419923	152419923	A	G	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1610A>G,NC_000006.11:g.152419923A>G	2018-11-30 14:45:04 UTC	8.0	CA366085697	NONE FOUND	GLY537CYS		
49	https://civic.genome.wustl.edu/links/variants/49	ESR1	2099	Y537N	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537N is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419922	152419922	T	A	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1609T>A,NC_000006.11:g.152419922T>A	2018-11-30 14:45:01 UTC	8.0	CA366085693	NONE FOUND	GLY537ASN		
50	https://civic.genome.wustl.edu/links/variants/50	ESR1	2099	Y537S	ESR1 biology has become a central focus in breast cancer therapy. In ER+ tumors, mutations in the ESR1 ligand binding domain have been shown to confer resistance to hormone therapy. This evidence has led to an increased use of targeted sequencing of the estrogen receptor in breast and ovarian cancer. Y537S is one of these ligand binding domain mutations, and is commonly implicated in this hormone resistance. Preliminary data suggests ER-degrading agents, such as fulvestrant, may be beneficial in treating ESR1 mutant, hormone resistant breast cancers.	ESR1 Ligand-Binding Domain	6	152419923	152419923	A	C	ENST00000206249.3	75	GRCh37					missense_variant	ENST00000206249.3:c.1610A>C,NC_000006.11:g.152419923A>C	2018-11-30 14:45:03 UTC	8.0	CA366085696	NONE FOUND	GLY537SER		
52	https://civic.genome.wustl.edu/links/variants/52	FGFR2	2263	FGFR2-MGEA5	In a clinical sequencing program for advanced stage cancers, Wu et al (2013, Cancer Discovery) has idenified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. Cell lines harboring these fusions were shown to respond to pazopanib. Additionally, tumor size reduction was achieved by both ponatinib and pazopanib treatments administered separately in a single patient with intrahepatic cholangiocarcinoma and this fusion. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.	FGFR fusions	10	123243212	123357917			ENST00000457416.2	75	GRCh37	10	103544209	103552700	ENST00000361464.3	transcript_fusion		2017-12-01 14:40:28 UTC	5.0		N/A			
53	https://civic.genome.wustl.edu/links/variants/53	FGFR3	2261	FGFR3-BAIAP2L1	In a clinical sequencing program for advanced stage cancers, Wu et al (2013, Cancer Discovery) has identified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. These fusions were shown to respond to pazopanib. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.	FGFR fusions	4	1795039	1810599			ENST00000340107.4	75	GRCh37	7	97991744	97920963	ENST00000005260.8	transcript_fusion		2017-12-01 14:40:28 UTC	3.0		N/A			
54	https://civic.genome.wustl.edu/links/variants/54	FGFR2	2263	FGFR2-TACC3	In a clinical sequencing program for advanced stage cancers, Wu et al has identified a number of FGFR fusions in patients with many different cancer types. These fusions were also found to retain oligomerization capability, and result in enhanced cell proliferation. These fusions were shown to respond to pazopanib. The authors use these cases to highlight the need for enhanced clinical sequencing efforts.	FGFR fusions	4	123243212	123357598			ENST00000358487.5	75	GRCh37	4	1723266	1741505	ENST00000313288.4	transcript_fusion		2017-12-01 14:40:28 UTC	7.5		N/A			
55	https://civic.genome.wustl.edu/links/variants/55	FLT3	2322	ITD	FLT3-ITD (internal tandem duplications) frequently occur in patients with hematologic malignancies such as chronic myelogenous leukemia, acute myeloid leukemia (AML) and myelodysplastic syndrome, but particularly in cytogenetically normal AML (CN-AML). These duplication events disrupt the juxtamembrane domain of FLT3 and can be the result of a duplication of internal FLT3 sequence or other unrelated sequence resulting in an in-frame duplication event. The length of these duplications can vary widely which may have prognostic consequences, but this has not been conclusively determined. FLT3-ITD mutations overall have generally been associated with poor prognosis. Additional genes associated with CN-AML such as NPM1 may modulate the prognosis associated with this variant.		13	28608219	28608351			ENST00000241453.7	75	GRCh37					inframe_insertion		2020-12-03 00:06:29 UTC	445.5		16270		38	https://civic.genome.wustl.edu/links/assertions/38
56	https://civic.genome.wustl.edu/links/variants/56	FLT3	2322	TKD MUTATION	FLT3 tyrosine kinase domain mutations (FLT3-TKD) are much less common than FLT3-ITD (internal tandem duplication) mutations and may not confer the same prognostic impact. Although the majority of mutations are point mutations effecting D835 (most frequently D835Y), a small proportion involve an in-frame deletion of I836. These mutations are within the activation loop of the second tyrosine kinase domain of FLT3 and thought to result in constitutive activation of the receptor.		13	28592642	28592642	C	A	ENST00000241453.7	75	GRCh37					nonsynonymous_variant	NC_000013.10:g.28592642C>A	2020-12-03 18:33:03 UTC	120.0	CA126347	16276			
57	https://civic.genome.wustl.edu/links/variants/57	GATA2	2624	EXPRESSION	GATA2 misregulation has been observed in a number of hematologic malignancies, as well as non-small cell lung cancer. Treatment of over-active GATA2 pathways using the proteasome inhibitor bortezomib has shown dramatic tumor regression in lung cancer.		3	128198270	128212028			ENST00000341105.2	75	GRCh37					N/A		2017-12-01 14:40:28 UTC	4.0		N/A			
58	https://civic.genome.wustl.edu/links/variants/58	IDH1	3417	R132	IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes, IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.		2	209113111	209113113			ENST00000415913.1	75	GRCh37					protein_altering_variant		2020-02-07 00:36:33 UTC	159.0		156444,375891,375890,375889,375893,375892	ARG132		
59	https://civic.genome.wustl.edu/links/variants/59	IDH1	3417	R132C	IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes and acute myeloid leukemia (AML), IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.		2	209113113	209113113	G	A	ENST00000415913.1	75	GRCh37					missense_variant	NM_005896.3:c.394C>T,NP_005887.2:p.Arg132Cys,NC_000002.11:g.209113113G>A,ENST00000415913.1:c.394C>T	2018-11-30 14:45:03 UTC	63.0	CA16602374	375891	RS121913499,ARG132CYS		
62	https://civic.genome.wustl.edu/links/variants/62	IDH2	3418	R140	IDH2 mutations have been observed in a number of hematologic malignancies. In acute myeloid leukemia, the R140 mutants show mixed results affecting overall survival as compared to their wild-type counterparts. In myelodysplastic syndromes, however, no prognostic link was discovered between IDH2 mutation status and overall survival.		15	90631934	90631934			ENST00000330062.3	75	GRCh37					protein_altering_variant		2017-12-01 14:40:29 UTC	60.0		375988,14716,375989	ARG140		
63	https://civic.genome.wustl.edu/links/variants/63	IDH2	3418	R172K	IDH2 mutations have been observed in a number of hematologic malignancies. In acute myeloid leukemia, the R172K mutation has been linked with poorer prognosis and worse overall survival than IDH2 wild-type patients. However, in myelodisplastic syndromes, studies did not find a prognostic association between this variant and patient outcomes.		15	90631838	90631838	C	T	ENST00000330062.3	75	GRCh37					missense_variant	NM_002168.3:c.515G>A,NP_002159.2:p.Arg172Lys,NC_000015.9:g.90631838C>T,ENST00000330062.3:c.515G>A	2018-11-30 14:43:17 UTC	35.0	CA16602462	375987	ARG172LYS,R120K,RS121913503		
64	https://civic.genome.wustl.edu/links/variants/64	JAK2	3717	V617F	JAK2 V617F is a highly recurrent mutation in myeloproliferative diseases. It is found in around 98% of patients with polycythemia vera, and just over half of the patients with essential thrombocythemia and primary myelofibrosis. While less associated with cancer, when it is seen, it is more likely to be in myeloid leukemias than lymphoid leukemias. The V617F mutation is an activating mutation, resulting in increased kinase activity. The mutation seems to be restricted to hematologic malignancies. Treatment of JAK mutant diseases with ruxolitinib has seen some clinical success.		9	5073770	5073770	G	T	ENST00000381652.3	75	GRCh37					missense_variant,gain_of_function_variant	NC_000009.11:g.5073770G>T,NM_004972.3:c.1849G>T,NP_004963.1:p.Val617Phe,ENST00000381652.3:c.1849G>T	2018-11-30 14:43:13 UTC	83.0	CA124183	14662	VAL617PHE,RS77375493		
65	https://civic.genome.wustl.edu/links/variants/65	KIT	3815	D816V	KIT D816V is a mutation observed in acute myeloid leukemia (AML). This variant has been linked to poorer prognosis and worse outcome in AML patients.	KIT Exon 17	4	55599321	55599321	A	T	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2447A>T,NP_000213.1:p.Asp816Val,ENST00000288135.5:c.2447A>T,NC_000004.11:g.55599321A>T	2019-08-05 23:11:21 UTC	67.0	CA123513	13852	ASP816VAL,RS121913507		
66	https://civic.genome.wustl.edu/links/variants/66	KIT	3815	EXON 11 MUTATION	c-KIT mutations in exon 11 lie within the juxtamembrane domain, and are very recurrent in gastrointestinal stromal tumors, often bearing a poorer prognosis than other KIT mutations. Cells harboring exon 11 mutations have shown sensitivity to the tyrosine kinase inhibitor imatinib, offering a better prognosis to patients treated with the drug in the first year. Small cohorts of melanoma patients harboring exon 11 KIT mutations have shown response to imatinib and sunitinib.	KIT Exon 11	4	55593582	55593708			ENST00000288135.5	75	GRCh37					coding_sequence_variant		2019-05-03 23:01:52 UTC	177.5					
67	https://civic.genome.wustl.edu/links/variants/67	KIT	3815	INTERNAL DUPLICATION	c-KIT internal duplications have been observed in exon 11, within the juxtamembrane domain. In a case study of an anal melanoma patient harboring this event, imatinib confered marked response. Also, cells harboring exon 11 mutations have shown sensitivity to the tyrosine kinase inhibitor imatinib, offering a better prognosis to patients treated with the drug in the first year.	KIT Exon 11	4	55593582	55593708			ENST00000288135.5	75	GRCh37					inframe_insertion		2017-12-01 14:40:29 UTC	7.5		N/A			
69	https://civic.genome.wustl.edu/links/variants/69	KIT	3815	EXON 14 MUTATION	c-KIT exon 14 mutations lie within the tyrosine kinase domain of the protein. While relatively rare in primary gastrointestinal tumors, they are notably more prevalent in refractory disease, suggesting a role in imatinib resistance. Unlike mutations in other KIT exons, exon 14 mutations seem relatively rare in melanoma.		4	55595501	55595651			ENST00000288135.5	75	GRCh37					exon_variant		2017-12-01 14:40:29 UTC	15.0					
72	https://civic.genome.wustl.edu/links/variants/72	KIT	3815	L576P	KIT L576P is an exon 11 mutation that lies within the juxtamembrane domain. It is one of the most recurrent KIT mutations in melanoma, and both in vitro and in vivo studies have shown sensitivity to imatinib.	KIT Exon 11	4	55593661	55593661	T	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1727T>C,NP_000213.1:p.Leu576Pro,ENST00000288135.5:c.1727T>C,NC_000004.11:g.55593661T>C	2019-08-05 23:05:14 UTC	16.0	CA16602401	375919	RS121913513,LEU576PRO		
73	https://civic.genome.wustl.edu/links/variants/73	KIT	3815	V654A	KIT V654A is an exon 13 mutation that lies within the tyrosine kinase 1 domain of the protein. It has been shown to be an activating mutation by in vitro studies. This mutation is associated with imatinib resistance in melanoma patients. However, second generation TKI's such as sunitinib and midostaurin (PKC 412) have seen success in acheiving tumor response.	KIT Exon 11	4	55594258	55594258	T	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1961T>C,NP_000213.1:p.Val654Ala,ENST00000288135.5:c.1961T>C,NC_000004.11:g.55594258T>C	2018-11-30 14:45:03 UTC	18.0	CA16602402	375921	RS121913523,VAL654ALA		
75	https://civic.genome.wustl.edu/links/variants/75	KRAS	3845	Exon 2 Mutation	Exon 2 mutations have been associated with reduced response rates or resistance to EGFR inhibitors in non-small cell lung and colorectal cancer. The NCCN guidelines for colorectal cancer contain recommendations that the targeted therapies cetuximab and panitumumab should only be used in the context of wild type KRAS.		12	25398208	25398329			ENST00000256078.4	75	GRCh37					missense_variant		2021-02-02 23:36:33 UTC	158.0					
76	https://civic.genome.wustl.edu/links/variants/76	KRAS	3845	G12	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.		12	25398284	25398285			ENST00000256078.4	75	GRCh37					protein_altering_variant		2017-12-01 14:40:29 UTC	115.0		45122,12578,12582,12579,12583,12584	GLY12		
77	https://civic.genome.wustl.edu/links/variants/77	KRAS	3845	G12/G13	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.		12	25398280	25398285			ENST00000256078.4	75	GRCh37					protein_altering_variant		2020-09-04 15:20:53 UTC	191.0		45122,12578,12582,12579,12583,12580,12584,177778,45123,12593,375968,375967,45124			
78	https://civic.genome.wustl.edu/links/variants/78	KRAS	3845	G12C	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.	EGFR TKI Resistance	12	25398285	25398285	C	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.34G>T,NP_004976.2:p.Gly12Cys,NC_000012.11:g.25398285C>A,ENST00000256078.4:c.34G>T	2020-11-25 00:38:35 UTC	91.0	CA122528	12578	GLY12CYS,RS121913530		
79	https://civic.genome.wustl.edu/links/variants/79	KRAS	3845	G12D	While the KRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still actively debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G13 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. The NCCN guidelines for colorectal cancer contain recommendations that the targeted therapies cetuximab and panitumumab should only be used in the context of wild type KRAS. However, cetuximab treatment was shown to extend survival in a single cohort of colorectal patients with G12D mutations. Overall, the interpretation for KRAS mutations in most clinical scenarios is still undecided.	EGFR TKI Resistance	12	25398284	25398284	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.35G>A,NP_004976.2:p.Gly12Asp,NC_000012.11:g.25398284C>T,ENST00000256078.4:c.35G>A	2020-12-07 01:36:02 UTC	162.0	CA122538	12582	GLY12ASP,RS121913529		
80	https://civic.genome.wustl.edu/links/variants/80	KRAS	3845	G13	While the KRAS G13 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort in patients with colorectal and pancreatic cancer, however this hypothesis is in need of further validation. This mutation, along with the mutations affecting the neighboring G12 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, cetuximab treatment was shown to extend survival in a cohort of colorectal patients.		12	25398281	25398282			ENST00000256078.4	75	GRCh37					missense_variant,inframe_insertion		2017-12-01 14:40:29 UTC	20.0		12580,45123,12593,375968,375967,45124,163769,45125	GLY13		
81	https://civic.genome.wustl.edu/links/variants/81	KRAS	3845	G13D	While the KRAS G13 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated. Often associated with tumors that are wild-type for other drivers (EGFR and ALK specifically), the prognosis for patients with this mutation seems to be worse than the KRAS wild-type cohort. This mutation, along with the mutations affecting the neighboring G12 position, may result in a less responsive tumor when treated with first-generation TKI's like gefitinib. However, results are conflicting with retrospective analyses suggesting a better response to EGFR-Inhibition. A recent prospective phase-II study (12 patients, Schirripa et. al. 2015) could not reproduce this finding and another prospective phase II trial is currently ongoing.		12	25398281	25398281	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_033360.3:c.38G>A,NP_004976.2:p.Gly13Asp,NC_000012.11:g.25398281C>T,ENST00000256078.4:c.38G>A	2020-12-01 23:56:10 UTC	97.0	CA122534	12580	GLY13ASP,RS112445441		
82	https://civic.genome.wustl.edu/links/variants/82	MAP2K1	5604	P124S	MAP2K1 P124S is a recurrent mutation in melanoma, and is seen in bladder and colon cancer to a lesser degree. The P124S mutation has been shown to contribute to AZD6244 resistance in melanoma cell lines, but considerably less so than its Q56P counterpart.		15	66729162	66729162	C	T	ENST00000307102.5	75	GRCh37					missense_variant	ENST00000307102.5:c.370C>T,NC_000015.9:g.66729162C>T,NM_002755.3:c.370C>T,NP_002746.1:p.Pro124Ser	2018-11-30 14:43:05 UTC	3.0	CA16602456	375981	PRO124SER		
83	https://civic.genome.wustl.edu/links/variants/83	MAP2K1	5604	Q56P	MAP2K1 Q56P is a recurrent mutation in melanoma and gastric cancer. This mutation has been shown to confer considerable resistance to AZD6244 treatment of melanoma cell lines.		15	66727451	66727451	A	C	ENST00000307102.5	75	GRCh37					missense_variant	ENST00000307102.5:c.167A>C,NC_000015.9:g.66727451A>C,NM_002755.3:c.167A>C,NP_002746.1:p.Gln56Pro	2018-11-30 14:43:05 UTC	3.0	CA16602453	375978	GLN56PRO		
85	https://civic.genome.wustl.edu/links/variants/85	MGMT	4255	PROMOTER METHYLATION	MGMT promoter methylation has been observed to impact tumor progression in glioblastoma multiforme. In patients exhibiting promoter methylation, the akylating agent carmustine has shown efficacy. In patients lacking methylation, combining carmustine with the MGMT inhibitor O(6)-benzylguanine may be effective, but more experiments are required. Clinical trials have also shown selective sensitivity of promoter methylation-positive patients to temozolomide, making a case for wider methylation screening in GBM patients.		10	131264495	131265656			ENST00000306010.7	75	GRCh37					N/A		2017-12-01 14:40:29 UTC	136.0					
86	https://civic.genome.wustl.edu/links/variants/86	NPM1	4869	EXON 12 MUTATION	NPM1 exon 12 mutations are frequently identified in patients with cytogenetically normal acute myeloid leukemia (AML) and often co-occur with FLT3-ITD. FLT3 status should also be evaluated as co-occurence with FLT3-ITD may impact prognosis. Exon 12 mutations have been identified as a predictor of good prognostic outcomes in the absence of FLT3-ITD. Due to their high frequency, NPM1 mutations have been retrospectively analyzed in the context of a number of therapies including variable results following ATRA treatment as well as improved response to high-dose daunorubicin or valproic acid. Additionally, multiple groups have shown increased surface expression of CD33 associated with NPM1 mutation, suggesting these patients may respond to anti-CD33 therapy. Cytoplasmic sequestration of NPM1 (NPM1c) is associated with a good response to induction therapy.	NPM1 Exon 12	5	170837531	170837569			ENST00000517671.1	75	GRCh37					exon_variant		2017-12-01 14:40:29 UTC	454.0		N/A			
87	https://civic.genome.wustl.edu/links/variants/87	NPM1	4869	W288FS	NPM1 W288fs (aka NPM1-A) is located in exon 12 of NPM1 and is the most common NPM1 mutation identified in acute myeloid leukemia. This mutation results in cytoplasmic localization of NPM1 (NPM1c) which is associated with a good response to induction therapy. Although it is the most extensively studied NPM1 exon 12 mutation, it is generally grouped with other exon 12 mutations for patient analysis (see NPM1 Exon 12 variants for more information).	NPM1 Exon 12	5	170837547	170837548		TCTG	ENST00000517671.1	75	GRCh37					frameshift_elongation	NM_002520.6:c.860_863dupTCTG,NC_000005.9:g.170837544_170837547dupTCTG,NP_002511.1:p.Trp288Cysfs,ENST00000517671.1:c.860_863dupTCTG	2018-11-30 14:43:20 UTC	43.75	CA280199	13998	NPM1-A,RS587776806,TRP288FS		
92	https://civic.genome.wustl.edu/links/variants/92	NRAS	4893	G12	While the NRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated.		1	115258747	115258748			ENST00000369535.4	75	GRCh37					missense_variant		2017-12-01 14:40:29 UTC	15.0		40468,39648,177778,219097,40470,40469			
93	https://civic.genome.wustl.edu/links/variants/93	NRAS	4893	G13D	While the NRAS G12 region is a widely studied recurrent region in cancer, its impact on clinical action is still debated.		1	115258744	115258744	C	T	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.38G>A,NP_002515.1:p.Gly13Asp,NC_000001.10:g.115258744C>T,ENST00000369535.4:c.38G>A	2018-11-30 14:43:05 UTC	5.0	CA123620	13901	GLY13ASP,RS121434596		
94	https://civic.genome.wustl.edu/links/variants/94	NRAS	4893	Q61	NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. Two melanoma patients, each harboring mutations at this locus (Q61L and Q61R), responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.		1	115256528	115256530			ENST00000369535.4	75	GRCh37					missense_variant		2020-11-25 00:09:17 UTC	100.0		73058,13900,375874,375871,373003,280409,375875	GLN61		
95	https://civic.genome.wustl.edu/links/variants/95	NRAS	4893	Q61L	NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. A melanoma patient harboring a mutation at this locus responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.		1	115256529	115256529	T	A	ENST00000369535.4	75	GRCh37					missense_variant	NP_002515.1:p.Gln61Leu,NC_000001.10:g.115256529T>A,NM_002524.4:c.182A>T,ENST00000369535.4:c.182A>T	2020-11-10 21:54:02 UTC	12.5	CA16602361	375874	GLN61LEU,RS11554290		
96	https://civic.genome.wustl.edu/links/variants/96	NRAS	4893	Q61R	NRAS Q61 mutations have been found in multiple myeloma, gastrointestinal stromal tumors, melanoma, and others. A melanoma patient harboring a mutation at this locus responded to treatment with the akylating agent temozolomide. However, in colorectal cancer patients, mutations at this locus have been shown to confer resistance to cetuximab. The prognostic impact of mutations at this locus is currently under study.		1	115256529	115256529	T	C	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.182A>G,NP_002515.1:p.Gln61Arg,NC_000001.10:g.115256529T>C,ENST00000369535.4:c.182A>G	2018-11-30 14:43:06 UTC	5.0	CA123618	13900	GLN61ARG,RS11554290		
98	https://civic.genome.wustl.edu/links/variants/98	PDGFRA	5156	D842I	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152092	55152093	GA	AT	ENST00000257290.5	75	GRCh37					missense_variant	ENST00000257290.5:c.2524_2525delinsAT,NC_000004.11:g.55152092_55152093delinsAT,NP_006197.1:p.Asp842Ile,NM_006206.5:c.2524_2525delGAinsAT	2018-11-30 14:43:06 UTC	4.0	CA16602522	376055	ASP842ILE		
99	https://civic.genome.wustl.edu/links/variants/99	PDGFRA	5156	D842V	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. Exogenous expression of the A842V mutation resulted in constitutive tyrosine phosphorylation of PDGFRA in the absence of ligand in 293T cells and cytokine-independent proliferation of the IL-3-dependent Ba/F3 cell line, both evidence that this is an activating mutation. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152093	55152093	A	T	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2525A>T,NP_006197.1:p.Asp842Val,ENST00000257290.5:c.2525A>T,NC_000004.11:g.55152093A>T	2019-05-03 23:38:41 UTC	100.5	CA123194	13543	ASP842VAL,RS121908585		
100	https://civic.genome.wustl.edu/links/variants/100	PDGFRA	5156	D842Y	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152092	55152092	G	T	ENST00000257290.5	75	GRCh37					missense_variant	ENST00000257290.5:c.2524G>T,NC_000004.11:g.55152092G>T,NM_006206.5:c.2524G>T,NP_006197.1:p.Asp842Tyr	2018-11-30 14:43:17 UTC	4.0	CA16602703	376250	ASP842TYR,RS121913265		
101	https://civic.genome.wustl.edu/links/variants/101	PDGFRA	5156	I843DEL	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152095	55152097	ATC		ENST00000257290.5	75	GRCh37					inframe_deletion	ENST00000257290.5:c.2527_2529delATC,NC_000004.11:g.55152095_55152097del	2019-02-23 02:08:03 UTC	5.0	CA645526434	NONE FOUND	DELI843		
102	https://civic.genome.wustl.edu/links/variants/102	PDGFRA	5156	D842_I843delinsVM	PDGFRA D842 mutations are characterized broadly as imatinib resistance mutations. The DI842-843VM variant is the result of a double point mutation. This is most well characterized in gastrointestinal stromal tumors, but other cell lines containing these mutations have been shown to be resistant as well. In imatinib resistant cell lines, a number of other therapeutics have demonstrated efficacy. These include; crenolanib, sirolimus, and midostaurin (PKC412).	Imatinib Resistance	4	55152093	55152097	ACATC	TCATG	ENST00000257290.5	75	GRCh37					missense_variant	NC_000004.11:g.55152093_55152097delinsTCATG	2020-06-18 02:06:36 UTC	4.0	CA658820703	NONE FOUND			
103	https://civic.genome.wustl.edu/links/variants/103	PIK3CA	5290	E542K	PIK3CA E545K/E542K variants are the second most recurrent PIK3CA mutations in breast cancer and are highly recurrent mutations in many other cancer types. Colorectal cancer patients with the PIK3CA E545K variant, and possibly other variants in the E545 region, may indicate poor prognosis relative to patients with other PIK3CA variants or wild-type PIK3CA. The literature also suggests that E545/E542 variants may confer resistance to EGFR inhibitors (e.g., cetuximab). An FDA approved treatment regimen including a targeted PIK3CA inhibitor is available for specific subtypes of breast cancer. While PIK3CA variants are highly prevalent in many other cancer types, targeted therapies for PIK3CA variants are still in early clinical trial phases in other cancer types.		3	178936082	178936082	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1624G>A,NP_006209.2:p.Glu542Lys,ENST00000263967.3:c.1624G>A,NC_000003.11:g.178936082G>A	2020-12-30 23:52:03 UTC	72.5	CA333572	31944	GLU542LYS,RS121913273		
104	https://civic.genome.wustl.edu/links/variants/104	PIK3CA	5290	E545K	PIK3CA E545K/E542K are the second most recurrent PIK3CA mutations in breast cancer, and are highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with either patients with other PIK3CA variant or wild-type PIK3CA. There is also data to suggest that E545/542 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.		3	178936091	178936091	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1633G>A,NP_006209.2:p.Glu545Lys,ENST00000263967.3:c.1633G>A,NC_000003.11:g.178936091G>A	2021-01-20 23:47:51 UTC	72.5	CA123334	13655	GLU545LYS,RS104886003		
105	https://civic.genome.wustl.edu/links/variants/105	PIK3CA	5290	Exon 21 Mutation	PIK3CA Exon 21 Mutations (e.g., H1047R; often referred to as Exon 20 mutations if counting only coding exons) are among the most recurrent mutations in cancer, especially breast cancer. Of PIK3CA mutant breast cancers, over half harbor this mutation. Meta-analyses have shown that patients harboring this mutation may have worse overall survival, but other studies have shown no difference between Exon 21 and other PIK3CA mutants from a prognostic standpoint. While very prevalent, targeted therapies for this particular mutation are still in early clinical trial phases.		3	178951882	178952495			ENST00000263967.3	75	GRCh37					exon_variant		2021-02-02 23:03:21 UTC	45.0			EXON 20 MUTATION		
106	https://civic.genome.wustl.edu/links/variants/106	PIK3CA	5290	Exon 10 Mutation	PIK3CA Exon 10 Mutations (e.g. E545K/E542K; often referred to as Exon 9 mutations if counting only coding exons) are the second most recurrent PIK3CA mutations in breast cancer, and highly recurrent mutations in many other cancer types. E545K, and possibly the other mutations in the E545 region, may present patients with a poorer prognosis than patients with either patients with other PIK3CA variant or wild-type PIK3CA. There is also data to suggest that exon 10 mutations may confer resistance to EGFR inhibitors like cetuximab. While very prevalent, targeted therapies for variants in PIK3CA are still in early clinical trial phases.		3	178935998	178936122			ENST00000263967.3	75	GRCh37					exon_variant		2021-02-02 23:02:37 UTC	45.0		31944,13655	EXON 9 MUTATION		
107	https://civic.genome.wustl.edu/links/variants/107	PIK3CA	5290	H1047R	PIK3CA H1047R is one of the most recurrent single nucleotide variants in cancer, especially breast cancer. Of PIK3CA-mutant breast cancers, over half harbor this mutation. Meta-analyses have shown that patients harboring this mutation may have worse overall survival, but other studies have shown no difference between H1047R and other PIK3CA mutants from a prognostic standpoint. While very prevalent, targeted therapies for this particular mutation are still in early clinical trial phases.		3	178952085	178952085	A	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3140A>G,NP_006209.2:p.His1047Arg,ENST00000263967.3:c.3140A>G,NC_000003.11:g.178952085A>G	2021-01-28 22:44:18 UTC	108.5	CA123326	13652	HIS1047ARG,RS121913279		
108	https://civic.genome.wustl.edu/links/variants/108	PML	5371	PML-RARA	The PML-RARA fusion is seen as a diagnostic event in acute promyelocytic leukemia (APL). Both in vitro and in vivo studies have shown sensitivity to ATRA in APL patients harboring the PML-RARa fusion. Recent interest has been shown in combining ATRA and arsenic trioxide for treating these patients, and early results seem promising.		15	74287058	74325755			ENST00000268058.3	75	GRCh37	17	38504568	38513048	ENST00000254066.5	transcript_fusion	N/A	2017-12-01 14:40:29 UTC	132.5		N/A		15	https://civic.genome.wustl.edu/links/assertions/15
110	https://civic.genome.wustl.edu/links/variants/110	PTEN	5728	R233*	PTEN R233* has been shown to be a loss of function mutation, and PTEN loss has been the subject of considerable research in breast cancer. PTEN loss may sensitize cells to PI3K-mTOR inhibition. While still being debated, there is data to support that PTEN loss is both associated with poorer prognosis, and no change in prognosis.	PTEN Loss-of-Function	10	89717672	89717672	C	T	ENST00000371953.3	75	GRCh37					stop_gained,loss_of_function_variant	NM_000314.6:c.697C>T,NP_000305.3:p.Arg233Ter,ENST00000371953.3:c.697C>T,NC_000010.10:g.89717672C>T	2018-11-30 14:43:07 UTC	19.0	CA000549	7813	R233X,ARG233TER,RS121909219		
112	https://civic.genome.wustl.edu/links/variants/112	RET	5979	C634W	RET C634W has been implicated as an alternate mechanism of activating RET in medullary thyroid cancer. While there currently are no RET-specific inhibiting agents, promiscuous kinase inhibitors have seen some success in treating RET overactivity. Data suggests however, that the C634W mutation may lead to drug resistance, especially against the VEGFR-inhibitor motesanib.	Motesanib Resistance	10	43609950	43609950	C	G	ENST00000355710.3	75	GRCh37					missense_variant	NM_020975.4:c.1902C>G,NP_065681.1:p.Cys634Trp,ENST00000355710.3:c.1902C>G,NC_000010.10:g.43609950C>G	2018-11-30 14:45:03 UTC	3.0	CA008378	13918	CYS634TRP		
113	https://civic.genome.wustl.edu/links/variants/113	RET	5979	M918T	RET M819T is the most common somatically acquired mutation in medullary thyroid cancer (MTC). While there currently are no RET-specific inhibiting agents, promiscuous kinase inhibitors have seen some success in treating RET overactivity. Data suggests however, that the M918T mutation may lead to drug resistance, especially against the VEGFR-inhibitor motesanib. It has also been suggested that RET M819T leads to more aggressive MTC with a poorer prognosis.	Motesanib Resistance	10	43617416	43617416	T	C	ENST00000355710.3	75	GRCh37					missense_variant	NM_020975.4:c.2753T>C,NP_065681.1:p.Met918Thr,ENST00000355710.3:c.2753T>C,NC_000010.10:g.43617416T>C	2019-11-04 16:41:53 UTC	86.0	CA009082	13919	MET918THR,RS74799832		
114	https://civic.genome.wustl.edu/links/variants/114	SF3B1	23451	K666N	SF3B1 K666N is a variant found in myelodysplastic syndromes, chronic leukemias, and more recently, breast cancer. This somatic mutation has been linked to better overall outcome and event-free survival in MDS patients.	HEAT domain mutation	2	198267359	198267359	C	A	ENST00000335508.6	75	GRCh37					missense_variant	NM_012433.3:c.1998G>T,NP_036565.2:p.Lys666Asn,ENST00000335508.6:c.1998G>T,NC_000002.11:g.198267359C>A	2018-11-30 14:43:08 UTC	2.0	CA280929	219098	LYS666ASN,RS377023736		
116	https://civic.genome.wustl.edu/links/variants/116	TP53	7157	R175H	While loss-of-function events in TP53 are very common in cancer, the R175H variant seems not only to result in loss of tumor-suppression, but also acts as a gain-of-function mutation that promotes tumorigenesis in mouse models. Cell lines harboring this mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been shown that the R175H mutation is correlated with worse overall survival than wild-type TP53, but is not as detrimental as the R248W variant. This variant is rare in population databases (ACMG code: PM2; 0.000003980 total exome AF gnomAD v2.1.1).		17	7578406	7578406	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.524G>A,NP_000537.3:p.Arg175His,NC_000017.10:g.7578406C>T,ENST00000269305.4:c.524G>A	2019-05-16 23:35:59 UTC	22.0	CA000251	12374	ARG175HIS,RS28934578,R43H,R136H		
117	https://civic.genome.wustl.edu/links/variants/117	TP53	7157	R248Q	While loss-of-function events in TP53 are very common in cancer, the R248 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, R248 mutations have been shown to confer worse overall survival. The R248Q mutation has also shown an increased invasive behavior in cell lines. This is specific to the 248Q variant.		17	7577538	7577538	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.743G>A,NP_000537.3:p.Arg248Gln,NC_000017.10:g.7577538C>T,ENST00000269305.4:c.743G>A	2020-06-22 16:57:58 UTC	46.0	CA000387	12356	ARG248GLN,RS11540652		
118	https://civic.genome.wustl.edu/links/variants/118	TP53	7157	R248W	While loss-of-function events in TP53 are very common in cancer, the R248 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, R248 mutations have been shown to confer worse overall survival.		17	7577539	7577539	G	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.742C>T,NP_000537.3:p.Arg248Trp,NC_000017.10:g.7577539G>A,ENST00000269305.4:c.742C>T	2018-11-30 14:43:08 UTC	19.0	CA000382	12347	ARG248TRP,RS121912651		
119	https://civic.genome.wustl.edu/links/variants/119	TP53	7157	R249	This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R249 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.		17	7577535	7577535	C	G	ENST00000269305.4	75	GRCh37					protein_altering_variant	NC_000017.10:g.7577535C>G	2018-11-30 14:43:09 UTC	30.0	CA16602484	376015	ARG249		
121	https://civic.genome.wustl.edu/links/variants/121	TP53	7157	R273C	While loss-of-function events in TP53 are very common in cancer, the R273 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R273 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.		17	7577121	7577121	G	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.817C>T,NP_000537.3:p.Arg273Cys,NC_000017.10:g.7577121G>A,ENST00000269305.4:c.817C>T	2018-12-18 22:59:33 UTC	41.5	CA000432	43594	ARG273CYS,RS121913343		
122	https://civic.genome.wustl.edu/links/variants/122	TP53	7157	R273H	While loss-of-function events in TP53 are very common in cancer, the R273 variants seem not only to result in loss of tumor-suppression, but also act as a gain-of-function mutation that can promote tumorigenesis in mouse models. This mutant is also more responsive to treatment with doxorubicin than its wild-type counterparts. While the prognostic impact of individual TP53 mutations is influenced by the cohort being studied, it has been suggested that the R273 mutants have been correlated with worse overall survival in breast cancer patients when compared to wild-type.		17	7577120	7577120	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.818G>A,NP_000537.3:p.Arg273His,NC_000017.10:g.7577120C>T,ENST00000269305.4:c.818G>A	2020-07-17 20:50:57 UTC	41.0	CA000434	12366	ARG273HIS,RS28934576		
124	https://civic.genome.wustl.edu/links/variants/124	TSC1	7248	FRAMESHIFT TRUNCATION	In a small cohort study of bladder cancer, patients with TSC1 mutations showed better responses to and increased treatment duration tolerance with the mTOR inhibitor everolimus. Additionally, patient-derived bladder cancer cell lines with TSC1 or TSC2 mutations are much more sensitive to everolimus treatment than TSC1/TSC2 wildtype cells.	TSC Loss	9	135766735	135820008			ENST00000298552.3	75	GRCh37					frameshift_truncation		2017-12-01 14:40:29 UTC	18.0					
125	https://civic.genome.wustl.edu/links/variants/125	TSC1	7248	LOSS-OF-FUNCTION	In a small cohort study of bladder cancer, patients with TSC1 mutations showed better responses to and increased treatment duration tolerance with the mTOR inhibitor everolimus. Additionally, patient-derived bladder cancer cell lines with TSC1 or TSC2 mutations are much more sensitive to everolimus treatment than TSC1/TSC2 wildtype cells.	TSC Loss	9	135766735	135820008			ENST00000298552.3	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:29 UTC	15.0		N/A			
127	https://civic.genome.wustl.edu/links/variants/127	U2AF1	7307	Q157P/R	U2AF1 Q157P/R has been shown to be a recurrent mutation in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and lung adenocarcinomas. This mutation is less common than the S34F mutation, occurs in the second zinc finger domain of U2AF1 and has been demonstrated to alter splicing. The impact of U2AF1 mutations on overall survival in MDS has been debated, however, patients with U2AF1 mutations were shown to be at an increased risk of transformation to secondary AML. The presence of this mutation was not associated with a specific prognostic outcome in AML when compared to U2AF1 wildtype patients.		21	44514777	44514777	T	G	ENST00000291552.4	75	GRCh37					missense_variant	NC_000021.8:g.44514777T>G	2017-12-01 14:40:29 UTC	50.0					
128	https://civic.genome.wustl.edu/links/variants/128	U2AF1	7307	S34Y/F	U2AF1 S34Y/F has been shown to be a recurrent mutation in acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and lung adenocarcinomas. This mutation is the most commonly identified variant in MDS, occurs in the first zinc finger domain of U2AF1 and has been demonstrated to alter splicing. The impact of U2AF1 mutations on overall survival in MDS has been debated, however, patients with U2AF1 mutations were shown to be at an increased risk of transformation to secondary AML. The presence of this mutation was not associated with a specific prognostic outcome in AML when compared to U2AF1 wildtype patients.		21	44524456	44524456	G	A	ENST00000291552.4	75	GRCh37					missense_variant	NC_000021.8:g.44524456G>A	2017-12-01 14:40:29 UTC	40.0					
129	https://civic.genome.wustl.edu/links/variants/129	WT1	7490	EXON 7 MUTATION	WT1 exon 7 mutations have been shown to be recurrent in acute myeloid leukemia. Many sources have examined the prognostic impact of these, agreeing that the mutant exon 7 cohort is correlated with worse overall survival and a number of poor prognistic outcomes. This may be the result of an overall poor response to chemotherapy from WT1 mutant tumors.		11	32417803	32417953			ENST00000332351.3	75	GRCh37					exon_variant		2017-12-01 14:40:29 UTC	130.0		N/A			
130	https://civic.genome.wustl.edu/links/variants/130	WT1	7490	EXON 9 MUTATION	WT1 exon 9 mutations have been shown to be recurrent in acute myeloid leukemia, although at a less frequent rate than their exon 7 counterparts. Many sources have examined the prognostic impact of these, agreeing that the mutant exon 9 cohort is correlated with worse overall survival and a number of poor prognistic outcomes. This may be the result of an overall poor response to chemotherapy from WT1 mutant tumors.		11	32413518	32413610			ENST00000332351.3	75	GRCh37					exon_variant		2017-12-01 14:40:29 UTC	35.0		N/A			
131	https://civic.genome.wustl.edu/links/variants/131	BRCA1	672	LOSS-OF-FUNCTION	BRCA1 loss of function mutations have been shown to increase risk of breast and ovarian cancer in those carrying the allele in their germline. Treating BRCA mutant patients with PARP inhibitors such as Olaparib has led to significant response.	BRCA Germline Variants	17	41196312	41277387			ENST00000357654.3	75	GRCh37					loss_of_heterozygosity,loss_of_function_variant		2021-01-28 19:35:04 UTC	104.0		N/A			
132	https://civic.genome.wustl.edu/links/variants/132	BRCA2	675	LOSS-OF-FUNCTION	BRCA2 loss of function mutations have been shown to increase risk of breast and ovarian cancer in those carrying the allele in their germline. Treating BRCA mutant patients with PARP inhibitors such as Olaparib has led to significant response.	BRCA Germline Variants	13	32889611	32973347			ENST00000380152.3	75	GRCh37					loss_of_function_variant		2018-07-12 18:17:32 UTC	126.0		N/A			
133	https://civic.genome.wustl.edu/links/variants/133	EGFR	1956	EXON 19 DELETION	Deletions within exon 19 of EGFR are most common in lung cancer. These deletions, in non-small cell lung cancer, have been shown to be sensitive to the EGFR tyrosine kinase inhibitors gefitinib, afatinib, and erlotinib. There is also data to suggest that this event is a good prognostic marker in lung adenocarcinoma. Examples of exon 19 deletions include: p.746_A750delELREA, p.747_753delinsS, p.747_752delLREATS, and p.747_751delLREAT.		7	55242415	55242513			ENST00000275493.2	75	GRCh37					inframe_deletion	ENST00000275493.2:c.2185_2283del	2020-08-20 05:17:38 UTC	278.0		N/A			
134	https://civic.genome.wustl.edu/links/variants/134	EGFR	1956	G719S	While not as recurrent as the L858R mutation, EGFR G719S has also been shown to be an activating mutation. In lung cancer cell lines, it also confers sensitivity to the tyrosine kinase inhibitors gefitinib and erlotinib.		7	55241707	55241707	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2155G>A,NC_000007.13:g.55241707G>A,NM_005228.4:c.2155G>A,NP_005219.2:p.Gly719Ser	2018-11-30 14:43:02 UTC	23.0	CA126722	16612	GLY719SER,RS28929495		
135	https://civic.genome.wustl.edu/links/variants/135	NOTCH1	4851	D1642H	Activating mutations in NOTCH1, including D1642H, have been shown to be poor prognostic markers in lung cancer.		9	139399219	139399219	C	G	ENST00000277541.6	75	GRCh37					missense_variant	ENST00000277541.6:c.4924G>C,NC_000009.11:g.139399219C>G,NM_017617.4:c.4924G>C,NP_060087.3:p.Asp1642His	2018-11-30 14:43:02 UTC	20.0	CA16602788	376345	ASP1642HIS		
136	https://civic.genome.wustl.edu/links/variants/136	NOTCH1	4851	R2327W	Activating mutations in NOTCH1, including R2327W, have been shown to be poor prognostic markers in lung cancer.		9	139391212	139391212	G	A	ENST00000277541.6	75	GRCh37					missense_variant	NM_017617.4:c.6979C>T,NP_060087.3:p.Arg2327Trp,NC_000009.11:g.139391212G>A	2018-11-30 14:43:02 UTC	20.0	CA5339772	376346	ARG2327TRP		
137	https://civic.genome.wustl.edu/links/variants/137	NOTCH1	4851	V2444FS	Activating mutations in NOTCH1, including a frameshift insertion at V2444, have been shown to be poor prognostic markers in lung cancer.		9	139390861	139390861	G	TGT	ENST00000277541.6	75	GRCh37					frameshift_variant	ENST00000277541.6:c.7330delinsACA	2017-12-01 14:40:29 UTC	20.0		NONE FOUND	VAL2444FS		
138	https://civic.genome.wustl.edu/links/variants/138	NOTCH1	4851	S2275FS	Activating mutations in NOTCH1, including a frameshift insertion at S2275, have been shown to be poor prognostic markers in lung cancer.		9	139391369	139391370		A	ENST00000277541.6	75	GRCh37					plus_1_frameshift_variant	ENST00000277541.6:c.6821_6822insT,NC_000009.11:g.139391369_139391370insA	2018-11-30 14:43:01 UTC	20.0	CA645544343	NONE FOUND			
139	https://civic.genome.wustl.edu/links/variants/139	DDR2	4921	L63V	Activating mutations in DDR2, including L63V, has been shown to be sensitive to dasatinib in cell lines.		1	162724415	162724415	C	G	ENST00000367922.3	75	GRCh37					missense_variant	NM_006182.2:c.187C>G,NP_006173.2:p.Leu63Val,ENST00000367922.3:c.187C>G,NC_000001.10:g.162724415C>G	2018-11-30 14:43:01 UTC	4.0	CA1217196		LEU63VAL		
140	https://civic.genome.wustl.edu/links/variants/140	DDR2	4921	L239R	Activating mutations in DDR2, including L239R, has been shown to be sensitive to dasatinib in cell lines.		1	162729630	162729630	T	G	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.716T>G,NC_000001.10:g.162729630T>G	2018-11-30 14:43:01 UTC	4.0	CA16602598	376141	LEU239ARG		
141	https://civic.genome.wustl.edu/links/variants/141	DDR2	4921	G253C	Activating mutations in DDR2, including G253C, has been shown to be sensitive to dasatinib in cell lines.		1	162729671	162729671	G	T	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.757G>T,NC_000001.10:g.162729671G>T	2018-11-30 14:43:01 UTC	4.0	CA16602599	376142	GLY253CYS		
142	https://civic.genome.wustl.edu/links/variants/142	DDR2	4921	G505S	Activating mutations in DDR2, including G505S, has been shown to be sensitive to dasatinib in cell lines.		1	162741822	162741822	G	A	ENST00000367922.3	75	GRCh37					missense_variant	NM_006182.2:c.1513G>A,NP_006173.2:p.Gly505Ser,ENST00000367922.3:c.1513G>A,NC_000001.10:g.162741822G>A	2018-11-30 14:43:02 UTC	4.0	CA1217584	282994	GLY505SER,RS115169993		
143	https://civic.genome.wustl.edu/links/variants/143	DDR2	4921	I638F	DDR2 I638F has been shown to be a loss of function mutation, but also confers sensitivity to dasatinib in cell lines.		1	162745497	162745497	A	T	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.1912A>T,NC_000001.10:g.162745497A>T	2018-11-30 14:43:02 UTC	4.0	CA16602600	376143	ILE638PHE		
144	https://civic.genome.wustl.edu/links/variants/144	DDR2	4921	G774V	Activating mutations in DDR2, including G774V, has been shown to be sensitive to dasatinib in cell lines.		1	162748407	162748407	G	T	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.2321G>T,NC_000001.10:g.162748407G>T	2018-11-30 14:43:02 UTC	4.0	CA16602601	376144	GLY774VAL		
145	https://civic.genome.wustl.edu/links/variants/145	DDR2	4921	S768R	Activating mutations in DDR2, including S768R, has been shown to be sensitive to dasatinib in cell lines.		1	162748390	162748390	T	A	ENST00000367922.3	75	GRCh37					missense_variant	ENST00000367922.3:c.2304T>A,NC_000001.10:g.162748390T>A	2018-11-30 14:43:17 UTC	7.5	CA16602365	375878	SER768ARG		
148	https://civic.genome.wustl.edu/links/variants/148	KRAS	3845	G12A	KRAS G12A, like EGFR T790M, has been shown to be capable of driving acquired resistance to tyrosine kinase inhibitors in lung adenocarcinoma.	EGFR TKI Resistance	12	25398284	25398284	C	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.35G>C,NP_004976.2:p.Gly12Ala,NC_000012.11:g.25398284C>G,ENST00000256078.4:c.35G>C	2020-11-25 00:51:56 UTC	63.0	CA135567	45122	GLY12ALA,RS121913529		
151	https://civic.genome.wustl.edu/links/variants/151	BCL2	596	IGH-BCL2	The typically reciprocal t(14;18)(q32;q21) translocation involves rearrangement between the immunoglobulin heavy chain locus on chromosome 14 and the 3' UTR of BCL2 on chromosome 18, leading to the overexpression of BCL2. This rearrangment is observed in >80% of patients with follicular lymphoma.		14	106032614	107288051				75	GRCh37	18	60794268	60987019	ENST00000333681.4	transcript_regulatory_region_fusion		2017-12-01 14:40:29 UTC	20.0		N/A	RECIPROCAL T(14;18)(Q32;Q21)		
152	https://civic.genome.wustl.edu/links/variants/152	BCL2	596	EXPRESSION			18	60790579	60987361			ENST00000398117.1	75	GRCh37					N/A		2017-12-01 14:40:29 UTC	40.0		N/A			
153	https://civic.genome.wustl.edu/links/variants/153	FOXP1	27086	AMPLIFICATION	Amplication in FOXP1 has been shown to be associated with the ABC subtype of DLBCL.		3	71003844	71633140			ENST00000318789.4	75	GRCh37					transcript_amplification		2017-12-01 14:40:29 UTC	15.0		N/A			
154	https://civic.genome.wustl.edu/links/variants/154	REL	5966	AMPLIFICATION			2	61108709	61149800			ENST00000295025.8	75	GRCh37					transcript_amplification		2017-12-01 14:40:29 UTC	20.0		N/A			
155	https://civic.genome.wustl.edu/links/variants/155	RUNX1	861	MUTATION	RUNX1 mutations are associated with poor prognosis in patients with acute myeloid leukemia or adult T-cell acute lymphocytic leukemia. In younger (<60 years old) AML patients, allogeneic stem cell transplant at complete remission led to much better relapse-free survival than repetitive cycles of high-dose cytarabine.		21	36160098	36421641			ENST00000300305.3	75	GRCh37					transcript_variant,loss_of_function_variant		2017-12-01 14:40:29 UTC	110.0		N/A			
156	https://civic.genome.wustl.edu/links/variants/156	IGF2	3481	OVEREXPRESSION			11	2150348	2170833			ENST00000300632.5	75	GRCh37					N/A	N/A	2017-12-01 14:40:29 UTC	6.0		N/A			
157	https://civic.genome.wustl.edu/links/variants/157	TET2	54790	MUTATION	TET2 mutations are commonly found in acute myeloid leukemia occurring in 9-23% of cases with many occurring in the elderly. Generally these mutations are loss-of-function which have been shown in mouse models to impair hematopoietic stem cell differentiation and cause aberrant hematopoiesis. These mutations have been found to be mutually exclusive with MLL and IDH1/2 mutations and have been associated with shortened event-free-survival and disease-free-survival when co-occurring with NPM1+/FLT3- genotypes. Overall Survival has been found to be shorter when occurring with NPM1+/FLT3+ genotypes. Studies involving "CN AML" and "de novo AML" however have been unable to elucidate a clinical impact.		4	106067450	106200973			ENST00000513237.1	75	GRCh37					gene_variant,loss_of_function_variant		2017-12-01 14:40:29 UTC	120.0		N/A			
158	https://civic.genome.wustl.edu/links/variants/158	AURKA	6790	EXPRESSION			20	54944446	54967393			ENST00000395913.3	75	GRCh37					N/A		2017-12-01 14:40:29 UTC	30.0		N/A			
159	https://civic.genome.wustl.edu/links/variants/159	VHL	7428	LOSS-OF-FUNCTION			3	10182692	10193904			ENST00000256474.2	75	GRCh37					loss_of_function_variant	N/A	2017-12-01 14:40:29 UTC	15.0		N/A			
160	https://civic.genome.wustl.edu/links/variants/160	VHL	7428	MUTATION			3	10182692	10193904			ENST00000256474.2	75	GRCh37					gene_variant,loss_of_function_variant		2018-07-12 18:43:47 UTC	85.0		N/A			
161	https://civic.genome.wustl.edu/links/variants/161	PBRM1	55193	MUTATION			3	52581857	52719852			ENST00000394830.3	75	GRCh37					transcription_variant,loss_of_function_variant		2017-12-01 14:40:29 UTC	30.0		N/A			
163	https://civic.genome.wustl.edu/links/variants/163	EZH2	2146	MUTATION			7	148504477	148581370			ENST00000320356.2	75	GRCh37					protein_altering_variant		2017-12-01 14:40:29 UTC	35.0		N/A			
164	https://civic.genome.wustl.edu/links/variants/164	FLI1	2313	EWSR1-FLI1 Type 1	Although multiple fusion transcripts have been described, type 1 consists of EWSR1 exon 7 fused to FLI1 exon 6, the most common arrangement in Ewings Sarcoma.		22	29664007	29683123			ENST00000397938.2	75	GRCh37	11	128675261	128683162	ENST00000527786.2	transcript_fusion		2017-12-01 14:40:29 UTC	20.0					
165	https://civic.genome.wustl.edu/links/variants/165	EZH2	2146	Y646	Mutations of Y646 are associated with a diagnosis of Germinal Center B type DLBCL and Follicular non-Hodgkin Lymphoma. In vitro experimental findings suggest that this may be due to reduced methyltransferase activity of EZH2 on protein H3K27 (Morin et al., 2010).		7	148508726	148508728			ENST00000320356.2	75	GRCh37					protein_altering_variant		2017-12-01 14:40:29 UTC	42.0		376218,76768,376217,76769	Y641		
167	https://civic.genome.wustl.edu/links/variants/167	KMT2D	8085	LOSS-OF-FUNCTION			12	49412758	49449107			ENST00000301067.7	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:29 UTC	15.0		N/A			
168	https://civic.genome.wustl.edu/links/variants/168	BTK	695	C481S			X	100611165	100611165	A	T	ENST00000308731.7	75	GRCh37					missense_variant	ENST00000308731.7:c.1441T>A,NC_000023.10:g.100611165A>T,NM_000061.2:c.1441T>A,NP_000052.1:p.Cys481Ser	2018-11-30 14:43:09 UTC	40.0	CA16602659	376204	CYS481SER,RS1057519826		
169	https://civic.genome.wustl.edu/links/variants/169	AKT1	207	Q79K			14	105243048	105243048	G	T	ENST00000407796.2	75	GRCh37					missense_variant	NC_000014.8:g.105243048G>T,NM_001014432.1:c.235C>A,NP_001014432.1:p.Gln79Lys,ENST00000407796.2:c.235C>A	2018-11-30 14:43:10 UTC	14.0	CA16602625	376168	Q17K,GLN79LYS		
170	https://civic.genome.wustl.edu/links/variants/170	ALK	238	EML4-ALK and AMPLIFICATION			2	42396490	42528380			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion,transcript_amplification	N/A	2020-05-28 21:33:32 UTC	11.0		N/A			
171	https://civic.genome.wustl.edu/links/variants/171	ALK	238	ALK FUSION G1202R	ALK fusion with G1202R mutation in the ALK kinase domain was first identified in a lung adenocarcinoma patient who had progressed after 10 months of responding to crizotinib. Further characterization of this variant verified crizotinib resistance and additionally demonstrated resistance to multiple next generation ALK inhibitors including ceritinib, alectinib and brigatinib. Experiments using the HSP90 inhibitor  17-AAG have indicated potential sensitivity of EML4-ALK G1202R to this drug, suggesting this variant may be an HSP90 client protein.		2	29443613	29443613	C	T	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3604G>A,NC_000002.11:g.29443613C>T,NM_004304.4:c.3604G>A,NP_004295.2:p.Gly1202Arg	2018-11-30 14:43:25 UTC	23.5	CA16602592	376134	ALK FUSION GLY1202ARG,RS1057519783		
172	https://civic.genome.wustl.edu/links/variants/172	ALK	238	EML4-ALK S1206Y		Crizotinib Resistance	2	29443600	29443600	G	T	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3617C>A,NC_000002.11:g.29443600G>T,NM_004304.4:c.3617C>A,NP_004295.2:p.Ser1206Tyr	2018-11-30 14:43:12 UTC	6.0	CA16602591	376133	EML4-ALK SER1206TYR,RS1057519782		
173	https://civic.genome.wustl.edu/links/variants/173	ALK	238	EML4-ALK T1151INST	The ALK fusion variant with insertion of T at amino acid 1151 was found in an ALK rearranged lung adenocarcinoma which had progressed after responding to crizotinib treatment. The mutation was absent in tumor sample taken before crizotinib treatment. Characterization of the variant using cell lines expressing EML4-ALK with 1151 T insert found the variant to be highly crizotinib resistant, and other work demonstrated resistance to next generation inhibitor alectinib, while resistance to tool compound TAE684 indicates potential resistance to the next generation ALK inhibitor ceritinib which is derived from TAE684. Other experiments suggest theraputic potential for HSP90 inhibitors, as EML4-ALK T1151 Tins sensitivity to 17-AAG has been observed.		2	29445271	29445272		CGT	ENST00000389048.3	75	GRCh37					inframe_insertion,transcript_fusion	NC_000002.11:g.29445271_29445272insCGT	2018-11-30 14:43:26 UTC	18.0	CA645528802		T1151_L1152INST		
174	https://civic.genome.wustl.edu/links/variants/174	APC	324	MUTATION			5	112043218	112181936			ENST00000457016.1	75	GRCh37							2017-12-01 14:40:29 UTC	7.0					
175	https://civic.genome.wustl.edu/links/variants/175	AR	367	F877L			X	66943549	66943549	T	C	ENST00000374690.3	75	GRCh37					missense_variant	ENST00000374690.3:c.2629T>C,NC_000023.10:g.66943549T>C,NM_000044.4:c.2629T>C,NP_000035.2:p.Phe877Leu	2018-11-30 14:43:04 UTC	4.0	CA16602789	376347	PHE877LEU		
176	https://civic.genome.wustl.edu/links/variants/176	AR	367	W742			X	66937370	66937372			ENST00000374690.3	75	GRCh37					missense_variant		2017-12-01 14:40:29 UTC	4.0		NONE FOUND	TRP742		
177	https://civic.genome.wustl.edu/links/variants/177	ASXL1	171023	MUTATION	ASXL1 mutations are most frequently observed in the absence of FLT3-ITD and NPM1 mutations in acute myeloid leukemia (AML) patients and seem to be enriched in older patients (>60 years). These mutations are associated with poor prognosis with respect to both survival and compete remission rates.		20	30946155	31027122			ENST00000375687.4	75	GRCh37					protein_altering_variant		2017-12-01 14:40:29 UTC	100.0		N/A			
178	https://civic.genome.wustl.edu/links/variants/178	ATM	472	MUTATION			11	108093559	108239826			ENST00000278616.4	75	GRCh37					transcription_variant,loss_of_function_variant		2020-06-08 17:30:51 UTC	90.5		N/A			
179	https://civic.genome.wustl.edu/links/variants/179	ATM	472	UNDEREXPRESSION			11	108093559	108239826			ENST00000278616.4	75	GRCh37					N/A		2019-09-05 19:33:00 UTC	39.0		N/A			
180	https://civic.genome.wustl.edu/links/variants/180	AURKA	6790	AMPLIFICATION			20	54944446	54967393			ENST00000395913.3	75	GRCh37					transcript_amplification		2017-12-01 14:40:29 UTC	0.75		N/A			
181	https://civic.genome.wustl.edu/links/variants/181	AURKA	6790	OVEREXPRESSION			20	54944446	54967393			ENST00000395913.3	75	GRCh37					N/A		2017-12-01 14:40:29 UTC	38.0		N/A			
182	https://civic.genome.wustl.edu/links/variants/182	BAP1	8314	EXPRESSION			3	52435029	52444366			ENST00000460680.1	75	GRCh37					N/A		2017-12-01 14:40:29 UTC	15.0		N/A			
183	https://civic.genome.wustl.edu/links/variants/183	BAP1	8314	MUTATION	BAP1 is a tumor suppressor gene, mutations in this gene have been observed in a number of cancers including melanoma, and renal cancers. These mutations generally lead to loss-of-function and mutations in the UHC domain of BAP1 have been shown to lead to structural instability and -amyloid aggregation in models. Germline mutations are associated with an increased risk of tumorgenesis and can lead to the development of "atypical Spitz tumours (ASTs), cutaneous melanoma (CM), epithelioid malignant mesothelioma (MM) and clear cell RCC".		3	52435029	52444366			ENST00000460680.1	75	GRCh37					protein_altering_variant,loss_of_function_variant		2017-12-01 14:40:29 UTC	73.5		N/A			
184	https://civic.genome.wustl.edu/links/variants/184	BRAF	673	AKAP9-BRAF		BRAF Fusions	7	91570181	91625114			ENST00000356239.3	75	GRCh37	7	140434279	140487384	ENST00000288602.6	transcript_fusion	N/A	2017-12-01 14:40:29 UTC	20.0		N/A			
185	https://civic.genome.wustl.edu/links/variants/185	BRCA1	672	Mutation			17	41197646	41277500			ENST00000471181.2	75	GRCh37					gene_variant,loss_of_function_variant		2021-01-29 22:19:05 UTC	275.0		N/A			
186	https://civic.genome.wustl.edu/links/variants/186	BRCA2	675	MUTATION			13	32889611	32973347			ENST00000380152.3	75	GRCh37					gene_variant,loss_of_function_variant		2020-08-27 23:26:41 UTC	282.5		N/A			
187	https://civic.genome.wustl.edu/links/variants/187	CCNE1	898	AMPLIFICATION			19	30302805	30315215			ENST00000262643.3	75	GRCh37					transcript_amplification	N/A	2017-12-01 14:40:29 UTC	27.0		N/A			
189	https://civic.genome.wustl.edu/links/variants/189	DNMT3A	1788	MUTATION	DNMT3A mutations occur in a variety of myeloid malignancies. These mutations are associated with adverse prognosis in acute myeloid leukemia (AML), particularly in the context of NPM1 and FLT3-ITD mutations, which often co-occur. Early results indicate AML patients with DNMT3A mutations may respond better to decitabine than those with wild-type. Shorter survival has been indicated in patients with T-cell acute lymphoblastic leukemia and myelodysplastic syndrome, however, larger cohorts are required to verify this finding. DNMT3A mutations have been suggested as a pre-leukemic lesion and found in older individuals with clonal hematopoiesis but no overt malignancy.		2	25455845	25565459			ENST00000264709.3	75	GRCh37					transcript_variant		2017-12-01 14:40:29 UTC	115.0		N/A			
190	https://civic.genome.wustl.edu/links/variants/190	EGFR	1956	AMPLIFICATION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					transcript_amplification		2017-12-01 14:40:29 UTC	133.0		N/A			
191	https://civic.genome.wustl.edu/links/variants/191	EGFR	1956	COPY NUMBER VARIATION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					copy_number_change		2018-07-10 19:12:56 UTC	60.0		N/A			
193	https://civic.genome.wustl.edu/links/variants/193	EGFR	1956	OVEREXPRESSION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					N/A		2020-10-20 06:02:35 UTC	145.0		N/A			
194	https://civic.genome.wustl.edu/links/variants/194	ERG	2078	EWSR1-ERG	EWSR1-ERG is found in 5% of patients with Ewing Sarcoma and considered to be diagnostic of this disease, a small tumor more often found in bone, but less frequently in soft tissue. To better identify EWSR1-ERG in patients, conventional cytogenetics methods were analyzed: FISH and RT-PCR. Ultimately concluding that more than one method is needed to accurately diagnose patients due to the strengths and weaknesses of each individual method.		22	29664007	29683123			ENST00000397938.2	75	GRCh37	21	39751949	39755845	ENST00000398907.1	transcript_fusion		2017-12-01 14:40:29 UTC	25.0		N/A			
195	https://civic.genome.wustl.edu/links/variants/195	ERG	2078	TMPRSS2-ERG	TMPRSS2 fusions are prevalent in Prostate Cancer. TMPRSS2 fusion with ETS family members such as ERG are among the most common. Fusion of TMPRSS2 with ERG may result in overexpression of ERG driven by the TMPRSS2 androgen-responsive promoter elements. Due to the high prevalence of this fusion, it may have diagnostic utility for prostate cancer, especially ERG expression positive prostate cancer.		21	42879877	42879992			ENST00000398585.3	75	GRCh37	21	39751949	39817544	ENST00000398910.1	transcript_fusion		2017-12-01 14:40:30 UTC	15.0		N/A			
196	https://civic.genome.wustl.edu/links/variants/196	FGFR3	2261	Y375C			4	1806099	1806099	A	G	ENST00000340107.4	75	GRCh37					missense_variant	NC_000004.11:g.1806099A>G,NM_001163213.1:c.1124A>G,NP_000133.1:p.Tyr373Cys,ENST00000340107.4:c.1124A>G	2018-11-30 14:43:12 UTC	15.0	CA341413	16342	TYR375CYS,Y373C,RS121913485		
197	https://civic.genome.wustl.edu/links/variants/197	FLI1	2313	EWSR1-FLI1			22	29664007	29683123			ENST00000397938.2	75	GRCh37	11	128651853	128683162	ENST00000527786.2	transcript_fusion		2017-12-01 14:40:30 UTC	25.0					
198	https://civic.genome.wustl.edu/links/variants/198	FOXL2	668	C134W	The variant C134W on the FOXL2 gene was revealed to have a high frequency (95-97%) in the adult form of granulosa cell tumors that comprises 5% of ovarian cancers. Due to the mutation's high frequency, future therapeutics might target for this single apparent mechanism. However, the consequence of this mutation remain unknown.		3	138665163	138665163	G	C	ENST00000330315.3	75	GRCh37					missense_variant	NC_000003.11:g.138665163G>C	2018-11-30 14:45:24 UTC	70.0	CA16602790				
199	https://civic.genome.wustl.edu/links/variants/199	IDH2	3418	R172	IDH2 R172 is a gain-of-function mutation commonly observed in acute myeloid leukemia and is enriched in those patients which are cytogenetically normal. R172 is analogous to IDH1 R132 mutations and leads to neomorphic enzymatic activity. Specifically this mutation "catalyzes the conversion of alpha ketoglurarate to beta-hydrozyglutarate" leading to increased levels of beta-hydrozyglutarate. This in turn leads to hypermethylation of target genes and an inhibition of cellular differentiation. R172 mutations generally lead to worse overall survival and higher rates of relapse compared to the most common IDH2 mutations in AML (R140).		15	90631837	90631839			ENST00000330062.3	75	GRCh37					protein_altering_variant		2017-12-01 14:40:30 UTC	105.0		N/A	ARG172		
200	https://civic.genome.wustl.edu/links/variants/200	IKZF1	10320	DELETION	IKZF1 deletions have been reported in a variety of cancer types including pediatric B-cell precursor acute lymphoblastic leukemia (BCP ALL), Chronic Myeloid Leukemia, diffuse large B-cell lymphoma, myelodysplastic syndrome, T-cell ALL as well as solid tumors of the large intestine, lung, and liver. The clinical impact of these deletions is unknown for many cancer types however a poor outcome has been observed in leukemia based disease. This gene has been strongly implicated as a regulator for "normal  hematopoiesis". In regards to BCP ALL, mouse models have shown that mutations in IKZF1 are not sufficient in and of themselves to cause disease.  Haploinsuffeciency in combination with BCR-ABL1 however, will accelerate leukemiagenesis possibly indicating that at least in regards to BCP ALL these are secondary events that may be necessary for the development of leukaemic clones.		7	50344378	50472799			ENST00000331340.3	75	GRCh37					transcript_ablation		2020-06-22 16:45:10 UTC	120.0				28	https://civic.genome.wustl.edu/links/assertions/28
201	https://civic.genome.wustl.edu/links/variants/201	KIT	3815	M541L			4	55593464	55593464	A	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1621A>C,NP_000213.1:p.Met541Leu,ENST00000288135.5:c.1621A>C,NC_000004.11:g.55593464A>C	2018-11-30 14:43:12 UTC	25.0	CA160347	41599	MET541LEU,RS3822214		
202	https://civic.genome.wustl.edu/links/variants/202	KIT	3815	V560DEL	V560 Resides within the Juxtamembrane domain on exon 11 of KIT. In melanoma this region is one 4 hotspots and is the 3rd highest recurrently mutated region. Mouse models have shown that mutations in this hotspot lead to  constitutive phosphorylation of KIT which will induce a stronger activation of the PI3K pathway however it is currently unknown if deletions follow the same model. Case studies in Gastrointestinal Stromal Tumors with V560DEL have reported a sensitivity when treated with imatinib and regorafenib.		4	55593612	55593614	GTT		ENST00000288135.5	75	GRCh37					amino_acid_deletion,inframe_deletion	NC_000004.11:g.55593612_55593614del,ENST00000288135.5:c.1675_1677delGTT,NM_000222.2:c.1675_1677delGTT,NP_000213.1:p.Val560del	2019-02-25 19:11:08 UTC	14.5	CA123529	13859	VAL560DEL,V559DEL,V555DEL,V556DEL		
203	https://civic.genome.wustl.edu/links/variants/203	KRAS	3845	Q61			12	25380275	25380277			ENST00000256078.4	75	GRCh37					protein_altering_variant		2020-03-16 21:03:00 UTC	40.0		177881,177777,45116,375966,45115,376324,45117	GLN61		
204	https://civic.genome.wustl.edu/links/variants/204	NCOA3	8202	AMPLIFICATION			20	46130646	46285621			ENST00000372004.3	75	GRCh37					transcript_amplification		2017-12-01 14:40:30 UTC	15.0		N/A			
205	https://civic.genome.wustl.edu/links/variants/205	NCOA3	8202	OVEREXPRESSION			20	46130646	46285621			ENST00000372004.3	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	15.0		N/A			
206	https://civic.genome.wustl.edu/links/variants/206	NOTCH1	4851	MUTATION			9	139388896	139440314			ENST00000277541.6	75	GRCh37					protein_altering_variant		2017-12-01 14:40:30 UTC	100.0		N/A			
207	https://civic.genome.wustl.edu/links/variants/207	NOTCH1	4851	P2514FS	This mutation disrupts the C-terminal PEST domain that in normal conditions promotes degradation,  resulting in accumulation of an active NOTCH1 isoform sustaining deregulated signaling.		9	139390649	139390650			ENST00000277541.6	75	GRCh37					frameshift_truncation	NC_000009.11:g.139390649_139390650del	2017-12-01 14:40:30 UTC	35.0		NONE FOUND	PRO2514ARGFS		
208	https://civic.genome.wustl.edu/links/variants/208	NRAS	4893	MUTATION			1	115247090	115259515			ENST00000369535.4	75	GRCh37					transcript_variant,gain_of_function_variant		2020-12-07 02:35:36 UTC	213.0		N/A			
209	https://civic.genome.wustl.edu/links/variants/209	PAX8	7849	PAX8-PPARG	PAX8-PPAR gamma is a oncogene caused by a translocation between 2q13 and 3p25 resulting in an in-frame fusion between the two genes. It has been observed in Follicular Thyroid Cancer (FTC) and is one of two known fusion products involving PPAR gamma in FTC indicating this region may be a breakpoint hotspot. Studies have indicated that the fusion product increases cell viability and proliferation and decreases apoptosis.		2	113992971	114036521			ENST00000429538.3	75	GRCh37	3	12329400	12475810	ENST00000397015.2	transcript_fusion		2020-05-06 20:51:55 UTC	15.0		N/A	T(2;3)(Q13;P25)		
210	https://civic.genome.wustl.edu/links/variants/210	PGR	5241	EXPRESSION			11	100900355	101001255			ENST00000325455.5	75	GRCh37					N/A		2020-12-10 02:06:48 UTC	60.0		N/A			
212	https://civic.genome.wustl.edu/links/variants/212	PIK3CA	5290	Amplification			3	178866311	178957881			ENST00000263967.3	75	GRCh37					transcript_amplification	N/A	2021-02-02 22:57:53 UTC	28.0		N/A			
213	https://civic.genome.wustl.edu/links/variants/213	PTEN	5728	DELETION			10	89622870	89731687			ENST00000371953.3	75	GRCh37					transcript_ablation		2017-12-01 14:40:30 UTC	55.0					
214	https://civic.genome.wustl.edu/links/variants/214	PTEN	5728	LOSS			10	89622870	89731687			ENST00000371953.3	75	GRCh37					loss_of_function_variant	N/A	2021-01-28 22:39:36 UTC	283.0		N/A			
215	https://civic.genome.wustl.edu/links/variants/215	SF3B1	23451	MUTATION			2	198254508	198299815			ENST00000335508.6	75	GRCh37					protein_altering_variant		2017-12-01 14:40:30 UTC	130.0		N/A			
216	https://civic.genome.wustl.edu/links/variants/216	SMAD4	4089	MUTATION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					transcript_variant,loss_of_function_variant		2017-12-01 14:40:30 UTC	25.0		N/A			
217	https://civic.genome.wustl.edu/links/variants/217	SMARCA4	6597	MUTATION			19	11071598	11172958			ENST00000358026.2	75	GRCh37					gene_variant,loss_of_function_variant		2017-12-01 14:40:30 UTC	25.0		N/A			
218	https://civic.genome.wustl.edu/links/variants/218	SMARCA4	6597	INACTIVATING MUTATION			19	11071598	11172958			ENST00000358026.2	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:30 UTC	20.0					
219	https://civic.genome.wustl.edu/links/variants/219	TERT	7015	AMPLIFICATION			5	1253282	1295162			ENST00000310581.5	75	GRCh37					transcript_amplification		2017-12-01 14:40:30 UTC	15.0		N/A			
220	https://civic.genome.wustl.edu/links/variants/220	TERT	7015	PROMOTER MUTATION	TERT promoter mutations are activating and commonly found at two hotspots within the TERT promoter region which occur 124 and 146 base pairs (hg19) upstream of the translation start site. These hotspots, termed C228T and C250T are observed in many cancer types and have a particularly high prevalence in glioblastoma (83%), melanoma (71%), bladder cancer (66%) and hepatocelluar carcinoma (HCC) (47%). The two mutations are usually heterozygous and mutually exclusive and result in an increased similarity to an ETS binding domain and may act as a binding site to an ETS transcription factor. These mutations are thought to be early events in tumorgenesis and aid in cellular immortality. Decreased overall survival in patients with these mutations have been observed in medulloblastoma, thyroid cancer, urogenital cancer, melanoma, and laryngeal tumors. The presence of these mutations has also been shown to be predictive of malignant/premalignant nodules in HCC and meningiomas.		5	1295161	1295373			ENST00000310581.5	75	GRCh37					regulatory_region_variant		2020-04-28 23:02:41 UTC	95.0			-124C>T,-146C>T		
221	https://civic.genome.wustl.edu/links/variants/221	TP53	7157	DELETERIOUS MUTATION	Deleterious mutations are mutations of TP53 with prior characterization demonstrating significant deleterious effect on TP53 protein function. Inactivating TP53 mutations prevent on target activity and efficacy of MDM2-TP53 interaction inhibitors.		17	7571720	7590856			ENST00000269305.4	75	GRCh37							2017-12-01 14:40:30 UTC	78.0					
222	https://civic.genome.wustl.edu/links/variants/222	TP53	7157	MUTATION			17	7571720	7590856			ENST00000269305.4	75	GRCh37					protein_altering_variant		2018-07-12 18:40:59 UTC	400.0		N/A			
223	https://civic.genome.wustl.edu/links/variants/223	TP53	7157	TRUNCATING MUTATION			17	7573998	7579714			ENST00000269305.4	75	GRCh37					frameshift_truncation		2017-12-01 14:40:30 UTC	40.0		N/A			
224	https://civic.genome.wustl.edu/links/variants/224	TTF1	7270	AMPLIFICATION			9	135251008	135282209			ENST00000334270.2	75	GRCh37					transcript_amplification		2017-12-01 14:40:30 UTC	15.0		N/A			
230	https://civic.genome.wustl.edu/links/variants/230	CHEK2	11200	LOSS-OF-FUNCTION			22	29083732	29137832			ENST00000328354.6	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:30 UTC	25.0		N/A			
236	https://civic.genome.wustl.edu/links/variants/236	CDK12	51755	LOSS-OF-FUNCTION			17	37618292	37691399			ENST00000447079.4	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:30 UTC	4.0		N/A			
238	https://civic.genome.wustl.edu/links/variants/238	NT5C2	22978	R367Q			10	104852955	104852955	C	T	ENST00000343289.5	75	GRCh37					missense_variant	NC_000010.10:g.104852955C>T	2020-01-23 23:26:10 UTC	17.0	CA16602791	376349	ARG367GLN		
239	https://civic.genome.wustl.edu/links/variants/239	NT5C2	22978	K359Q			10	104852980	104852980	T	G	ENST00000343289.5	75	GRCh37					missense_variant	NC_000010.10:g.104852980T>G,NM_012229.4:c.1075A>C,NP_036361.1:p.Lys359Gln,ENST00000343289.5:c.1075A>C	2018-11-30 14:43:14 UTC	28.0	CA16602792	376350	LYS359GLN		
240	https://civic.genome.wustl.edu/links/variants/240	NT5C2	22978	D407A			10	104850745	104850745	T	G	ENST00000343289.5	75	GRCh37					missense_variant	NC_000010.10:g.104850745T>G,NM_012229.4:c.1220A>C,NP_036361.1:p.Asp407Ala,ENST00000343289.5:c.1220A>C	2018-11-30 14:43:13 UTC	8.0	CA16602793	376351	ASP407ALA		
241	https://civic.genome.wustl.edu/links/variants/241	ABL1	25	BCR-ABL F317L	BCR-ABL F317L, like the similar BCR-ABL T315I mutation, is becoming a common clinical marker for resistance to front-line therapies in CML. It has been shown to confer resistance to dasatinib, but responds well to ponatinib and other second generation inhibitors.	Imatinib Resistance	9	133748288	133748288	T	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NC_000009.11:g.133748288T>C,NP_005148.2:p.Phe317Leu,NM_005157.5:c.949T>C,ENST00000318560.5:c.949T>C	2020-07-11 00:38:27 UTC	109.5	CA16602794	376352,376094	F336L,F317L,RS1057519773		
242	https://civic.genome.wustl.edu/links/variants/242	TP53	7157	DNA BINDING DOMAIN MUTATION			17	7577149	7578443			ENST00000269305.4	75	GRCh37					DNA_binding_site		2017-12-01 14:40:30 UTC	35.0		N/A			
243	https://civic.genome.wustl.edu/links/variants/243	ATM	472	S2289*	A frameshift mutation at the DNA level predicted to cause truncation before the C-terminal phosphoinositide 3-kinase (PI3K) catalytic domain at amino acid 2289.		11	108196840	108196841	TC		ENST00000278616.4	75	GRCh37					frameshift_truncation	ENST00000278616.4:c.6863_6864delTC	2020-11-21 21:41:33 UTC	7.5	CA10588507	NONE FOUND	V2288FS*1		
244	https://civic.genome.wustl.edu/links/variants/244	ATM	472	N2875H	A missense mutation within the C-terminal phosphoinositide 3-kinase (PI3K) catalytic domain		11	108218044	108218044	A	C	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.8623A>C,NC_000011.9:g.108218044A>C,NM_000051.3:c.8623A>C,NP_000042.3:p.Asn2875His	2018-11-30 14:43:14 UTC	7.5	CA16602795	376353	ASN2875HIS,RS1057519869		
245	https://civic.genome.wustl.edu/links/variants/245	NF2	4771	Y177FS			22	30051593	30051594		T	ENST00000338641.4	75	GRCh37					frameshift_elongation	ENST00000338641.4:c.527_528insT,NC_000022.10:g.30051593_30051594insT	2018-11-30 14:43:14 UTC	7.5	CA645601016	NONE FOUND	TYR177FS		
247	https://civic.genome.wustl.edu/links/variants/247	PDGFRA	5156	V561A			4	55141036	55141036	T	C	ENST00000257290.5	75	GRCh37					missense_variant	ENST00000257290.5:c.1682T>C,NC_000004.11:g.55141036T>C,NM_006206.5:c.1682T>C,NP_006197.1:p.Val561Ala	2018-11-30 14:43:15 UTC	3.0	CA16602796	376354	VAL561ALA,RS121908586		
248	https://civic.genome.wustl.edu/links/variants/248	TERT	7015	C228T			5	1295228	1295228	G	A	ENST00000310581.5	75	GRCh37					regulatory_region_variant	NC_000005.9:g.1295228G>A	2018-11-30 14:43:15 UTC	40.0	CA557858711	NONE FOUND	-124C>T		
249	https://civic.genome.wustl.edu/links/variants/249	XRCC1	7515	R194W			19	44057574	44057574	G	A	ENST00000262887.5	75	GRCh37					missense_variant	NM_006297.2:c.580C>T,NP_006288.2:p.Arg194Trp,ENST00000262887.5:c.580C>T,NC_000019.9:g.44057574G>A	2018-11-30 14:43:15 UTC	20.0	CA9488737	376355	RS1799782,ARG194TRP		
250	https://civic.genome.wustl.edu/links/variants/250	GSTP1	2950	DELETION			11	67351066	67354131			ENST00000398606.3	75	GRCh37					transcript_ablation		2017-12-01 14:40:30 UTC	4.0					
251	https://civic.genome.wustl.edu/links/variants/251	BIRC7	79444	AMPLIFICATION			20	61867235	61871859			ENST00000217169.3	75	GRCh37					transcript_amplification		2017-12-01 14:40:30 UTC	4.0		N/A			
252	https://civic.genome.wustl.edu/links/variants/252	EGFR	1956	EXON 4 DELETION			7	55214299	55214433			ENST00000275493.2	75	GRCh37					exon_loss_variant	ENST00000275493.2:c.425_559del	2017-12-01 14:40:30 UTC	4.0		N/A			
254	https://civic.genome.wustl.edu/links/variants/254	KRAS	3845	RS61764370	Germline variant in the 3' UTR of KRAS that predicts resistance to platinum-based therapy.		12	25360224	25360224	A	C	ENST00000311936.3	75	GRCh37					3_prime_UTR_variant	NM_004985.4:c.*2505T>G,NC_000012.11:g.25360224A>C,ENST00000311936.3:c.*2505T>G	2018-11-30 14:43:01 UTC	30.0	CA10637079	308084			
255	https://civic.genome.wustl.edu/links/variants/255	ERCC5	2073	RS751402			13	103498198	103498198	A	G	ENST00000355739.4	75	GRCh37					5_prime_UTR_variant,SNP	NC_000013.10:g.103498198A>G	2020-05-12 16:11:40 UTC	15.0	CA10642711	310903			
256	https://civic.genome.wustl.edu/links/variants/256	KIT	3815	3' UTR MUTATION			4	55604724	55606881			ENST00000288135.5	75	GRCh37					3_prime_UTR_variant		2017-12-01 14:40:30 UTC	15.0					
257	https://civic.genome.wustl.edu/links/variants/257	EZH2	2146	INTRON 6 MUTATION			7	148524359	148525831			ENST00000320356.2	75	GRCh37					intron_variant		2017-12-01 14:40:30 UTC	20.0					
258	https://civic.genome.wustl.edu/links/variants/258	MTHFR	4524	A222V			1	11856378	11856378	G	A	ENST00000376592.1	75	GRCh37					missense_variant	NM_005957.4:c.665C>T,NP_005948.3:p.Ala222Val,ENST00000376592.1:c.665G>A,NC_000001.10:g.11856378G>A	2018-11-30 14:43:36 UTC	55.0	CA170990	3520	RS1801133,C677T,ALA222VAL		
259	https://civic.genome.wustl.edu/links/variants/259	GSTP1	2950	I105V			11	67352689	67352689	A	G	ENST00000398606.3	75	GRCh37					missense_variant	NM_000852.3:c.313A>G,NP_000843.1:p.Ile105Val,ENST00000398606.3:c.313A>G,NC_000011.9:g.67352689A>G	2018-11-30 14:43:15 UTC	20.0	CA6142790	37340	ILE105VAL		
260	https://civic.genome.wustl.edu/links/variants/260	ABCG2	9429	Q141K			4	89052323	89052323	G	T	ENST00000237612.3	75	GRCh37					missense_variant	NC_000004.11:g.89052323G>T	2018-11-30 14:43:22 UTC	15.0	CA129179	30389	GLN141LYS		
261	https://civic.genome.wustl.edu/links/variants/261	XRCC1	7515	Q399R	XRCC1 Q399R germline polymorphism (NM_006297.2:c.1196A>G) is associated with better outcome for patients with NSCLC and increased response to chemotherapy for patients with cervical cancer.		19	44055726	44055726	T	C	ENST00000262887.5	75	GRCh37					missense_variant	NM_006297.2:c.1196A>G,NP_006288.2:p.Gln399Arg,NC_000019.9:g.44055726T>C,ENST00000262887.5:c.1196A>G	2019-03-22 01:41:07 UTC	40.0	CA9488516	225976	GLN399ARG,RS25487		
262	https://civic.genome.wustl.edu/links/variants/262	ABCB1	5243	S893T			7	87160618	87160618	A	T	ENST00000265724.3	75	GRCh37					missense_variant	NM_000927.4:c.2677T>A,NP_000918.2:p.Ser893Thr,NC_000007.13:g.87160618A>T,ENST00000265724.3:c.2677T>A	2018-11-30 14:43:17 UTC	15.0	CA179696	166619	A893S,SER893THR,RS2032582		
263	https://civic.genome.wustl.edu/links/variants/263	ABCB1	5243	I1145I	ABCB1 I1145I is a germline polymorphism that has improved responses in cancer. Specifically, it can indicate sensitivity to platinum-based chemotherapies for patients with NSCLC or better outcome for HER2-positive metastatic breast cancer patients.		7	87138645	87138645	A	G	ENST00000265724.3	75	GRCh37					synonymous_variant	NM_000927.4:c.3435T>C,NP_000918.2:p.Ile1145=,NC_000007.13:g.87138645A>G,ENST00000265724.3:c.3435T>C	2019-03-22 01:39:44 UTC	25.0	CA4327768	225939	T3435C,RS1045642,3435C-T,ILE1145=		
264	https://civic.genome.wustl.edu/links/variants/264	ERCC2	2068	K751Q			19	45854919	45854919	T	G	ENST00000391945.4	75	GRCh37					missense_variant	NC_000019.9:g.45854919T>G	2018-11-30 14:43:17 UTC	35.0	CA158782	134105	LYS751GLN		
265	https://civic.genome.wustl.edu/links/variants/265	TYMS	7298	5' TANDEM REPEAT			18	657604	657742			ENST00000323274.10	75	GRCh37					5_prime_UTR_variant,short_tandem_repeat_variation		2017-12-01 14:40:30 UTC	15.0					
266	https://civic.genome.wustl.edu/links/variants/266	LRP1B	53353	EXON 12-22 DELETION			2	141665446	141777671			ENST00000389484.3	75	GRCh37					exon_loss_variant	ENST00000389484.3:c.1790_3520del	2019-10-11 15:33:32 UTC	3.0		N/A			
267	https://civic.genome.wustl.edu/links/variants/267	FGFR1	2260	AMPLIFICATION	FGFR1 amplifications are the most common aberrations of the FGFR family in cancer. One study reports FGFR1 aberrations in 3.5% of 4,853 patients of which most are FGFR1 amplifications (Helsten et. al., 2016). Preclinically, FGFR1 amplifications have also been shown to confer sensitivity to FGFR1 inhibitors (Weiss et. al., 2010). Clinical studies are currently ongoing (e.g. NCT01004224).		8	38268656	38325363			ENST00000425967.3	75	GRCh37					transcript_amplification		2020-01-10 19:25:38 UTC	170.5		N/A			
268	https://civic.genome.wustl.edu/links/variants/268	FGFR1	2260	EXPRESSION	FGFR1 high expression has been reported in 11.8% (178 patients) of oral squamous cell carcinoma patients, and was enriched in early stages (Freier et. al., 2007). Another study reports FGFR1 expression in 35% of primary HNSSC (353 patients) (Gke et. al., 2015). In both studies, FGFR1 gene amplification and expression do not correlate well with about 35% of samples with FGFR1 amplification overexpressing FGFR1 (Gke et. al., 2015). FGFR1 expression also correlated with sensitivity to FGFR1 inhibitors in preclinical models of lung cancer (Wynes et. al., 2014), HNSSC (Gke et. al., 2015) and urothelial carcinoma (Lamont et. al., 2011).		8	38268656	38325363			ENST00000425967.3	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	46.0		N/A			
269	https://civic.genome.wustl.edu/links/variants/269	ROS1	6098	REARRANGEMENT	ROS1 is a receptor tyrosine kinase that frequently forms gene fusions in several cancer types. Approximately 2% of NSCLC patients harbor a ROS1 gene fusion. Several fusion partners have been described with a constant ROS1-breakpoint, maintaining the kinase domain (Solomon B, 2015). Following case-studies and retrospective analyses, an expansion cohort of a phase-1 study showed clinical benefit of crizotinib in ROS1 rearranged NSCLC. The benefit was independent of the type of ROS1-rearrangement (Shaw et. al.,2014).		6	117609463	117747018			ENST00000368508.3	75	GRCh37					transcript_fusion		2020-06-08 16:54:46 UTC	108.0		N/A			
270	https://civic.genome.wustl.edu/links/variants/270	MET	4233	AMPLIFICATION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					transcript_amplification		2017-12-01 14:40:30 UTC	81.5		N/A			
271	https://civic.genome.wustl.edu/links/variants/271	ATR	545	I774FS	Single A insertion or deletion in the 10 A mononucleotide run in exon 10 of ATR results in a frameshift of codon I774. In patients with endometrial cancer, this mutation has only been observed in patients with microsatellite instability.		3	142274740	142274740			ENST00000350721.4	75	GRCh37					frameshift_truncation	NC_000003.11:g.142274740del	2017-12-01 14:40:30 UTC	20.0					
272	https://civic.genome.wustl.edu/links/variants/272	CDKN2A	1029	p16 EXPRESSION	CDKN2A (p16) expression is a surrogate marker of HPV infection in oropharyngeal squamous cell carcinoma. CDKN2A and p53 are inactivated through HPV proteins E6 and E7 and therefore not altered in expression level in HPV-associated carcinomas. However, there is no perfect overlap between p16 expression and HPV status with some 10-12.5% of HPV-negative tumors expressing p16. (Seiwert, T JCO, 2014). p16 positivity is a well-established positive prognostic factor in squamous cell cancer of the head and neck in the primary and, as increasing evidence suggests, recurrent/metastatic disease settings. Predictive information from HPV status have not been established to date. A lack of benefit from EGFR-inhibitors has been proposed by some studies. Other studies were not able to reproduce this finding.		9	21968055	21974865			ENST00000498124.1	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	180.0		N/A			
273	https://civic.genome.wustl.edu/links/variants/273	RET	5979	KIF5B-RET	In a study by Takeuchi et. al. a fusion screen was performed in 1529 lung cancer samples. 14 adenocarcinomas with KIF5B-RET and CCDC6-RET fusions were identified. (Takeuchi K et. al., 2012)		10	32306071	32345359			ENST00000302418.4	75	GRCh37	10	43609928	43625799	ENST00000355710.3	transcript_fusion		2017-12-01 14:40:30 UTC	10.0		N/A			
274	https://civic.genome.wustl.edu/links/variants/274	HRAS	3265	G13D			11	534285	534285	C	T	ENST00000451590.1	75	GRCh37					missense_variant	NC_000011.9:g.534285C>T,NP_005334.1:p.Gly13Asp,NM_005343.3:c.38G>A,ENST00000451590.1:c.38G>A	2018-11-30 14:43:17 UTC	7.5	CA256488	12604	GLY13ASP,RS104894226		
275	https://civic.genome.wustl.edu/links/variants/275	HRAS	3265	MUTATION			11	533873	534289			ENST00000451590.1	75	GRCh37					coding_transcript_variant		2017-12-01 14:40:30 UTC	3.0		376033,12613,12602,35554,180848,160364			
276	https://civic.genome.wustl.edu/links/variants/276	CD274	29126	EXPRESSION			9	5450525	5470547			ENST00000381577.3	75	GRCh37					N/A	N/A	2018-07-10 18:58:03 UTC	335.0		N/A			
277	https://civic.genome.wustl.edu/links/variants/277	MTOR	2475	MUTATION			1	11166592	11322564			ENST00000361445.4	75	GRCh37					protein_altering_variant		2017-12-01 14:40:30 UTC	22.5		N/A			
278	https://civic.genome.wustl.edu/links/variants/278	AKT2	208	EXPRESSION			19	40736224	40791302			ENST00000392038.2	75	GRCh37					N/A		2018-04-11 12:29:55 UTC	15.0		N/A			
279	https://civic.genome.wustl.edu/links/variants/279	NF2	4771	K159FS*16			22	30050673	30050675			ENST00000338641.4	75	GRCh37					frameshift_truncation		2017-12-01 14:40:30 UTC	7.5		NONE FOUND	LYS159FS*16		
281	https://civic.genome.wustl.edu/links/variants/281	FBXW7	55294	MUTATION			4	153245446	153332714			ENST00000281708.4	75	GRCh37					protein_altering_variant,loss_of_function_variant		2017-12-01 14:40:30 UTC	20.0					
282	https://civic.genome.wustl.edu/links/variants/282	SMAD4	4089	UNDEREXPRESSION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	3.0		N/A			
283	https://civic.genome.wustl.edu/links/variants/283	MTOR	2475	H1968Y			1	11188519	11188519	G	A	ENST00000361445.4	75	GRCh37					missense_variant,gain_of_function_variant	ENST00000361445.4:c.5902C>T,NC_000001.10:g.11188519G>A,NM_004958.3:c.5902C>T,NP_004949.1:p.His1968Tyr	2018-11-30 14:43:16 UTC	3.0	CA16602797	376357	HIS1968TYR		
284	https://civic.genome.wustl.edu/links/variants/284	MTOR	2475	P2213S			1	11184580	11184580	G	A	ENST00000361445.4	75	GRCh37					missense_variant,gain_of_function_variant	ENST00000361445.4:c.6637C>T,NC_000001.10:g.11184580G>A,NM_004958.3:c.6637C>T,NP_004949.1:p.Pro2213Ser	2018-11-30 14:43:16 UTC	3.0	CA16602798	376358	PRO2213SER		
285	https://civic.genome.wustl.edu/links/variants/285	BRAF	673	AGK-BRAF		BRAF Fusions	7	141250989	141255367			ENST00000355413.4	75	GRCh37	7	140434279	140494267	ENST00000288602.6	transcript_fusion	N/A	2017-12-01 14:40:30 UTC	7.0		N/A			
286	https://civic.genome.wustl.edu/links/variants/286	BRAF	673	PAPSS1-BRAF		BRAF Fusions	4	108603171	108641608			ENST00000265174.4	75	GRCh37	7	140434279	140487384	ENST00000288602.6	gene_fusion,transcript_fusion		2017-12-01 14:40:30 UTC	6.0		N/A	T(4;7)(Q24;Q34)		
287	https://civic.genome.wustl.edu/links/variants/287	BRAF	673	TRIM24-BRAF		BRAF Fusions	7	138145079	138239711			ENST00000343526.4	75	GRCh37	7	140434279	140487384	ENST00000288602.6	transcript_fusion		2017-12-01 14:40:30 UTC	6.0		N/A			
288	https://civic.genome.wustl.edu/links/variants/288	BRAF	673	L597R		Other V600's	7	140453145	140453145	A	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1790T>G,NP_004324.2:p.Leu597Arg,NC_000007.13:g.140453145A>C,ENST00000288602.6:c.1790T>G	2018-11-30 14:45:06 UTC	12.0	CA123649	13968	LEU597ARG,RS121913366		
289	https://civic.genome.wustl.edu/links/variants/289	ERBB3	2065	OVEREXPRESSION			12	56473645	56497289			ENST00000267101.3	75	GRCh37					N/A		2020-10-12 23:39:46 UTC	37.0		N/A			
290	https://civic.genome.wustl.edu/links/variants/290	NT5E	4907	OVEREXPRESSION			6	86159809	86205496			ENST00000257770.3	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	15.0		N/A			
291	https://civic.genome.wustl.edu/links/variants/291	EZH2	2146	OVEREXPRESSION			7	148504477	148581370			ENST00000320356.2	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	20.0		N/A			
292	https://civic.genome.wustl.edu/links/variants/292	MYD88	4615	OVEREXPRESSION			3	38179969	38184510			ENST00000417037.2	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	2.0		N/A			
294	https://civic.genome.wustl.edu/links/variants/294	PIK3CA	5290	P471L			3	178928226	178928226	C	T	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.1412C>T,NC_000003.11:g.178928226C>T,NM_006218.3:c.1412C>T,NP_006209.2:p.Pro471Leu	2018-11-30 14:43:16 UTC	7.5	CA16602799	376359	PRO471LEU,RS1057519872		
296	https://civic.genome.wustl.edu/links/variants/296	RIT1	6016	OVEREXPRESSION			1	155870065	155880706			ENST00000368322.3	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	15.0		N/A			
297	https://civic.genome.wustl.edu/links/variants/297	RIT1	6016	MUTATION			1	155870065	155880706			ENST00000368322.3	75	GRCh37					transcript_variant		2017-12-01 14:40:30 UTC	3.0		N/A			
298	https://civic.genome.wustl.edu/links/variants/298	MYCN	4613	AMPLIFICATION			2	16080686	16087129			ENST00000281043.3	75	GRCh37					transcript_amplification		2017-12-01 14:40:30 UTC	43.0		N/A			
299	https://civic.genome.wustl.edu/links/variants/299	SMO	6608	D473H			7	128849189	128849189	G	C	ENST00000249373.3	75	GRCh37					missense_variant	NM_005631.4:c.1417G>A,NP_005622.1:p.Asp473His,ENST00000249373.3:c.1417G>A,NC_000007.13:g.128849189G>C	2018-11-30 14:43:06 UTC	13.5	CA16602418	375938	ASP473HIS		
300	https://civic.genome.wustl.edu/links/variants/300	SMO	6608	MUTATION			7	128828713	128853386			ENST00000249373.3	75	GRCh37					coding_transcript_variant		2018-02-15 23:04:46 UTC	44.0					
301	https://civic.genome.wustl.edu/links/variants/301	PTCH1	5727	MUTATION			9	98205262	98270943			ENST00000331920.6	75	GRCh37					gene_variant,loss_of_function_variant		2018-02-15 23:06:46 UTC	25.0					
302	https://civic.genome.wustl.edu/links/variants/302	PTCH1	5727	LOH			9	98205262	98270943			ENST00000331920.6	75	GRCh37					loss_of_heterozygosity		2017-12-01 14:40:30 UTC	10.0		N/A			
303	https://civic.genome.wustl.edu/links/variants/303	STK11	6794	EXON 1-2 MUTATION			19	1205740	1218499			ENST00000326873.7	75	GRCh37					exon_variant		2017-12-01 14:40:30 UTC	20.0					
304	https://civic.genome.wustl.edu/links/variants/304	STK11	6794	UNDEREXPRESSION			19	1205740	1228428			ENST00000326873.7	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	2.0		N/A			
305	https://civic.genome.wustl.edu/links/variants/305	SYK	6850	OVEREXPRESSION			9	93564069	93660831			ENST00000375754.4	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	3.0		N/A			
306	https://civic.genome.wustl.edu/links/variants/306	ERBB2	2064	AMPLIFICATION	Her2 (ERBB2) amplifications are seen in up to 20% of breast cancers and were associated with aggressive disease and poor prognosis when discovered. Trastuzumab first found considerable success, and was approved for treatment, in HER2 positive metastatic breast cancer (MBC) which had progressed under chemotherapy.  These metastatic cancers nonetheless progressed under trastuzumab, and other forms of therapy were studied for next line treatments, including tyrosine kinase inhibitors.  Lapatinib, a reversible inhibitor of tyrosine kinase activity in ErbB1 and ErbB2, and afatinib, an irreversible inhibitor of all 4 ErbB forms were shown to have activity in trastuzumab-progressed HER2 MBC.  Interestingly trastuzumab itself also turned out to remain effective in treatment of trastuzumab-progressed HER2 MBC.  The LUX-Breast 1 trial compared a TKI-based treatment (afatinib) to a trastuzumab-based treatment of trastuzumab-progressed HER2 MBC, and the LUX-Breast 3 trial addressed TKI application in the context of HER2 MBC with difficult to treat brain metastases.  In neither of these cases was the TKI more effective, making successful future replacement of trastuzumab-based therapy with a TKI in trastuzumab-progressed HER2 MBC seem unlikely.  Instead, a potential role for TKIs in this disease context is revealed in preclinical work suggesting synergism between TKI and trastuzumab action, and clinical trials with lapatinib or afatinib combined with trastuzumab indicate that dual HER2 blockade may be an effective therapy.  Dual antibody HER2 blockade with pertuzumab instead of TKI in HER2 MBC has also recently shown strong results in the CLEOPATRA trial. HER2 overexpression is targeted in neoadjuvant breast cancer treatment, and has also been successfully targeted in gastric cancer.		17	37856333	37884915			ENST00000269571.5	75	GRCh37					transcript_amplification	N/A	2021-01-13 01:14:37 UTC	880.0		N/A	OVEREXPRESSION	32	https://civic.genome.wustl.edu/links/assertions/32
307	https://civic.genome.wustl.edu/links/variants/307	ALK	238	EML4-ALK L1152R			2	29445270	29445270	A	C	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3455T>G,NC_000002.11:g.29445270A>C,NM_004304.4:c.3455T>G,NP_004295.2:p.Leu1152Arg	2018-11-30 14:43:16 UTC	10.0	CA16602594	376136	EML4-ALK LEU1152ARG,RS1057519785		
308	https://civic.genome.wustl.edu/links/variants/308	ALK	238	EML4-ALK G1269A	The EML4-ALK G1269A mutation has been identified in non-small cell lung cancer patients resistant to crizotinib. Cell line data from multiple groups have shown this mutation enhances resistance to crizotinib treatment in vitro.		2	29432682	29432682	C	G	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3806G>C,NC_000002.11:g.29432682C>G,NM_004304.4:c.3806G>C,NP_004295.2:p.Gly1269Ala	2018-11-30 14:43:31 UTC	17.5	CA16602590	376132	EML4-ALK GLY1269ALA,RS1057519781		
310	https://civic.genome.wustl.edu/links/variants/310	ERBB4	2066	MUTATION	ERBB4 mutations have been identified in melanoma, lung adenocarcinoma and medulloblastoma. In-vitro studies suggest that melanoma cell lines harboring an ERBB4 mutation are sensitive to ERBB4 inhibition with lapatinib.		2	212295697	212578308			ENST00000342788.4	75	GRCh37					transcript_variant,gain_of_function_variant		2017-12-01 14:40:30 UTC	4.0					
311	https://civic.genome.wustl.edu/links/variants/311	PIK3CA	5290	Mutation	PIK3CA mutations are observed in many cancers among the most prevalent are breast cancer, colorectal cancer, and head and neck squamous cell carcinoma. These mutations have been observed in up to 40%, 20%, and 21% respectively for each of these cancer types with mutations commonly occurring within the helical exon 9 and kinase domain of exon 20. In breast cancer PIK3CA mutations have been associated with better prognosis, and a greater survival outcome, however the PI3K pathway is also associated with increased drug resistance (trastuzumab/lapatinib). PIK3CA mutations in both HNSCC and CRC have been associated with resistance to anti-EGFR therapeutic agents and mutations in exon 9 and 20 are associated with a poorer prognosis in CRC. Interestingly PIK3CA mutations in HNSCC have been observed to be absent from a number of ethnic groups including greek, german, and vietnamese populations.		3	178866311	178957881			ENST00000263967.3	75	GRCh37					transcript_variant,gain_of_function_variant		2021-02-02 22:57:37 UTC	424.0		N/A		22	https://civic.genome.wustl.edu/links/assertions/22
312	https://civic.genome.wustl.edu/links/variants/312	EGFR	1956	VIII	The EGFRvIII variant is an oncogenic mutation that has been reported in several cancers including glioblastoma multiforme, breast, lung, head and neck, ovarian and prostate. In high-grade gliomas, EGFRvIII has been reported in about 30% of cases with EGFR amplification. The EGFRvIII mutation leads to deletion of the receptor ectodomain exons 2-7. The presence of this variant has been linked with clinical response to EGFR TKI. (Arteaga and Engelmann, 2014)		7	55087058	55223523			ENST00000275493.2	75	GRCh37					disruptive_inframe_deletion		2020-07-17 21:29:16 UTC	69.0					
313	https://civic.genome.wustl.edu/links/variants/313	PTEN	5728	EXPRESSION			10	89622870	89731687			ENST00000371953.3	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	54.5		N/A			
314	https://civic.genome.wustl.edu/links/variants/314	NRG1	3084	EXPRESSION			8	31497942	32622294			ENST00000523534.1	75	GRCh37					N/A		2017-12-01 14:40:30 UTC	37.0		N/A			
315	https://civic.genome.wustl.edu/links/variants/315	AREG	374	EXPRESSION			4	75310851	75320726			ENST00000395748.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	58.0		N/A			
316	https://civic.genome.wustl.edu/links/variants/316	TGFA	7039	EXPRESSION			2	70674412	70781147			ENST00000295400.6	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
317	https://civic.genome.wustl.edu/links/variants/317	EGFR	1956	G724S			7	55241722	55241722	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2170G>A,NC_000007.13:g.55241722G>A,NM_005228.4:c.2170G>A,NP_005219.2:p.Gly724Ser	2018-11-30 14:43:06 UTC	4.0	CA16602800	376360	GLY724SER,RS1051753269		
318	https://civic.genome.wustl.edu/links/variants/318	EREG	2069	EXPRESSION			4	75230860	75254468			ENST00000244869.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	35.5		N/A			
320	https://civic.genome.wustl.edu/links/variants/320	MAPK1	5594	E322K			22	22127164	22127164	C	T	ENST00000215832.6	75	GRCh37					missense_variant,gain_of_function_variant	ENST00000215832.6:c.964G>A,NC_000002.11:g.22127164C>T,NP_002736.3:p.Glu322Lys,NM_002745.4:c.964G>A	2018-11-30 14:44:52 UTC	10.0	CA16602885	376450	GLU322LYS		
321	https://civic.genome.wustl.edu/links/variants/321	MAPK1	5594	AMPLIFICATION			22	22108789	22221919			ENST00000215832.6	75	GRCh37					transcript_amplification		2017-12-01 14:40:31 UTC	4.0		N/A			
322	https://civic.genome.wustl.edu/links/variants/322	KRAS	3845	A146V			12	25378561	25378561	G	A	ENST00000256078.4	75	GRCh37					missense_variant	ENST00000256078.4:c.437C>T,NC_000012.11:g.25378561G>A,NP_004976.2:p.Ala146Val,NM_004985.4:c.437C>T	2018-11-30 14:42:56 UTC	8.0	CA16602440	375962	ALA146VAL,RS1057519725		
323	https://civic.genome.wustl.edu/links/variants/323	MET	4233	MUTATION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					transcription_variant,gain_of_function_variant		2017-12-01 14:40:31 UTC	15.0		N/A			
324	https://civic.genome.wustl.edu/links/variants/324	MET	4233	EXON 14 SKIPPING MUTATION	Exon 14 mutations have been observed in ~3% of patients with NSCLC (28/933 reported by Awad et al J Clin Onc 2016), confirmed to cause exon skipping when available, and associated with concurrent MET amplification. Responses to the c-MET inhibitor crizotinib have been reported in preclinical models and in individual case reports as well as a small-scale clinical trial (17 patients treated, Drilon et al., 2016 (suppl; abstr 108; ASCO ID 167889-176)). Larger studies are needed but enrollment of patients with MET exon 14 skipping mutation in trials with MET inhibitors or off-label treatment is encouraged (Paik et al., 2015 (suppl; abstr 8021)).		7	116411903	116412043			ENST00000318493.6	75	GRCh37					exon_loss_variant		2020-01-21 11:01:57 UTC	65.5		N/A			
325	https://civic.genome.wustl.edu/links/variants/325	FGFR3	2261	EXPRESSION			4	1795039	1810599			ENST00000440486.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
326	https://civic.genome.wustl.edu/links/variants/326	CBLC	23624	EXPRESSION			19	45281126	45303891			ENST00000270279.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
327	https://civic.genome.wustl.edu/links/variants/327	PTPRD	5789	MUTATION			9	8314246	10033790			ENST00000381196.4	75	GRCh37					transcript_variant,loss_of_function_variant		2017-12-01 14:40:31 UTC	3.0		N/A			
328	https://civic.genome.wustl.edu/links/variants/328	DEFA1	1667	EXPRESSION			8	6835172	6837602			ENST00000382692.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0					
329	https://civic.genome.wustl.edu/links/variants/329	ERCC1	2067	EXPRESSION			19	45916692	45926824			ENST00000013807.5	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	30.0		N/A			
330	https://civic.genome.wustl.edu/links/variants/330	NOTCH1	4851	AMPLIFICATION			9	139388896	139440314			ENST00000277541.6	75	GRCh37					transcript_amplification		2017-12-01 14:40:31 UTC	12.0		N/A			
331	https://civic.genome.wustl.edu/links/variants/331	WEE1	7465	RS3910384			11	9599943	9599943	A	G	ENST00000450114.2	75	GRCh37					intron_variant,polymorphic_sequence_variant	NC_000011.9:g.9599943A>G,ENST00000450114.2:c.1141+1133A>G	2018-11-30 14:43:13 UTC	15.0	CA15681425	NONE FOUND	INTRON POLYMORPHISM		
332	https://civic.genome.wustl.edu/links/variants/332	FNTB	2342	RS11623866			14	65453063	65453063	G	C	ENST00000246166.2	75	GRCh37					regulatory_region_variant	NC_000014.8:g.65453063G>C	2018-11-30 14:43:14 UTC	10.0	CA13941207				
333	https://civic.genome.wustl.edu/links/variants/333	PTPRT	11122	PROMOTER HYPERMETHYLATION															N/A		2017-12-01 14:40:31 UTC	2.0					
334	https://civic.genome.wustl.edu/links/variants/334	VEGFA	7422	Decreased Peri-therapeutic Expression			6	43738444	43752346			ENST00000372055.4	75	GRCh37					N/A		2021-01-22 01:01:48 UTC	10.0		N/A			
335	https://civic.genome.wustl.edu/links/variants/335	DNMT1	1786	EXPRESSION			19	10244022	10305811			ENST00000340748.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	18.0		N/A			
336	https://civic.genome.wustl.edu/links/variants/336	KRAS	3845	Mutation			12	25362365	25403737			ENST00000256078.4	75	GRCh37					protein_altering_variant		2021-02-02 23:37:38 UTC	545.5		N/A			
337	https://civic.genome.wustl.edu/links/variants/337	PDCD4	27250	EXPRESSION	A new study, a retrospective analysis of 77 patients, has implicated PDCD4 expression in the sensitivity to paclitaxel. However, this finding came from a large proteome screen and has not yet been replicated in independent patient sets.		10	112631596	112659763			ENST00000393104.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	20.0					
338	https://civic.genome.wustl.edu/links/variants/338	MGMT	4255	RS16906252			10	131265545	131265545	C	T	ENST00000306010.7	75	GRCh37					synonymous_variant	NC_000010.10:g.131265545C>T	2018-11-30 14:43:06 UTC	15.0	CA5747879				
339	https://civic.genome.wustl.edu/links/variants/339	TFF3	7033	EXPRESSION			21	43731777	43735761			ENST00000518498.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
340	https://civic.genome.wustl.edu/links/variants/340	DKK1	22943	NUCLEAR EXPRESSION			10	54074056	54077417			ENST00000373970.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0					
341	https://civic.genome.wustl.edu/links/variants/341	CD44	960	ISOFORM EXPRESSION			11	35160728	35251574			ENST00000428726.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0					
342	https://civic.genome.wustl.edu/links/variants/342	EGF	1950	EXPRESSION			4	110834047	110933422			ENST00000265171.5	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
343	https://civic.genome.wustl.edu/links/variants/343	MDM2	4193	EXPRESSION			12	69201956	69239214			ENST00000462284.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	20.0		N/A			
344	https://civic.genome.wustl.edu/links/variants/344	HMOX1	3162	EXPRESSION			22	35776828	35790207			ENST00000216117.8	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
345	https://civic.genome.wustl.edu/links/variants/345	SPHK1	8877	OVEREXPRESSION			17	74380731	74383936			ENST00000323374.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
346	https://civic.genome.wustl.edu/links/variants/346	CASP8	841	EXPRESSION			2	202122759	202152434			ENST00000358485.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
347	https://civic.genome.wustl.edu/links/variants/347	TYMS	7298	EXPRESSION			18	657604	673578			ENST00000323274.10	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	40.0		N/A			
348	https://civic.genome.wustl.edu/links/variants/348	PBK	55872	OVEREXPRESSION			8	27667137	27695612			ENST00000301905.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
349	https://civic.genome.wustl.edu/links/variants/349	SMARCA4	6597	UNDEREXPRESSION			19	11071598	11172958			ENST00000358026.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	30.0		N/A			
350	https://civic.genome.wustl.edu/links/variants/350	SETBP1	26040	EXON 4 MUTATION			18	42531877	42531918			ENST00000282030.5	75	GRCh37					exon_variant		2017-12-01 14:40:31 UTC	15.0					
351	https://civic.genome.wustl.edu/links/variants/351	SETBP1	26040	G870S			18	42531913	42531913	G	A	ENST00000282030.5	75	GRCh37					missense_variant	NM_015559.2:c.2608G>A,NP_056374.2:p.Gly870Ser,ENST00000282030.5:c.2608G>A,NC_000018.9:g.42531913G>A	2018-11-30 14:43:10 UTC	3.0	CA114719	1035	GLY870SER,RS267607040		
352	https://civic.genome.wustl.edu/links/variants/352	ALK	238	EML4-ALK C1156Y-L1198F	EML4-ALK C1156Y alone is resistant to crizotinib in non-small cell lung cancer (NSCLC) which has been shown to be modulated (both increased sensitivity and resistance) by additional ALK mutations. A case report showed that an NSCLC harboring EML4-ALK C1156Y-L1198F was resistant to lorlatinib but this second mutation re-sensitized this tumor to crizotinib.		2	29443625	29445258			ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion		2020-05-11 16:58:32 UTC	20.0					
354	https://civic.genome.wustl.edu/links/variants/354	EGFR	1956	EXPRESSION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					N/A		2020-10-12 23:37:01 UTC	60.0		N/A			
355	https://civic.genome.wustl.edu/links/variants/355	CDKN1A	1026	EXPRESSION			6	36646487	36655108			ENST00000405375.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
356	https://civic.genome.wustl.edu/links/variants/356	ALCAM	214	EXPRESSION			3	105085753	105295744			ENST00000306107.5	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0					
357	https://civic.genome.wustl.edu/links/variants/357	STMN1	3925	EXPRESSION			1	26211931	26232957			ENST00000426559.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
358	https://civic.genome.wustl.edu/links/variants/358	RSF1	51773	AMPLIFICATION			11	77371041	77532063			ENST00000308488.6	75	GRCh37					transcript_amplification		2017-12-01 14:40:31 UTC	10.0		N/A			
359	https://civic.genome.wustl.edu/links/variants/359	AR	367	OVEREXPRESSION			X	66764465	66950461			ENST00000374690.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
360	https://civic.genome.wustl.edu/links/variants/360	CDKN1B	1027	CYTOPLASMIC MISLOCALIZATION			12	12870058	12875305			ENST00000228872.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0					
361	https://civic.genome.wustl.edu/links/variants/361	ERBB3	2065	EXPRESSION			12	56473645	56497289			ENST00000267101.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	6.0		N/A			
362	https://civic.genome.wustl.edu/links/variants/362	AR	367	V7 EXPRESSION			X	66764662	66915917			ENST00000504326.1	75	GRCh37							2020-11-18 20:07:32 UTC	15.0					
363	https://civic.genome.wustl.edu/links/variants/363	UGT1A	7361	EXPRESSION			2	234526291	234681956			ENST00000373450.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
364	https://civic.genome.wustl.edu/links/variants/364	ERBB4	2066	NUCLEAR TRANSLOCATION			2	212240446	213403565			ENST00000342788.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
365	https://civic.genome.wustl.edu/links/variants/365	ERBB4	2066	EXPRESSION			2	212240446	213403565			ENST00000342788.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	5.0		N/A			
366	https://civic.genome.wustl.edu/links/variants/366	SLFN11	91607	EXPRESSION			17	33677324	33700639			ENST00000394566.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
367	https://civic.genome.wustl.edu/links/variants/367	RAC1	5879	P29S			7	6426892	6426892	C	T	ENST00000356142.4	75	GRCh37					missense_variant	ENST00000356142.4:c.85C>T,NC_000007.13:g.6426892C>T	2018-11-30 14:42:56 UTC	4.0	CA16602801	376362	PRO29SER		
368	https://civic.genome.wustl.edu/links/variants/368	BIRC5	332	NUCLEAR EXPRESSION			17	76210267	76221717			ENST00000301633.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
369	https://civic.genome.wustl.edu/links/variants/369	TP53	7157	WILD TYPE			17	7571720	7590856			ENST00000269305.4	75	GRCh37					wild_type		2017-12-01 14:40:31 UTC	68.0		N/A			
370	https://civic.genome.wustl.edu/links/variants/370	MRE11	4361	LOSS			11	94152895	94227074			ENST00000323929.3	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:31 UTC	2.0		N/A			
371	https://civic.genome.wustl.edu/links/variants/371	TOP1	7150	AMPLIFICATION			20	39657458	39753127			ENST00000361337.2	75	GRCh37					transcript_amplification		2017-12-01 14:40:31 UTC	5.0		N/A			
372	https://civic.genome.wustl.edu/links/variants/372	CDKN1B	1027	EXPRESSION			12	12870058	12875305			ENST00000228872.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
373	https://civic.genome.wustl.edu/links/variants/373	AGR2	10551	EXPRESSION			7	16831435	16844704			ENST00000419304.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	5.0		N/A			
374	https://civic.genome.wustl.edu/links/variants/374	NAPRT	93100	PROMOTER HYPERMETHYLATION															N/A		2017-12-01 14:40:31 UTC	3.0					
375	https://civic.genome.wustl.edu/links/variants/375	EGFR	1956	EXON 18 OVEREXPRESSION			7	55237999	55238735			ENST00000344576.2	75	GRCh37					exon_variant		2017-12-01 14:40:31 UTC	10.0		N/A			
376	https://civic.genome.wustl.edu/links/variants/376	ZEB1	6935	EXPRESSION			10	31608101	31818741			ENST00000361642.5	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	5.0		N/A			
377	https://civic.genome.wustl.edu/links/variants/377	TIMP1	7076	OVEREXPRESSION			X	47441712	47446188			ENST00000218388.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	12.0		N/A			
378	https://civic.genome.wustl.edu/links/variants/378	PTP4A3	11156	OVEREXPRESSION			8	142402093	142441394			ENST00000521578.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
379	https://civic.genome.wustl.edu/links/variants/379	TYMS	7298	AMPLIFICATION			18	657604	673578			ENST00000323274.10	75	GRCh37					transcript_amplification		2017-12-01 14:40:31 UTC	15.0		N/A			
380	https://civic.genome.wustl.edu/links/variants/380	IGF1R	3480	EXPRESSION			15	99192200	99507759			ENST00000268035.6	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
381	https://civic.genome.wustl.edu/links/variants/381	EPHB4	2050	EXPRESSION			7	100400187	100425121			ENST00000358173.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
382	https://civic.genome.wustl.edu/links/variants/382	TYMS	7298	UNDEREXPRESSION			18	657604	673578			ENST00000323274.10	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	20.0		N/A			
383	https://civic.genome.wustl.edu/links/variants/383	TOP2A	7153	EXPRESSION			17	38544768	38574202			ENST00000423485.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
384	https://civic.genome.wustl.edu/links/variants/384	TOP1	7150	EXPRESSION			20	39657458	39753127			ENST00000361337.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	25.0		N/A			
385	https://civic.genome.wustl.edu/links/variants/385	PRKAA2	5563	T172 PHOSPHORYLATION			1	57159476	57159478			ENST00000371244.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	0.5					
386	https://civic.genome.wustl.edu/links/variants/386	HSPA5	3309	EXPRESSION			9	127997132	128003609			ENST00000324460.6	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	20.0		N/A			
387	https://civic.genome.wustl.edu/links/variants/387	EIF4EBP1	1978	PHOSPHORYLATION			8	37888200	37914663			ENST00000338825.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	4.0					
388	https://civic.genome.wustl.edu/links/variants/388	KIT	3815	MUTATION			4	55524085	55606881			ENST00000288135.5	75	GRCh37					transcript_variant,gain_of_function_variant		2017-12-01 14:40:31 UTC	17.0		N/A			
389	https://civic.genome.wustl.edu/links/variants/389	TUBB3	10381	EXPRESSION			16	89989687	90002505			ENST00000315491.7	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	12.0		N/A			
390	https://civic.genome.wustl.edu/links/variants/390	EGFR	1956	Y1092 PHOSPHORYLATION	Although referred to as Y1068 in the literature, based on the recognition peptide described, this tyrosine occurs at Y1039 (ENST00000454757.2 v75) or Y1092 (ENST00000275493.2 v75).		7	55272951	55272953			ENST00000275493.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0			Y1039 PHOSPHORYLATION		
391	https://civic.genome.wustl.edu/links/variants/391	IGF1R	3480	NUCLEAR EXPRESSION			15	99192200	99507759			ENST00000268035.6	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
392	https://civic.genome.wustl.edu/links/variants/392	CFLAR	8837	EXPRESSION			2	201980827	202041410			ENST00000309955.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
393	https://civic.genome.wustl.edu/links/variants/393	PROM1	8842	EXPRESSION			4	15969857	16085324			ENST00000510224.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0					
394	https://civic.genome.wustl.edu/links/variants/394	FOXP3	50943	EXPRESSION			X	49106897	49121288			ENST00000376207.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	20.0		N/A			
395	https://civic.genome.wustl.edu/links/variants/395	RPS6	6194	PHOSPHORYLATION			9	19376309	19376323			ENST00000380394.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0					
396	https://civic.genome.wustl.edu/links/variants/396	JAK1	3716	OVEREXPRESSION			1	65298912	65432187			ENST00000342505.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	4.0		N/A			
397	https://civic.genome.wustl.edu/links/variants/397	BRCA1	672	EXPRESSION			17	41196312	41277387			ENST00000357654.3	75	GRCh37					N/A	N/A	2017-12-01 14:40:31 UTC	2.0		N/A			
398	https://civic.genome.wustl.edu/links/variants/398	DUSP6	1848	EXPRESSION			12	89741009	89747048			ENST00000279488.7	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0		N/A			
399	https://civic.genome.wustl.edu/links/variants/399	BRAF	673	MUTATION			7	140453136	140481403			ENST00000288602.6	75	GRCh37					gene_variant,gain_of_function_variant		2019-02-28 18:10:14 UTC	151.0					
400	https://civic.genome.wustl.edu/links/variants/400	HSPB1	3315	EXPRESSION			7	75931861	75933612			ENST00000248553.6	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
401	https://civic.genome.wustl.edu/links/variants/401	NQO1	1728	EXPRESSION			16	69743304	69760854			ENST00000320623.5	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
402	https://civic.genome.wustl.edu/links/variants/402	NQO1	1728	P187S			16	69745145	69745145	G	A	ENST00000320623.5	75	GRCh37					missense_variant	NM_000903.2:c.559C>T,NP_000894.1:p.Pro187Ser,NC_000016.9:g.69745145G>A	2018-11-30 14:43:10 UTC	2.0	CA126904	16809	PRO187SER		
403	https://civic.genome.wustl.edu/links/variants/403	BRCA1	672	UNDEREXPRESSION			17	41196312	41277387			ENST00000357654.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
404	https://civic.genome.wustl.edu/links/variants/404	ABCB1	5243	EXPRESSION			7	87133175	87342564			ENST00000265724.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
405	https://civic.genome.wustl.edu/links/variants/405	CXCR4	7852	EXPRESSION			2	136871919	136873813			ENST00000409817.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
406	https://civic.genome.wustl.edu/links/variants/406	MAGEH1	28986	EXPRESSION			X	55478538	55479998			ENST00000342972.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0					
407	https://civic.genome.wustl.edu/links/variants/407	ABCC3	8714	AMPLIFICATION			17	48712218	48769613			ENST00000285238.8	75	GRCh37					transcript_amplification		2017-12-01 14:40:31 UTC	3.0		N/A			
408	https://civic.genome.wustl.edu/links/variants/408	ABCC10	89845	EXPRESSION			6	43395292	43418168			ENST00000372530.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	3.0					
409	https://civic.genome.wustl.edu/links/variants/409	ASNS	440	AMPLIFICATION			7	97481430	97501854			ENST00000175506.4	75	GRCh37					transcript_amplification		2017-12-01 14:40:31 UTC	2.0		N/A			
410	https://civic.genome.wustl.edu/links/variants/410	CDX2	1045	EXPRESSION			13	28536274	28545276			ENST00000381020.7	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	20.0					
411	https://civic.genome.wustl.edu/links/variants/411	STAT3	6774	SH2 DOMAIN MUTATION			17	40465342	40475372			ENST00000264657.5	75	GRCh37					protein_altering_variant		2017-12-01 14:40:31 UTC	20.0					
412	https://civic.genome.wustl.edu/links/variants/412	POU5F1	5460	EXPRESSION			6	31132120	31138470			ENST00000259915.8	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	2.0		N/A			
413	https://civic.genome.wustl.edu/links/variants/413	ERBB2	2064	KINASE DOMAIN MUTATION			17	37879863	37882870			ENST00000269571.5	75	GRCh37					protein_altering_variant		2017-12-01 14:40:31 UTC	17.5		N/A			
414	https://civic.genome.wustl.edu/links/variants/414	ERBB2	2064	Y772_A775DUP	Mutations in the HER2 kinase domain occur at a 2-4% frequency in lung adenocarcinomas, the majority of which are in exon 20 as in-frame duplications or insertions in a small 8 codon region (774-781 or 775-782). These are analogous to the exon 20 alterations found in EGFR TK domain. The M774 insertion, M774insAYVM, represents 62.5% of all HER2 kinase domain mutations identified (when combined with the A775insYVMA mutations as they translate to the identical amino acid sequence changes). As demonstrated in mouse models (Perrera et al., PNAS 2009) and subsequent clinical trials in human lung adenocarcinoma with these insertions, HER2 YVMA mutants predict response to several targeted HER2 agonists such as afatinib, trastuzumab, neratinib and TDM-1 (trastuzumab emtansine) as monotherapy or combined with specific chemotherapies.		17	37880996	37880997		TACGTGATGGCT	ENST00000269571.5	75	GRCh37					inframe_insertion	NM_001005862.2:c.2224_2235dupTACGTGATGGCT,ENST00000269571.5:c.2314_2325dupTACGTGATGGCT,NC_000017.10:g.37880985_37880996dupTACGTGATGGCT,NC_000017.10:g.37880993_37880994insGCTTACGTGATG	2018-11-30 14:45:23 UTC	36.0	CA135369	44985	A775INSYVMA,P.A775_G776INSYVMA,P.E770_A771INSAYVM,TYR772_ALA775DUP,A775_G776INSYVMA,M774INSAYVM		
415	https://civic.genome.wustl.edu/links/variants/415	EGFR	1956	C797S			7	55249091	55249091	T	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2389T>A,NC_000007.13:g.55249091T>A,NM_005228.4:c.2389T>A,NP_005219.2:p.Cys797Ser	2018-11-30 14:43:20 UTC	17.5	CA16602785	376342	CYS797SER,RS1057519861		
416	https://civic.genome.wustl.edu/links/variants/416	ERBB2	2064	SERUM LEVELS			17	37856333	37884915			ENST00000269571.5	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	35.0		NONE FOUND			
417	https://civic.genome.wustl.edu/links/variants/417	THBS2	7058	UNDEREXPRESSION			6	169615875	169654139			ENST00000366787.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0		N/A			
419	https://civic.genome.wustl.edu/links/variants/419	NTRK1	4914	NTRK1 FUSIONS		NTRK1 Fusions	1	156844175	156851434			ENST00000524377.1	75	GRCh37					transcript_fusion		2020-09-18 04:21:02 UTC	77.5		N/A		8	https://civic.genome.wustl.edu/links/assertions/8
420	https://civic.genome.wustl.edu/links/variants/420	IDH1	3417	R132H	IDH1 R132 mutations have been observed in a number of cancer types, and appear to behave quite differently in different environments. In myelodysplastic syndromes and acute myeloid leukemia (AML), IDH1 R132 mutations have been shown to be associated with worse outcome and shorter overall survival. They have also been linked to cytogenetically normal AML, an intermediate risk subtype of the disease. However, in glioblastoma and astrocytoma, patients with IDH1 mutations have shown better overall survival than patients with wild-type IDH1. Also in contrast to AML, in glioblastoma, IDH1 mutations have been associated with the specific cytogenetic abnormalities, 1p and 19q deletions.		2	209113112	209113112	C	T	ENST00000415913.1	75	GRCh37					missense_variant	NM_001282386.1:c.395G>A,NP_005887.2:p.Arg132His,NC_000002.11:g.209113112C>T,ENST00000415913.1:c.395G>A	2018-11-30 14:43:24 UTC	9.0	CA170874	156444	ARG132HIS,RS121913500		
421	https://civic.genome.wustl.edu/links/variants/421	TERT	7015	RS2736100			5	1286516	1286516	C	A	ENST00000310581.5	75	GRCh37					coding_transcript_intron_variant,polymorphic_sequence_variant	NC_000005.9:g.1286516C>A,ENST00000310581.5:c.1574-3777G>T,NM_001193376.1:c.1574-3777G>T,NP_001180305.1:p.=	2018-11-30 14:43:20 UTC	10.0	CA11915794	375480			
422	https://civic.genome.wustl.edu/links/variants/422	STAG2	10735	UNDEREXPRESSION			X	123095568	123236506			ENST00000371157.3	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	14.0		N/A			
423	https://civic.genome.wustl.edu/links/variants/423	HLA-DRA	3122	EXPRESSION			6	32407619	32412823			ENST00000395388.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	15.0					
424	https://civic.genome.wustl.edu/links/variants/424	MYD88	4615	L265P			3	38182641	38182641	T	C	ENST00000396334.3	75	GRCh37					missense_variant,gain_of_function_variant	NC_000003.11:g.38182641T>C	2018-11-30 14:43:03 UTC	31.0	CA130043	37055	LEU265PRO,L273P,LEU273PRO		
425	https://civic.genome.wustl.edu/links/variants/425	KRAS	3845	G12V	KRAS mutations are the most common mutations in pancreatic cancer occurring in > 90% of cases. Of these the G12D activating mutation is the most prevalent and results in a loss of GTPase activity which in turn leads to a constitutively active form of KRAS. This is enough to cause pre-cancerous pancreatic intraepithelial lesions		12	25398284	25398284	C	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.35G>T,NP_004976.2:p.Gly12Val,NC_000012.11:g.25398284C>A,ENST00000256078.4:c.35G>T	2020-11-25 01:08:18 UTC	60.0	CA122540	12583	GLY12VAL,RS121913529		
426	https://civic.genome.wustl.edu/links/variants/426	BRAF	673	WILD TYPE			7	140434279	140624564			ENST00000288602.6	75	GRCh37					wild_type	N/A	2017-12-01 14:40:31 UTC	10.0		N/A			
427	https://civic.genome.wustl.edu/links/variants/427	NRAS	4893	Q61K			1	115256530	115256530	G	T	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.181C>A,NP_002515.1:p.Gln61Lys,NC_000001.10:g.115256530G>T,ENST00000369535.4:c.181C>A	2020-12-11 18:23:09 UTC	24.5	CA151263	73058	GLN61LYS,RS121913254		
428	https://civic.genome.wustl.edu/links/variants/428	MRE11	4361	FRAMESHIFT MUTATION			11	94152895	94227074			ENST00000323929.3	75	GRCh37					frameshift_variant		2017-12-01 14:40:31 UTC	10.0					
429	https://civic.genome.wustl.edu/links/variants/429	KIT	3815	EXPRESSION			4	55524085	55606881			ENST00000288135.5	75	GRCh37					N/A		2019-02-08 19:04:28 UTC	20.0		N/A			
431	https://civic.genome.wustl.edu/links/variants/431	CBFB	865	CBFB-MYH11	CBFB-MYH11 is the result of inv(16)(p13q22) or t(16;16)(p13;q22) and is sufficient for the diagnosis of acute myeloid leukemia (in the correct setting) according to WHO criteria, even when blast counts are <20% (Vardiman et al, Blood 2008). This fusion is typically associated with favorable prognosis relative to other AML subtypes (including cytogenetically normal); however, the impact of additional mutations in the context of this fusion is incompletely understood. AMLs with this fusion are often grouped with other rearrangements affecting genes encoding core binding factor subunits, referred to as CBF AMLs.		16	67063148	67116211			ENST00000412916.2	75	GRCh37	16	15797029	15820911	ENST00000396324.3	transcript_fusion		2017-12-01 14:40:31 UTC	20.0		N/A	INV(16)(P13.1;Q22),T(16;16)(P13.1;Q22)		
432	https://civic.genome.wustl.edu/links/variants/432	KMT2A	4297	MLL-MLLT3															transcript_fusion		2017-12-01 14:40:31 UTC	40.0			T(9;11)(P22;Q23),KMT2A-MLLT3	16	https://civic.genome.wustl.edu/links/assertions/16
433	https://civic.genome.wustl.edu/links/variants/433	HIF1A	3091	3' UTR Polymorphism			14	62213848	62213848	T	C	ENST00000394997.1	75	GRCh37					3_prime_UTR_variant,SNP	NC_000014.8:g.62213848T>C	2018-11-30 14:43:08 UTC	10.0	CA7216212				
434	https://civic.genome.wustl.edu/links/variants/434	HIF1A	3091	OVEREXPRESSION			14	62162258	62214976			ENST00000394997.1	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	25.0		N/A			
435	https://civic.genome.wustl.edu/links/variants/435	EPAS1	2034	OVEREXPRESSION			2	46524541	46613836			ENST00000263734.3	75	GRCh37					N/A		2020-12-18 06:19:05 UTC	25.0		N/A			
436	https://civic.genome.wustl.edu/links/variants/436	VHL	7428	LOSS			3	10182692	10193904			ENST00000256474.2	75	GRCh37					loss_of_function_variant	N/A	2017-12-01 14:40:31 UTC	23.0		N/A			
437	https://civic.genome.wustl.edu/links/variants/437	FLT3	2322	D835			13	28592642	28592642	C	A	ENST00000241453.7	75	GRCh37					protein_altering_variant	NC_000013.10:g.28592642C>A	2018-11-30 14:43:22 UTC	46.0	CA126347	16276		33	https://civic.genome.wustl.edu/links/assertions/33
438	https://civic.genome.wustl.edu/links/variants/438	PSMB8	5696	NUCLEAR EXPRESSION			6	32808494	32812480			ENST00000374881.2	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
439	https://civic.genome.wustl.edu/links/variants/439	PBK	55872	NUCLEAR EXPRESSION			8	27667137	27695612			ENST00000301905.4	75	GRCh37					N/A		2017-12-01 14:40:31 UTC	10.0		N/A			
440	https://civic.genome.wustl.edu/links/variants/440	PTTG1	9232	OVEREXPRESSION			5	159848829	159855748			ENST00000352433.5	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	10.0		N/A			
441	https://civic.genome.wustl.edu/links/variants/441	LEPR	3953	UNDEREXPRESSION			1	65886335	66107242			ENST00000349533.6	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	10.0		N/A			
442	https://civic.genome.wustl.edu/links/variants/442	EGFR	1956	MUTATION			7	55086794	55279321			ENST00000275493.2	75	GRCh37					inframe_variant		2021-01-21 07:52:18 UTC	280.0		N/A			
443	https://civic.genome.wustl.edu/links/variants/443	EGFR	1956	G465R		ECD MUTATION	7	55227926	55227926	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1393G>A,NC_000007.13:g.55227926G>A	2018-11-30 14:43:23 UTC	20.0	CA367579504	NONE FOUND	GLY465ARG		
444	https://civic.genome.wustl.edu/links/variants/444	NEDD9	4739	EXPRESSION			6	11185051	11382581			ENST00000504387.1	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	15.0		N/A			
445	https://civic.genome.wustl.edu/links/variants/445	ETS2	2114	RS461155			21	40191638	40191638	A	G	ENST00000360214.3	75	GRCh37					synonymous_variant	NC_000021.8:g.40191638A>G,NM_005239.5:c.1023A>G,ENST00000360214.3:c.1023A>G,NP_005230.1:p.Pro341=	2018-11-30 14:43:31 UTC	10.0	CA10025650	NONE FOUND	P341P,P481P,PRO341=		
446	https://civic.genome.wustl.edu/links/variants/446	KRT18	3875	UNDEREXPRESSION			12	53342655	53346684			ENST00000388837.2	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	2.0		N/A			
447	https://civic.genome.wustl.edu/links/variants/447	FGF13	2258	CYTOPLASMIC EXPRESSION			X	137715011	138286269			ENST00000370603.3	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	15.0		N/A			
448	https://civic.genome.wustl.edu/links/variants/448	SSX1	6756	SS18-SSX1		SYT-SSX fusions													transcript_fusion		2017-12-01 14:40:32 UTC	145.0			T(X;18)(P11.23;Q11)		
449	https://civic.genome.wustl.edu/links/variants/449	SSX2	6757	SS18-SSX2		SYT-SSX fusions													transcript_fusion		2017-12-01 14:40:32 UTC	85.0			T(X;18)(P11.21;Q11)		
450	https://civic.genome.wustl.edu/links/variants/450	SSX4	6759	SS18-SSX4		SYT-SSX fusions	18	23612363	23670589			ENST00000415083.2	75	GRCh37	X	48261524	48265521	ENST00000376884.2	transcript_fusion		2017-12-01 14:40:32 UTC	5.0					
451	https://civic.genome.wustl.edu/links/variants/451	ABCB1	5243	S893A/T	Refer to  https://www.pharmgkb.org/rsid/rs2032582  for more information.		7	87160618	87160618	A	C	ENST00000265724.3	75	GRCh37					missense_variant	NC_000007.13:g.87160618A>C	2018-11-30 14:42:57 UTC	15.0	CA179699	166619,166622	RS2032582		
453	https://civic.genome.wustl.edu/links/variants/453	EGFR	1956	S492R		ECD MUTATION	7	55228009	55228009	C	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1476C>A,NC_000007.13:g.55228009C>A,NP_005219.2:p.Ser492Arg,NM_005228.4:c.1476C>A	2018-11-30 14:43:01 UTC	23.0	CA16602784	376341	SER492ARG		
454	https://civic.genome.wustl.edu/links/variants/454	EGFR	1956	R451C			7	55227884	55227884	C	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1351C>T,NC_000007.13:g.55227884C>T,NM_001346898.1:c.1351C>T,NP_001333827.1:p.Arg451Cys	2018-11-30 14:42:58 UTC	2.0	CA158917074	NONE FOUND	ARG451CYS,RS377567759		
455	https://civic.genome.wustl.edu/links/variants/455	EGFR	1956	K467T		ECD MUTATION	7	55227933	55227933	A	C	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.1400A>C,NC_000007.13:g.55227933A>C	2018-11-30 14:43:03 UTC	6.0	CA367579521	N/A	LYS467THR		
456	https://civic.genome.wustl.edu/links/variants/456	FCGR2A	2212	H167R			1	161479745	161479745	A	G	ENST00000271450.6	75	GRCh37					missense_variant	NM_001136219.1:c.500A>G,NP_001129691.1:p.His167Arg,ENST00000271450.6:c.500A>G,NC_000001.10:g.161479745A>G	2018-11-30 14:42:56 UTC	35.0	CA124361	14823	RS1801274,H131R,H166R,HIS167ARG		
457	https://civic.genome.wustl.edu/links/variants/457	FCGR3A	2214	F212V			1	161514542	161514542	A	C	ENST00000367969.3	75	GRCh37					missense_variant	NC_000001.10:g.161514542A>C,NM_001127593.1:c.526T>G,NP_001121065.1:p.Phe176Val,ENST00000367969.3:c.526T>G	2018-11-30 14:42:58 UTC	35.0	CA1211378	225994	RS396991,V158F,PHE176VAL		
458	https://civic.genome.wustl.edu/links/variants/458	FCGR2B	2213	I232T			1	161643798	161643798	T	C	ENST00000358671.5	75	GRCh37					missense_variant	NM_004001.4:c.695T>C,NP_003992.3:p.Ile232Thr,ENST00000358671.5:c.695T>C,NC_000001.10:g.161643798T>C	2018-11-30 14:42:58 UTC	20.0	CA117549	5467	RS1050501,ILE232THR		
460	https://civic.genome.wustl.edu/links/variants/460	EGFR	1956	P753S			7	55242487	55242487	C	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2257C>T,NC_000007.13:g.55242487C>T,NM_005228.4:c.2257C>T,NP_005219.2:p.Pro753Ser	2018-11-30 14:43:03 UTC	7.5	CA4266020	376081	PRO753SER,RS121913231		
461	https://civic.genome.wustl.edu/links/variants/461	PML	5371	B2 DOMAIN MUTATION	The B2 domain in PML is the binding site for ATRA. Point mutations in this region have been associated with ATRA resistance in patients with APL.	PML-RARa B2 Domain	15	74315213	74315219			ENST00000268058.3	75	GRCh37					missense_variant		2017-12-01 14:40:32 UTC	20.0					
462	https://civic.genome.wustl.edu/links/variants/462	PML	5371	PML-RARA A216V	A216V in the B2 domain of PML is one of the variants found in a patient with ATRA-resistant APL.	PML-RARa B2 Domain	15	74315213	74315213	C	T	ENST00000268058.3	75	GRCh37					missense_variant	NC_000015.9:g.74315213C>T	2020-06-08 17:05:59 UTC	30.0	CA393121894	NONE FOUND			
463	https://civic.genome.wustl.edu/links/variants/463	PML	5371	PML-RARA L218P	L218P in the B2 domain of PML is one of the variants found in a patient with ATRA-resistant APL.	PML-RARa B2 Domain	15	74315219	74315219	T	C	ENST00000268058.3	75	GRCh37					missense_variant	NC_000015.9:g.74315219T>C	2018-11-30 14:43:09 UTC	7.5	CA393121927	NONE FOUND			
464	https://civic.genome.wustl.edu/links/variants/464	MET	4233	EXON 14 MUTATION and AMPLIFICATION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					exon_loss_variant,transcript_amplification		2020-05-28 20:05:19 UTC	7.5		N/A			
465	https://civic.genome.wustl.edu/links/variants/465	ROS1	6098	CD74-ROS1 G2032R	The G2032R missense mutation has been observed in patients with crizotinib-resistant non-small cell lung cancer harboring CD74-ROS1 rearrangement. Independent in vitro studies have confirmed that this mutation confers marked resistance to crizotinib cells over CD74-ROS1 alone. Multiple groups have indicated CD74-ROS1 G2032R expressing cell lines are sensitive to both cabozantinib and foretinib individually administered in vitro. One group additionally showed this mutation conferred relative resistance to alectinib, brigatinib, ceritinib, and AZD3463 in vitro.		6	117638347	117638347	C	T	ENST00000368508.3	75	GRCh37					missense_variant,transcript_fusion	NC_000006.11:g.117638347C>T	2018-11-30 14:43:24 UTC	31.5	CA16602597	376139			
466	https://civic.genome.wustl.edu/links/variants/466	FGFR1	2260	ZNF198-FGFR1															transcript_fusion		2017-12-01 14:40:32 UTC	10.0		N/A	T(8;13)(P11;Q12)		
467	https://civic.genome.wustl.edu/links/variants/467	KDR	3791	A1065T			4	55955969	55955969	C	T	ENST00000263923.4	75	GRCh37					missense_variant	NM_002253.2:c.3193G>A,NP_002244.1:p.Ala1065Thr,ENST00000263923.4:c.3193G>A,NC_000004.11:g.55955969C>T	2018-11-30 14:43:16 UTC	3.0	CA2924178	NONE FOUND	ALA1065THR,RS56302315		
468	https://civic.genome.wustl.edu/links/variants/468	KDR	3791	D717V			4	55968180	55968180	T	A	ENST00000263923.4	75	GRCh37					missense_variant	ENST00000263923.4:c.2150A>T,NC_000004.11:g.55968180T>A	2018-11-30 14:43:18 UTC	3.0	CA356908090	NONE FOUND	ASP717VAL		
469	https://civic.genome.wustl.edu/links/variants/469	TSC2	7249	Q1178*			16	2130300	2130300	C	T	ENST00000219476.3	75	GRCh37					stop_gained	NM_000548.4:c.3532C>T,NP_000539.2:p.Gln1178Ter,ENST00000219476.3:c.3532C>T,NC_000016.9:g.2130300C>T	2018-11-30 14:43:21 UTC	12.5	CA019253	49263	Q1178X,GLN1178TER,RS45517297		
470	https://civic.genome.wustl.edu/links/variants/470	MTOR	2475	F2108L			1	11187094	11187094	G	T	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6324C>A,NC_000001.10:g.11187094G>T	2018-11-30 14:43:23 UTC	16.5	CA338391533	NONE FOUND	PHE2108LEU		
471	https://civic.genome.wustl.edu/links/variants/471	RAD51D	5892	R186*			17	33433425	33433425	G	A	ENST00000345365.6	75	GRCh37					stop_gained	NC_000017.10:g.33433425G>A	2018-11-30 14:42:58 UTC	5.0	CA129082	30285	R186X,ARG186TER,RS387906843		
472	https://civic.genome.wustl.edu/links/variants/472	ALDH1A2	8854	EXPRESSION			15	58245622	58358616			ENST00000249750.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	30.0		N/A			
473	https://civic.genome.wustl.edu/links/variants/473	ALDH1A2	8854	UNDEREXPRESSION			15	58245622	58358616			ENST00000249750.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	2.0		N/A			
474	https://civic.genome.wustl.edu/links/variants/474	CIP2A	57650	EXPRESSION			3	108268716	108308299			ENST00000295746.8	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	15.0		N/A			
475	https://civic.genome.wustl.edu/links/variants/475	CIP2A	57650	UNDEREXPRESSION			3	108268716	108308299			ENST00000295746.8	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	3.0		N/A			
476	https://civic.genome.wustl.edu/links/variants/476	MIR218-1	407000	EXPRESSION			4	20529898	20530007			ENST00000384999.1	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	15.0		N/A			
477	https://civic.genome.wustl.edu/links/variants/477	BRCA1	672	P968FS			17	41244645	41244646		GA	ENST00000471181.2	75	GRCh37					frameshift_truncation	NM_007294.3:c.2902_2903insTC,NP_009225.1:p.Pro968Leufs,NC_000017.10:g.41244645_41244646insGA,ENST00000471181.2:c.2902_2903insTC	2018-11-30 14:44:14 UTC	20.0	CA001889	91602	3021INSTC,PRO968LEUFS,RS398122670		
479	https://civic.genome.wustl.edu/links/variants/479	KRAS	3845	Q22*			12	25398255	25398255	G	A	ENST00000256078.4	75	GRCh37					stop_gained	ENST00000256078.4:c.64C>T,NC_000012.11:g.25398255G>A,NM_004985.4:c.64C>T,NP_004976.2:p.Gln22Ter	2018-11-30 14:43:00 UTC	5.0	CA384157370	NONE FOUND	Q22X,GLN22TER		
481	https://civic.genome.wustl.edu/links/variants/481	DDX43	55510	OVEREXPRESSION			6	74104471	74127292			ENST00000370336.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	4.0		N/A			
482	https://civic.genome.wustl.edu/links/variants/482	KIT	3815	RS3733542			4	55602765	55602765	G	C	ENST00000288135.5	75	GRCh37					synonymous_variant	NM_000222.2:c.2586G>C,NP_000213.1:p.Leu862=,ENST00000288135.5:c.2586G>C,NC_000004.11:g.55602765G>C	2018-11-30 14:43:07 UTC	5.0	CA2923796	255572	LEU862=		
483	https://civic.genome.wustl.edu/links/variants/483	TBK1	29110	OVEREXPRESSION			12	64845660	64895888			ENST00000331710.5	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	2.0		N/A			
485	https://civic.genome.wustl.edu/links/variants/485	STK11	6794	LOSS			19	1205740	1228428			ENST00000326873.7	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:32 UTC	23.0		N/A			
486	https://civic.genome.wustl.edu/links/variants/486	HAVCR2	84868	OVEREXPRESSION			5	156512843	156536725			ENST00000307851.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	10.5		N/A			
487	https://civic.genome.wustl.edu/links/variants/487	MMP2	4313	SERUM LEVELS			16	55512883	55540603			ENST00000219070.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	25.0					
488	https://civic.genome.wustl.edu/links/variants/488	MMP9	4318	SERUM LEVELS			20	44637547	44645200			ENST00000372330.3	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	15.0					
490	https://civic.genome.wustl.edu/links/variants/490	HSPH1	10808	NUCLEAR EXPRESSION			13	31710765	31736064			ENST00000320027.5	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	11.0					
491	https://civic.genome.wustl.edu/links/variants/491	HSPH1	10808	T17 DELETION			13	31722621	31722637			ENST00000320027.5	75	GRCh37					short_tandem_repeat_variation		2017-12-01 14:40:32 UTC	10.0					
492	https://civic.genome.wustl.edu/links/variants/492	ECSCR	641700	EXPRESSION															N/A		2017-12-01 14:40:32 UTC	5.0					
493	https://civic.genome.wustl.edu/links/variants/493	ROBO4	54538	EXPRESSION			11	124753587	124768177			ENST00000306534.3	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	5.0					
494	https://civic.genome.wustl.edu/links/variants/494	PIM1	5292	NUCLEAR EXPRESSION			6	37137979	37143202			ENST00000373509.5	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	10.0		N/A			
495	https://civic.genome.wustl.edu/links/variants/495	MDM2	4193	SNP309			12	69202580	69202580	T	G	ENST00000462284.1	75	GRCh37					coding_transcript_intron_variant	NC_000012.11:g.69202580T>G	2018-11-30 14:42:58 UTC	10.0	CA123622	13904			
496	https://civic.genome.wustl.edu/links/variants/496	ERBB2	2064	L866M	This mutation was shown to be an activating mutation and conferred sensitivity to a combination of trastuzumab with neratinib or lapatinib in colorectal cancer patient-derived xenografts.		17	37881404	37881404	C	A	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2596C>A,NC_000017.10:g.37881404C>A,NM_001289937.1:c.2596C>A,NP_001276866.1:p.Leu866Met	2018-11-30 14:43:11 UTC	4.0	CA399304874	NONE FOUND	LEU866MET		
497	https://civic.genome.wustl.edu/links/variants/497	ERBB2	2064	S310F/Y	ERBB2 S310F/Y was one of the first ERBB2 variants to be functionally classified (Greulich et al. 2012). This mutation was shown to be an activating mutation (through hyperphosphorylation) in an in vitro assay. In the same paper, this mutation (along with other ERBB2 activating mutations) in murine Ba/F3 cells have been shown to be sensitive to the ERBB2 inhibitors (afatinib, lapatinib and neratinib). More recent evidence may show that HER2 acitivating mutations confer sensitivity to a host of tyrosine kinase inhibitors, which is the topic of current clinical trials and research.		17	37868208	37868208			ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.929C>T,NC_000017.10:g.37868208C>T	2017-12-01 14:40:32 UTC	4.0		376189,376188			
498	https://civic.genome.wustl.edu/links/variants/498	MIR218-1	407000	UNDEREXPRESSION			4	20529898	20530007			ENST00000384999.1	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	3.0		N/A			
499	https://civic.genome.wustl.edu/links/variants/499	ALK	238	ALK FUSIONS	Following the initial discovery and characterization of NPM-ALK fusion mutation in anaplastic large cell lymphoma (ALCL), EML4-ALK fusions were found to be driver mutations in a subset of lung adenocarcinomas. ALK fusions bring the C-terminal ALK kinase domain together with the N terminal region of the fusion partner, and have since been found in a range of cancers including inflammatory myofibroblastic tumor, renal cell carcinoma, diffuse large B cell lymphoma and colorectal cancer.   In a Phase I trial for crizotinib, a 92% response rate was seen in the subset of patients with a specific EML4-ALK variant, which was higher than the 57% rate in the overall ALK-rearranged population, but the subpopulation numbers were insufficient to correlate variant type with patient response.   Due to restricted wild-type ALK expression, and also mild phenotypes seen in ALK knockout mice, ALK fusions are desirable targets.  ALK inhibitor TAE684 was used in initial characterizations of ALK fusion cancer drivers, and crizotinib  a small molecule ATP-competitor RTK inhibitor which is highly selective for ALK and MET - has been approved as first line therapy in ALK-rearranged NSCLC.     ALK-rearrangement defines an NSCLC subtype that makes up 3-5% of NSCLC cases, and is characterized by higher proportions of younger patients and never smokers. EML4-ALK variant 1 is the most common ALK fusion in NSCLC and was the first to be discovered and demonstrate cancer driver properties in vitro and in mouse models. A Phase I study of crizotinib in ALK-rearranged NSCLC demonstrated an increase in overall survival when compared to standard chemotherapy. These and other initial results prompted accelerated approval for crizotinib in NSCLC.  Continued clinical work demonstrated benefit with crizotinib over chemotherapy in multi-armed studies, and as first line therapy. Crizotinib was also found to remain beneficial to NSCLC patients who had progressed on crizotinib. Additionally, crizotinib was shown to increase intracranial disease control in brain metastasis occurring from ALK-rearranged NSCLC.	ALK Fusions	2	29415640	29446394			ENST00000389048.3	75	GRCh37					transcript_fusion		2020-12-10 19:29:28 UTC	648.0		N/A	REARRANGEMENT	3,34	https://civic.genome.wustl.edu/links/assertions/3	https://civic.genome.wustl.edu/links/assertions/34
500	https://civic.genome.wustl.edu/links/variants/500	ALK	238	EML4-ALK e20-e20	EML4-ALK variant 2 consists of a fusion of the ALK kinase domain (exons 20-29) with EML4 exons 1-20. Variant 2 has cytoplasmic distribution and makes up ~10% of EML4-ALK fusions found in NSCLC,. Although the specific variant is not consistently reported, single cases demonstrating response to crizotinib treatment in NSCLC and a differentiated malignant neoplasm of unknown origin have been reported. In vitro, this variant has shown greater sensitivity to ALK inhibition with TAE684 and crizotinib than the EML4-ALK variants 1 (E13;A20), 3a (E6;A20) and 3b (E6ins33;A20). The variant was reported to be less stable in cells than other variants, and may be a client protein of Hsp90. Along these lines the variant has shown preclinical sensitivity to Hsp90 inhibition.	ALK Fusions	2	42396490	42552694			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2020-12-04 18:24:17 UTC	16.5		N/A			
501	https://civic.genome.wustl.edu/links/variants/501	ALK	238	EML4-ALK e2-e20		ALK Fusions	2	42396490	42472827			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2020-12-04 18:24:29 UTC	1.75		N/A			
502	https://civic.genome.wustl.edu/links/variants/502	KDR	3791	R961W			4	55961059	55961059	G	A	ENST00000263923.4	75	GRCh37					missense_variant	NM_002253.2:c.2881C>T,NP_002244.1:p.Arg961Trp,ENST00000263923.4:c.2881C>T,NC_000004.11:g.55961059G>A	2018-11-30 14:43:18 UTC	2.5	CA2924278	NONE FOUND	ARG961TRP,RS530419081		
503	https://civic.genome.wustl.edu/links/variants/503	ALK	238	EML4-ALK e6-e20	The EML4-ALK variant 3a consists of the ALK kinase domain fused to EML4 exons 1-6, while the 3b variant has an additional 33bp of intronic EML4 sequence between EML4 and ALK regions. The two variants were found to originate from a single genomic rearrangement, and 3a/3b is found in ~ 30% of EML4-ALK positive NSCLC. Variant 3a has cytoplasmic and nuclear distribution. In vitro, these variants have shown sensitivity to ALK inhibitors TAE684 and crizotinib but less sensitive than other EML4-ALK variants. The H2228 cell line contains 3a and 3b variants and is described as having cyctostatic response to ALK inhibition as opposed to apoptotic. In a study of 31 NSCLC patients with EML4-ALK rearrangements, 4/5 patients with the 3a variant showed a partial response while 1 showed progressive disease (the only PD observed). In cells the 3a variant was reported to be more stable than other variants, less sensitive to crizotinib and not to respond to Hsp90 inhibition.	ALK Fusions	2	42396490	42491871			ENST00000318522.5	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2020-12-04 18:24:47 UTC	25.0		N/A			
504	https://civic.genome.wustl.edu/links/variants/504	TP53	7157	P47S			17	7579548	7579548	G	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.139C>T,NP_000537.3:p.Pro47Ser,NC_000017.10:g.7579548G>A,ENST00000269305.4:c.139C>T	2018-11-30 14:43:23 UTC	0.5	CA000053	43588	PRO47SER,RS1800371		
505	https://civic.genome.wustl.edu/links/variants/505	GNAQ	2776	MUTATION			9	80331003	80646374			ENST00000286548.4	75	GRCh37							2017-12-01 14:40:32 UTC	26.0					
506	https://civic.genome.wustl.edu/links/variants/506	GNA11	2767	MUTATION			19	3094408	3124002			ENST00000078429.4	75	GRCh37							2017-12-01 14:40:32 UTC	24.0					
507	https://civic.genome.wustl.edu/links/variants/507	GNAQ	2776	Q209			9	80409487	80409489			ENST00000286548.4	75	GRCh37					protein_altering_variant		2017-12-01 14:40:32 UTC	20.0		375957,375956,375955	GLN209		
508	https://civic.genome.wustl.edu/links/variants/508	PMS2	5395	K706FS*19			7	6022512	6022512			ENST00000265849.7	75	GRCh37					minus_1_frameshift_variant	NM_000535.6:c.2117delA,NP_000526.2:p.Lys706Serfs,NC_000007.13:g.6022512del	2017-12-01 14:40:32 UTC	10.0		142765	RS587782704,LYS706SERFS		
509	https://civic.genome.wustl.edu/links/variants/509	KIT	3815	EXON 9 MUTATION	In patients with gastrointestinal stromal tumors (GIST), imatinib has improved outcomes for patients with KIT mutations. However, acquired resistance to imatinib is common. Patients harboring exon 9 KIT mutations may benefit from higher imatinib doses (800mg/daily). Similarly, imatinib-refractory tumors showed sensitivity to sunitinib treatment. Improved responses to either treatment were not observed in patients with exon 11 mutations.		4	55592023	55592216			ENST00000288135.5	75	GRCh37					exon_variant		2019-03-21 20:36:22 UTC	102.5					
510	https://civic.genome.wustl.edu/links/variants/510	PTEN	5728	MUTATION			10	89622870	89731687			ENST00000371953.3	75	GRCh37					protein_altering_variant		2017-12-01 14:40:32 UTC	31.0		N/A			
511	https://civic.genome.wustl.edu/links/variants/511	FGFR2	2263	MUTATION			10	123239371	123357917			ENST00000457416.2	75	GRCh37					transcript_variant,gain_of_function_variant		2017-12-01 14:40:32 UTC	8.0		376157,376156,376317,13272			
512	https://civic.genome.wustl.edu/links/variants/512	ALK	238	MUTATION			2	29415640	30144432			ENST00000389048.3	75	GRCh37					gene_variant,gain_of_function_variant		2017-12-01 14:40:32 UTC	20.0		N/A			
513	https://civic.genome.wustl.edu/links/variants/513	ALK	238	NPM-ALK		ALK Fusions	5	170814120	170818803			ENST00000517671.1	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-12-01 14:40:32 UTC	27.0		N/A	T(2;5)(P23;Q35)		
514	https://civic.genome.wustl.edu/links/variants/514	ALK	238	RANBP2-ALK		ALK Fusions	2	109335937	109375004			ENST00000283195.6	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-12-01 14:40:32 UTC	10.0		N/A			
515	https://civic.genome.wustl.edu/links/variants/515	FGFR1	2260	N546K			8	38274849	38274849	G	T	ENST00000341462.5	75	GRCh37					missense_variant	NM_023110.2:c.1638C>A,NP_075598.2:p.Asn546Lys,ENST00000341462.5:c.1638C>A,NC_000008.10:g.38274849G>T	2018-11-30 14:43:21 UTC	0.5	CA357830	224896	ASN546LYS,RS779707422		
516	https://civic.genome.wustl.edu/links/variants/516	ROS1	6098	CD74-ROS1 L2026M	The L2026M mutation is considered a gatekeeper mutation located in the inhibitor binding pocket of ROS1 and corresponding to L1196M in ALK and T790M in EGFR. This mutation has not been reportedly observed in a patient but inferred as a variant likely to emerge in crizotinib-resistant tumors. In vitro kinase activity, structural predictions and growth inhibition assays indicate the L2026M mutation in the CD74-ROS1 fusion provides crizotinib resistance. Additional preclinical assays have indicated that crizotinib resistant cells harboring this mutation are sensitive to PF-06463922 and foretinib.		6	117638365	117638365	G	T	ENST00000368508.3	75	GRCh37					missense_variant,transcript_fusion	NC_000006.11:g.117638365G>T,ENST00000368508.3:c.6076C>A	2018-11-30 14:43:26 UTC	9.0	CA365441006	NONE FOUND			
517	https://civic.genome.wustl.edu/links/variants/517	ROS1	6098	CD74-ROS1 L2155S			6	117630062	117630062	A	G	ENST00000368508.3	75	GRCh37					missense_variant,transcript_fusion	NC_000006.11:g.117630062A>G	2018-11-30 14:43:11 UTC	3.0	CA365440144	NONE FOUND			
518	https://civic.genome.wustl.edu/links/variants/518	ROS1	6098	CD74-ROS1 G2101A			6	117631376	117631376	C	G	ENST00000368508.3	75	GRCh37					missense_variant,transcript_fusion	NC_000006.11:g.117631376C>G	2018-11-30 14:43:07 UTC	4.0	CA365440505	NONE FOUND			
519	https://civic.genome.wustl.edu/links/variants/519	FLT3	2322	MUTATION			13	28577411	28674729			ENST00000241453.7	75	GRCh37					transcript_variant,gain_of_function_variant		2020-07-13 20:08:51 UTC	85.0					
520	https://civic.genome.wustl.edu/links/variants/520	ALK	238	CLTC-ALK	The t(2;17)(p23;q23) translocation results in the CLTC-ALK fusion protein, the most common ALK fusion observed in diffuse large B cell lymphoma (DLBCL). ALK-rearranged DLBCL is less responsive to CHOP chemotherapy. Preclinical work indicates that CLTC-ALK DLBCL is responsive to ALK inhibition in cell lines and mouse models, and two case studies show short response followed by progression when heavily pretreated and advanced ALK-positive DLBCL is treated with crizotinib (one case CLTC-ALK, one case an unknown ALK fusion).	ALK Fusions	17	57697219	57768072			ENST00000269122.3	75	GRCh37	2	29415640	29446394	ENST00000389048.3	transcript_fusion		2017-12-01 14:40:32 UTC	19.0		N/A	T(2;17)(P23;Q23)		
521	https://civic.genome.wustl.edu/links/variants/521	U2AF1	7307	MUTATION			21	44513066	44527697			ENST00000291552.4	75	GRCh37					protein_altering_variant		2017-12-01 14:40:32 UTC	20.0		N/A			
522	https://civic.genome.wustl.edu/links/variants/522	BRAF	673	DEL 485-490			7	140477838	140477855	AGGTGCTGTCACATTCAA		ENST00000288602.6	75	GRCh37					inframe_deletion	ENST00000288602.6:c.1453_1470del	2019-08-01 19:07:30 UTC	3.0	unregistered	NONE FOUND			
524	https://civic.genome.wustl.edu/links/variants/524	DUX4	100288687	DUX4 FUSIONS															transcript_fusion		2017-12-01 14:40:32 UTC	11.5					
525	https://civic.genome.wustl.edu/links/variants/525	B4GALT1	2683	EXPRESSION			9	33110635	33167354			ENST00000379731.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	15.0		N/A			
526	https://civic.genome.wustl.edu/links/variants/526	BCL2L11	10018	DELETION POLYMORPHISM			2	111883195	111886097			ENST00000393256.3	75	GRCh37					polymorphic_sequence_variant		2017-12-01 14:40:32 UTC	40.0					
527	https://civic.genome.wustl.edu/links/variants/527	ALK	238	ALK FUSION I1171	Multiple case reports indicate that the I1171T missense mutation in ALK-rearranged non-small cell lung cancer (NSCLC) confers resistance to crizotinib and alectinib but is sensitive to ceritinib treatment. These results have been validated in vitro. In vitro evidence indicates this mutation interferes with alectinib binding the active site of ALK and may explain the sensitivity to the structurally distinct ALK inhibitor ceritinib.		2	29445213	29445213	A	G	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3512T>C,NC_000002.11:g.29445213A>G,NM_004304.4:c.3512T>C,NP_004295.2:p.Ile1171Thr	2018-11-30 14:43:29 UTC	42.5	CA346462880	375888	ALK FUSION ILE1171		
528	https://civic.genome.wustl.edu/links/variants/528	ALK	238	EML4-ALK  V1180L	The V1180L missense mutation was identified in a mutagenesis screen to find mutations that conferred resistance to alectinib in a non-small cell lung cancer cell line. This mutation shows resistance to crizotinib and alectinib but sensitivity to TAE684, ceritinib and more mild sensitivity to brigatinib. Similar to I1171T, it resides in the ATP pocket of ALK and likely interferes with alectinib and crizotinib binding as a mechanism of resistance.		2	29443679	29443679	C	G	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3538G>C,NC_000002.11:g.29443679C>G	2018-11-30 14:43:29 UTC	13.0	CA346473150	NONE FOUND	EML4-ALK VAL1180LEU		
529	https://civic.genome.wustl.edu/links/variants/529	SIRT1	23411	OVEREXPRESSION			10	69644427	69678147			ENST00000212015.6	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	16.0		N/A			
530	https://civic.genome.wustl.edu/links/variants/530	KRAS	3845	G12R			12	25398285	25398285	C	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.34G>C,NP_004976.2:p.Gly12Arg,NC_000012.11:g.25398285C>G,ENST00000256078.4:c.34G>C	2020-11-25 00:59:25 UTC	32.5	CA122531	12579	GLY12ARG,RS121913530		
531	https://civic.genome.wustl.edu/links/variants/531	TP53	7157	P72R	This polymorphism is relatively widely studied across cancer types, but meta-analyses in breast, lung and cervical cancer cohorts have so far been inconclusive as to the significance of a patient's genotype at this locus as it relates to cancer susceptibility and prognosis.		17	7579472	7579472	G	C	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.215C>G,NP_000537.3:p.Pro72Arg,NC_000017.10:g.7579472G>C,ENST00000269305.4:c.215C>G	2018-11-30 14:43:09 UTC	45.0	CA000072	12351	PRO72ARG,P33R,RS1042522		
532	https://civic.genome.wustl.edu/links/variants/532	PALB2	79728	BIALLELIC INACTIVATION			16	23614491	23652631			ENST00000261584.4	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:32 UTC	17.5					
533	https://civic.genome.wustl.edu/links/variants/533	SMAD4	4089	EXPRESSION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	15.0		N/A			
534	https://civic.genome.wustl.edu/links/variants/534	FANCC	2176	LOSS-OF-FUNCTION			9	97861336	98079984			ENST00000289081.3	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:32 UTC	3.0		N/A			
535	https://civic.genome.wustl.edu/links/variants/535	PDGFRB	5159	EBF1-PDGFRB	EBF1-PDGFRB fusions are associated with Ph-like acute lymphoblastic leukemia lacking the BCR-ABL fusion. Case reports have shown positive responses to imatinib treatment.		5	158134987	158526769			ENST00000517373.1	75	GRCh37	5	149493400	149505140	ENST00000261799.4	transcript_fusion		2020-07-11 05:52:03 UTC	32.5		N/A		19	https://civic.genome.wustl.edu/links/assertions/19
537	https://civic.genome.wustl.edu/links/variants/537	RB1	5925	EXPRESSION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	10.0		N/A			
538	https://civic.genome.wustl.edu/links/variants/538	MLH1	4292	METHYLATION															N/A		2017-12-01 14:40:32 UTC	10.0		N/A			
539	https://civic.genome.wustl.edu/links/variants/539	PTPN11	5781	EXPRESSION			12	112856718	112947717			ENST00000351677.2	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	10.0		N/A			
540	https://civic.genome.wustl.edu/links/variants/540	FLT3	2322	T227M	FLT3 T227M (rs1933437) is a common polymorphism with a GMAF around .60 based on the Exome Aggregation Consortium (ExAC) data. Its role in cancer predisposition is still unknown, however it may be associated with the development of leukopenia in patients treated with sunitinib.		13	28624294	28624294	G	A	ENST00000241453.7	75	GRCh37					missense_variant,SNP	NM_004119.2:c.680C>T,NP_004110.2:p.Thr227Met,NC_000013.10:g.28624294G>A,ENST00000241453.7:c.680C>T	2018-11-30 14:43:26 UTC	15.0	CA159846	134447	RS1933437,THR227MET		
541	https://civic.genome.wustl.edu/links/variants/541	PALB2	79728	L531FS*30			16	23646276	23646276			ENST00000261584.4	75	GRCh37					minus_1_frameshift_variant,SNP		2017-12-01 14:40:32 UTC	15.0			LEU531FS*30		
542	https://civic.genome.wustl.edu/links/variants/542	MTOR	2475	S2215Y			1	11184573	11184573	G	T	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6644C>A,NC_000001.10:g.11184573G>T,NM_004958.3:c.6644C>A,NP_004949.1:p.Ser2215Tyr	2018-11-30 14:43:11 UTC	2.0	CA16602587	376129	SER2215TYR		
543	https://civic.genome.wustl.edu/links/variants/543	MTOR	2475	C1483Y			1	11217230	11217230	C	T	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.4448G>A,NC_000001.10:g.11217230C>T,NM_004958.3:c.4448G>A,NP_004949.1:p.Cys1483Tyr	2018-11-30 14:43:18 UTC	2.0	CA16602888	376453	CYS1483TYR		
544	https://civic.genome.wustl.edu/links/variants/544	MTOR	2475	E1799K			1	11190804	11190804	C	T	ENST00000361445.4	75	GRCh37					missense_variant	NM_004958.3:c.5395G>A,NP_004949.1:p.Glu1799Lys,NC_000001.10:g.11190804C>T,ENST00000361445.4:c.5395G>A	2018-11-30 14:43:11 UTC	2.0	CA279594	217823	GLU1799LYS,RS863225264		
545	https://civic.genome.wustl.edu/links/variants/545	FGFR2	2263	N550K			10	123258034	123258034	A	T	ENST00000457416.2	75	GRCh37					missense_variant,gain_of_function_variant	NM_022970.3:c.1650T>A,NP_075259.4:p.Asn550Lys,ENST00000457416.2:c.1650T>A,NC_000010.10:g.123258034A>T	2018-11-30 14:43:21 UTC	3.0	CA16602614	376157	ASN550LYS,N549K,RS121913476		
546	https://civic.genome.wustl.edu/links/variants/546	ACTA1	58	EXPRESSION			1	229566992	229569841			ENST00000366684.3	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	10.0		N/A			
547	https://civic.genome.wustl.edu/links/variants/547	RB1	5925	OVEREXPRESSION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					N/A		2017-12-01 14:40:32 UTC	2.0		N/A			
548	https://civic.genome.wustl.edu/links/variants/548	PPP1R15A	23645	RS557806			19	49377242	49377242	G	C	ENST00000200453.5	75	GRCh37					missense_variant,polymorphic_sequence_variant	NM_014330.3:c.752G>C,NP_055145.3:p.Arg251Pro,ENST00000200453.5:c.752G>C,NC_000019.9:g.49377242G>C	2018-11-30 14:43:11 UTC	5.0	CA9560103	NONE FOUND	ARG251PRO,R251P		
549	https://civic.genome.wustl.edu/links/variants/549	ALK	238	F1245C			2	29436859	29436859	A	C	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3734T>G,NP_004295.2:p.Phe1245Cys,NC_000002.11:g.29436859A>C,ENST00000389048.3:c.3734T>G	2020-12-03 18:33:03 UTC	10.5	CA279597	217856	PHE1245CYS,RS863225283		
550	https://civic.genome.wustl.edu/links/variants/550	ALK	238	DEL4-11			2	29497965	29754982			ENST00000389048.3	75	GRCh37					inframe_deletion		2017-12-01 14:40:32 UTC	3.0					
551	https://civic.genome.wustl.edu/links/variants/551	ALK	238	ALK FUSION F1245C	In neuroblastoma, F1245 is one of three hotspot ALK mutations found at a high frequency. In a case study, a pretreated non-small cell lung cancer (NSCLC) patient with EML4-ALK F1245C mutation responded well to ceritinib after slow disease progression during crizotinib treatment. Crizotinib resistance was attributed to the F1245C mutation, although the ALK-rearrangement was not sequenced prior to crizotinib treatment. The patient's slow onset of disease progression during crizotinib treatment mirrors preclinical findings that indicate ALK-fusion with F1245C has moderate resistance to crizotinib compared to the fusion alone.		2	29436859	29436859	A	C	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	NM_004304.4:c.3734T>G,NP_004295.2:p.Phe1245Cys,NC_000002.11:g.29436859A>C,ENST00000389048.3:c.3734T>G	2018-11-30 14:43:26 UTC	14.5	CA279597	217856	RS863225283,ALK FUSION PHE1245CYS		
552	https://civic.genome.wustl.edu/links/variants/552	ALK	238	ALK FUSION G1269A			2	29432682	29432682	C	G	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3806G>C,NC_000002.11:g.29432682C>G,NM_004304.4:c.3806G>C,NP_004295.2:p.Gly1269Ala	2018-11-30 14:43:19 UTC	10.0	CA16602590	376132	ALK FUSION GLY1269ALA,RS1057519781		
553	https://civic.genome.wustl.edu/links/variants/553	CDK4	1019	AMPLIFICATION			12	58141510	58146304			ENST00000257904.6	75	GRCh37					transcript_amplification		2017-12-01 14:40:32 UTC	30.0		N/A			
554	https://civic.genome.wustl.edu/links/variants/554	CDKN2A	1029	LOSS			9	21967752	21994623			ENST00000579755.1	75	GRCh37					loss_of_function_variant		2020-12-04 15:57:33 UTC	42.5		N/A			
555	https://civic.genome.wustl.edu/links/variants/555	CDKN2B	1030	LOSS			9	22002902	22009362			ENST00000276925.6	75	GRCh37					transcript_ablation		2017-12-01 14:40:32 UTC	5.0		N/A			
556	https://civic.genome.wustl.edu/links/variants/556	CDK4	1019	R24C			12	58145431	58145431	G	A	ENST00000257904.6	75	GRCh37					missense_variant	NM_000075.3:c.70C>T,NP_000066.1:p.Arg24Cys,ENST00000257904.6:c.70C>T,NC_000012.11:g.58145431G>A	2018-11-30 14:43:16 UTC	1.0	CA126982	16928	ARG24CYS,RS11547328		
557	https://civic.genome.wustl.edu/links/variants/557	ASXL1	171023	EXON 12 MUTATION			20	31021087	31021720			ENST00000375687.4	75	GRCh37					exon_variant		2017-12-01 14:40:33 UTC	20.0					
558	https://civic.genome.wustl.edu/links/variants/558	GNA11	2767	Q209			19	3118942	3118942			ENST00000078429.4	75	GRCh37					missense_variant		2017-12-01 14:40:33 UTC	15.0		376001			
559	https://civic.genome.wustl.edu/links/variants/559	CALR	811	EXON 9 FRAMESHIFT	Exon 9 insertions and deletions have become part of the WHO diagnostic criteria for essential thrombocythemia (ET) and primary myelofibrosis (PMF) (Arber et al, 2016). These mutations are typically heterozygous and in the absence of JAK2 and MPL mutations. Approximately 80% of observed mutations are type 1 (p.L367fs*46), the result of a 52bp deletion, or type 2 (p.K385fs*47), the result of a 5-bp TTGTC insertion, and studies have suggested phenotypic and prognostic differences between them. In PMF patients, CALR exon 9 mutations have been associated with improved median survival.		19	13054527	13054727			ENST00000316448.5	75	GRCh37					exon_variant		2017-12-01 14:40:33 UTC	80.0					
560	https://civic.genome.wustl.edu/links/variants/560	CSF3R	1441	MUTATION			1	36932096	36933444			ENST00000373106.1	75	GRCh37					protein_altering_variant		2017-12-01 14:40:33 UTC	30.0		N/A			
562	https://civic.genome.wustl.edu/links/variants/562	EGFR	1956	S768I			7	55249005	55249005	G	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2303G>T,NC_000007.13:g.55249005G>T,NM_005228.4:c.2303G>T,NP_005219.2:p.Ser768Ile	2020-08-13 17:11:48 UTC	20.5	CA135840	45251	SER768ILE,RS121913465		
563	https://civic.genome.wustl.edu/links/variants/563	BRAF	673	V600K		Other V600's	7	140453136	140453137	AC	TT	ENST00000288602.6	75	GRCh37					missense_variant	ENST00000288602.6:c.1798_1799delinsAA,NC_000007.13:g.140453136_140453137delinsTT,NM_004333.4:c.1798_1799delGTinsAA,NP_004324.2:p.Val600Lys	2021-01-05 22:01:14 UTC	107.5	CA16602420	375941	VAL600LYS,RS121913227	11,13	https://civic.genome.wustl.edu/links/assertions/11	https://civic.genome.wustl.edu/links/assertions/13
564	https://civic.genome.wustl.edu/links/variants/564	SMAD4	4089	LOSS			18	48556583	48611409			ENST00000342988.3	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:33 UTC	15.0		N/A			
565	https://civic.genome.wustl.edu/links/variants/565	SF3B1	23451	K700E		HEAT domain mutation	2	198266834	198266834	T	C	ENST00000335508.6	75	GRCh37					missense_variant	NM_012433.3:c.2098A>G,NP_036565.2:p.Lys700Glu,ENST00000335508.6:c.2098A>G,NC_000002.11:g.198266834T>C	2018-11-30 14:43:27 UTC	2.0	CA2042597	376004	LYS700GLU,RS559063155		
566	https://civic.genome.wustl.edu/links/variants/566	MAP2K7	5609	E116K			19	7975157	7975157	G	A	ENST00000397979.3	75	GRCh37					missense_variant	NC_000019.9:g.7975157G>A	2018-11-30 14:43:27 UTC	25.0	CA304968685	NONE FOUND	GLU116LYS		
567	https://civic.genome.wustl.edu/links/variants/567	PDGFRA	5156	PDGFRA FUSIONS															transcript_fusion		2017-12-01 14:40:33 UTC	100.0		N/A			
568	https://civic.genome.wustl.edu/links/variants/568	PDGFRB	5159	PDGFRB FUSIONS															transcript_fusion		2017-12-01 14:40:33 UTC	140.0					
569	https://civic.genome.wustl.edu/links/variants/569	FGFR1	2260	FGFR1 FUSIONS			8	38268656	38325363			ENST00000425967.3	75	GRCh37					transcript_fusion	N/A	2019-06-21 23:18:27 UTC	103.0		N/A			
570	https://civic.genome.wustl.edu/links/variants/570	IDH2	3418	MUTATION			15	90626277	90645736			ENST00000330062.3	75	GRCh37					protein_altering_variant		2019-11-27 01:11:14 UTC	74.0		N/A			
571	https://civic.genome.wustl.edu/links/variants/571	JAK2	3717	PCM1-JAK2										GRCh37					transcript_fusion		2020-10-20 18:15:20 UTC	57.5		N/A	T(8;9)(P22;P24.1)		
572	https://civic.genome.wustl.edu/links/variants/572	MTOR	2475	E2014K and E2419K			1	11174420	11187857			ENST00000361445.4	75	GRCh37					missense_variant		2020-05-28 20:11:36 UTC	5.0		376131,156709			
573	https://civic.genome.wustl.edu/links/variants/573	RICTOR	253260	AMPLIFICATION			5	38938021	39074510			ENST00000357387.3	75	GRCh37					transcript_amplification		2021-01-27 01:40:41 UTC	12.5		N/A			
574	https://civic.genome.wustl.edu/links/variants/574	PDGFRA	5156	FIP1L1-PDGFRA	Prospective trials of patients with hypereosinophilic syndrome harboring the FIP1L1-PDGFRA fusion identified marked response to imatinib treatment (Gotlib and Cool, Leukemia 2008). Imatinib is FDA approved for the treatment of &quot;adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the FIP1L1-PDGFR fusion kinase&quot; (NDA021588).		4	54243812	54294350			ENST00000337488.6	75	GRCh37	4	55141008	55164414	ENST00000257290.5	transcript_fusion		2019-06-21 23:25:04 UTC	63.5		N/A			
576	https://civic.genome.wustl.edu/links/variants/576	ROS1	6098	TFG-ROS1			3	100428269	100447702			ENST00000240851.4	75	GRCh37	6	117609463	117642557	ENST00000368508.3	transcript_fusion		2017-12-01 14:40:33 UTC	7.5		N/A			
577	https://civic.genome.wustl.edu/links/variants/577	PDGFRA	5156	FIP1L1-PDGFRA T674I	A case study of relapsed myeloproliferative hypereosinophilic syndrome suggests that a T674I mutation in the PDGFRA split kinase domain of FIP1L1-PDGFRA fusions may confer resistance to imatinib.		4	55144547	55144547	C	T	ENST00000257290.5	75	GRCh37					missense_variant,transcript_fusion	NC_000004.11:g.55144547C>T,ENST00000257290.5:c.2021C>T,NM_006206.5:c.2021C>T,NP_006197.1:p.Thr674Ile	2019-01-11 13:38:58 UTC	15.5	CA123215	13550	THR674ILE,RS121908587		
578	https://civic.genome.wustl.edu/links/variants/578	BIRC5	332	OVEREXPRESSION			17	76210267	76221717			ENST00000301633.4	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	20.0		N/A			
579	https://civic.genome.wustl.edu/links/variants/579	BRAF	673	D594A		Kinase Dead BRAF Mutation	7	140453154	140453154	T	G	ENST00000288602.6	75	GRCh37					missense_variant	ENST00000288602.6:c.1781A>C,NC_000007.13:g.140453154T>G,NM_004333.4:c.1781A>C,NP_004324.2:p.Asp594Ala	2018-11-30 14:43:27 UTC	0.75	CA16602532	376070	ASP594ALA,RS121913338		
580	https://civic.genome.wustl.edu/links/variants/580	BRAF	673	D594V		Kinase Dead BRAF Mutation	7	140453154	140453154	T	A	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1781A>T,NP_004324.2:p.Asp594Val,NC_000007.13:g.140453154T>A,ENST00000288602.6:c.1781A>T	2018-11-30 14:43:27 UTC	0.75	CA16602425	375946	ASP594VAL,RS121913338		
581	https://civic.genome.wustl.edu/links/variants/581	BRAF	673	K483M	The K483M variant is a kinase dead loss-of-function variant in the catalytic site of BRAF. This engineered variant is often used as a control when evaluating other BRAF variants.	Kinase Dead BRAF Mutation	7	140477859	140477860	TT	CA	ENST00000288602.6	75	GRCh37					missense_variant,loss_of_function_variant	NC_000007.13:g.140477859_140477860delinsCA,ENST00000288602.6:c.1448_1449delinsTG	2019-07-30 00:01:03 UTC	0.75	CA913112072	NONE FOUND	LYS483MET		
582	https://civic.genome.wustl.edu/links/variants/582	BRAF	673	L597S			7	140453145	140453146	AG	GA	ENST00000288602.6	75	GRCh37					missense_variant	NC_000007.13:g.140453145_140453146delinsGA,NM_004333.4:c.1789_1790delCTinsTC,NP_004324.2:p.Leu597Ser,ENST00000288602.6:c.1789_1790delCTinsTC	2018-11-30 14:43:28 UTC	9.5	CA16602421	375942	LEU597SER		
583	https://civic.genome.wustl.edu/links/variants/583	BRAF	673	L597Q			7	140453145	140453145	A	T	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1790T>A,NP_004324.2:p.Leu597Gln,NC_000007.13:g.140453145A>T,ENST00000288602.6:c.1790T>A	2018-11-30 14:43:28 UTC	14.5	CA16602257	76687	LEU597GLN,RS121913366		
584	https://civic.genome.wustl.edu/links/variants/584	BRAF	673	K601E			7	140453134	140453134	T	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1801A>G,NP_004324.2:p.Lys601Glu,NC_000007.13:g.140453134T>C,ENST00000288602.6:c.1801A>G	2018-11-30 14:43:28 UTC	3.0	CA123645	13966	LYS601GLU,RS121913364		
585	https://civic.genome.wustl.edu/links/variants/585	BRAF	673	L597V			7	140453146	140453146	G	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1789C>G,NP_004324.2:p.Leu597Val,NC_000007.13:g.140453146G>C,ENST00000288602.6:c.1789C>G	2018-11-30 14:43:28 UTC	7.5	CA123651	13969	LEU597VAL,RS121913369		
586	https://civic.genome.wustl.edu/links/variants/586	KIT	3815	AMPLIFICATION			4	55524085	55606881			ENST00000288135.5	75	GRCh37					transcript_amplification		2017-12-01 14:40:33 UTC	15.0		N/A			
587	https://civic.genome.wustl.edu/links/variants/587	NF1	4763	MUTATION			17	29421945	29704695			ENST00000358273.4	75	GRCh37					protein_altering_variant,loss_of_function_variant		2017-12-01 14:40:33 UTC	32.0		N/A			
588	https://civic.genome.wustl.edu/links/variants/588	ALK	238	HIP1-ALK I1171N			2	29445213	29445213	A	T	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3512T>A,NC_000002.11:g.29445213A>T,NM_004304.4:c.3512T>A,NP_004295.2:p.Ile1171Asn	2018-11-30 14:43:29 UTC	5.0	CA16602371	375888	HIP1-ALK ILE1171ASN,RS1057519698		
589	https://civic.genome.wustl.edu/links/variants/589	ALK	238	EML4-ALK I1171S			2	29445213	29445213	A	C	ENST00000389048.3	75	GRCh37					missense_variant,transcript_fusion	ENST00000389048.3:c.3512T>G,NC_000002.11:g.29445213A>C	2018-11-30 14:43:28 UTC	5.0	CA346462883	N/A	EML4-ALK ILE1171SER		
590	https://civic.genome.wustl.edu/links/variants/590	BIRC3	330	TRUNCATING MUTATION			11	102201730	102207833			ENST00000263464.3	75	GRCh37					frameshift_variant		2017-12-01 14:40:33 UTC	10.0					
591	https://civic.genome.wustl.edu/links/variants/591	RAF1	5894	AMPLIFICATION			3	12625100	12705725			ENST00000251849.4	75	GRCh37					transcript_amplification		2017-12-01 14:40:33 UTC	10.0		N/A			
592	https://civic.genome.wustl.edu/links/variants/592	KRAS	3845	Amplification			12	25362365	25403737			ENST00000256078.4	75	GRCh37					transcript_amplification	N/A	2021-02-02 23:37:27 UTC	27.0		N/A			
594	https://civic.genome.wustl.edu/links/variants/594	CEBPA	1050	BIALLELIC INACTIVATION			19	33790840	33793470			ENST00000498907.2	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:33 UTC	25.0		N/A			
595	https://civic.genome.wustl.edu/links/variants/595	SRSF2	6427	MUTATION			17	74732402	74733113			ENST00000392485.2	75	GRCh37					gene_variant		2017-12-01 14:40:33 UTC	25.0					
596	https://civic.genome.wustl.edu/links/variants/596	NRAS	4893	G12/G13			1	115258744	115258748			ENST00000369535.4	75	GRCh37					protein_altering_variant		2017-12-01 14:40:33 UTC	20.0		13901,40468,39648,177778,40471,13899,219097,40470,40469,375877,375876,376221			
597	https://civic.genome.wustl.edu/links/variants/597	RET	5979	Overexpression			10	43572475	43625799			ENST00000355710.3	75	GRCh37					N/A		2021-01-28 17:53:23 UTC	7.5		N/A			
599	https://civic.genome.wustl.edu/links/variants/599	CTLA4	1493	CTLA4-CD28	A survey of 115 T-cell lymphoma samples of diverse subtypes identified this fusion in 26 of 45 cases of angioimmunoblastic T-cell lymphomas (58%), nine of 39 peripheral T-cell lymphomas, not otherwise specified (23%), and nine of 31 extranodal NK/T cell lymphomas (29%).		2	204732509	204736210			ENST00000302823.3	75	GRCh37	2	204599507	204603635	ENST00000324106.8	transcript_fusion		2017-12-01 14:40:33 UTC	5.0		N/A			
600	https://civic.genome.wustl.edu/links/variants/600	AR	367	MUTATION			X	66764465	66950461			ENST00000374690.3	75	GRCh37					transcript_variant		2017-12-01 14:40:33 UTC	20.0		N/A			
601	https://civic.genome.wustl.edu/links/variants/601	NOTCH1	4851	LOSS-OF-FUNCTION			9	139388896	139440314			ENST00000277541.6	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:33 UTC	2.0		N/A			
602	https://civic.genome.wustl.edu/links/variants/602	CDK6	1021	OVEREXPRESSION			7	92234235	92463231			ENST00000265734.4	75	GRCh37					N/A		2020-06-08 17:33:39 UTC	24.0		N/A			
603	https://civic.genome.wustl.edu/links/variants/603	FLT3	2322	OVEREXPRESSION			13	28577411	28674729			ENST00000241453.7	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	7.5		N/A			
604	https://civic.genome.wustl.edu/links/variants/604	GNAQ	2776	Q209P			9	80409488	80409488	T	G	ENST00000286548.4	75	GRCh37					missense_variant	NC_000009.11:g.80409488T>G,NM_002072.4:c.626A>C,NP_002063.2:p.Gln209Pro,ENST00000286548.4:c.626A>C	2018-11-30 14:43:29 UTC	8.0	CA16602436	375957	GLN209PRO,RS121913492		
605	https://civic.genome.wustl.edu/links/variants/605	PTEN	5728	V317FS			10	89720799	89720802	TACT		ENST00000371953.3	75	GRCh37					frameshift_variant	ENST00000371953.3:c.950_953delTACT,NC_000010.10:g.89720799_89720802del	2018-11-30 14:43:29 UTC	3.0	CA000646	NONE FOUND	VAL317FS		
606	https://civic.genome.wustl.edu/links/variants/606	RB1	5925	LOSS-OF-FUNCTION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:33 UTC	6.0		N/A			
607	https://civic.genome.wustl.edu/links/variants/607	ESR1	2099	OVEREXPRESSION			6	152128686	152424406			ENST00000206249.3	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	20.0		N/A			
609	https://civic.genome.wustl.edu/links/variants/609	MTOR	2475	M2327I			1	11177096	11177096	C	A	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6981G>T,NC_000001.10:g.11177096C>A	2018-11-30 14:43:30 UTC	7.0	CA338383476	NONE FOUND	MET2327ILE		
610	https://civic.genome.wustl.edu/links/variants/610	MTOR	2475	A2034V			1	11187796	11187796	G	A	ENST00000361445.4	75	GRCh37					missense_variant	ENST00000361445.4:c.6101C>T,NC_000001.10:g.11187796G>A	2018-11-30 14:43:30 UTC	8.0	CA338393920	NONE FOUND	ALA2034VAL		
611	https://civic.genome.wustl.edu/links/variants/611	BRAF	673	D594G	This BRAF mutation has a markedly reduced kinase activity and leads to paradoxical MEK-pathway activation via CRAF binding.		7	140453154	140453154	T	C	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1781A>G,NP_004324.2:p.Asp594Gly,NC_000007.13:g.140453154T>C,ENST00000288602.6:c.1781A>G	2019-11-26 21:52:46 UTC	36.0	CA123657	13972	ASP594GLY,RS121913338		
612	https://civic.genome.wustl.edu/links/variants/612	FLT3	2322	D835H			13	28592642	28592642	C	G	ENST00000241453.7	75	GRCh37					missense_variant	NM_004119.2:c.2503G>C,NP_004110.2:p.Asp835His,ENST00000241453.7:c.2503G>C,NC_000013.10:g.28592642C>G	2018-11-30 14:43:30 UTC	7.5	CA280208	16273	ASP835HIS,RS121913488		
613	https://civic.genome.wustl.edu/links/variants/613	FLT3	2322	D835H/Y			13	28592642	28592642	C	G/A	ENST00000241453.7	75	GRCh37					missense_variant	NM_004119.2:c.2503G>C,NP_004110.2:p.Asp835His,NM_004119.2:c.2503G>T,NP_004110.2:p.Asp835Tyr,ENST00000241453.7:c.2503G>C,ENST00000241453.7:c.2503G>T	2017-12-01 14:40:33 UTC	1.0		16273,16276	ASP835HIS,ASP835TYR		
614	https://civic.genome.wustl.edu/links/variants/614	JAK1	3716	Q503*			1	65321333	65321333	G	A	ENST00000342505.4	75	GRCh37					stop_gained	NC_000001.10:g.65321333G>A,ENST00000342505.4:c.1507C>T	2018-11-30 14:43:30 UTC	10.0	CA340669637	NONE FOUND	Q503X,GLN503TER		
615	https://civic.genome.wustl.edu/links/variants/615	JAK2	3717	c.1641+1dup			9	5070053	5070054		G	ENST00000381652.3	75	GRCh37						NC_000009.11:g.5070053_5070054insG	2020-06-06 18:26:00 UTC	10.0	CA913189235				
616	https://civic.genome.wustl.edu/links/variants/616	B2M	567	S14FS			15	45003786	45003789	TCTT		ENST00000558401.1	75	GRCh37					frameshift_truncation	ENST00000558401.1:c.42_45delTCTT,NC_000015.9:g.45003786_45003789del	2018-11-30 14:43:30 UTC	7.5	CA645576720				
617	https://civic.genome.wustl.edu/links/variants/617	BRAF	673	PPFIBP2-BRAF		BRAF Fusions	11	7535001	7586998			ENST00000299492.4	75	GRCh37	7	140434279	140481493	ENST00000288602.6	transcript_fusion		2017-12-01 14:40:33 UTC	5.0		N/A			
618	https://civic.genome.wustl.edu/links/variants/618	BRAF	673	KIAA1549-BRAF		BRAF Fusions	7	138545885	138666064			ENST00000440172.1	75	GRCh37	7	140434279	140487384	ENST00000288602.6	transcript_fusion		2020-12-01 00:28:26 UTC	105.5		N/A		27,26,25	https://civic.genome.wustl.edu/links/assertions/27	https://civic.genome.wustl.edu/links/assertions/26	https://civic.genome.wustl.edu/links/assertions/25
621	https://civic.genome.wustl.edu/links/variants/621	MET	4233	OVEREXPRESSION			7	116312459	116436396			ENST00000318493.6	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	64.0		N/A			
623	https://civic.genome.wustl.edu/links/variants/623	POT1	25913	MUTATION			7	124462440	124570035			ENST00000357628.3	75	GRCh37					protein_altering_variant,loss_of_function_variant		2017-12-01 14:40:33 UTC	15.0		N/A			
624	https://civic.genome.wustl.edu/links/variants/624	MKI67	4288	EXPRESSION			10	129894923	129924649			ENST00000368654.3	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	35.0		N/A			
625	https://civic.genome.wustl.edu/links/variants/625	RAD23B	5887	EXPRESSION			9	110045560	110094475			ENST00000358015.3	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	2.0		N/A			
626	https://civic.genome.wustl.edu/links/variants/626	RET	5979	CCDC6-RET															transcript_fusion		2019-11-08 18:41:16 UTC	12.5		N/A			
627	https://civic.genome.wustl.edu/links/variants/627	MAP2K1	5604	C121S			15	66729154	66729154	G	C	ENST00000307102.5	75	GRCh37					missense_variant	ENST00000307102.5:c.362G>C,NC_000015.9:g.66729154G>C,NM_002755.3:c.362G>C,NP_002746.1:p.Cys121Ser	2018-11-30 14:43:31 UTC	10.0	CA16602455	375980	CYS121SER		
628	https://civic.genome.wustl.edu/links/variants/628	FGFR3	2261	S249C			4	1803568	1803568	C	G	ENST00000340107.4	75	GRCh37					missense_variant	NC_000004.11:g.1803568C>G,NM_000142.4:c.746C>G,NP_000133.1:p.Ser249Cys,ENST00000340107.4c.746C>G	2020-09-16 04:39:15 UTC	11.0	CA126380	16339	SER249CYS,RS121913483		
629	https://civic.genome.wustl.edu/links/variants/629	FGFR2	2263	AMPLIFICATION			10	123239371	123357917			ENST00000457416.2	75	GRCh37					transcript_amplification		2017-12-01 14:40:33 UTC	25.0		N/A			
630	https://civic.genome.wustl.edu/links/variants/630	FGF3	2248	AMPLIFICATION			11	69624992	69633792			ENST00000334134.2	75	GRCh37					transcript_amplification		2017-12-01 14:40:33 UTC	10.0		N/A			
631	https://civic.genome.wustl.edu/links/variants/631	VHL	7428	R200W (c.598C>T)			3	10191605	10191605	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.598C>T,NP_000542.1:p.Arg200Trp,ENST00000256474.2:c.598C>T,NC_000003.11:g.10191605C>T	2018-11-30 14:43:32 UTC	10.0	CA020510	2232	ARG200TRP,C.598C>T,RS28940298		
632	https://civic.genome.wustl.edu/links/variants/632	RB1	5925	PHOSPHORYLATION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	15.0					
633	https://civic.genome.wustl.edu/links/variants/633	PIK3R1	5295	MUTATION			5	67511548	67597649			ENST00000521381.1	75	GRCh37					missense_variant,gain_of_function_variant		2017-12-01 14:40:33 UTC	2.0					
634	https://civic.genome.wustl.edu/links/variants/634	STK11	6794	D194E			19	1220489	1220489	C	A	ENST00000326873.7	75	GRCh37					missense_variant,loss_of_heterozygosity	NM_000455.4:c.582C>A,NP_000446.1:p.Asp194Glu,ENST00000326873.7:c.582C>A,NC_000019.9:g.1220489C>A	2018-11-30 14:43:33 UTC	5.0	CA023096	185384	ASP194GLU,RS786202134		
635	https://civic.genome.wustl.edu/links/variants/635	AKT2	208	AMPLIFICATION			19	40736224	40791302			ENST00000392038.2	75	GRCh37					transcript_amplification		2017-12-01 14:40:33 UTC	2.5		N/A			
636	https://civic.genome.wustl.edu/links/variants/636	PTEN	5728	R130*			10	89692904	89692904	C	T	ENST00000371953.3	75	GRCh37					stop_gained	NM_000314.6:c.388C>T,NP_000305.3:p.Arg130Ter,ENST00000371953.3:c.388C>T,NC_000010.10:g.89692904C>T	2018-11-30 14:43:32 UTC	2.0	CA000433	7819	R130X,ARG130TER,RS121909224		
637	https://civic.genome.wustl.edu/links/variants/637	FBXW7	55294	LOSS-OF-FUNCTION			4	153242410	153457253			ENST00000281708.4	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:33 UTC	4.5		N/A			
638	https://civic.genome.wustl.edu/links/variants/638	RB1	5925	M695FS*26			13	49033946	49033947		A	ENST00000267163.4	75	GRCh37					frameshift_truncation	ENST00000267163.4:c.2083_2084insA,NC_000013.10:g.49033946_49033947insA	2019-07-30 00:01:09 UTC	2.0	CA913189236	NONE FOUND			
639	https://civic.genome.wustl.edu/links/variants/639	JUN	3725	OVEREXPRESSION			1	59246465	59249785			ENST00000371222.2	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	5.0		N/A			
640	https://civic.genome.wustl.edu/links/variants/640	FOS	2353	OVEREXPRESSION			14	75745477	75748933			ENST00000303562.4	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	5.0		N/A			
641	https://civic.genome.wustl.edu/links/variants/641	CDKN2A	1029	RS3814960			9	21975017	21975017	C	T	ENST00000498124.1	75	GRCh37					5_prime_UTR_exon_variant	NC_000009.11:g.21975017C>T	2018-11-30 14:43:32 UTC	15.0	CA12951936	NONE FOUND			
642	https://civic.genome.wustl.edu/links/variants/642	MDM2	4193	RS34886328			12	69234988	69234988	A		ENST00000462284.1	75	GRCh37					3_prime_UTR_truncation		2020-05-20 14:29:45 UTC	10.0	CA238461468				
643	https://civic.genome.wustl.edu/links/variants/643	CBLB	868	RS2305035			3	105439026	105439026	G	A	ENST00000264122.4	75	GRCh37					synonymous_variant,polymorphic_sequence_variant	NC_000003.11:g.105439026G>A,NM_001321788.1:c.1272C>T,ENST00000264122.4:c.1272C>T	2018-11-30 14:43:32 UTC	10.0	CA2524814	NONE FOUND	D424D		
644	https://civic.genome.wustl.edu/links/variants/644	PRDM1	639	MUTATION			6	106534195	106557813			ENST00000369096.4	75	GRCh37					transcript_variant,loss_of_function_variant		2017-12-01 14:40:33 UTC	20.0		N/A			
645	https://civic.genome.wustl.edu/links/variants/645	IDH1	3417	MUTATION			2	209101803	209116275			ENST00000415913.1	75	GRCh37					transcript_variant		2019-12-20 09:45:01 UTC	83.0					
646	https://civic.genome.wustl.edu/links/variants/646	SMAD4	4089	DELETION			18	48556583	48611409			ENST00000342988.3	75	GRCh37					transcript_ablation		2017-12-01 14:40:33 UTC	15.0					
647	https://civic.genome.wustl.edu/links/variants/647	LRP1B	53353	DELETION			2	140988992	142889270			ENST00000389484.3	75	GRCh37					transcript_ablation		2017-12-01 14:40:33 UTC	20.0					
648	https://civic.genome.wustl.edu/links/variants/648	ATRX	546	Underexpression			X	76760356	77041702			ENST00000373344.5	75	GRCh37					N/A		2021-01-08 22:17:37 UTC	19.0		N/A	UNDEREXPRESSION		
649	https://civic.genome.wustl.edu/links/variants/649	MET	4233	D1228N			7	116423407	116423407	G	A	ENST00000397752.3	75	GRCh37					missense_variant	NM_001127500.2:c.3736G>A,NP_001120972.1:p.Asp1246Asn,NC_000007.13:g.116423407G>A,ENST00000397752.3:c.3682G>A	2018-11-30 14:43:33 UTC	5.0	CA257000	13884	D1246N,ASP1246ASN		
650	https://civic.genome.wustl.edu/links/variants/650	CASP8	841	D302H			2	202149589	202149589	G	C	ENST00000264275.5	75	GRCh37					missense_variant,polymorphic_sequence_variant	NM_001228.4:c.904G>C,NP_001219.2:p.Asp302His,ENST00000264275.5:c.904G>C,NC_000002.11:g.202149589G>C	2018-11-30 14:43:33 UTC	15.0	CA119051	7762	RS1045485,D285H,ASP302HIS		
651	https://civic.genome.wustl.edu/links/variants/651	AXL	558	EXPRESSION			19	41725108	41767671			ENST00000301178.4	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	20.0		N/A			
652	https://civic.genome.wustl.edu/links/variants/652	GAS6	2621	EXPRESSION			13	114523524	114567046			ENST00000357389.3	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	23.0					
653	https://civic.genome.wustl.edu/links/variants/653	ETV4	2118	OVEREXPRESSION			17	41605212	41623800			ENST00000319349.5	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	15.0		N/A			
654	https://civic.genome.wustl.edu/links/variants/654	STAG3	10734	UNDEREXPRESSION			7	99775186	99812003			ENST00000426455.1	75	GRCh37					N/A		2017-12-01 14:40:33 UTC	4.0		N/A			
655	https://civic.genome.wustl.edu/links/variants/655	MAP2K1	5604	Q56_V60del			15	66727449	66727463	CCAGAAGCAGAAGGT		ENST00000307102.5	75	GRCh37					inframe_deletion	ENST00000307102.5:c.165_179del,NC_000015.9:g.66727449_66727463del	2019-07-30 00:01:10 UTC	10.0	CA912992484	NONE FOUND			
656	https://civic.genome.wustl.edu/links/variants/656	BRAF	673	BRAF-CUL1		BRAF Fusions	7	140434279	140487384			ENST00000288602.6	75	GRCh37	7	148395737	148457588	ENST00000602748.1	transcript_fusion		2017-12-01 14:40:33 UTC	5.0		N/A			
657	https://civic.genome.wustl.edu/links/variants/657	BRAF	673	ZKSCAN1-BRAF		BRAF Fusions	7	99613222	99627575			ENST00000426572.1	75	GRCh37	7	140434279	140482957	ENST00000288602.6	transcript_fusion		2017-12-01 14:40:33 UTC	7.5		N/A			
658	https://civic.genome.wustl.edu/links/variants/658	BRAF	673	L505H			7	140477794	140477794	A	T	ENST00000288602.6	75	GRCh37					missense_variant	ENST00000288602.6:c.1514T>A,NC_000007.13:g.140477794A>T,NM_004333.4:c.1514T>A,NP_004324.2:p.Leu505His	2018-11-30 14:43:33 UTC	19.0	CA369588358	NONE FOUND	LEU505HIS		
660	https://civic.genome.wustl.edu/links/variants/660	HIF1A	3091	EXPRESSION			14	62164340	62214489			ENST00000539097.1	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	10.0		N/A			
661	https://civic.genome.wustl.edu/links/variants/661	BRCA2	675	D3095E			13	32968854	32968854	C	A	ENST00000544455.1	75	GRCh37					missense_variant	NM_000059.3:c.9285C>A,NP_000050.2:p.Asp3095Glu,ENST00000544455.1:c.9285C>A,NC_000013.10:g.32968854C>A	2020-12-12 22:27:09 UTC	7.5	CA10586089	252859	ASP3095GLU,RS80359198		
662	https://civic.genome.wustl.edu/links/variants/662	MLH1	4292	EXPRESSION			3	37034823	37092409			ENST00000231790.2	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	15.0		N/A			
663	https://civic.genome.wustl.edu/links/variants/663	BCOR	54880	Mutation			X	39910501	40036582			ENST00000342274.4	75	GRCh37					transcript_variant		2021-01-20 21:52:46 UTC	15.0					
664	https://civic.genome.wustl.edu/links/variants/664	CDH1	999	MUTATION			16	68771128	68869451			ENST00000261769.5	75	GRCh37					transcription_variant		2017-12-01 14:40:34 UTC	0.5		N/A			
665	https://civic.genome.wustl.edu/links/variants/665	RHOA	387	MUTATION			3	49396578	49449635			ENST00000418115.1	75	GRCh37					transcription_variant,gain_of_function_variant		2020-05-06 21:03:21 UTC	0.5					
666	https://civic.genome.wustl.edu/links/variants/666	ERBB2	2064	MUTATION			17	37868196	37881332			ENST00000269571.5	75	GRCh37					missense_variant		2018-07-10 18:54:39 UTC	37.5					
667	https://civic.genome.wustl.edu/links/variants/667	MEN1	4221	FRAMESHIFT TRUNCATION			11	64572092	64572092	C		ENST00000337652.1	75	GRCh37					frameshift_truncation	NC_000011.9:g.64572092del	2018-11-30 14:43:34 UTC	5.0	CA16044439				
668	https://civic.genome.wustl.edu/links/variants/668	KMT2C	58508	MUTATION			7	151832010	152133090			ENST00000262189.6	75	GRCh37					transcription_variant,loss_of_function_variant		2017-12-01 14:40:34 UTC	15.0					
669	https://civic.genome.wustl.edu/links/variants/669	STAG2	10735	MUTATION			X	123176418	123217308			ENST00000218089.9	75	GRCh37					protein_altering_variant		2017-12-01 14:40:34 UTC	20.0		N/A			
670	https://civic.genome.wustl.edu/links/variants/670	MYCL	4610	EXPRESSION			1	40361098	40367685			ENST00000397332.2	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	1.0					
671	https://civic.genome.wustl.edu/links/variants/671	HGF	3082	EXPRESSION			7	81328322	81399514			ENST00000222390.5	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	2.0					
672	https://civic.genome.wustl.edu/links/variants/672	SOX10	6663	LOSS			22	38368307	38380544			ENST00000396884.2	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:34 UTC	4.0		N/A			
673	https://civic.genome.wustl.edu/links/variants/673	FGF2	2247	EXPRESSION			4	123747863	123819391			ENST00000264498.3	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	4.0					
674	https://civic.genome.wustl.edu/links/variants/674	EIF1AX	1964	MUTATION			X	20156713	20159754			ENST00000379607.5	75	GRCh37					transcript_variant		2017-12-01 14:40:34 UTC	10.0					
683	https://civic.genome.wustl.edu/links/variants/683	PAX8	7849	EXPRESSION			2	113973574	114036527			ENST00000429538.3	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	40.0		N/A			
691	https://civic.genome.wustl.edu/links/variants/691	ERRFI1	54206	E384*			1	8073509	8073509	C	A	ENST00000377482.5	75	GRCh37					stop_gained,loss_of_function_variant	NC_000001.10:g.8073509C>A	2018-11-30 14:43:34 UTC	5.0	CA338219584	NONE FOUND	E384X,GLU384TER		
692	https://civic.genome.wustl.edu/links/variants/692	ESR1	2099	S463P			6	152415537	152415537	T	C	ENST00000440973.1	75	GRCh37					missense_variant	ENST00000440973.1:c.1387T>C,NC_000006.11:g.152415537T>C	2018-11-30 14:43:34 UTC	2.0	CA16602414	375934	SER463PRO		
693	https://civic.genome.wustl.edu/links/variants/693	SGK1	6446	OVEREXPRESSION			6	134490384	134639196			ENST00000367858.5	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	24.0		N/A			
694	https://civic.genome.wustl.edu/links/variants/694	BRAF	673	G596C			7	140453149	140453149	C	A	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1786G>T,NP_004324.2:p.Gly596Cys,NC_000007.13:g.140453149C>A,ENST00000288602.6:c.1786G>T	2018-11-30 14:43:35 UTC	0.0	CA135098	44814	GLY596CYS,RS121913361		
695	https://civic.genome.wustl.edu/links/variants/695	SMARCB1	6598	UNDEREXPRESSION			22	24129150	24176703			ENST00000344921.6	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	2.0		N/A			
696	https://civic.genome.wustl.edu/links/variants/696	SMARCB1	6598	DELETION			22	24129150	24176703			ENST00000344921.6	75	GRCh37					transcript_ablation		2017-12-01 14:40:34 UTC	3.0					
697	https://civic.genome.wustl.edu/links/variants/697	NF2	4771	LOSS			22	29999547	30094587			ENST00000338641.4	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:34 UTC	4.0		N/A			
698	https://civic.genome.wustl.edu/links/variants/698	NF1	4763	LOSS			17	29421945	29704695			ENST00000358273.4	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:34 UTC	3.0		N/A			
699	https://civic.genome.wustl.edu/links/variants/699	SH2B3	10019	RS3184504			12	111884608	111884608	T	C	ENST00000341259.2	75	GRCh37					missense_variant,polymorphic_sequence_variant	NC_000012.11:g.111884608T>C,NM_005475.2:c.784T>C,ENST00000341259.2:c.784T>C	2018-11-30 14:43:35 UTC	10.0	CA6789733	NONE FOUND	ARG262TRP,R262W,TRP262ARG		
700	https://civic.genome.wustl.edu/links/variants/700	KIF23	9493	EXPRESSION			15	69706688	69740756			ENST00000260363.4	75	GRCh37					N/A		2017-12-01 14:40:34 UTC	15.0		N/A			
701	https://civic.genome.wustl.edu/links/variants/701	ERBB3	2065	V104M			12	56478854	56478854	G	A	ENST00000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56478854G>A	2018-11-30 14:43:36 UTC	15.0	CA16602847	376410	VAL104MET		
702	https://civic.genome.wustl.edu/links/variants/702	ERBB3	2065	R103G			12	56478851	56478851	C	G	ENST00000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56478851C>G	2018-11-30 14:43:35 UTC	15.0	CA385279657	NONE FOUND	ARG103GLY		
703	https://civic.genome.wustl.edu/links/variants/703	ERBB3	2065	G284R			12	56481922	56481922	G	A	ENST00000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56481922G>A	2018-11-30 14:43:37 UTC	15.0	CA16602624	376167	GLY284ARG		
705	https://civic.genome.wustl.edu/links/variants/705	GADD45A	1647	rs681673			1	68152388	68152388	T	C	ENST00000370986.4	75	GRCh37					coding_transcript_intron_variant		2018-11-30 14:43:35 UTC	15.0	CA10728634		1506T>C		
706	https://civic.genome.wustl.edu/links/variants/706	EWSR1	2130	EWSR1-FLI1	In approximately 90% of Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET) a translocation t(11;22)(q24; q12) is identified, fusing the 5 exons (containing the transactivatin domain, at least exon 1-7) of EWSR1, with the 3 exons (from exon 9, coding the DNA binding domain) of FLI1.		22	29664307	29688158			ENST00000414183.2	75	GRCh37	11	128638013	128683162	ENST00000527786.2	transcript_fusion		2017-12-01 14:40:34 UTC	45.0		N/A	EWS-FLI,T(11;22)(Q24;Q12)		
708	https://civic.genome.wustl.edu/links/variants/708	BRCA2	675	TRUNCATING MUTATION															feature_truncation		2017-12-01 14:40:34 UTC	2.5					
709	https://civic.genome.wustl.edu/links/variants/709	BRCA1	672	Alu insertion																	2017-12-01 14:40:34 UTC	7.5					
711	https://civic.genome.wustl.edu/links/variants/711	KLLN	100144748	PROMOTER METHYLATION															gene_silenced_by_DNA_methylation		2017-12-01 14:40:34 UTC	30.0					
712	https://civic.genome.wustl.edu/links/variants/712	EGFR	1956	D761Y			7	55242511	55242511	G	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2281G>T,NM_005228.4:c.2281G>T,NP_005219.2:p.Asp761Tyr,NC_000007.13:g.55242511G>T	2018-11-30 14:43:37 UTC	7.5	CA135827	45244	ASP761TYR,RS121913418		
713	https://civic.genome.wustl.edu/links/variants/713	CRBN	51185	MUTATION			3	3191695	3221394			ENST00000231948.4	75	GRCh37							2017-12-01 14:40:34 UTC	7.5					
714	https://civic.genome.wustl.edu/links/variants/714	TSC1	7248	R1062W			9	135771933	135771933	G	A	ENST00000298552.3	75	GRCh37					missense_variant	NM_000368.3:c.3184C>T,NP_000359.1:p.Arg1062Trp,ENST00000298552.3:c.3184C>T,NC_000009.11:g.135771933G>A	2018-11-30 14:43:37 UTC	8.0	CA007223	49015	ARG1062TRP		
715	https://civic.genome.wustl.edu/links/variants/715	STK11	6794	MUTATION			19	1205740	1223074			ENST00000326873.7	75	GRCh37					gene_variant		2019-06-20 12:11:09 UTC	40.0		N/A			
716	https://civic.genome.wustl.edu/links/variants/716	PDGFRA	5156	AMPLIFICATION			4	55095264	55164414			ENST00000257290.5	75	GRCh37					transcript_amplification		2017-12-01 14:40:34 UTC	3.0		N/A			
717	https://civic.genome.wustl.edu/links/variants/717	DDIT3	1649	EWSR1-DDIT3			22	29664307	29687588			ENST00000414183.2	75	GRCh37	12	57910376	57911536	ENST00000346473.3	transcript_fusion		2017-12-01 14:40:34 UTC	7.5		N/A	T(12;22)(Q13;Q12),EWS-CHOP		
718	https://civic.genome.wustl.edu/links/variants/718	EGFR	1956	G719			7	55241707	55241708			ENST00000275493.2	75	GRCh37					protein_altering_variant		2017-12-01 14:40:34 UTC	25.0		16612,45225,45224,16611,376075			
719	https://civic.genome.wustl.edu/links/variants/719	BRD4	23476	BRD4-NUTM1																	2019-12-16 02:49:58 UTC	25.5		N/A			
720	https://civic.genome.wustl.edu/links/variants/720	EGFR	1956	S720			7	55241710	55241711			ENST00000275493.2	75	GRCh37					protein_altering_variant		2017-12-01 14:40:34 UTC	7.5					
721	https://civic.genome.wustl.edu/links/variants/721	CYP2D6	1565	LOSS-OF-FUNCTION			22	42522501	42526908			ENST00000360608.5	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:34 UTC	20.0		N/A			
722	https://civic.genome.wustl.edu/links/variants/722	DDIT3	1649	FUS-DDIT3															transcript_fusion		2020-03-17 10:27:02 UTC	70.0					
723	https://civic.genome.wustl.edu/links/variants/723	EGFR	1956	K757R			7	55242500	55242500	A	G	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2270A>G,NC_000007.13:g.55242500A>G	2018-11-30 14:45:08 UTC	7.5	CA4266023	NONE FOUND			
724	https://civic.genome.wustl.edu/links/variants/724	EGFR	1956	E746G			7	55242467	55242467	A	G	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2237A>G,NC_000007.13:g.55242467A>G	2018-11-30 14:43:33 UTC	2.5	CA367584149	NONE FOUND	GLU746GLY		
725	https://civic.genome.wustl.edu/links/variants/725	MLH1	4292	E13FS*3			3	37035075	37035075	G		ENST00000231790.2	75	GRCh37					frameshift_truncation	NM_000249.3:c.37delG,NP_000240.1:p.Glu13Argfs,ENST00000231790.2:c.37delG,NC_000003.11:g.37035075del	2018-11-30 14:43:43 UTC	0.5	CA010006	90190	GLU13ARGFS,RS63750081		
726	https://civic.genome.wustl.edu/links/variants/726	EGFR	1956	EXON 20 INSERTION			7	55248991	55249022			ENST00000275493.2	75	GRCh37					inframe_insertion		2017-12-01 14:40:34 UTC	15.0					
727	https://civic.genome.wustl.edu/links/variants/727	MSH2	4436	R383*			2	47656951	47656951	C	T	ENST00000233146.2	75	GRCh37					stop_gained	NM_000251.2:c.1147C>T,NP_000242.1:p.Arg383Ter,ENST00000233146.2:c.1147C>T,NC_000002.11:g.47656951C>T	2018-11-30 14:43:33 UTC	0.5	CA017356	90554	R383X,ARG383TER,RS63749849		
728	https://civic.genome.wustl.edu/links/variants/728	MLH1	4292	V534R			3	37081718	37081719	GT	AG	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.1600_1601delinsAG,NC_000003.11:g.37081718_37081719delinsAG	2019-07-30 00:01:14 UTC	0.25	CA913102764	NONE FOUND	VAL534ARG		
729	https://civic.genome.wustl.edu/links/variants/729	UGT1A1	54658	UGT1A1*28			2	234668881	234668882		TATATATATATATA	ENST00000305208.5	75	GRCh37					microsatellite	NC_000002.11:g.234668881_234668882TA[7]	2019-08-01 19:07:50 UTC	50.0	unregistered	226028	RS8175347		
730	https://civic.genome.wustl.edu/links/variants/730	MLH1	4292	G606FS*2			3	37089094	37089095	GG		ENST00000231790.2	75	GRCh37					frameshift_truncation	ENST00000231790.2:c.1816_1817delGG,NC_000003.11:g.37089094_37089095del	2019-07-30 00:01:15 UTC	0.5	CA913102766	NONE FOUND	GLY606FS		
731	https://civic.genome.wustl.edu/links/variants/731	MLH1	4292	c.790+1G>A			3	37056036	37056036	G	A	ENST00000231790.2	75	GRCh37					splice_donor_variant	NM_000249.3:c.790+1G>A,NC_000003.11:g.37056036G>A,ENST00000231790.2:c.790+1G>A	2020-06-13 00:51:53 UTC	0.5	CA012109	90356	RS267607789		
732	https://civic.genome.wustl.edu/links/variants/732	UGT1A1	54658	UGT1A1*60															microsatellite		2017-12-01 14:40:34 UTC	20.0					
733	https://civic.genome.wustl.edu/links/variants/733	MLH1	4292	K618DEL			3	37089130	37089132	AAG		ENST00000231790.2	75	GRCh37					inframe_deletion	NC_000003.11:g.37089130_37089132del,ENST00000231790.2:c.1852_1854delAAG,NM_000249.3:c.1852_1854delAAG,NP_000240.1:p.Lys618del	2018-11-30 14:43:43 UTC	0.5	CA007087	17080	RS63751247,LYS618DEL		
735	https://civic.genome.wustl.edu/links/variants/735	MLH1	4292	R687FS			3	37090464	37090464	C		ENST00000231790.2	75	GRCh37					frameshift_variant	NM_000249.3:c.2059delC,NP_000240.1:p.Arg687Glyfs,ENST00000231790.2:c.2059delC,NC_000003.11:g.37090464del	2018-11-30 14:43:43 UTC	0.5	CA279809	218022	ARG687GLYFS,RS863225381		
736	https://civic.genome.wustl.edu/links/variants/736	EGFR	1956	V769_770insASV			7	55249009	55249010		GCCAGCGTG	ENST00000275493.2	75	GRCh37					direct_tandem_duplication	NM_005228.4:c.2300_2308dupCCAGCGTGG	2018-11-30 14:43:36 UTC	7.5	CA180588	177678	VAL769_ASP770INSALASERVAL		
737	https://civic.genome.wustl.edu/links/variants/737	DPYD	1806	DPYD*2A HOMOZYGOSITY			1	97915614	97915614	C	T	ENST00000370192.3	75	GRCh37					splice_donor_variant	NC_000001.10:g.97915614C>T,NM_000110.3:c.1905+1G>A,ENST00000370192.3:c.1905+1G>A	2018-11-30 14:43:38 UTC	50.0	CA114277	432	RS3918290,DPYD*2A,DPYD:IVS14 + 1G>A,C.1905+1G>A		
738	https://civic.genome.wustl.edu/links/variants/738	DPYD	1806	DPYD*13 HOMOZYGOSITY			1	97981343	97981343	A	C	ENST00000370192.3	75	GRCh37					missense_variant	NM_000110.3:c.1679T>G,NP_000101.2:p.Ile560Ser,ENST00000370192.3:c.1679T>G,NC_000001.10:g.97981343A>C	2018-11-30 14:43:38 UTC	50.0	CA228118	88975	RS55886062,ILE560SER,I560S		
739	https://civic.genome.wustl.edu/links/variants/739	FOS	2353	TRUNCATING FUSION			14	75745477	75748127			ENST00000303562.4	75	GRCh37					stop_gained,transcript_fusion		2017-12-01 14:40:34 UTC	7.5					
740	https://civic.genome.wustl.edu/links/variants/740	DPYD	1806	RS67376798 HOMOZYGOSITY															polymorphic_sequence_variant		2017-12-01 14:40:34 UTC	50.0		88974	C.2846A>T,P.ASP949VAL,N949V		
741	https://civic.genome.wustl.edu/links/variants/741	MLH1	4292	R100*			3	37042536	37042536	C	T	ENST00000231790.2	75	GRCh37					stop_gained	NM_000249.3:c.298C>T,NP_000240.1:p.Arg100Ter,ENST00000231790.2:c.298C>T,NC_000003.11:g.37042536C>T	2018-11-30 14:43:44 UTC	0.5	CA009575	36550	ARG100TER,R100X,RS63751221		
742	https://civic.genome.wustl.edu/links/variants/742	WWTR1	25937	WWTR1-CAMTA1			3	149235022	149290787			ENST00000465804.1	75	GRCh37	1	7721786	7829766	ENST00000303635.7	transcript_fusion		2017-12-01 14:40:34 UTC	20.0		N/A	T(1;3)(P36.3;Q25)		
743	https://civic.genome.wustl.edu/links/variants/743	MLH1	4292	T117M			3	37045935	37045935	C	T	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.350C>T,NP_000240.1:p.Thr117Met,ENST00000231790.2:c.350C>T,NC_000003.11:g.37045935C>T	2018-11-30 14:43:38 UTC	0.5	CA009872	17094	THR117MET,RS63750781		
744	https://civic.genome.wustl.edu/links/variants/744	MLH1	4292	Q426FS			3	37067365	37067365	C		ENST00000231790.2	75	GRCh37					frameshift_truncation	ENST00000231790.2:c.1276delC,NC_000003.11:g.37067365del	2019-07-30 00:00:19 UTC	0.5	CA913102760	NONE FOUND	GLN426FS		
745	https://civic.genome.wustl.edu/links/variants/745	MLH1	4292	V49A			3	37038139	37038139	T	C	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.146T>C,NC_000003.11:g.37038139T>C	2018-11-30 14:43:38 UTC	0.5	CA352035388	NONE FOUND	VAL49ALA		
746	https://civic.genome.wustl.edu/links/variants/746	MLH1	4292	D667FS			3	37090406	37090406	C		ENST00000231790.2	75	GRCh37					frameshift_truncation	NC_000003.11:g.37090406del,ENST00000231790.2:c.2001del	2019-07-30 00:01:17 UTC	0.5	CA913102767	NONE FOUND	ASP667FS		
747	https://civic.genome.wustl.edu/links/variants/747	MLH1	4292	M1L			3	37035039	37035039	A	T	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.1A>T,NC_000003.11:g.37035039A>T	2018-11-30 14:43:39 UTC	0.5	CA352059785	NONE FOUND	MET1LEU		
748	https://civic.genome.wustl.edu/links/variants/748	MLH1	4292	*757L			3	37092143	37092143	A	T	ENST00000231790.2	75	GRCh37					stop_lost	ENST00000231790.2:c.2270A>T,NC_000003.11:g.37092143A>T	2018-11-30 14:45:08 UTC	0.25	CA352069936	NONE FOUND	X757L		
749	https://civic.genome.wustl.edu/links/variants/749	MLH1	4292	R265G			3	37058999	37058999	C	G	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.793C>G,NC_000003.11:g.37058999C>G	2018-11-30 14:43:44 UTC	0.5	CA352045752	NONE FOUND	ARG265GLY		
750	https://civic.genome.wustl.edu/links/variants/750	MLH1	4292	V213FS			3	37053551	37053551	T		ENST00000231790.2	75	GRCh37					frameshift_truncation	ENST00000231790.2:c.638delT,NC_000003.11:g.37053551del	2019-07-30 00:01:18 UTC	0.5	CA913102758	NONE FOUND	VAL213FS		
751	https://civic.genome.wustl.edu/links/variants/751	MLH1	4292	N551T			3	37081770	37081770	A	C	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.1652A>C,NP_000240.1:p.Asn551Thr,ENST00000231790.2:c.1652A>C,NC_000003.11:g.37081770A>C	2018-11-30 14:43:39 UTC	0.25	CA006238	89819	ASN551THR,RS63750271		
752	https://civic.genome.wustl.edu/links/variants/752	MLH1	4292	A424T			3	37067359	37067359	G	A	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.1270G>A,NP_000240.1:p.Ala424Thr,ENST00000231790.2:c.1270G>A,NC_000003.11:g.37067359G>A	2018-11-30 14:43:39 UTC	0.25	CA028060	220203	ALA424THR,RS377433038		
753	https://civic.genome.wustl.edu/links/variants/753	MLH1	4292	Q149*			3	37048546	37048546	C	T	ENST00000231790.2	75	GRCh37					stop_gained	NM_000249.3:c.445C>T,NP_000240.1:p.Gln149Ter,ENST00000231790.2:c.445C>T,NC_000003.11:g.37048546C>T	2018-11-30 14:45:04 UTC	0.5	CA010427	90219	Q149X,GLN149TER,RS63751302		
754	https://civic.genome.wustl.edu/links/variants/754	MLH1	4292	R226*			3	37053589	37053589	C	T	ENST00000231790.2	75	GRCh37					stop_gained	NM_000249.3:c.676C>T,NP_000240.1:p.Arg226Ter,ENST00000231790.2:c.676C>T,NC_000003.11:g.37053589C>T	2018-11-30 14:43:39 UTC	0.5	CA011496	17087	R226X,ARG226TER,R128*,RS63751615		
756	https://civic.genome.wustl.edu/links/variants/756	MLH1	4292	P536FS			3	37081726	37081726	T		ENST00000231790.2	75	GRCh37					frameshift_truncation	NC_000003.11:g.37081726del,ENST00000231790.2:c.1608del	2019-07-30 00:01:20 UTC	0.5	CA913102765	NONE FOUND	PRO536FS		
757	https://civic.genome.wustl.edu/links/variants/757	MLH1	4292	G67R			3	37038192	37038192	G	A	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.199G>A,NP_000240.1:p.Gly67Arg,ENST00000231790.2:c.199G>A,NC_000003.11:g.37038192G>A	2018-11-30 14:43:39 UTC	0.5	CA008104	89992	GLY67ARG,RS63750206		
758	https://civic.genome.wustl.edu/links/variants/758	MLH1	4292	I68S			3	37038196	37038196	T	G	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.203T>G,NC_000003.11:g.37038196T>G	2018-11-30 14:43:40 UTC	0.5	CA352035494	NONE FOUND	ILE68SER		
759	https://civic.genome.wustl.edu/links/variants/759	MLH1	4292	G65D			3	37038187	37038187	G	A	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.194G>A,NP_000240.1:p.Gly65Asp,ENST00000231790.2:c.194G>A,NC_000003.11:g.37038187G>A	2018-11-30 14:43:40 UTC	0.5	CA007735	89955	GLY65ASP,RS63751465		
760	https://civic.genome.wustl.edu/links/variants/760	MLH1	4292	A681V			3	37090447	37090447	C	T	ENST00000231790.2	75	GRCh37					missense_variant	NM_000249.3:c.2042C>T,NP_000240.1:p.Ala681Val,ENST00000231790.2:c.2042C>T,NC_000003.11:g.37090447C>T	2018-11-30 14:43:40 UTC	0.5	CA008313	90011	ALA681VAL,A440V,RS63750864		
761	https://civic.genome.wustl.edu/links/variants/761	MSH6	2956	P138T			2	48018217	48018217	C	A	ENST00000234420.5	75	GRCh37					missense_variant	ENST00000234420.5:c.412C>A,NC_000002.11:g.48018217C>A	2018-11-30 14:43:40 UTC	0.25	CA346737117	NONE FOUND	PRO138THR		
762	https://civic.genome.wustl.edu/links/variants/762	MSH2	4436	V273FS			2	47641433	47641433	T		ENST00000233146.2	75	GRCh37					frameshift_variant	ENST00000233146.2:c.818delT,NC_000002.11:g.47641433del	2019-07-30 00:01:36 UTC	0.5	CA913090558				
763	https://civic.genome.wustl.edu/links/variants/763	MSH2	4436	E28FS			2	47630413	47630414		G	ENST00000233146.2	75	GRCh37					frameshift_elongation	NC_000002.11:g.47630414dupG	2019-07-30 00:01:22 UTC	0.5	CA913189237	NONE FOUND			
764	https://civic.genome.wustl.edu/links/variants/764	VHL	7428	E55FS (c.163_164delGA)			3	10183694	10183695	GA		ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Glu55fs,NC_000003.11:g.10183694_10183695del,ENST00000256474.2:c.163_164delGA	2018-11-30 14:43:48 UTC	0.5	CA645524641	NONE FOUND	C.163_164DELGA,GLU55FS		
765	https://civic.genome.wustl.edu/links/variants/765	MSH6	2956	I891FS			2	48027794	48027795	TC		ENST00000234420.5	75	GRCh37					frameshift_truncation	ENST00000234420.5:c.2672_2673delTC,NC_000002.11:g.48027794_48027795del	2019-07-30 00:01:26 UTC	0.5	CA913090565	NONE FOUND	ILE891FS		
766	https://civic.genome.wustl.edu/links/variants/766	VHL	7428	E55RfsTer11 (c.163delG)			3	10183694	10183694	G		ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Glu55fs,NP_000542.1:p.Glu55ArgfsTer11,NM_000551.2:c.163delG,NC_000003.11:g.10183694del,ENST00000256474.2:c.163delG	2018-11-30 14:43:44 UTC	7.5	CA432536363	428800	C.163DELG,GLU55ARGFS		
767	https://civic.genome.wustl.edu/links/variants/767	MSH6	2956	R1242H			2	48033421	48033421	G	A	ENST00000234420.5	75	GRCh37					missense_variant	NM_000179.2:c.3725G>A,NP_000170.1:p.Arg1242His,ENST00000234420.5:c.3725G>A,NC_000002.11:g.48033421G>A	2018-11-30 14:43:41 UTC	0.5	CA014077	140866	ARG1242HIS,RS63750119		
769	https://civic.genome.wustl.edu/links/variants/769	MLH1	4292	M490T			3	37070334	37070334	T	C	ENST00000231790.2	75	GRCh37					missense_variant	ENST00000231790.2:c.1469T>C,NC_000003.11:g.37070334T>C	2018-11-30 14:43:41 UTC	0.25	CA352056416	NONE FOUND	MET490THR		
770	https://civic.genome.wustl.edu/links/variants/770	MSH2	4436	K172*			2	47637380	47637380	A	T	ENST00000233146.2	75	GRCh37					stop_gained	ENST00000233146.2:c.514A>T,NC_000002.11:g.47637380A>T	2018-11-30 14:43:54 UTC	0.5	CA346730730	NONE FOUND	K172X,LYS172TER		
771	https://civic.genome.wustl.edu/links/variants/771	VHL	7428	A56FS (c.164_165insG)			3	10183695	10183696		G	ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Ala56fs,NP_000542.1:p.Ala56GlyfsTer74,NM_000551.2:c.164_165insG,NC_000003.11:g.10183695_10183696insG,NC_000003.11:g.10183697dupG	2020-12-04 16:45:34 UTC	7.5	CA645524645	NONE FOUND	164INSG,C.164_165INSG,377_378INSG		
772	https://civic.genome.wustl.edu/links/variants/772	HOXB13	10481	G84E			17	46805705	46805705	C	T	ENST00000290295.7	75	GRCh37					missense_variant	NC_000017.10:g.46805705C>T,NM_006361.5:c.251G>A,NP_006352.2:p.Gly84Glu,ENST00000290295.7:c.251G>A	2018-11-30 14:43:36 UTC	40.0	CA288225	128031	RS138213197,GLY84GLU		
773	https://civic.genome.wustl.edu/links/variants/773	MSH2	4436	E483G			2	47690231	47690231	A	G	ENST00000233146.2	75	GRCh37					missense_variant	NC_000002.11:g.47690231A>G,ENST00000233146.2:c.1448A>G	2018-11-30 14:43:41 UTC	0.5	CA346726930	NONE FOUND	GLU483GLY		
774	https://civic.genome.wustl.edu/links/variants/774	PDGFRA	5156	TNKS2-PDGFRA			10	93558069	93619405			ENST00000371627.4	75	GRCh37	4	55141008	55164414	ENST00000257290.5	transcript_fusion		2017-12-01 14:40:34 UTC	7.5		N/A			
775	https://civic.genome.wustl.edu/links/variants/775	MSH6	2956	V352I			2	48026176	48026176	G	A	ENST00000234420.5	75	GRCh37					missense_variant	NM_000179.2:c.1054G>A,NP_000170.1:p.Val352Ile,ENST00000234420.5:c.1054G>A,NC_000002.11:g.48026176G>A	2018-11-30 14:43:41 UTC	0.5	CA007915	182617	VAL352ILE,RS730881787		
776	https://civic.genome.wustl.edu/links/variants/776	MSH6	2956	R1242C			2	48033420	48033420	C	T	ENST00000234420.5	75	GRCh37					missense_variant	NM_000179.2:c.3724C>T,NP_000170.1:p.Arg1242Cys,ENST00000234420.5:c.3724C>T,NC_000002.11:g.48033420C>T	2018-11-30 14:45:08 UTC	0.5	CA10578156	232375	ARG1242CYS,RS587779285		
777	https://civic.genome.wustl.edu/links/variants/777	SLCO1B1	10599	RS4149056			12	21331549	21331549	T	C	ENST00000256958.2	75	GRCh37					missense_variant,polymorphic_sequence_variant	NC_000012.11:g.21331549T>C,NM_006446.4:c.521T>C,NP_006437.3:p.Val174Ala,ENST00000256958.2:c.521T>C	2018-11-30 14:43:41 UTC	15.0	CA6476722	37346	VAL174ALA,V174A		
778	https://civic.genome.wustl.edu/links/variants/778	SLCO1B1	10599	N130D			12	21329738	21329738	A	G	ENST00000256958.2	75	GRCh37					missense_variant	NC_000012.11:g.21329738A>G	2018-11-30 14:43:33 UTC	15.0	CA6476674	259983	ASN130ASP,RS2306283		
779	https://civic.genome.wustl.edu/links/variants/779	TYMS	7298	RS34743033			18	657646	657646	C	T	ENST00000323274.10	75								2017-12-01 14:40:34 UTC	15.0					
780	https://civic.genome.wustl.edu/links/variants/780	GLI1	2735	ACTB-GLI1	Fusion of the hedgehog pathway component gene GLI1 to the -actin gene (ACTB)  has been described as a mechanism of GLI1,and by extension hedgehog pathway, activation. These fusions have been described in histologically distinctive soft tissue tumours showing a pericytic phenotype.  Gene fusions retain the DNA-binding zinc finger domains of GLI1 and it is likely that the replacement of the promoter region of GLI1with that of the ubiquitously expressed ACTB gene leads to deregulation of GLI expression and its downstream target genes.														gene_fusion		2017-12-01 14:40:34 UTC	15.0		N/A	T(7;12)(P21-22;Q13-15)		
781	https://civic.genome.wustl.edu/links/variants/781	ERBB3	2065	V855A			12	56491672	56491672	T	C	ENST00000267101.3	75	GRCh37					missense_variant	NC_000012.11:g.56491672T>C,ENST000000267101.3:c.2564T>C	2020-10-30 00:11:31 UTC	2.0	CA385313732	NONE FOUND	VAL855ALA		
782	https://civic.genome.wustl.edu/links/variants/782	FGFR2	2263	FGFR2-BICC1			10	123239371	123357917			ENST00000457416.2	75	GRCh37	10	60461834	60591195	ENST00000373886.3	transcript_fusion		2017-12-01 14:40:34 UTC	38.0		N/A			
783	https://civic.genome.wustl.edu/links/variants/783	FGFR2	2263	FGFR2-AHCYL1			10	123239371	123357917			ENST00000457416.2	75	GRCh37	1	110554984	110566357	ENST00000369799.5	transcript_fusion		2017-12-01 14:40:34 UTC	23.0		N/A			
784	https://civic.genome.wustl.edu/links/variants/784	CDKN2B	1030	METHYLATION			9	22009121	22009172			ENST00000276925.6	75	GRCh37					N/A		2017-12-01 14:40:35 UTC	20.0		N/A			
785	https://civic.genome.wustl.edu/links/variants/785	CHEK2	11200	1100DELC			22	29091857	29091857	G		ENST00000328354.6	75	GRCh37					frameshift_truncation	NC_000022.10:g.29091857delG,NM_007194.3:c.1100delC,NP_009125.1:p.Thr367Metfs,ENST00000328354.6:c.1100delC,NC_000022.10:g.29091857del	2018-11-30 14:43:59 UTC	15.0	CA288251	128042	THR367METFS,RS555607708		
787	https://civic.genome.wustl.edu/links/variants/787	CHEK2	11200	I157T			22	29121087	29121087	A	G	ENST00000328354.6	75	GRCh37					missense_variant	NM_007194.3:c.470T>C,NP_009125.1:p.Ile157Thr,ENST00000328354.6:c.470T>C,NC_000022.10:g.29121087A>G	2018-11-30 14:43:55 UTC	15.0	CA117630	5591	ILE157THR,I200T,RS17879961		
788	https://civic.genome.wustl.edu/links/variants/788	CHEK2	11200	IVS2+1G>A																	2017-12-01 14:40:35 UTC	10.0					
792	https://civic.genome.wustl.edu/links/variants/792	PTPRD	5789	V253I			9	8521481	8521481	C	T	ENST00000381196.4	75	GRCh37					missense_variant	NM_002839.3:c.757G>A,NP_002830.1:p.Val253Ile,NC_000009.11:g.8521481C>T	2018-11-30 14:43:42 UTC	10.0	CA4984656	NONE FOUND	VAL253ILE		
793	https://civic.genome.wustl.edu/links/variants/793	VHL	7428	A56fs (c.164_165insA)			3	10183695	10183696		A	ENST00000256474.2	75	GRCh37					frameshift_truncation	NP_000542.1:p.Ala56fs,NP_000542.1:p.Ala56GlyfsTer74,NM_000551.2:c.164_165insA,NC_000003.11:g.10183695_10183696insA,NC_000003.11:g.10183695dupA,NC_000003.12:g.10142011dup	2020-05-11 22:25:36 UTC	5.0	CA658795187	NONE FOUND	165INSA,C.164_165INSA		
794	https://civic.genome.wustl.edu/links/variants/794	VHL	7428	E55= (c.165G>A)			3	10183696	10183696	G	A	ENST00000256474.2	75	GRCh37					synonymous_variant	NM_000551.2:c.165G>A,NC_000003.11:g.10183696G>A,ENST00000256474.2:c.165G>A,NP_000542.1:p.Glu55=	2020-10-23 05:54:26 UTC	5.0	CA432536364	486721	GLU55GLU,C.165G>A,RS1553619391,GLU55=,E55E (C.165G>A)		
795	https://civic.genome.wustl.edu/links/variants/795	RRM1	6240	OVEREXPRESSION			11	4116039	4160106			ENST00000300738.5	75	GRCh37					N/A		2017-12-01 14:40:35 UTC	2.0		N/A			
796	https://civic.genome.wustl.edu/links/variants/796	RRM2	6241	OVEREXPRESSION			2	10262455	10271545			ENST00000360566.2	75	GRCh37					N/A		2017-12-01 14:40:35 UTC	2.0		N/A			
797	https://civic.genome.wustl.edu/links/variants/797	POLE	5426	MUTATION			12	133202900	133256623			ENST00000320574.5	75	GRCh37					gene_variant		2017-12-01 14:40:35 UTC	15.0		N/A			
798	https://civic.genome.wustl.edu/links/variants/798	MET	4233	D1228V			7	116423408	116423408	A	T	ENST00000397752.3	75	GRCh37					missense_variant	ENST00000397752.3:c.3683A>T,NC_000007.13:g.116423408A>T	2018-11-30 14:43:42 UTC	20.0	CA368991571	NONE FOUND	ASP1228VAL		
799	https://civic.genome.wustl.edu/links/variants/799	RB1	5925	MUTATION			13	48877911	49056122			ENST00000267163.4	75	GRCh37					gene_variant		2017-12-01 14:40:35 UTC	10.0					
800	https://civic.genome.wustl.edu/links/variants/800	NTRK1	4914	SQSTM1-NTRK1		NTRK1 Fusions													transcript_fusion		2020-09-17 04:47:58 UTC	30.0		N/A			
801	https://civic.genome.wustl.edu/links/variants/801	NTRK3	4916	ETV6-NTRK3			12	11802788	12022903			ENST00000396373.4	75	GRCh37	15	88483984	88418230	ENST00000394480.2	transcript_fusion		2020-12-03 01:15:35 UTC	107.0		N/A		39	https://civic.genome.wustl.edu/links/assertions/39
802	https://civic.genome.wustl.edu/links/variants/802	RUNX1	861	K83E			21	36259163	36259163	T	C	ENST00000344691.4	75	GRCh37					missense_variant	NC_000021.8:g.36259163T>C,NP_001001890.1:p.Lys83Glu,NM_001001890.2:c.247A>G,ENST00000344691.4:c.247A>G	2018-11-30 14:43:44 UTC	10.0	CA248613	14465	LYS83GLU,K110E,RS121912498		
803	https://civic.genome.wustl.edu/links/variants/803	RUNX1	861	Y260*			21	36171704	36171704	G	T	ENST00000344691.4	75	GRCh37					stop_gained	NM_001001890.2:c.780C>A,NP_001001890.1:p.Tyr260Ter,NC_000021.8:g.36171704G>T,ENST00000344691.4:c.780C>A	2018-11-30 14:43:42 UTC	7.5	CA248619	14467	Y260X,TYR260TER,RS121912499		
804	https://civic.genome.wustl.edu/links/variants/804	RUNX1	861	R135FSX177																	2017-12-01 14:40:35 UTC	10.0					
805	https://civic.genome.wustl.edu/links/variants/805	NTRK3	4916	ETV6-NTRK3 G623R			15	88476265	88476265	C	T	ENST00000394480.2	75	GRCh37					missense_variant,transcript_fusion	NC_000015.9:g.88476265C>T,ENST00000394480.2:c.1867G>A	2018-11-30 14:43:45 UTC	10.0	CA393914380	NONE FOUND	GLY623ARG		
806	https://civic.genome.wustl.edu/links/variants/806	RUNX1	861	D198Y	D198Y was observed in a pedigree with a history of Familial platelet disorder with predisposition to acute myeloid leukemia. It occurs within the Runt domain of RUNX1, known to be associated with the disease.		21	36231792	36231792	C	A	ENST00000300305.3	75	GRCh37					missense_variant,loss_of_function_variant	NC_000021.8:g.36231792C>A	2018-11-30 14:44:38 UTC	7.5	CA410207975	NONE FOUND	ASP198TYR		
807	https://civic.genome.wustl.edu/links/variants/807	RUNX1	861	A107P			21	36252962	36252962	C	G	ENST00000344691.4	75	GRCh37					missense_variant	NM_001754.4:c.400G>C,NP_001745.2:p.Ala134Pro,NC_000021.8:g.36252962C>G,ENST00000344691.4:c.400G>C	2018-11-30 14:43:42 UTC	12.5	CA248623	14468	A134P,ALA134PRO,RS74315451		
808	https://civic.genome.wustl.edu/links/variants/808	MSH2	4436	LOSS			2	47630108	47710367			ENST00000233146.2	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:35 UTC	7.5		N/A			
809	https://civic.genome.wustl.edu/links/variants/809	MSH6	2956	LOSS			2	48010221	48037240			ENST00000234420.5	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:35 UTC	7.5		N/A			
810	https://civic.genome.wustl.edu/links/variants/810	RUNX1	861	T148HFSX9			21	36252913	36252920	GCTGCGGT		ENST00000300305.3	75	GRCh37					frameshift_truncation	NM_001754.4:c.442_449delACCGCAGC,NP_001745.2:p.Thr148Hisfs,NC_000021.8:g.36252913_36252920del,ENST00000300305.3:c.442_449delACCGCAGC	2018-11-30 14:43:45 UTC	5.0	CA248627	14470	C.442_449DEL,THR148HISFSX9,RS587776811		
814	https://civic.genome.wustl.edu/links/variants/814	DDX41	51428	R164W			5	176942767	176942767	G	A	ENST00000507955.1	75	GRCh37					missense_variant		2018-11-30 14:43:45 UTC	7.5	CA358665				
816	https://civic.genome.wustl.edu/links/variants/816	ERBB2	2064	G776L			17	37880997	37880998	GG	CT	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2326_2327delinsCT,NC_000017.10:g.37880997_37880998delinsCT,NP_001276866.1:p.Gly776Leu,NM_001289937.1:c.2326_2327delinsCT	2019-07-30 00:01:28 UTC	7.5	CA913189238	NONE FOUND	GLY776LEU		
817	https://civic.genome.wustl.edu/links/variants/817	ERBB2	2064	G778_P780DUP			17	37881011	37881012		GGCTCCCCA	ENST00000269571.5	75	GRCh37					inframe_insertion	NM_004448.3:c.2332_2340dupGGCTCCCCA,ENST00000269571.5:c.2332_2340dupGGCTCCCCA	2018-11-30 14:43:42 UTC	15.0	CA135401	44993	GLY778_PRO780DUP		
818	https://civic.genome.wustl.edu/links/variants/818	ERBB2	2064	M774DELINSWLV			17	37880991	37880991	A	TGGCTGG	ENST00000269571.5	75	GRCh37					inframe_indel		2017-12-01 14:40:35 UTC	7.5		NONE FOUND			
819	https://civic.genome.wustl.edu/links/variants/819	PTPRB	5787	LOSS-OF-FUNCTION			12	70910630	71031220			ENST00000334414.6	75	GRCh37					loss_of_function_variant		2017-12-01 14:40:35 UTC	3.0		N/A			
820	https://civic.genome.wustl.edu/links/variants/820	VHL	7428	A149S (c.445G>T)			3	10188302	10188302	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NP_000542.1:p.Ala149Ser,NM_000551.2:c.445G>T,ENST00000256474.2:c.445G>T,NC_000003.11:g.10188302G>T	2018-11-30 14:43:43 UTC	17.5	CA020355	127829	ALA149SER,C.445G>T,RS587780077		
821	https://civic.genome.wustl.edu/links/variants/821	HLA-C	3107	COPY-NEUTRAL LOSS OF HETEROZYGOSITY																	2017-12-01 14:40:35 UTC	7.5					
822	https://civic.genome.wustl.edu/links/variants/822	JAK1	3716	S703I			1	65311203	65311203	C	A	ENST00000342505.4	75	GRCh37					missense_variant	ENST00000342505.4:c.2108G>T,NC_000001.10:g.65311203C>A	2018-11-30 14:43:46 UTC	4.0	CA340667333	NONE FOUND	SER703ILE		
823	https://civic.genome.wustl.edu/links/variants/823	EPCAM	4072	3' EXON DELETION			2	47612305	47614173			ENST00000263735	75	GRCh37					disruptive_inframe_deletion		2017-12-01 14:40:35 UTC	20.0					
825	https://civic.genome.wustl.edu/links/variants/825	ARAF	369	S490T			X	47429340	47429340	T	A	ENST00000377045.4	75	GRCh37					missense_variant		2018-11-30 14:43:46 UTC	2.5	CA412818377	NONE FOUND	SER490THR		
826	https://civic.genome.wustl.edu/links/variants/826	GNAS	2778	R201C			20	57484420	57484420	C	T	ENST00000371085.3	75	GRCh37					missense_variant	NM_000516.5:c.601C>T,NP_000507.1:p.Arg201Cys,NC_000020.10:g.57484420C>T,ENST00000371085.3:c.601C>T	2018-11-30 14:43:46 UTC	5.0	CA126067	15933	ARG201CYS,R202C,RS11554273		
827	https://civic.genome.wustl.edu/links/variants/827	FGFR3	2261	MUTATION			4	1795039	1810599			ENST00000340107.4	75	GRCh37							2021-01-04 21:16:09 UTC	70.0					
829	https://civic.genome.wustl.edu/links/variants/829	VHL	7428	M54IFS (c.162_166delGGAGG)			3	10183693	10183697	GGAGG		ENST00000256474.2	75	GRCh37					frameshift_truncation	NM_000551.2:c.162_166delGGAGG,NP_000542.1:p.Met54IlefsTer76,NC_000003.11:g.10183693_10183697del,ENST00000256474.2:c.162_166delGGAGG	2018-11-30 14:43:48 UTC	0.5	CA645524639	NONE FOUND	C.162_166DELGGAGG,MET54ILEFS		
830	https://civic.genome.wustl.edu/links/variants/830	FGFR3	2261	FGFR3-TACC3			4	1795039	1808661			ENST00000340107.4	75	GRCh37	4	1741429	1746898	ENST00000313288.4	transcript_fusion		2020-01-03 23:00:54 UTC	30.0		495323			
838	https://civic.genome.wustl.edu/links/variants/838	PTEN	5728	R173C			10	89711899	89711899	C	T	ENST00000371953.3	75	GRCh37					missense_variant	NM_000314.6:c.517C>T,NP_000305.3:p.Arg173Cys,ENST00000371953.3:c.517C>T,NC_000010.10:g.89711899C>T	2018-11-30 14:43:47 UTC	10.75	CA000498	189500	ARG173CYS,RS121913293		
839	https://civic.genome.wustl.edu/links/variants/839	ALK	238	ALTERNATIVE TRANSCRIPT (ATI)	This novel ALK transcript (alternative isoform) initiates from a de novo alternative transcription initiation (ATI) site in ALK intron 19.																2019-07-31 17:58:55 UTC	20.0			ALK(ATI),ALK INTRON 19 ATI ISOFORM,ALK ALTERNATIVE ISOFORM		
843	https://civic.genome.wustl.edu/links/variants/843	VHL	7428	EXON 1-3 DELETION			3	10183532	10191649			ENST00000256474.2	75	GRCh37					exon_loss_variant	ENST00000256474.2:c.1-?_642+?del	2018-12-14 19:03:57 UTC	17.5					
844	https://civic.genome.wustl.edu/links/variants/844	VHL	7428	EXON 1 DELETION			3	10183532	10183871			ENST00000256474.2	75	GRCh37					exon_loss_variant	ENST00000256474.2:c.1-?_340+?del	2018-12-14 19:03:58 UTC	20.0					
845	https://civic.genome.wustl.edu/links/variants/845	VHL	7428	EXON 1-2 DELETION			3	10183532	10188320			ENST00000256474.2	75	GRCh37					exon_loss_variant	ENST00000256474.2:c.1-?_463+?del	2017-12-01 14:40:35 UTC	7.5					
846	https://civic.genome.wustl.edu/links/variants/846	VHL	7428	M1FS (c.1_17del17)			3	10183532	10183548	ATGCCCCGGAGGGCGGA		ENST00000256474.2	75	GRCh37					start_lost	ENST00000256474.2:c.1_17del17,NC_000003.11:g.10183532_10183548del,NM_000551.3:c.1_17del	2018-11-30 14:43:47 UTC	0.5	CA645524623	NONE FOUND	C.1_17DEL17,MET1FS		
847	https://civic.genome.wustl.edu/links/variants/847	VHL	7428	M1? (c.1-1_20del21)			3	10183531	10183551	AATGCCCCGGAGGGCGGAGAA		ENST00000256474.2	75	GRCh37					start_lost	NP_000542.1:p.0,NP_000542.1:p.Met1?,NM_000551.3:c.1-1_20del21,ENST00000256474.2:c.1-1_20del21,NC_000003.11:g.10183531_10183551del	2018-11-30 14:43:48 UTC	0.5	CA645524624	NONE FOUND	MET1 LOSS,START LOSS,NO INITIATION,C.1-1_20DEL21		
848	https://civic.genome.wustl.edu/links/variants/848	VHL	7428	M1? (c.3G>A)			3	10183534	10183534	G	A	ENST00000256474.2	75	GRCh37					start_lost	NP_000542.1:p.0,NP_000542.1:p.Met1?,NM_000551.3:c.3G>A,ENST00000256474.2:c.3G>A,NC_000003.11:g.10183534G>A	2020-12-12 22:54:54 UTC	0.5	CA020331	135406	MET1 LOSS,START LOSS,NO INITIATION,C.3G>A,RS578091032		
849	https://civic.genome.wustl.edu/links/variants/849	VHL	7428	N7D (c.19A>G)			3	10183550	10183550	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NC_000003.11:g.10183550A>G,NM_000551.3:c.19A>G,ENST00000256474.2:c.19A>G,NP_000542.1:c.Asn7Asp	2018-11-30 14:43:47 UTC	0.25	CA351747044	NONE FOUND	ASN7ASP,C.19A>G,RS1311403806		
850	https://civic.genome.wustl.edu/links/variants/850	VHL	7428	P25L (c.74C>T)			3	10183605	10183605	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.74C>T,NP_000542.1:p.Pro25Leu,ENST00000256474.2:c.74C>T,NC_000003.11:g.10183605C>T	2018-11-30 14:43:47 UTC	7.5	CA020538	93330	PRO25LEU,C.74C>T,RS35460768		
851	https://civic.genome.wustl.edu/links/variants/851	VHL	7428	P59fs (c.173_174insC)			3	10183704	10183705		C	ENST00000256474.2	75	GRCh37					plus_1_frameshift_variant,frameshift_truncation	ENST00000256474.2:c.173_174insC,NP_000542.1:p.Pro59AlafsTer73,NM_000551.3:c.173_174insC,NC_000003.11:g.10183704_10183705insC	2018-11-30 14:43:48 UTC	7.5	CA658795188	NONE FOUND	PRO59FS,C.173_174INSC		
852	https://civic.genome.wustl.edu/links/variants/852	VHL	7428	Y98FS (c.291_310del20)			3	10183822	10183841	CTACCCAACGCTGCCGCCTG		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.291_310del,NC_000003.11:g.10183822_10183841del,NM_000551.3:c.291_310del,NP_000542.1:p.Tyr98HisfsTer27	2018-11-30 14:43:43 UTC	0.5	CA645524819	NONE FOUND	C.291_310DEL20,TYR98FS		
860	https://civic.genome.wustl.edu/links/variants/860	NTRK1	4914	EXPRESSION			1	156830686	156851434			ENST00000524377.1	75	GRCh37					N/A		2017-12-01 14:40:35 UTC	20.0		N/A			
862	https://civic.genome.wustl.edu/links/variants/862	PDGFRA	5156	P577S			4	55141083	55141083	C	T	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.1729C>T,NP_006197.1:p.Pro577Ser,NC_000004.11:g.55141083C>T,ENST00000257290.5:c.1729C>T	2018-11-30 14:43:50 UTC	3.0	CA16602636	376181	PRO577SER,RS1057519811		
863	https://civic.genome.wustl.edu/links/variants/863	PDGFRA	5156	R841K			4	55152090	55152090	G	A	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2522G>A,NP_006197.1:p.Arg841Lys,NC_000004.11:g.55152090G>A,ENST00000257290.5:c.2522G>A	2018-11-30 14:43:50 UTC	3.0	CA16602638	376183	ARG841LYS,RS1057519813		
864	https://civic.genome.wustl.edu/links/variants/864	PDGFRA	5156	H845Y			4	55152101	55152101	C	T	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2533C>T,NP_006197.1:p.His845Tyr,NC_000004.11:g.55152101C>T,ENST00000257290.5:c.2533C>T	2018-11-30 14:43:50 UTC	3.0	CA16602639	376184	HIS845TYR,RS1057519814		
865	https://civic.genome.wustl.edu/links/variants/865	PDGFRA	5156	G853D			4	55152126	55152126	G	A	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.4:c.2558G>A,NP_006197.1:p.Gly853Asp,NC_000004.11:g.55152126G>A,ENST00000257290.5:c.2558G>A	2018-11-30 14:43:50 UTC	3.0	CA16602640	376185	GLY853ASP,RS763576329		
867	https://civic.genome.wustl.edu/links/variants/867	MTAP	4507	Underexpression																	2020-06-18 01:16:57 UTC	1.0					
868	https://civic.genome.wustl.edu/links/variants/868	VPS37A	137492	UNDEREXPRESSION			8	17104080	17155533			ENST00000324849.4	75	GRCh37					N/A		2018-07-06 21:29:59 UTC	3.0		N/A			
870	https://civic.genome.wustl.edu/links/variants/870	BTK	695	T316A			X	100613633	100613633	T	C	ENST00000308731.7	75	GRCh37					missense_variant	ENST00000308731.7:c.946T>C,NM_000061.2:c.946T>C,NC_000023.10:g.100613633T>C	2018-11-30 14:43:50 UTC	10.0	CA413928923	NONE FOUND	THR316ALA		
871	https://civic.genome.wustl.edu/links/variants/871	ERBB2	2064	T862A			17	37881392	37881392	A	G	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2584A>G,NC_000017.10:g.37881392A>G,NM_001289937.1:c.2584A>G,NP_001276866.1:p.Thr862Ala	2018-11-30 14:43:51 UTC	3.0	CA399304738	NONE FOUND	THR862ALA		
872	https://civic.genome.wustl.edu/links/variants/872	ERBB2	2064	V773A			17	37880989	37880989	T	C	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2318T>C,NC_000017.10:g.37880989T>C,NM_004448.3:c.2318T>C,NP_004439.2:p.Val773Ala	2018-11-30 14:42:56 UTC	3.0	CA399302815	NONE FOUND	VAL773ALA		
873	https://civic.genome.wustl.edu/links/variants/873	ERBB2	2064	N857S			17	37881378	37881378	A	G	ENST00000269571.5	75	GRCh37					missense_variant	NC_000017.10:g.37881378A>G,NP_004439.2:p.Asn857Ser,NM_004448.3:c.2570A>G,ENST00000269571.5:c.2570A>G	2018-11-30 14:43:51 UTC	3.0	CA123601	13880	ASN857SER,N827S,N842S,RS28933370		
874	https://civic.genome.wustl.edu/links/variants/874	ERBB2	2064	H878Y			17	37881440	37881440	C	T	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2632C>T,NC_000017.10:g.37881440C>T,NM_001289937.1:c.2632C>T,NP_001276866.1:p.His878Tyr	2018-11-30 14:42:58 UTC	3.0	CA399305170	NONE FOUND	HIS878TYR		
875	https://civic.genome.wustl.edu/links/variants/875	ERBB2	2064	OVEREXPRESSION															N/A		2018-07-12 18:55:06 UTC	77.5		N/A			
876	https://civic.genome.wustl.edu/links/variants/876	GNAS	2778	R201															amino_acid_substitution		2019-07-22 18:29:52 UTC	15.0					
877	https://civic.genome.wustl.edu/links/variants/877	GNAS	2778	c.393T>C			20	57428713	57428713	T	C	ENST00000371100	75	GRCh37					missense_variant		2020-12-16 19:15:50 UTC	165.0	CA409455494		LEU69SER,LEU131=		
878	https://civic.genome.wustl.edu/links/variants/878	NRAS	4893	G12D			1	115258747	115258747	C	T	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.35G>A,NP_002515.1:p.Gly12Asp,NC_000001.10:g.115258747C>T,ENST00000369535.4:c.35G>A	2020-11-25 22:29:11 UTC	7.5	CA130425	39648	RS121913237,GLY12ASP		
879	https://civic.genome.wustl.edu/links/variants/879	TP53	7157	G245S			17	7577548	7577548	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NC_000017.10:g.7577548C>T,NM_000546.5:c.733G>A,NP_000537.3:p.Gly245Ser,ENST00000269305.4:c.733G>A	2019-03-13 00:00:07 UTC	4.0	CA000367	12365	RS28934575		
881	https://civic.genome.wustl.edu/links/variants/881	PIK3CA	5290	E545Q			3	178936091	178936091	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1633G>C,NP_006209.2:p.Glu545Gln,NC_000003.11:g.178936091G>C,ENST00000263967.3:c.1633G>C	2020-11-25 22:27:46 UTC	7.5	CA16602379	375896	RS104886003,GLU545GLN		
883	https://civic.genome.wustl.edu/links/variants/883	PIK3CA	5290	E545G			3	178936092	178936092	A	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1634A>G,NP_006209.2:p.Glu545Gly,NC_000003.11:g.178936092A>G,ENST00000263967.3:c.1634A>G	2018-11-30 14:44:09 UTC	2.0	CA123336	13656	RS121913274,GLU545GLY		
885	https://civic.genome.wustl.edu/links/variants/885	PIK3CA	5290	Q546K			3	178936094	178936094	C	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1636C>A,NP_006209.2:p.Gln546Lys,NC_000003.11:g.178936094C>A,ENST00000263967.3:c.1636C>A	2020-11-25 22:50:55 UTC	5.0	CA123338	13657	RS121913286,GLN546LYS		
892	https://civic.genome.wustl.edu/links/variants/892	ABL1	25	BCR-ABL F359V			9	133748414	133748414	T	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.1075T>G,NP_005148.2:p.Phe359Val,NC_000009.11:g.133748414T>G,ENST00000318560.5:c.1075T>G	2020-03-16 21:53:25 UTC	54.0	CA16602557	376096	RS121913452,BCR-ABL F378V,BCR-ABL PHE359VAL,BCR-ABL1 F359V,BCR-ABL1 PHE359VAL		
893	https://civic.genome.wustl.edu/links/variants/893	NRAS	4893	Q61H			1	115256528	115256528	T	G	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.183A>C,NP_002515.1:p.Gln61His,NC_000001.10:g.115256528T>G,ENST00000369535.4:c.183A>C	2018-11-30 14:43:49 UTC	0.0	CA16602358	375871	RS121913255,GLN61HIS		
896	https://civic.genome.wustl.edu/links/variants/896	NRAS	4893	G13R			1	115258745	115258745	C	G	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.37G>C,NP_002515.1:p.Gly13Arg,NC_000001.10:g.115258745C>G,ENST00000369535.4:c.37G>C	2020-12-02 00:11:28 UTC	2.5	CA151261	13899	RS121434595,GLY13ARG		
897	https://civic.genome.wustl.edu/links/variants/897	NRAS	4893	G12C			1	115258748	115258748	C	A	ENST00000369535.4	75	GRCh37					missense_variant	NM_002524.4:c.34G>T,NP_002515.1:p.Gly12Cys,NC_000001.10:g.115258748C>A,ENST00000369535.4:c.34G>T	2018-11-30 14:43:49 UTC	0.0	CA297020	40468	RS121913250,GLY12CYS		
901	https://civic.genome.wustl.edu/links/variants/901	ATM	472	T2666A			11	108204681	108204681	A	G	ENST00000278616.4	75	GRCh37					missense_variant	NC_000011.9:g.108204681A>G	2020-06-08 17:30:18 UTC	3.0	CA349494	219594			
903	https://civic.genome.wustl.edu/links/variants/903	ATM	472	R3008C			11	108236086	108236086	C	T	ENST00000278616.4	75	GRCh37					missense_variant	NC_000011.9:g.108236086C>T	2020-06-08 17:30:18 UTC	3.0	CA294307				
905	https://civic.genome.wustl.edu/links/variants/905	KRAS	3845	A146P			12	25378562	25378562	C	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.436G>C,NP_004976.2:p.Ala146Pro,NC_000012.11:g.25378562C>G,ENST00000256078.4:c.436G>C	2021-02-01 23:24:27 UTC	7.5	CA16602441	375963	RS121913527,ALA146PRO		
906	https://civic.genome.wustl.edu/links/variants/906	KRAS	3845	A146T			12	25378562	25378562	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.436G>A,NP_004976.2:p.Ala146Thr,NC_000012.11:g.25378562C>T,ENST00000256078.4:c.436G>A	2018-11-30 14:43:49 UTC	21.0	CA245262	197243	RS121913527,ALA146THR		
907	https://civic.genome.wustl.edu/links/variants/907	KRAS	3845	Q61H			12	25380275	25380275	T	G	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.183A>C,NP_004976.2:p.Gln61His,NC_000012.11:g.25380275T>G,ENST00000256078.4:c.183A>C	2020-11-25 00:12:07 UTC	7.5	CA180922	177881	RS17851045,GLN61HIS		
908	https://civic.genome.wustl.edu/links/variants/908	KRAS	3845	Q61L			12	25380276	25380276	T	A	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.182A>T,NP_004976.2:p.Gln61Leu,NC_000012.11:g.25380276T>A,ENST00000256078.4:c.182A>T	2020-03-17 11:30:12 UTC	7.5	CA210876	45116	RS121913240,GLN61LEU		
909	https://civic.genome.wustl.edu/links/variants/909	KRAS	3845	Q61R			12	25380276	25380276	T	C	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.182A>G,NP_004976.2:p.Gln61Arg,NC_000012.11:g.25380276T>C,ENST00000256078.4:c.182A>G	2020-03-17 11:20:18 UTC	7.5	CA261702	45115	RS121913240,GLN61ARG		
910	https://civic.genome.wustl.edu/links/variants/910	KRAS	3845	Q61K			12	25380277	25380277	G	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.181C>A,NP_004976.2:p.Gln61Lys,NC_000012.11:g.25380277G>T,ENST00000256078.4:c.181C>A	2020-03-17 11:11:25 UTC	7.5	CA180750	177777	RS121913238,GLN61LYS		
913	https://civic.genome.wustl.edu/links/variants/913	KRAS	3845	G12S			12	25398285	25398285	C	T	ENST00000256078.4	75	GRCh37					missense_variant	NM_004985.4:c.34G>A,NP_004976.2:p.Gly12Ser,NC_000012.11:g.25398285C>T,ENST00000256078.4:c.34G>A	2020-11-25 01:02:37 UTC	38.0	CA135565	12584	RS121913530,GLY12SER		
916	https://civic.genome.wustl.edu/links/variants/916	TP53	7157	R282W										GRCh37							2017-12-01 14:40:36 UTC	0.0					
918	https://civic.genome.wustl.edu/links/variants/918	TP53	7157	R273L			17	7577120	7577120	C	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.818G>T,NP_000537.3:p.Arg273Leu,NC_000017.10:g.7577120C>A,ENST00000269305.4:c.818G>T	2018-11-30 14:45:06 UTC	0.0	CA001530	376655	RS28934576,ARG273LEU		
922	https://civic.genome.wustl.edu/links/variants/922	TP53	7157	Y220C			17	7578190	7578190	T	C	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.659A>G,NP_000537.3:p.Tyr220Cys,NC_000017.10:g.7578190T>C,ENST00000269305.4:c.659A>G	2020-07-17 20:53:01 UTC	15.5	CA000315	127819	RS121912666,TYR220CYS		
929	https://civic.genome.wustl.edu/links/variants/929	PIK3CA	5290	R88Q										GRCh37							2017-12-01 14:40:36 UTC	0.0					
930	https://civic.genome.wustl.edu/links/variants/930	PIK3CA	5290	N345K			3	178921553	178921553	T	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1035T>A,NP_006209.2:p.Asn345Lys,NC_000003.11:g.178921553T>A,ENST00000263967.3:c.1035T>A	2018-11-30 14:43:48 UTC	0.0	CA16602517	376050	RS121913284,ASN345LYS		
931	https://civic.genome.wustl.edu/links/variants/931	PIK3CA	5290	C420R			3	178927980	178927980	T	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1258T>C,NP_006209.2:p.Cys420Arg,NC_000003.11:g.178927980T>C,ENST00000263967.3:c.1258T>C	2020-11-25 22:33:52 UTC	5.0	CA180900	31945	RS121913272,CYS420ARG		
940	https://civic.genome.wustl.edu/links/variants/940	PIK3CA	5290	G1049R			3	178952090	178952090	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3145G>C,NP_006209.2:p.Gly1049Arg,NC_000003.11:g.178952090G>C,ENST00000263967.3:c.3145G>C	2018-11-30 14:43:24 UTC	0.0	CA16602520	376053	RS121913277,GLY1049ARG		
941	https://civic.genome.wustl.edu/links/variants/941	PDGFRA	5156	V561D			4	55141036	55141036	T	A	ENST00000257290.5	75	GRCh37					missense_variant	NM_006206.5:c.1682T>A,NP_006197.1:p.Val561Asp,NC_000004.11:g.55141036T>A,ENST00000257290.5:c.1682T>A	2019-04-26 20:30:33 UTC	8.5	CA123203	13546	RS121908586		
943	https://civic.genome.wustl.edu/links/variants/943	PDGFRA	5156	D842_H845DELDIMH										GRCh37							2019-02-23 02:20:30 UTC	2.0					
946	https://civic.genome.wustl.edu/links/variants/946	KIT	3815	Y503_F504insAY			4	55592185	55592186		GCCTAT	ENST00000288135.5	75	GRCh37					inframe_insertion	NC_000004.11:g.55592185_55592186insGCCTAT	2019-02-23 01:32:09 UTC	2.0	CA645516719				
948	https://civic.genome.wustl.edu/links/variants/948	KIT	3815	K550_W557del			4	55593582	55593605	AAACCCATGTATGAAGTACAGTGG		ENST00000288135.5	75	GRCh37					inframe_deletion	ENST00000288135.5:c.1648_1671del AAACCCATGTATGAAGTACAGTGG	2019-07-09 22:39:44 UTC	4.0	CA645516733	NONE FOUND			
949	https://civic.genome.wustl.edu/links/variants/949	KIT	3815	K550_K558del			4	55593582	55593608	AAACCCATGTATGAAGTACAGTGGAAG		ENST00000288135.5	75	GRCh37					inframe_deletion	NM_000222.2:c.1648_1674del27,NP_000213.1:p.Lys550_Lys558del,NC_000004.11:g.55593582_55593608del27,ENST00000288135.5:c.1648_1674del27	2019-05-03 23:20:46 UTC	5.0	CA123524	13857	RS121913234,KPMYEVQWK550-558DEL		
961	https://civic.genome.wustl.edu/links/variants/961	KIT	3815	W557_K558DELWK			4	55593603	55593608	TGGAAG		ENST00000288135.5	75	GRCh37							2019-07-09 23:06:16 UTC	14.5	CA356974	222957			
964	https://civic.genome.wustl.edu/links/variants/964	KIT	3815	K558_V559del			4	55593606	55593611	AAGGTT		ENST00000288135.5	75	GRCh37						ENST00000288135.5:c.1672_1677delAAGGTT	2019-05-03 23:51:42 UTC	5.0	CA645516838	NONE FOUND			
968	https://civic.genome.wustl.edu/links/variants/968	KIT	3815	V559D			4	55593610	55593610	T	A	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1676T>A,NP_000213.1:p.Val559Asp,NC_000004.11:g.55593610T>A,ENST00000288135.5:c.1676T>A	2019-07-09 22:59:38 UTC	11.5	CA123522	13856	RS121913517,VAL559ASP		
971	https://civic.genome.wustl.edu/links/variants/971	KIT	3815	V560D			4	55593613	55593613	T	A	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.1679T>A,NM_000222.2:c.1679T>A,NP_000213.1:p.Val560Asp,NC_000004.11:g.55593613T>A	2019-07-09 22:10:34 UTC	14.5	CA16602396	375914	VAL560ASP,RS121913521		
972	https://civic.genome.wustl.edu/links/variants/972	KIT	3815	V560G			4	55593613	55593613	T	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1679T>G,NP_000213.1:p.Val560Gly,NC_000004.11:g.55593613T>G,ENST00000288135.5:c.1679T>G	2019-07-09 23:18:47 UTC	5.0	CA16602398	375916,376735	RS121913521,VAL560GLY		
977	https://civic.genome.wustl.edu/links/variants/977	KIT	3815	D579DEL			4	55593669	55593671	GAT		ENST00000288135.5	75	GRCh37					inframe_deletion	ENST00000288135.5:c.1735_1737delGAT,NM_000222.2:c.1735_1737delGAT,NP_000213.1:p.Asp579del,NC_000004.11:g.55593669_55593671delGAT	2019-05-03 23:59:30 UTC	12.5	CA16611553	409725	ASP579DEL		
978	https://civic.genome.wustl.edu/links/variants/978	KIT	3815	K642E			4	55594221	55594221	A	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.1924A>G,NP_000213.1:p.Lys642Glu,NC_000004.11:g.55594221A>G,ENST00000288135.5:c.1924A>G	2019-07-09 23:29:53 UTC	10.0	CA123547	13866	RS121913512,LYS642GLU		
983	https://civic.genome.wustl.edu/links/variants/983	KIT	3815	D816H		KIT Exon 17	4	55599320	55599320	G	C	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2446G>C,NP_000213.1:p.Asp816His,NC_000004.11:g.55599320G>C,ENST00000288135.5:c.2446G>C	2018-11-30 14:43:57 UTC	7.5	CA123540	13863	ASP816HIS,RS121913506		
986	https://civic.genome.wustl.edu/links/variants/986	KIT	3815	D820Y		KIT Exon 17	4	55599332	55599332	G	T	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2458G>T,NP_000213.1:p.Asp820Tyr,NC_000004.11:g.55599332G>T,ENST00000288135.5:c.2458G>T	2019-03-21 20:40:04 UTC	14.5	CA16602408	375928	ASP820TYR,RS1057519710		
987	https://civic.genome.wustl.edu/links/variants/987	KIT	3815	N822H		KIT Exon 17	4	55599338	55599338	A	C			GRCh37					missense_variant		2019-02-26 00:00:03 UTC	0.0	CA356911968				
989	https://civic.genome.wustl.edu/links/variants/989	KIT	3815	Y823D		KIT Exon 17	4	55599341	55599341	T	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2467T>G,NP_000213.1:p.Tyr823Asp,NC_000004.11:g.55599341T>G,ENST00000288135.5:c.2467T>G	2018-11-30 14:45:05 UTC	7.5	CA16602561	376101	TYR823ASP,RS1057519761		
990	https://civic.genome.wustl.edu/links/variants/990	KIT	3815	A829P			4	55602664	55602664	G	C			GRCh37					missense_variant		2019-07-26 15:24:13 UTC	8.0	CA16602413				
992	https://civic.genome.wustl.edu/links/variants/992	BRAF	673	G469A			7	140481402	140481402	C	G	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1406G>C,NP_004324.2:p.Gly469Ala,NC_000007.13:g.140481402C>G,ENST00000288602.6:c.1406G>C	2018-11-30 14:43:53 UTC	5.0	CA123655	13971	RS121913355,GLY469ALA		
993	https://civic.genome.wustl.edu/links/variants/993	BRAF	673	G469E	The BRAF G469E mutation has a markedly reduced kinase activity and thus activates the MEK pathway through CRAF binding.		7	140481402	140481402	C	T			GRCh37					missense_variant		2019-03-22 01:59:05 UTC	6.0	CA279970		RS121913355		
994	https://civic.genome.wustl.edu/links/variants/994	EGFR	1956	R108K										GRCh37							2020-08-28 05:34:57 UTC	3.0					
995	https://civic.genome.wustl.edu/links/variants/995	EGFR	1956	T263P										GRCh37					missense_variant		2020-08-28 05:43:54 UTC	3.0					
996	https://civic.genome.wustl.edu/links/variants/996	EGFR	1956	A289V			7	55221822	55221822	C	T	ENST00000275493.2	75	GRCh37					missense_variant	NM_005228.4:c.866C>T,NP_005219.2:p.Ala289Val,NC_000007.13:g.55221822C>T,ENST00000275493.2:c.866C>T	2018-11-30 14:43:57 UTC	3.0	CA16602664	376209	RS149840192,ALA289VAL		
999	https://civic.genome.wustl.edu/links/variants/999	EGFR	1956	G719A			7	55241708	55241708	G	C	ENST00000275493.2	75	GRCh37					missense_variant	NM_005228.4:c.2156G>C,NP_005219.2:p.Gly719Ala,NC_000007.13:g.55241708G>C,ENST00000275493.2:c.2156G>C	2018-11-30 14:44:00 UTC	5.0	CA135775	45225	RS121913428,GLY719ALA		
1001	https://civic.genome.wustl.edu/links/variants/1001	EGFR	1956	V742A										GRCh37							2017-12-01 14:40:36 UTC	0.0					
1002	https://civic.genome.wustl.edu/links/variants/1002	EGFR	1956	E746_A750del			7	55242465	55242479	GGAATTAAGAGAAGC		ENST00000275493.2	75	GRCh37					inframe_deletion		2020-04-23 00:07:19 UTC	17.5	CA175996	163343	RS121913421,E746_A750DELELREA		
1003	https://civic.genome.wustl.edu/links/variants/1003	EGFR	1956	E746_T751>I										GRCh37							2017-12-01 14:40:36 UTC	0.0					
1012	https://civic.genome.wustl.edu/links/variants/1012	EGFR	1956	L747_P753delinsS			7	55242470	55242487	TAAGAGAAGCAACATCTC		ENST00000275493.2	75	GRCh37					inframe_deletion		2020-06-26 00:00:13 UTC	0.0	CA126710	16608	RS121913438		
1017	https://civic.genome.wustl.edu/links/variants/1017	EGFR	1956	R831H			7	55259434	55259434	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2492G>A,NC_000007.13:g.55259434G>A	2018-11-30 14:43:58 UTC	0.0	CA4266102	NONE FOUND	RS150036236,ARG831HIS		
1018	https://civic.genome.wustl.edu/links/variants/1018	EGFR	1956	L838V										GRCh37							2017-12-01 14:40:37 UTC	0.0					
1020	https://civic.genome.wustl.edu/links/variants/1020	EGFR	1956	L861Q										GRCh37							2020-08-28 05:36:55 UTC	10.5					
1021	https://civic.genome.wustl.edu/links/variants/1021	ABL1	25	BCR-ABL M244V			9	133738330	133738330	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.730A>G,NP_005148.2:p.Met244Val,NC_000009.11:g.133738330A>G,ENST00000318560.5:c.730A>G	2020-08-29 00:09:38 UTC	57.0	CA16602545	376084	RS121913456,M263V,MET263VAL,BCR-ABL MET244VAL,BCR-ABL1 M244V,BCR-ABL1 MET244VAL		
1022	https://civic.genome.wustl.edu/links/variants/1022	ABL1	25	BCR-ABL L248V			9	133738342	133738342	C	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.742C>G,NP_005148.2:p.Leu248Val,NC_000009.11:g.133738342C>G,ENST00000318560.5:c.742C>G	2020-07-11 00:25:07 UTC	33.0	CA16602546	376085	RS121913455,L267V,LEU248VAL		
1023	https://civic.genome.wustl.edu/links/variants/1023	ABL1	25	BCR-ABL G250E			9	133738349	133738349	G	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.749G>A,NP_005148.2:p.Gly250Glu,NC_000009.11:g.133738349G>A,ENST00000318560.5:c.749G>A	2019-12-20 21:55:38 UTC	51.0	CA16602547	376086	RS121913453,BCR-ABL G269E,BCR-ABL GLY250GLU,BCR-ABL1 G250E,BCR-ABL1 GLY250GLU		
1024	https://civic.genome.wustl.edu/links/variants/1024	ABL1	25	BCR-ABL Q252H			9	133738356	133738356	G	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.756G>C,NP_005148.2:p.Gln252His,NC_000009.11:g.133738356G>C,ENST00000318560.5:c.756G>C	2020-01-17 00:03:51 UTC	17.5	CA16602548	376087	RS121913458,BCR-ABL Q271H,BCR-ABL1 Q252H,BCR-ABL1 GLN252HIS		
1025	https://civic.genome.wustl.edu/links/variants/1025	ABL1	25	BCR-ABL Y253H			9	133738357	133738357	T	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.757T>C,NP_005148.2:p.Tyr253His,NC_000009.11:g.133738357T>C,ENST00000318560.5:c.757T>C	2020-07-31 23:01:46 UTC	74.5	CA122584	12627	RS121913461,Y272H,TYR272HIS,BCR-ABL TYR253HIS,BCR-ABL1 Y253H,BCR-ABL1 TYR253HIS		
1026	https://civic.genome.wustl.edu/links/variants/1026	ABL1	25	Y253F			9	133738358	133738358	A	T	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.758A>T,NM_005157.5:c.758A>T,NP_005148.2:p.Tyr253Phe,NC_000009.11:g.133738358A>T	2019-12-20 21:52:06 UTC	6.5	CA16602550	376089	RS121913460,Y272F,TYR253PHE,TYR272PHE		
1027	https://civic.genome.wustl.edu/links/variants/1027	ABL1	25	BCR-ABL D276G			9	133747520	133747520	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.827A>G,NP_005148.2:p.Asp276Gly,NM_005157.5:c.827A>G,NC_000009.11:g.133747520A>G	2019-12-20 22:05:31 UTC	18.0	CA200645023	NONE FOUND	RS121913447,BCR-ABL ASP276GLY,BCR-ABL D295G,BCR-ABL1 D295G		
1029	https://civic.genome.wustl.edu/links/variants/1029	ABL1	25	BCR-ABL M351T			9	133748391	133748391	T	C	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.1052T>C,NP_005148.2:p.Met351Thr,NC_000009.11:g.133748391T>C,ENST00000318560.5:c.1052T>C	2020-07-31 22:25:38 UTC	50.0	CA122590	12629	RS121913457,BCR-ABL M370T,BCR-ABL MET351THR,BCR-ABL MET370THR		
1030	https://civic.genome.wustl.edu/links/variants/1030	ABL1	25	BCR-ABL H396R			9	133750356	133750356	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.1187A>G,NP_005148.2:p.His396Arg,NC_000009.11:g.133750356A>G,ENST00000318560.5:c.1187A>G	2020-03-16 21:40:23 UTC	36.0	CA16602558	376097	RS121913454,BCR-ABL HIS415ARG,BCR-ABL HIS396ARG,BCR-ABL H415R,BCR-ABL1 H396R,BCR-ABL1 HIS396ARG		
1066	https://civic.genome.wustl.edu/links/variants/1066	TP53	7157	M237I			17	7577570	7577570	C	A	ENST00000269305.4	75	GRCh37					missense_variant	ENST00000269305.4:c.711G>T	2020-10-12 23:21:00 UTC	7.0	CA287488024	NONE FOUND	MET237ILE		
1068	https://civic.genome.wustl.edu/links/variants/1068	TP53	7157	Y234C			17	7577580	7577580	T	C	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.701A>G,NP_000537.3:p.Tyr234Cys,NC_000017.10:g.7577580T>C,ENST00000269305.4:c.701A>G	2018-11-30 14:42:57 UTC	0.0	CA000337	127820	TYR234CYS,Y102C,Y195C,RS587780073		
1092	https://civic.genome.wustl.edu/links/variants/1092	TP53	7157	V157F			17	7578461	7578461	C	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.469G>T,NP_000537.3:p.Val157Phe,NC_000017.10:g.7578461C>A,ENST00000269305.4:c.469G>T	2018-11-30 14:45:22 UTC	4.0	CA000222	12353	RS121912654,VAL157PHE		
1106	https://civic.genome.wustl.edu/links/variants/1106	BRAF	673	G464V			7	140481417	140481417	C	A	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1391G>T,NP_004324.2:p.Gly464Val,NC_000007.13:g.140481417C>A,ENST00000288602.6:c.1391G>T	2018-11-30 14:44:02 UTC	5.0	CA135076	40364	RS121913348,GLY464VAL		
1108	https://civic.genome.wustl.edu/links/variants/1108	TP53	7157	R282L			17	7577093	7577093	C	A	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.845G>T,NP_000537.3:p.Arg282Leu,NC_000017.10:g.7577093C>A,ENST00000269305.4:c.845G>T	2018-11-30 14:44:04 UTC	0.0	CA000456	182938	ARG282LEU,R150L,R243L,RS730882008		
1109	https://civic.genome.wustl.edu/links/variants/1109	TP53	7157	R213P			17	7578211	7578211	C	G	ENST00000269305.4	75	GRCh37					missense_variant	NM_000546.5:c.638G>C,NP_000537.3:p.Arg213Pro,NC_000017.10:g.7578211C>G,ENST00000269305.4:c.638G>C	2018-11-30 14:45:08 UTC	0.0	CA10580932	231214	ARG213PRO,R174P,R81P,RS587778720		
1151	https://civic.genome.wustl.edu/links/variants/1151	PIK3CA	5290	H1047L			3	178952085	178952085	A	T	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.3140A>T,NP_006209.2:p.His1047Leu,NC_000003.11:g.178952085A>T,ENST00000263967.3:c.3140A>T	2018-11-30 14:44:05 UTC	0.0	CA123328	13653	RS121913279,HIS1047LEU		
1152	https://civic.genome.wustl.edu/links/variants/1152	ABL1	25	BCR-ABL F486S			9	133755488	133755488	T	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1457T>C,NC_000009.11:g.133755488T>C,NM_005157.5:c.1457T>C,NP_005148.2:p.Phe486Ser	2019-12-20 21:55:13 UTC	25.0	CA375251598	NONE FOUND	BCR-ABL F505S,BCR-ABL PHE486SER,BCR-ABL1 PHE486SER,BCR-ABL1 F486S		
1155	https://civic.genome.wustl.edu/links/variants/1155	ATM	472	K293*			11	108115729	108115729	A	T	ENST00000278616.4	75	GRCh37					stop_gained	ENST00000278616.4:c.877A>T,NM_000051.3:c.877A>T,NP_000042.3:p.Lys293Ter,NC_000011.9:g.108115729A>T	2020-06-08 17:30:18 UTC	3.0	CA16041383	370378	K293X,LYS293TER,RS1057516442		
1158	https://civic.genome.wustl.edu/links/variants/1158	ATM	472	F1025L			11	108142131	108142131	T	G	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.3075T>G,NC_000011.9:g.108142131T>G,NM_000051.3:c.3075T>G,NP_000042.3:p.Phe1025Leu	2020-06-08 17:30:19 UTC	3.0	CA382547708	NONE FOUND	PHE1025LEU		
1160	https://civic.genome.wustl.edu/links/variants/1160	ATM	472	D1930V			11	108180913	108180913	A	T	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.5789A>T,NC_000011.9:g.108180913A>T,NM_000051.3:c.5789A>T,NP_000042.3:p.Asp1930Val	2020-06-08 17:30:52 UTC	2.0	CA382548326	NONE FOUND	M72L,ASP1930VAL,MET72LEU		
1162	https://civic.genome.wustl.edu/links/variants/1162	ATM	472	E2187*			11	108192134	108192134	G	T	ENST00000278616.4	75	GRCh37					stop_gained	ENST00000278616.4:c.6559G>T,NC_000011.9:g.108192134G>T,NM_000051.3:c.6559G>T,NP_000042.3:p.Glu2187Ter	2020-06-08 17:30:18 UTC	3.0	CA382554382	NONE FOUND	E2187X,GLU2187TER		
1163	https://civic.genome.wustl.edu/links/variants/1163	ATM	472	L2427P			11	108199938	108199938	T	C	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.7280T>C,NC_000011.9:g.108199938T>C,NM_000051.3:c.7280T>C,NP_000042.3:p.Leu2427Pro	2020-06-08 17:30:19 UTC	3.0	CA382559785	NONE FOUND	LEU2427PRO		
1164	https://civic.genome.wustl.edu/links/variants/1164	ATM	472	F2732V			11	108206614	108206614	T	G	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.8194T>G,NC_000011.9:g.108206614T>G,NM_000051.3:c.8194T>G,NP_000042.3:p.Phe2732Val	2020-06-08 17:30:20 UTC	3.0	CA16619250	422531	PHE2732VAL,RS876659619		
1166	https://civic.genome.wustl.edu/links/variants/1166	ATM	472	K468FS			11	108121594	108121595	AA		ENST00000278616.4	75	GRCh37					frameshift_variant	NM_000051.3:c.1402_1403delAA,NP_000042.3:p.Lys468Glufs,NC_000011.9:g.108121594_108121595delAA,ENST00000278616.4:c.1402_1403delAA,NC_000011.9:g.108121594_108121595del	2020-06-08 17:30:53 UTC	2.0	CA163840	140889	LYS468GLUFS		
1168	https://civic.genome.wustl.edu/links/variants/1168	ATM	472	D1682H			11	108170479	108170479	G	C	ENST00000278616.4	75	GRCh37					missense_variant	NM_000051.3:c.5044G>C,NP_000042.3:p.Asp1682His,NC_000011.9:g.108170479G>C,ENST00000278616.4:c.5044G>C	2020-06-08 17:30:20 UTC	3.0	CA115932	3026	RS121434217,ASP1682HIS		
1169	https://civic.genome.wustl.edu/links/variants/1169	ATM	472	A2062V			11	108186827	108186827	C	T	ENST00000278616.4	75	GRCh37					missense_variant	ENST00000278616.4:c.6185C>T,NC_000011.9:g.108186827C>T,NM_000051.3:c.6185C>T,NP_000042.3:p.Ala2062Val	2020-06-08 17:30:20 UTC	3.0	CA382550752	NONE FOUND	ALA2062VAL		
1172	https://civic.genome.wustl.edu/links/variants/1172	ATM	472	C2488Y			11	108201096	108201096	G	A	ENST00000278616.4	75	GRCh37					missense_variant	NM_000051.3:c.7463G>A,NP_000042.3:p.Cys2488Tyr,NC_000011.9:g.108201096G>A,ENST00000278616.4:c.7463G>A	2020-06-08 17:30:21 UTC	3.0	CA196568	187037	CYS2488TYR,RS774281788		
1173	https://civic.genome.wustl.edu/links/variants/1173	ABL1	25	BCR-ABL E255V			9	133738364	133738364	A	T	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.764A>T,NP_005148.2:p.Glu255Val,NC_000009.11:g.133738364A>T,ENST00000318560.5:c.764A>T	2020-07-10 23:42:49 UTC	47.0	CA16602552	376091	RS121913449,BCR-ABL E274V,BCR-ABL GLU255VAL,BCR-ABL1 E274V,BCR-ABL1 GLU255VAL		
1178	https://civic.genome.wustl.edu/links/variants/1178	PIK3CA	5290	R93W			3	178916890	178916890	C	T	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.277C>T,NC_000003.11:g.178916890C>T,NM_006218.2:c.277C>T,NP_006209.2:p.Arg93Trp	2018-11-30 14:44:06 UTC	0.0	CA355272477	NONE FOUND	ARG93TRP		
1181	https://civic.genome.wustl.edu/links/variants/1181	EGFR	1956	R776C										GRCh37							2017-12-01 14:40:38 UTC	0.0					
1183	https://civic.genome.wustl.edu/links/variants/1183	ABL1	25	BCR-ABL E292V			9	133747568	133747568	A	T	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.875A>T,NC_000009.11:g.133747568A>T,NM_005157.5:c.875A>T,NP_005148.2:p.Glu292Val	2020-06-15 19:50:07 UTC	2.0	CA375249260	NONE FOUND	E311V,GLU311VAL,BCR-ABL GLU292VAL,BCR-ABL1 E292V,BCR-ABL1 GLU292VAL		
1184	https://civic.genome.wustl.edu/links/variants/1184	ABL1	25	BCR-ABL F359C			9	133748415	133748415	T	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.1076T>G,NP_005148.2:p.Phe359Cys,NC_000009.11:g.133748415T>G,ENST00000318560.5:c.1076T>G	2020-04-26 21:31:13 UTC	41.5	CA16602582	376124	F378C,RS1057519775,BCR-ABL PHE359CYS,BCR-ABL1 F359C,BCR-ABL1 PHE359CYS		
1186	https://civic.genome.wustl.edu/links/variants/1186	BRAF	673	N581S			7	140453193	140453193	T	C			GRCh37					missense_variant		2018-11-30 14:44:05 UTC	5.0	CA180747		N189S,N9S,RS121913370		
1187	https://civic.genome.wustl.edu/links/variants/1187	EGFR	1956	A864T			7	55259532	55259532	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2590G>A,NC_000007.13:g.55259532G>A,NM_005228.3:c.2590G>A,NP_005219.2:p.Ala864Thr	2018-11-30 14:44:23 UTC	0.0	CA367580302	NONE FOUND	A811T,A819T,ALA864THR		
1188	https://civic.genome.wustl.edu/links/variants/1188	EGFR	1956	N826S										GRCh37					missense_variant		2017-12-01 14:40:38 UTC	0.0			N773S,N781S		
1198	https://civic.genome.wustl.edu/links/variants/1198	BRAF	673	A728V			7	140434515	140434515	G	A			GRCh37					missense_variant		2019-03-23 00:00:04 UTC	0.0	CA369537269		A336V		
1227	https://civic.genome.wustl.edu/links/variants/1227	AKT3	10000	E17K			1	243859016	243859016	C	T	ENST00000366539.1	75	GRCh37					missense_variant	NM_001206729.1:c.49G>A,NP_001193658.1:p.Glu17Lys,NC_000001.10:g.243859016C>T,ENST00000366539.1:c.49G>A	2018-11-30 14:44:56 UTC	3.0	CA130584	39816	RS397514606,GLU17LYS		
1230	https://civic.genome.wustl.edu/links/variants/1230	ABL1	25	BCR-ABL L384M			9	133750319	133750319	C	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1150C>A,NC_000009.11:g.133750319C>A,NM_005157.5:c.1150C>A,NP_005148.2:p.Leu384Met	2020-02-04 02:31:39 UTC	5.5	CA375249885	NONE FOUND	L403M,LEU403MET,LEU384MET,BCR-ABL1 L384M,BCR-ABL1 LEU384MET		
1231	https://civic.genome.wustl.edu/links/variants/1231	ABL1	25	BCR-ABL V299L			9	133747588	133747588	G	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.895G>C,NP_005148.2:p.Val299Leu,NC_000009.11:g.133747588G>C,ENST00000318560.5:c.895G>C	2019-12-30 03:31:29 UTC	22.0	CA16602575	376117	BCR-ABL VAL299LEU,BCR-ABL V318L,RS1057519771,BCR-ABL1 V299L,BCR-ABL1 VAL299LEU		
1232	https://civic.genome.wustl.edu/links/variants/1232	ABL1	25	BCR-ABL L387F			9	133750330	133750330	G	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1161G>C,NC_000009.11:g.133750330G>C,NM_005157.5:c.1161G>C,NP_005148.2:p.Leu387Phe	2019-03-12 01:01:03 UTC	7.0	CA375249910	NONE FOUND	L406F,LEU406PHE,LEU387PHE,BCR-ABL1 L387F,BCR-ABL1 LEU387PHE		
1233	https://civic.genome.wustl.edu/links/variants/1233	ABL1	25	BCR-ABL G398R			9	133750361	133750361	G	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1192G>C,NC_000009.11:g.133750361G>C,NM_005157.5:c.1192G>C,NP_005148.2:p.Gly398Arg	2018-11-30 14:44:10 UTC	5.0	CA375249980	NONE FOUND	BCR-ABL G417R,BCR-ABL GLY417ARG,BCR-ABL GLY398ARG,BCR-ABL1 G398R,BCR-ABL1 GLY398ARG		
1234	https://civic.genome.wustl.edu/links/variants/1234	PIK3CA	5290	K111N			3	178916946	178916946	G	C	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.333G>C,NP_006209.2:p.Lys111Asn,NC_000003.11:g.178916946G>C,ENST00000263967.3:c.333G>C	2021-01-28 21:30:34 UTC	5.0	CA16602917	376483	LYS111ASN,RS1057519934		
1235	https://civic.genome.wustl.edu/links/variants/1235	PIK3CA	5290	I391M			3	178927410	178927410	A	G	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.1173A>G,NP_006209.2:p.Ile391Met,NC_000003.11:g.178927410A>G,ENST00000263967.3:c.1173A>G	2020-08-14 21:19:33 UTC	3.0	CA161490	135038	ILE391MET,RS2230461		
1246	https://civic.genome.wustl.edu/links/variants/1246	BRCA1	672	Q1467*			17	41228590	41228590	G	A	ENST00000357654.3	75	GRCh37					stop_gained	NM_007294.3:c.4399C>T,NP_009225.1:p.Gln1467Ter,NC_000017.10:g.41228590G>A,ENST00000357654.3:c.4399C>T	2018-11-30 14:44:12 UTC	0.0	CA002821	55191	Q1467X,GLN1467TER,RS397509171		
1247	https://civic.genome.wustl.edu/links/variants/1247	BRCA2	675	M1R			13	32890599	32890599	T	G	ENST00000544455.1		GRCh37					missense_variant	NM_000059.3:c.2T>G,NC_000013.10:g.32890599T>G,NP_000050.2:p.Met1Arg,ENST00000544455.1:c.2T>G	2018-11-30 14:44:12 UTC	0.0	CA017013	51385	MET1ARG,RS80358547		
1248	https://civic.genome.wustl.edu/links/variants/1248	BRCA2	675	M1I			13	32890600	32890600	G	T	ENST00000544455.1	75	GRCh37					missense_variant	NC_000013.10:g.32890600G>T,NM_000059.3:c.3G>T,NP_000050.2:p.Met1Ile,ENST00000544455.1:c.3G>T	2018-11-30 14:44:06 UTC	0.0	CA019369	37871	MET1ILE,RS80358650		
1249	https://civic.genome.wustl.edu/links/variants/1249	BRCA2	675	V159M			13	32900287	32900287	G	A	ENST00000544455.1	75	GRCh37					missense_variant	ENST00000544455.1:c.475G>A,NM_000059.3:c.475G>A,NP_000050.2:p.Val159Met,NC_000013.10:g.32900287G>A	2018-11-30 14:44:06 UTC	0.0	CA020781	51711	VAL159MET,RS80358702		
1250	https://civic.genome.wustl.edu/links/variants/1250	BRCA2	675	V211L			13	32900751	32900751	G	C			GRCh37					missense_variant	NC_000013.10:g.32900751G>C	2018-11-30 14:45:05 UTC	0.0	CA16619647				
1251	https://civic.genome.wustl.edu/links/variants/1251	BRCA2	675	V211I			13	32900751	32900751	G	A			GRCh37					missense_variant	NC_000013.10:g.32900751G>A	2018-11-30 14:44:12 UTC	0.0	CA023848				
1252	https://civic.genome.wustl.edu/links/variants/1252	BRCA2	675	R2336P			13	32921033	32921033	G	C	ENST00000544455.1	75	GRCh37					missense_variant	NM_000059.3:c.7007G>C,NP_000050.2:p.Arg2336Pro,NC_000013.10:g.32921033G>C,ENST00000544455.1:c.7007G>C	2018-11-30 14:44:12 UTC	0.0	CA024716	52241	ARG2336PRO,RS28897743		
1255	https://civic.genome.wustl.edu/links/variants/1255	MGMT	4255	UNDEREXPRESSION			10	131265448	131566271			ENST00000306010.7	75	GRCh37					N/A		2017-12-01 14:40:38 UTC	65.0		N/A			
1257	https://civic.genome.wustl.edu/links/variants/1257	RRM1	6240	UNDEREXPRESSION			11	4116039	4160106			ENST00000300738.5	75	GRCh37					N/A		2017-12-01 14:40:38 UTC	85.0		N/A			
1260	https://civic.genome.wustl.edu/links/variants/1260	RET	5979	C609Y	There is some functional evidence that this variant leads to reduced RET activity (PMID: 9230192) and increased cell proliferation and resistance to apoptosis (PMID: 16715139). It has been widely reported in both familial and sporadic cases of multiple endocrine neoplasia type 2 with medullary thyroid cancers. Despite extensive WGS and Exome coverage for a combined total of ~150k alleles in the GNOMAD browser, this variant has never been observed.		10	43609070	43609070	G	A	ENST00000355710.3	75	GRCh37					missense_variant	NM_020630.4:c.1826G>A,NC_000010.10:g.43609070G>A,NP_065681.1:p.Cys609Tyr,ENST00000355710.3:c.1826G>A	2018-11-30 14:43:21 UTC	20.0	CA007824	13933	CYS609TYR		
1263	https://civic.genome.wustl.edu/links/variants/1263	KIT	3815	N822K		KIT Exon 17	4	55599340	55599340	T	A	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2466T>A,NP_000213.1:p.Asn822Lys,NC_000004.11:g.55599340T>A,ENST00000288135.5:c.2466T>A	2019-07-19 22:12:45 UTC	24.5	CA16602411	375931	ASN822LYS,RS121913514		
1264	https://civic.genome.wustl.edu/links/variants/1264	KIT	3815	C809G		KIT Exon 17	4	55599299	55599299	T	G	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.2425T>G,NC_000004.11:g.55599299T>G,NM_000222.2:c.2425T>G,NP_000213.1:p.Cys809Gly	2018-11-30 14:43:58 UTC	7.5	CA356911727	NONE FOUND	CYS809GLY		
1265	https://civic.genome.wustl.edu/links/variants/1265	KIT	3815	D820A		KIT Exon 17	4	55599333	55599333	A	C	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.2459A>C,NC_000004.11:g.55599333A>C,NM_000222.2:c.2459A>C,NP_000213.1:p.Asp820Ala	2018-11-30 14:43:05 UTC	7.5	CA356911952	NONE FOUND	ASP820ALA		
1266	https://civic.genome.wustl.edu/links/variants/1266	KIT	3815	D820G		KIT Exon 17	4	55599333	55599333	A	G	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2459A>G,NP_000213.1:p.Asp820Gly,NC_000004.11:g.55599333A>G,ENST00000288135.5:c.2459A>G	2018-11-30 14:43:09 UTC	7.5	CA123516	13853	ASP820GLY,RS121913682		
1267	https://civic.genome.wustl.edu/links/variants/1267	KIT	3815	T670I			4	55595519	55595519	C	T	ENST00000288135.5	75	GRCh37					missense_variant	NM_000222.2:c.2009C>T,NP_000213.1:p.Thr670Ile,NC_000004.11:g.55595519C>T,ENST00000288135.5:c.2009C>T	2019-07-26 15:25:01 UTC	21.5	CA16602525	376058	THR670ILE,RS121913516		
1269	https://civic.genome.wustl.edu/links/variants/1269	BRAF	673	AMPLIFICATION			7	140434279	140624564			ENST00000288602.6	75	GRCh37					transcript_amplification	N/A	2019-11-22 15:15:14 UTC	27.5		N/A			
1271	https://civic.genome.wustl.edu/links/variants/1271	ROS1	6098	G2032R			6	117638347	117638347	C	T	ENST00000368508.3	75	GRCh37					missense_variant	NC_000006.11:g.117638347C>T,NM_002944.2:c.6094G>A,NP_002935.2:p.Gly2032Arg,ENST00000368508.3:c.6094G>A	2020-12-03 18:33:04 UTC	2.5	CA16602597	376139	GLY2032ARG		
1272	https://civic.genome.wustl.edu/links/variants/1272	MAP2K1	5604	K57N			15	66727455	66727455	G	T	ENST00000307102.5	75	GRCh37					missense_variant	NM_002755.3:c.171G>T,NP_002746.1:p.Lys57Asn,NC_000015.9:g.66727455G>T,ENST00000307102.5:c.171G>T,NG_008305.1:g.53245G>T	2018-11-30 14:43:26 UTC	9.5	CA356995	223140	LYS57ASN,RS869025608		
1273	https://civic.genome.wustl.edu/links/variants/1273	CTAG1B	1485	OVEREXPRESSION																	2019-10-17 14:58:52 UTC	15.0					
1274	https://civic.genome.wustl.edu/links/variants/1274	CTAG2	30848	OVEREXPRESSION			X	153880246	153881853			ENST00000247306.4	75	GRCh37					N/A		2019-10-17 15:33:33 UTC	15.0		N/A			
1277	https://civic.genome.wustl.edu/links/variants/1277	NTRK3	4916	NTRK3 FUSIONS															transcript_fusion		2018-10-15 03:36:06 UTC	35.0		N/A			
1278	https://civic.genome.wustl.edu/links/variants/1278	NTRK1	4914	LMNA-NTRK1		NTRK1 Fusions	1	156084498	156108548			ENST00000368300.4	75	GRCh37	1	156844363	156851434	ENST00000524377.1	transcript_fusion		2018-10-15 03:35:59 UTC	20.0		N/A			
1280	https://civic.genome.wustl.edu/links/variants/1280	NTRK1	4914	AMPLIFICATION			1	156830686	156851434			ENST00000524377.1	75	GRCh37					transcript_amplification		2018-04-11 12:42:34 UTC	20.0		N/A			
1281	https://civic.genome.wustl.edu/links/variants/1281	NTRK3	4916	AMPLIFICATION			15	88418230	88799978			ENST00000394480.2	75	GRCh37					transcript_amplification	N/A	2018-07-10 18:50:58 UTC	20.0		N/A			
1282	https://civic.genome.wustl.edu/links/variants/1282	NTRK1	4914	LMNA-NTRK1 G595R and G667C			1	156846342	156849107			ENST00000524377.1	75	GRCh37					missense_variant,transcript_fusion		2020-05-28 22:30:56 UTC	10.0		NONE FOUND			
1284	https://civic.genome.wustl.edu/links/variants/1284	DCC	1630	EXPRESSION																	2017-12-01 14:40:39 UTC	15.0					
1285	https://civic.genome.wustl.edu/links/variants/1285	CTNNB1	1499	T41A			3	41266124	41266124	A	G	ENST00000349496.5	75	GRCh37					missense_variant	NM_001904.3:c.121A>G,NP_001895.1:p.Thr41Ala,NC_000003.11:g.41266124A>G,ENST00000349496.5:c.121A>G	2018-11-30 14:43:58 UTC	55.0	CA127269	17580	THR41ALA,RS121913412		
1286	https://civic.genome.wustl.edu/links/variants/1286	CTNNB1	1499	S45F			3	41266137	41266137	C	T	ENST00000349496.5	75	GRCh37					missense_variant	NM_001904.3:c.134C>T,NP_001895.1:p.Ser45Phe,NC_000003.11:g.41266137C>T,ENST00000349496.5:c.134C>T	2018-11-30 14:44:05 UTC	60.0	CA127283	17588	SER45PHE,RS121913409		
1287	https://civic.genome.wustl.edu/links/variants/1287	CTNNB1	1499	S45P			3	41266136	41266136	T	C	ENST00000349496.5	75	GRCh37					missense_variant	NM_001904.3:c.133T>C,NP_001895.1:p.Ser45Pro,NC_000003.11:g.41266136T>C,ENST00000349496.5:c.133T>C	2018-11-30 14:44:02 UTC	35.0	CA127285	17589	SER45PRO,RS121913407		
1293	https://civic.genome.wustl.edu/links/variants/1293	ARID1A	8289	LOSS-OF-FUNCTION																	2018-07-06 20:29:42 UTC	7.0					
1295	https://civic.genome.wustl.edu/links/variants/1295	ALK	238	F1245V			2	29436860	29436860	A	C	ENST00000389048.3	75	GRCh37					missense_variant	NM_004304.4:c.3733T>G,NP_004295.2:p.Phe1245Val,NC_000002.11:g.29436860A>C,ENST00000389048.3:c.3733T>G	2019-11-05 23:55:07 UTC	7.5	CA345003	65671	PHE1245VAL,RS281864720		
1296	https://civic.genome.wustl.edu/links/variants/1296	CTNNB1	1499	Activating Mutation			3	41240930	41281936			ENST00000349496.5	75	GRCh37					transcript_variant,gain_of_function_variant		2021-01-26 17:32:06 UTC	4.0		N/A			
1299	https://civic.genome.wustl.edu/links/variants/1299	MERTK	10461	OVEREXPRESSION			2	112656056	112787138			ENST00000295408.4	75	GRCh37					N/A		2017-12-01 14:40:39 UTC	3.0		N/A			
1300	https://civic.genome.wustl.edu/links/variants/1300	TP53	7157	CONSERVED DOMAIN MUT	This conserved domain mutation variant covers mutations in regions of p53 reported to be highly conserved during evolution. These regions span codons 117-143 (region II), 171-181 (region III), 234-258 (region (IV), and 270-286 (region V). Region I covers approximately codons 10 through 25 but does not appear in all studies on conserved domain mutations. There is overlap with these regions and reported regions of hotspot p53 mutations, where it is observed that hotspots for detrimental mutation correspond to more highly evolutionary conserved regions. While there is agreement and overlap between different reports, the literature does not seem to indicate an exact consensus on these regions of human p53 at this time, but the four highly conserved regions are part of the DNA binding domain, and are reported to exist within codons 97 to 292.		17	7577062	7579398			ENST00000269305.4	75								2018-07-06 14:54:43 UTC	15.0					
1301	https://civic.genome.wustl.edu/links/variants/1301	AKT3	10000	OVEREXPRESSION																	2018-07-19 20:08:49 UTC	7.0					
1302	https://civic.genome.wustl.edu/links/variants/1302	FLT3	2322	D835V			13	28592641	28592641	T	A	ENST00000241453.7	75	GRCh37					missense_variant	ENST00000241453.7:c.2504A>T,NM_004119.2:c.2504A>T,NP_004110.2:p.Asp835Val,NC_000013.10:g.28592641T>A	2018-11-30 14:45:21 UTC	18.0	CA126344	16272	RS121909646,ASP835VAL		
1303	https://civic.genome.wustl.edu/links/variants/1303	MYC	4609	OVEREXPRESSION																	2017-12-18 20:39:08 UTC	9.0					
1306	https://civic.genome.wustl.edu/links/variants/1306	TP53	7157	OVEREXPRESSION			17	7571720	7590856			ENST00000269305.4	75	GRCh37					N/A		2020-12-10 02:04:51 UTC	65.0		N/A			
1307	https://civic.genome.wustl.edu/links/variants/1307	TP53	7157	ALTERATION	P53 ALTERATION is a bucket type variant used in studies which is constructed by combining all cases of p53 mutation together with p53 overexpression. This includes cases which have p53 mutation or overexpression alone or as well as cases where both occur in combination.		17	7571720	7590856			ENST00000269305.4	74	GRCh37							2020-12-16 05:23:28 UTC	40.0		N/A			
1319	https://civic.genome.wustl.edu/links/variants/1319	GNAS	2778	R201H																	2017-12-01 14:40:39 UTC	5.0					
1403	https://civic.genome.wustl.edu/links/variants/1403	KIT	3815	N822K			4	55599340	55599340	T	G	ENST00000288135.5	75	GRCh37					missense_variant	NP_000213.1:p.Asn822Lys,ENST00000288135.5:c.2466T>G,NM_000222.2:c.2466T>G,NC_000004.11:g.55599340T>G	2019-03-21 20:41:10 UTC	5.0	CA16602412	375932	RS121913514		
1420	https://civic.genome.wustl.edu/links/variants/1420	EGFR	1956	G719D										GRCh37							2017-12-01 14:40:39 UTC	7.5					
1445	https://civic.genome.wustl.edu/links/variants/1445	EGFR	1956	D770_N771insSVD			7	55249013	55249014		GCGTGGACA			GRCh37							2018-11-30 14:44:14 UTC	0.0	CA135844				
1446	https://civic.genome.wustl.edu/links/variants/1446	EGFR	1956	H773_V774insH										GRCh37							2017-12-01 14:40:39 UTC	0.0					
1457	https://civic.genome.wustl.edu/links/variants/1457	EGFR	1956	L838P										GRCh37							2017-12-01 14:40:40 UTC	7.5					
1463	https://civic.genome.wustl.edu/links/variants/1463	EGFR	1956	T847I										GRCh37							2017-12-01 14:40:40 UTC	5.0					
1466	https://civic.genome.wustl.edu/links/variants/1466	EGFR	1956	V851I										GRCh37					missense_variant		2020-08-19 18:37:43 UTC	5.0					
1477	https://civic.genome.wustl.edu/links/variants/1477	EGFR	1956	L861R										GRCh37							2017-12-01 14:40:40 UTC	7.5					
1482	https://civic.genome.wustl.edu/links/variants/1482	EGFR	1956	E868G										GRCh37							2017-12-01 14:40:40 UTC	0.0					
1487	https://civic.genome.wustl.edu/links/variants/1487	ABL1	25	BCR-ABL E355G			9	133748403	133748403	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.1064A>G,NP_005148.2:p.Glu355Gly,NC_000009.11:g.133748403A>G,ENST00000318560.5:c.1064A>G	2020-07-11 00:15:26 UTC	34.5	CA16602556	376095	RS121913450,BCR-ABL GLU355GLY,BCR-ABL1 E355G,BCR-ABL1 GLU355GLY		
1488	https://civic.genome.wustl.edu/links/variants/1488	ABL1	25	BCR-ABL L387M			9	133750328	133750328	T	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1159T>A,NC_000009.11:g.133750328T>A,NM_005157.5:c.1159T>A,NP_005148.2:p.Leu387Met	2018-11-30 14:44:21 UTC	7.5	CA375249905	NONE FOUND	BCR-ABL LEU387MET,BCR-ABL1 L387M,BCR-ABL1 LEU387MET		
1497	https://civic.genome.wustl.edu/links/variants/1497	KIT	3815	P551_E554delPMYE			4	55593585	55593596					GRCh37					inframe_deletion		2019-07-09 23:03:31 UTC	6.0					
1499	https://civic.genome.wustl.edu/links/variants/1499	PIK3CA	5290	S158L			3	178917598	178917598	C	T	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.473C>T,NC_000003.11:g.178917598C>T,NM_006218.2:c.473C>T,NP_006209.2:p.Ser158Leu	2018-11-30 14:44:18 UTC	0.0	CA355274155	NONE FOUND	SER158LEU		
1500	https://civic.genome.wustl.edu/links/variants/1500	PIK3CA	5290	E81K			3	178916854	178916854	G	A	ENST00000263967.3	75	GRCh37					missense_variant	NM_006218.3:c.241G>A,NP_006209.2:p.Glu81Lys,NC_000003.11:g.178916854G>A,ENST00000263967.3:c.241G>A	2018-11-30 14:44:33 UTC	0.0	CA16602912	376478	GLU81LYS,RS1057519929		
1506	https://civic.genome.wustl.edu/links/variants/1506	ABL1	25	L298V			9	133747585	133747585	C	G	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.892C>G,NC_000009.11:g.133747585C>G,NM_005157.5:c.892C>G,NP_005148.2:p.Leu298Val	2018-11-30 14:45:26 UTC	2.5	CA375249299	NONE FOUND	L317V,LEU298VAL		
1507	https://civic.genome.wustl.edu/links/variants/1507	ABL1	25	BCR-ABL F311I			9	133748270	133748270	T	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.931T>A,NC_000009.11:g.133748270T>A,NM_005157.5:c.931T>A,NP_005148.2:p.Phe311Ile	2018-11-30 14:44:20 UTC	5.0	CA375249388	NONE FOUND	F330I,RS137853304,BCR-ABL PHE311ILE,BCR-ABL1 F311I,BCR-ABL1 PHE311ILE		
1509	https://civic.genome.wustl.edu/links/variants/1509	ABL1	25	BCR-ABL E453Q			9	133753888	133753888	G	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1357G>C,NC_000009.11:g.133753888G>C,NM_005157.5:c.1357G>C,NP_005148.2:p.Glu453Gln	2018-11-30 14:45:06 UTC	5.0	CA375251170	NONE FOUND	E472Q,BCR-ABL GLU453GLN,BCR-ABL1 E453Q,BCR-ABL1 GLU453GLN		
1510	https://civic.genome.wustl.edu/links/variants/1510	ARID1A	8289	Q456*			1	27057658	27057658	C	T	ENST00000324856.7	75	GRCh37					stop_gained	ENST00000324856.7:c.1366C>T	2019-03-13 00:00:09 UTC	0.0	CA339267901	NONE FOUND	Q73X		
1513	https://civic.genome.wustl.edu/links/variants/1513	EGFR	1956	H773_V774insNPH			7	55249012	55249013		AACCCCCAC			GRCh37					inframe_insertion		2018-11-30 14:44:53 UTC	0.0	CA180983				
1514	https://civic.genome.wustl.edu/links/variants/1514	EGFR	1956	D770_N771insGL			7	55249012	55249013		GGGTTA	ENST00000275493.2		GRCh37					inframe_insertion	NC_000007.13:g.55249012_55249013insGGGTTA,NM_005228.3:c.2310_2311insGGGTTA,NP_005219.2:p.Cys770_Gly771insGlyLeu	2018-11-30 14:44:18 UTC	0.0	CA645561585	45257	RS397517111		
1515	https://civic.genome.wustl.edu/links/variants/1515	EGFR	1956	A763_Y764insFQEA			7	55248992	55248993		TCCAGGAAGCCT	ENST00000275493.2		GRCh37					inframe_insertion	NP_001333827.1:p.Ala763_Tyr764insPheGlnGluAla,NC_000007.13:g.55248992_55248993insTCCAGGAAGCCT,NM_001346898.1:c.2290_2291insTCCAGGAAGCCT	2018-11-30 14:44:17 UTC	0.0	CA135833	NONE FOUND	RS397517106		
1517	https://civic.genome.wustl.edu/links/variants/1517	KRAS	3845	G13V			12	25398280	25398281	GC	AA	ENST00000256078.4	75	GRCh37					missense_variant	NC_000012.11:g.25398280_25398281delinsAA,ENST00000256078.4:c.38_39delinsTT,NM_004985.4:c.38_39delinsTT,NP_004976.2:p.Gly13Val	2018-11-30 14:44:22 UTC	5.0	CA645572107	45124	RS397517040,GLY13VAL		
1523	https://civic.genome.wustl.edu/links/variants/1523	ABL1	25	BCR-ABL F359I			9	133748414	133748414	T	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.1075T>A,NP_005148.2:p.Phe359Ile,NC_000009.11:g.133748414T>A,ENST00000318560.5:c.1075T>A	2019-12-20 21:50:50 UTC	29.5	CA16602580	376122	RS121913452,F378I,BCR-ABL PHE359ILE,BCR-ABL1 F359I,BCR-ABL1 PHE359ILE		
1524	https://civic.genome.wustl.edu/links/variants/1524	ABL1	25	BCR-ABL M343T			9	133748367	133748367	T	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1028T>C,NC_000009.11:g.133748367T>C,NM_005157.5:c.1028T>C,NP_005148.2:p.Met343Thr	2020-06-15 19:47:50 UTC	2.0	CA375249596	NONE FOUND	M362T,BCR-ABL MET343THR,BCR-ABL1 M343T,BCR-ABL1 MET343THR		
1525	https://civic.genome.wustl.edu/links/variants/1525	ABL1	25	BCR-ABL F317V			9	133748288	133748288	T	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.949T>G,NP_005148.2:p.Phe317Val,NC_000009.11:g.133748288T>G,ENST00000318560.5:c.949T>G	2019-12-20 21:54:27 UTC	7.0	CA16602578	376120	F336V,RS1057519773,BCR-ABL PHE317VAL,BCR-ABL1 F317V,BCR-ABL1 PHE317VAL		
1526	https://civic.genome.wustl.edu/links/variants/1526	ABL1	25	BCR-ABL E279K			9	133747528	133747528	G	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.835G>A,NC_000009.11:g.133747528G>A,NM_005157.5:c.835G>A,NP_005148.2:p.Glu279Lys	2020-06-15 21:50:40 UTC	7.5	CA375249162	NONE FOUND	BCR-ABL1 E279K,BCR-ABL GLU279LYS,BCR-ABL1 GLU279LYS,BCR-ABL E298K		
1527	https://civic.genome.wustl.edu/links/variants/1527	ABL1	25	BCR-ABL Q300R			9	133747592	133747592	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.899A>G,NC_000009.11:g.133747592A>G,NM_005157.5:c.899A>G,NP_005148.2:p.Gln300Arg	2020-06-15 19:44:13 UTC	5.0	CA375249312	NONE FOUND	Q319R,BCR-ABL GLN300ARG,BCR-ABL1 Q300R,BCR-ABL1 GLN300ARG		
1528	https://civic.genome.wustl.edu/links/variants/1528	ABL1	25	BCR-ABL F311L			9	133748270	133748270	T	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.931T>C,NP_005148.2:p.Phe311Leu,NC_000009.11:g.133748270T>C,ENST00000318560.5:c.931T>C	2018-11-30 14:45:25 UTC	7.0	CA122587	12628	RS137853304,F330L,BCR-ABL PHE311LEU,BCR-ABL1 F311L,BCR-ABL1 PHE311LEU		
1529	https://civic.genome.wustl.edu/links/variants/1529	ABL1	25	BCR-ABL N331S			9	133748331	133748331	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.992A>G,NC_000009.11:g.133748331A>G,NM_005157.5:c.992A>G,NP_005148.2:p.Asn331Ser	2018-11-30 14:45:27 UTC	2.5	CA5285356	NONE FOUND	N350S,RS144448357,BCR-ABL ASN331SER,BCR-ABL1 N331S,BCR-ABL1 ASN331SER		
1530	https://civic.genome.wustl.edu/links/variants/1530	ABL1	25	BCR-ABL L364P			9	133750260	133750260	T	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1091T>C,NC_000009.11:g.133750260T>C,NM_005157.5:c.1091T>C,NP_005148.2:p.Leu364Pro	2018-11-30 14:44:20 UTC	2.5	CA375249757	NONE FOUND	L383P,BCR-ABL LEU364PRO,BCR-ABL1 L364P,BCR-ABL1 LEU364PRO		
1531	https://civic.genome.wustl.edu/links/variants/1531	ABL1	25	BCR-ABL H396P			9	133750356	133750356	A	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1187A>C,NC_000009.11:g.133750356A>C,NM_005157.5:c.1187A>C,NP_005148.2:p.His396Pro	2019-12-30 04:37:39 UTC	9.0	CA375249969	NONE FOUND	BCR-ABL HIS396PRO,BCR-ABL1 H396P,BCR-ABL1 HIS396PRO		
1532	https://civic.genome.wustl.edu/links/variants/1532	ABL1	25	BCR-ABL D421G			9	133750431	133750431	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1262A>G,NC_000009.11:g.133750431A>G,NM_005157.5:c.1262A>G,NP_005148.2:p.Asp421Gly	2020-06-15 21:51:21 UTC	2.5	CA375250143	NONE FOUND	BCR-ABL1 D421G,BCR-ABL ASP421GLY,BCR-ABL1 ASP421GLY		
1534	https://civic.genome.wustl.edu/links/variants/1534	ABL1	25	BCR-ABL E450V			9	133753880	133753880	A	T	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1349A>T,NC_000009.11:g.133753880A>T,NM_005157.5:c.1349A>T,NP_005148.2:p.Glu450Val	2018-11-30 14:44:19 UTC	5.0	CA375251155	NONE FOUND	E469V,BCR-ABL GLU450VAL,BCR-ABL1 GLU450VAL,BCR-ABL1 E450V		
1535	https://civic.genome.wustl.edu/links/variants/1535	ABL1	25	BCR-ABL E453K			9	133753888	133753888	G	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1357G>A,NC_000009.11:g.133753888G>A,NM_005157.5:c.1357G>A,NP_005148.2:p.Glu453Lys	2018-11-30 14:45:25 UTC	2.5	CA375251169	NONE FOUND	E472K,BCR-ABL GLU453LYS,BCR-ABL1 E453K,BCR-ABL1 GLU453LYS		
1536	https://civic.genome.wustl.edu/links/variants/1536	ABL1	25	BCR-ABL E453A			9	133753889	133753889	A	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1358A>C,NC_000009.11:g.133753889A>C,NM_005157.5:c.1358A>C,NP_005148.2:p.Glu453Ala	2019-03-12 01:10:57 UTC	5.0	CA375251172	NONE FOUND	E472A,GLU453ALA,BCR-ABL1 E453A,BCR-ABL1 GLU453ALA		
1537	https://civic.genome.wustl.edu/links/variants/1537	ABL1	25	BCR-ABL P480A			9	133755469	133755469	C	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1438C>G,NC_000009.11:g.133755469C>G,NM_005157.5:c.1438C>G,NP_005148.2:p.Pro480Ala	2018-11-30 14:44:17 UTC	2.5	CA375251559	NONE FOUND	P499A,BCR-ABL PRO480ALA,BCR-ABL1 P480A,BCR-ABL1 PRO480ALA		
1549	https://civic.genome.wustl.edu/links/variants/1549	KIT	3815	K558NP			4	55593608	55593608	G	TCCT			GRCh37					inframe_insertion		2019-07-09 23:18:58 UTC	3.0					
1550	https://civic.genome.wustl.edu/links/variants/1550	KIT	3815	V560_L576DEL			4	55593612	55593662					GRCh37					inframe_deletion		2019-07-09 22:45:44 UTC	6.0					
1551	https://civic.genome.wustl.edu/links/variants/1551	KIT	3815	V569_L576DEL			4	55593639	55593662					GRCh37					inframe_deletion		2019-07-21 22:39:57 UTC	15.0					
1555	https://civic.genome.wustl.edu/links/variants/1555	BRCA1	672	W1815X			17	41199682	41199682	C	T			GRCh37					stop_gained		2020-12-13 23:45:53 UTC	2.0	CA003600		W125X,W1519X,W1550X,W1576X,W1768X,W1836X,W306X,W48X,W632X,W664X,W673X,W711X		
1558	https://civic.genome.wustl.edu/links/variants/1558	KIT	3815	A502_Y503insAY			4	55592182	55592183		GCCTAT			GRCh37					inframe_insertion		2021-02-09 15:47:20 UTC	7.0	_:CA				
1559	https://civic.genome.wustl.edu/links/variants/1559	KIT	3815	D816E			4	55599322	55599322	C	G	ENST00000288135.5	75	GRCh37					missense_variant	ENST00000288135.5:c.2448C>G	2019-07-19 22:43:39 UTC	8.0	CA356911882	NONE FOUND	D812E		
1566	https://civic.genome.wustl.edu/links/variants/1566	EGFR	1956	D770_N771insGT			7	55249012	55249013		GGCACA	ENST00000275493.2		GRCh37					inframe_insertion	NC_000007.13:g.55249012_55249013insGGCACA,NM_005228.3:c.2310_2311insGGCACA,NP_005219.2:p.Cys770_Gly771insGlyThr	2018-11-30 14:45:06 UTC	0.0	CA645561586				
1570	https://civic.genome.wustl.edu/links/variants/1570	SMO	6608	L412F			7	128846398	128846398	C	T	ENST00000249373.3	75	GRCh37					missense_variant	NM_005631.4:c.1234C>T,NP_005622.1:p.Leu412Phe,NC_000007.13:g.128846398C>T,ENST00000249373.3:c.1234C>T	2018-11-30 14:44:41 UTC	0.0	CA10584652	245609			
1571	https://civic.genome.wustl.edu/links/variants/1571	EGFR	1956	W731L										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1572	https://civic.genome.wustl.edu/links/variants/1572	EGFR	1956	E734Q										GRCh37					missense_variant		2017-12-01 14:40:41 UTC	0.0					
1573	https://civic.genome.wustl.edu/links/variants/1573	EGFR	1956	T785A										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1574	https://civic.genome.wustl.edu/links/variants/1574	EGFR	1956	C797Y			7	55249092	55249092	G	A	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2390G>A,NM_005228.3:c.2390G>A,NC_000007.13:g.55249092G>A,NP_005219.2:p.Cys797Tyr	2018-11-30 14:44:53 UTC	0.0	CA367578897	NONE FOUND	C744Y,C752Y,CYS797TYR		
1575	https://civic.genome.wustl.edu/links/variants/1575	EGFR	1956	Y801H										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1579	https://civic.genome.wustl.edu/links/variants/1579	EGFR	1956	A767_V769dupASV			7	55249000	55249001		GCCAGCGTG	ENST00000275493.2		GRCh37					inframe_insertion		2018-11-30 14:44:53 UTC	0.0	CA180588				
1580	https://civic.genome.wustl.edu/links/variants/1580	EGFR	1956	L747_S752delinsQ										GRCh37							2020-06-16 21:09:33 UTC	7.5					
1609	https://civic.genome.wustl.edu/links/variants/1609	ABL1	25	BCR-ABL V379I			9	133750304	133750304	G	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1135G>A,NC_000009.11:g.133750304G>A,NM_005157.5:c.1135G>A,NP_005148.2:p.Val379Ile	2019-01-31 10:15:13 UTC	7.0	CA375249852	NONE FOUND	V398I,BCR-ABL VAL379ILE,BCR-ABL1 V379I,BCR-ABL1 VAL379ILE		
1612	https://civic.genome.wustl.edu/links/variants/1612	ABL1	25	BCR-ABL A397P			9	133750358	133750358	G	C	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1189G>C,NC_000009.11:g.133750358G>C,NM_005157.5:c.1189G>C,NP_005148.2:p.Ala397Pro	2019-01-31 10:18:19 UTC	5.0	CA375249974	NONE FOUND	A416P,ALA397PRO,BCR-ABL1 A397P		
1613	https://civic.genome.wustl.edu/links/variants/1613	ABL1	25	S417Y			9	133750419	133750419	C	A	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.1250C>A,NC_000009.11:g.133750419C>A,NM_005157.5:c.1250C>A,NP_005148.2:p.Ser417Tyr	2018-11-30 14:44:25 UTC	0.0	CA375250115	NONE FOUND	S436Y,SER417TYR		
1625	https://civic.genome.wustl.edu/links/variants/1625	ABL1	25	BCR-ABL F317I			9	133748288	133748288	T	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	NM_005157.5:c.949T>A,NP_005148.2:p.Phe317Ile,NC_000009.11:g.133748288T>A,ENST00000318560.5:c.949T>A	2018-11-30 14:45:26 UTC	3.0	CA16602577	376119	F336I,RS1057519773,BCR-ABL PHE317ILE,BCR-ABL1 F317I,BCR-ABL1 PHE317ILE		
1627	https://civic.genome.wustl.edu/links/variants/1627	BRAF	673	G596R			7	140453149	140453149	C	G	ENST00000288602.6	75	GRCh37					missense_variant	NM_004333.4:c.1786G>C,NP_004324.2:p.Gly596Arg,NC_000007.13:g.140453149C>G,ENST00000288602.6:c.1786G>C	2018-11-30 14:44:48 UTC	5.0	CA16602422	375943	RS121913361,G204R,G24R,GLY596ARG		
1639	https://civic.genome.wustl.edu/links/variants/1639	ABL1	25	C475V			9	133753954	133755455	TG	GT	ENST00000318560.5	75	GRCh37					splice_donor_variant	ENST00000318560.5:c.1423_1424delinsGT,NC_000009.11:g.133753954_133755455delinsGT,NM_005157.6:c.1423_1424delinsGT	2020-12-03 18:33:04 UTC	5.0	CA913189156	NONE FOUND	CYS475VAL		
1640	https://civic.genome.wustl.edu/links/variants/1640	ABL1	25	BCR-ABL N336S			9	133748346	133748346	A	G	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1007A>G,NC_000009.11:g.133748346A>G,NM_005157.5:c.1007A>G,NP_005148.2:p.Asn336Ser	2020-06-15 19:47:02 UTC	5.0	CA375249553	NONE FOUND	N355S,BCR-ABL1 ASN336SER,BCR-ABL N336S,BCR-ABL1 N336S		
1647	https://civic.genome.wustl.edu/links/variants/1647	POLD1	5424	C284Y										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1648	https://civic.genome.wustl.edu/links/variants/1648	POLD1	5424	E374K										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1652	https://civic.genome.wustl.edu/links/variants/1652	PIK3R2	5296	N561D										GRCh37							2018-07-19 20:31:22 UTC	3.0					
1653	https://civic.genome.wustl.edu/links/variants/1653	PIK3CA	5290	D350G			3	178921567	178921567	A	G	ENST00000263967.3	75	GRCh37					missense_variant	ENST00000263967.3:c.1049A>G,NC_000003.11:g.178921567A>G,NM_006218.2:c.1049A>G,NP_006209.2:p.Asp350Gly	2018-11-30 14:44:35 UTC	2.0	CA355281594	521363	ASP350GLY		
1654	https://civic.genome.wustl.edu/links/variants/1654	NRAS	4893	Q179X										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1656	https://civic.genome.wustl.edu/links/variants/1656	ABL1	25	R351W			9	133748333	133748333	C	T	ENST00000372348.2	75	GRCh37					missense_variant	ENST00000372348.2:c.1051C>T,NC_000009.11:g.133748333C>T,NM_007313.2:c.1051C>T,NP_009297.2:p.Arg351Trp	2018-11-30 14:44:31 UTC	9.0	CA5285359	NONE FOUND	R332W,ARG351TRP,RS779478267		
1657	https://civic.genome.wustl.edu/links/variants/1657	ABL1	25	G340L			9	133748300	133748301	GG	CT	ENST00000372348.2	75	GRCh37					coding_sequence_variant		2019-08-01 19:08:35 UTC	3.0	unregistered		GLY340LEU		
1659	https://civic.genome.wustl.edu/links/variants/1659	KIT	3815	S628N			4	55594180	55594180	G	A			GRCh37					missense_variant		2019-08-05 23:11:46 UTC	9.5	CA356908374		S624N		
1664	https://civic.genome.wustl.edu/links/variants/1664	EGFR	1956	M766_A767insAI										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1665	https://civic.genome.wustl.edu/links/variants/1665	EGFR	1956	Y764_V765insHH										GRCh37							2017-12-01 14:40:41 UTC	0.0					
1666	https://civic.genome.wustl.edu/links/variants/1666	EGFR	1956	D770_N771insGY			7	55249010	55249012	GAC	GGGTAT	ENST00000275493.2		GRCh37					inframe_insertion		2020-11-23 00:00:13 UTC	10.0	unregistered				
1667	https://civic.genome.wustl.edu/links/variants/1667	EGFR	1956	P772_H773insYNP										GRCh37					inframe_insertion		2017-12-01 14:40:41 UTC	0.0					
1668	https://civic.genome.wustl.edu/links/variants/1668	EGFR	1956	P772_V774insPHV										GRCh37					inframe_insertion		2017-12-01 14:40:41 UTC	0.0					
1681	https://civic.genome.wustl.edu/links/variants/1681	JAK2	3717	F547 SPLICE SITE MUTATION			9	5070054	5070054	T	G			GRCh37					splice_donor_variant		2018-11-30 14:44:27 UTC	0.0	CA372825751				
1682	https://civic.genome.wustl.edu/links/variants/1682	ARID1A	8289	P1175FS*5										GRCh37					frameshift_variant		2017-12-01 14:40:41 UTC	0.0					
1686	https://civic.genome.wustl.edu/links/variants/1686	ACVR1	90	G328V		ACVR1 kinase domain mutation	2	158622516	158622516	C	A	ENST00000434821.1	75	GRCh37					missense_variant	NM_001105.4:c.983G>T,NP_001096.1:p.Gly328Val,NC_000002.11:g.158622516C>A,ENST00000434821.1:c.983G>T	2018-11-30 14:45:32 UTC	30.0	CA16602802	376363	GLY328VAL,RS387906589	9	https://civic.genome.wustl.edu/links/assertions/9
1687	https://civic.genome.wustl.edu/links/variants/1687	RET	5979	RET FUSIONS															transcript_fusion		2021-01-28 01:55:56 UTC	92.5		N/A			
1691	https://civic.genome.wustl.edu/links/variants/1691	FGFR3	2261	FGFR3 FUSIONS															transcript_fusion		2020-05-29 04:27:27 UTC	7.5		N/A			
1693	https://civic.genome.wustl.edu/links/variants/1693	CHEK1	1111	OVEREXPRESSION																	2017-12-18 20:29:46 UTC	4.0					
1695	https://civic.genome.wustl.edu/links/variants/1695	TP53	7157	R158H			17	7578457	7578457	C	T	ENST00000269305.4	75	GRCh37					missense_variant	ENST00000269305.4:c.473G>A	2019-03-13 00:00:10 UTC	4.0	CA000227	141963	ARG158HIS		
1696	https://civic.genome.wustl.edu/links/variants/1696	TP53	7157	R249S																	2018-04-30 23:29:01 UTC	4.0					
1697	https://civic.genome.wustl.edu/links/variants/1697	TP53	7157	R280K																	2018-04-30 23:28:31 UTC	4.0					
1698	https://civic.genome.wustl.edu/links/variants/1698	TP53	7157	R280T																	2018-04-30 23:23:28 UTC	4.0					
1699	https://civic.genome.wustl.edu/links/variants/1699	TP53	7157	R158L			17	7578457	7578457	C	A	ENST00000269305.4	75	GRCh37					missense_variant	ENST00000269305.4:c.473G>T	2019-03-13 00:00:02 UTC	4.0	CA397842028	528248	ARG158LEU		
1733	https://civic.genome.wustl.edu/links/variants/1733	VHL	7428	E46* (c.136G>T)			3	10183667	10183667	G	T	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.136G>T,NC_000003.11:g.10183667G>T,NM_000551.3:c.136G>T,NP_000542.1:p.Glu46Ter	2018-11-30 14:45:18 UTC	10.0	CA351748085	NONE FOUND	GLU46TER,E46X,C.136G>T		
1734	https://civic.genome.wustl.edu/links/variants/1734	VHL	7428	E52K (c.154G>A)			3	10183685	10183685	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.154G>A,NP_000542.1:p.Glu52Lys,NC_000003.11:g.10183685G>A,ENST00000256474.2:c.154G>A	2020-06-30 19:22:26 UTC	5.0	CA020056	161402	GLU52LYS,C.154G>A,RS373068386		
1736	https://civic.genome.wustl.edu/links/variants/1736	VHL	7428	E55* (c.163G>T)			3	10183694	10183694	G	T	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.163G>T,NC_000003.11:g.10183694G>T,NC_000003.12:g.10142010G>T,NM_000551.4:c.163G>T,NP_000542.1:p.Glu55Ter	2020-10-28 00:00:38 UTC	7.5	CA351748495	NONE FOUND	GLU55TER		
1738	https://civic.genome.wustl.edu/links/variants/1738	VHL	7428	L158P (c.473T>C)			3	10191480	10191480	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.473T>C,NP_000542.1:p.Leu158Pro,NC_000003.11:g.10191480T>C,ENST00000256474.2:c.473T>C	2019-03-21 17:40:47 UTC	22.5	CA020399	182980	C.473T>C,LEU158PRO,RS121913346		
1739	https://civic.genome.wustl.edu/links/variants/1739	VHL	7428	R167Q (c.500G>A)	R167Q is the most common point mutation in hereditary Von Hippel-Lindau (VHL) disease and disrupts the VHL genes binding to elongin C reducing the levels of the VHL-elongin B-elongin C (VBC) E3 ligase complex and inhibiting the ability of VHL to regulate HIF2. This partial function in turn leads to an increased risk of tumorgenesis. VHL derived clear cell renal cell carcinoma models however have shown the proteasome inhibitors bortezomib and carfilzomib can act to stabilize mutant VHL-R167Q leading to downregulation of HIF2 and suprressed tumorgenesis.		3	10191507	10191507	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.500G>A,NP_000542.1:p.Arg167Gln,NC_000003.11:g.10191507G>A,ENST00000256474.2:c.500G>A	2021-01-16 22:15:47 UTC	95.0	CA020454	2216	C.500G>A,ARG167GLN,RS5030821	4	https://civic.genome.wustl.edu/links/assertions/4
1741	https://civic.genome.wustl.edu/links/variants/1741	VHL	7428	Y98H (c.292T>C)			3	10183823	10183823	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.292T>C,NP_000542.1:p.Tyr98His,NC_000003.11:g.10183823T>C,ENST00000256474.2:c.292T>C	2020-06-22 16:29:23 UTC	67.5	CA020246	2223	C.292T>C,TYR98HIS,RS5030809		
1742	https://civic.genome.wustl.edu/links/variants/1742	VHL	7428	H115Q (c.345C>A)			3	10188202	10188202	C	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.345C>A,NP_000542.1:p.His115Gln,NC_000003.11:g.10188202C>A,NM_000551.3:c.345C>A	2019-03-21 22:27:31 UTC	5.0	CA351753631	496057	C.345C>A,HIS115GLN,RS864622646		
1743	https://civic.genome.wustl.edu/links/variants/1743	VHL	7428	F119L (c.357C>G)			3	10188214	10188214	C	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.357C>G,NC_000003.11:g.10188214C>G,NM_000551.3:c.357C>G,NP_000542.1:p.Phe119Leu	2020-06-25 18:22:55 UTC	22.5	CA351753726	625240	C.357C>G,PHE119LEU,RS1559428077		
1744	https://civic.genome.wustl.edu/links/variants/1744	VHL	7428	A149T (c.445G>A)			3	10188302	10188302	G	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.445G>A,NM_000551.3:c.445G>A,NP_000542.1:p.Ala149Thr,NC_000003.11:g.10188302G>A	2018-11-30 14:44:52 UTC	5.0	CA357066	223213	C.445G>A,ALA149THR,RS587780077		
1745	https://civic.genome.wustl.edu/links/variants/1745	VHL	7428	T157I (c.470C>T)			3	10191477	10191477	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.470C>T,NP_000542.1:p.Thr157Ile,NC_000003.11:g.10191477C>T,ENST00000256474.2:c.470C>T	2021-01-16 22:17:19 UTC	32.5	CA357133	223223	C.470C>T,THR157ILE,RS869025660		
1746	https://civic.genome.wustl.edu/links/variants/1746	VHL	7428	R161Q (c.482G>A)			3	10191489	10191489	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.482G>A,NP_000542.1:p.Arg161Gln,NC_000003.11:g.10191489G>A,ENST00000256474.2:c.482G>A	2020-06-17 14:33:04 UTC	65.0	CA020413	182983	C.482G>A,ARG161GLN,RS730882035		
1747	https://civic.genome.wustl.edu/links/variants/1747	VHL	7428	R167W (c.499C>T)			3	10191506	10191506	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.499C>T,NP_000542.1:p.Arg167Trp,NC_000003.11:g.10191506C>T,ENST00000256474.2:c.499C>T	2021-01-28 02:31:24 UTC	97.5	CA020450	2218	C.499C>T,ARG167TRP,R126W,RS5030820	42	https://civic.genome.wustl.edu/links/assertions/42
1748	https://civic.genome.wustl.edu/links/variants/1748	VHL	7428	L178P (c.533T>C)			3	10191540	10191540	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.533T>C,NM_000551.3:c.533T>C,NP_000542.1:p.Leu178Pro,NC_000003.11:g.10191540T>C	2021-01-14 00:38:08 UTC	42.5	CA351756245	428795	C.533T>C,LEU178PRO,RS5030822		
1750	https://civic.genome.wustl.edu/links/variants/1750	VHL	7428	V62fs (c.180del)			3	10183711	10183711	G		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant	NM_000551.3:c.180delG,NP_000542.1:p.Val62fs,NC_000003.11:g.10183711del,NC_000003.12:g.10142027del	2020-10-24 02:31:37 UTC	10.0	CA020069	182986	C.180DELG,VAL62CYSFS,NP_000542.1:P.VAL62CYSFS		
1752	https://civic.genome.wustl.edu/links/variants/1752	VHL	7428	Q73* (c.217C>T)			3	10183748	10183748	C	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.217C>T,NP_000542.1:p.Gln73Ter,NC_000003.11:g.10183748C>T,ENST00000256474.2:c.217C>T	2020-08-13 05:49:15 UTC	27.5	CA357036	223164	Q73X,C.217C>T,GLN73TER,RS869025619		
1754	https://civic.genome.wustl.edu/links/variants/1754	VHL	7428	N78H (c.232A>C)			3	10183763	10183763	A	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.232A>C,NC_000003.11:g.10183763A>C,NM_000551.3:c.232A>C,NP_000542.1:p.Asn78His	2020-08-13 05:50:36 UTC	32.5	CA351749283	NONE FOUND	C.232A>C,ASN78HIS		
1755	https://civic.genome.wustl.edu/links/variants/1755	VHL	7428	N78S (c.233A>G)			3	10183764	10183764	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.233A>G,NP_000542.1:p.Asn78Ser,NC_000003.11:g.10183764A>G,ENST00000256474.2:c.233A>G	2021-01-18 08:40:49 UTC	70.0	CA020131	93326	C.233A>G,ASN78SER,RS5030804		
1756	https://civic.genome.wustl.edu/links/variants/1756	VHL	7428	N78T (c.233A>C)			3	10183764	10183764	A	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.233A>C,NP_000542.1:p.Asn78Thr,NC_000003.11:g.10183764A>C,ENST00000256474.2:c.233A>C	2020-08-13 05:44:54 UTC	10.0	CA357095	223168	C.233A>C,ASN78THR,RS5030804		
1757	https://civic.genome.wustl.edu/links/variants/1757	VHL	7428	S80I (c.239G>T)			3	10183770	10183770	G	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.239G>T,NM_000551.3:c.239G>T,NP_000542.1:p.Ser80Ile,NC_000003.11:g.10183770G>T	2020-08-13 06:13:28 UTC	15.0	CA16621914	NONE FOUND	C.239G>T,SER80ILE,RS5030805		
1758	https://civic.genome.wustl.edu/links/variants/1758	VHL	7428	P86fs (c.254_255insC)			3	10183785	10183786		C	ENST00000256474.2	75	GRCh37					plus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10183785_10183786insC,NM_000551.3:c.254_255insC,NC_000003.12:g.10142101_10142102insC,NP_000542.1:p.Pro86fs	2020-11-03 00:00:33 UTC	10.0	unregistered	NONE FOUND	P86AFS*46		
1759	https://civic.genome.wustl.edu/links/variants/1759	VHL	7428	P86A (c.256C>G)			3	10183787	10183787	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.256C>G,NP_000542.1:p.Pro86Ala,NC_000003.11:g.10183787C>G,ENST00000256474.2:c.256C>G	2018-12-14 19:04:43 UTC	5.0	CA020174	93327	C.256C>G,PRO86ALA,RS398123481		
1760	https://civic.genome.wustl.edu/links/variants/1760	VHL	7428	P86L (c.257C>T)			3	10183788	10183788	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.257C>T,NP_000542.1:p.Pro86Leu,NC_000003.11:g.10183788C>T,ENST00000256474.2:c.257C>T	2021-01-16 22:01:28 UTC	27.5	CA020186	182977	C.257C>T,PRO86LEU,RS730882034		
1761	https://civic.genome.wustl.edu/links/variants/1761	VHL	7428	W88R (c.262T>A)			3	10183793	10183793	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.262T>A,NP_000542.1:p.Trp88Arg,NC_000003.11:g.10183793T>A,NM_000551.3:c.262T>A	2019-03-21 20:20:27 UTC	15.0	CA351750671	456577	C.262T>A,TRP88ARG,RS1553619431		
1762	https://civic.genome.wustl.edu/links/variants/1762	VHL	7428	S111FS (c.331delA)			3	10183862	10183862	A		ENST00000256474.2	75	GRCh37					frameshift_truncation	NC_000003.12:g.10142178del,NC_000003.11:g.10183862del,NM_000551.3:c.331del,NM_198156.2:c.331del,NP_937799.1:p.Ser111AlafsTer7,NM_001354723.1:c.331del,NP_001341652.1:p.Ser111AlafsTer6,ENST00000256474.2:c.331del	2019-07-04 00:00:04 UTC	10.0	CA432420649	NONE FOUND	C.331DELA,SER111FS		
1763	https://civic.genome.wustl.edu/links/variants/1763	VHL	7428	S111N (c.332G>A)			3	10183863	10183863	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.332G>A,NP_000542.1:p.Ser111Asn,NC_000003.11:g.10183863G>A,ENST00000256474.2:c.332G>A	2018-12-14 19:04:42 UTC	17.5	CA357091	223186	C.332G>A,SER111ASN,RS869025631		
1764	https://civic.genome.wustl.edu/links/variants/1764	VHL	7428	S111R (c.333C>G)			3	10183864	10183864	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.333C>G,NP_000542.1:p.Ser111Arg,NC_000003.11:g.10183864C>G,ENST00000256474.2:c.333C>G	2018-11-30 14:43:20 UTC	15.0	CA040305	223187	C.333C>G,SER111ARG,RS765978945		
1765	https://civic.genome.wustl.edu/links/variants/1765	EGFR	1956	Gain-of-function																	2018-07-10 18:49:07 UTC	20.0					
1766	https://civic.genome.wustl.edu/links/variants/1766	VHL	7428	Y112* (c.336C>A)			3	10183867	10183867	C	A	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.336C>A,NC_000003.11:g.10183867C>A,NM_000551.3:c.336C>A,NP_000542.1:p.Tyr112Ter	2018-11-30 14:45:20 UTC	10.0	CA16602183	NONE FOUND	C.336C>A,Y112X,TYR112TER		
1767	https://civic.genome.wustl.edu/links/variants/1767	VHL	7428	W117C (c.351G>T)			3	10188208	10188208	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.351G>T,NP_000542.1:p.Trp117Cys,NC_000003.11:g.10188208G>T,ENST00000256474.2:c.351G>T	2019-03-21 20:12:23 UTC	25.0	CA020294	167827	C.351G>T,TRP117CYS,RS727504215		
1768	https://civic.genome.wustl.edu/links/variants/1768	VHL	7428	L129Q (c.386insAGA)																	2017-12-01 14:40:42 UTC	10.0					
1769	https://civic.genome.wustl.edu/links/variants/1769	VHL	7428	L135* (c.404T>A)			3	10188261	10188261	T	A	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.404T>A,NC_000003.11:g.10188261T>A,NM_000551.3:c.404T>A,NP_000542.1:p.Leu135Ter	2020-08-13 06:14:05 UTC	10.0	CA351754021	NONE FOUND	C.404T>A,L135X,LEU135TER		
1770	https://civic.genome.wustl.edu/links/variants/1770	VHL	7428	N150fs (c.449del)	There are no similar variants in ClinVar with this exact genomic location.			10188305	10188305	A		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NM_000551.3:c.449del,NP_000542.1:p.Asn150IlefsTer9,NC_000003.12:g.10146622del,NC_000003.11:g.10188306del	2020-11-14 05:28:37 UTC	7.5		NONE FOUND	N150IFS*9,N150FS (C.448DELA)		
1771	https://civic.genome.wustl.edu/links/variants/1771	VHL	7428	P154fs (c.462delA)			3	10188319	10188319	A		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.462delA,NC_000003.11:g.10188319del,NM_000551.3:c.462del,NP_000542.1:p.Val155CysfsTer4	2018-11-30 14:44:29 UTC	7.5	CA432421926	NONE FOUND	C.462DELA,PRO154FS		
1772	https://civic.genome.wustl.edu/links/variants/1772	VHL	7428	C162R (c.484T>C)			3	10191491	10191491	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.484T>C,NM_000551.3:c.484T>C,NC_000003.11:g.10191491T>C,NP_000542.1:p.Cys162Arg	2021-01-16 22:00:40 UTC	22.5	CA351756117	496067	RS1553620313,C.484T>C,CYS162ARG		
1773	https://civic.genome.wustl.edu/links/variants/1773	VHL	7428	C162F (c.485G>T)			3	10191492	10191492	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.485G>T,NP_000542.1:p.Cys162Phe,NC_000003.11:g.10191492G>T,ENST00000256474.2:c.485G>T	2019-02-18 10:53:00 UTC	22.5	CA020418	43604	C.485G>T,CYS162PHE,RS397516444		
1774	https://civic.genome.wustl.edu/links/variants/1774	VHL	7428	C162W (c.486C>G)			3	10191493	10191493	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.486C>G,NP_000542.1:p.Cys162Trp,NC_000003.11:g.10191493C>G,ENST00000256474.2:c.486C>G	2020-06-17 05:22:59 UTC	32.5	CA357016	223227	C.486C>G,CYS162TRP,RS869025662		
1775	https://civic.genome.wustl.edu/links/variants/1775	VHL	7428	V166D (c.497T>A)			3	10191504	10191504	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.497T>A,NC_000003.11:g.10191504T>A,NM_000551.3:c.497T>A,NP_000542.1:p.Val166Asp	2018-11-30 14:45:18 UTC	10.0	CA351756176	625254	C.497T>A,VAL166ASP		
1776	https://civic.genome.wustl.edu/links/variants/1776	VHL	7428	L184P (c.551T>C)			3	10191558	10191558	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.551T>C,NP_000542.1:p.Leu184Pro,NC_000003.11:g.10191558T>C,ENST00000256474.2:c.551T>C	2020-12-04 20:29:03 UTC	32.5	CA16617792	419447	C.551T>C,LEU184PRO,RS1064793878	41	https://civic.genome.wustl.edu/links/assertions/41
1777	https://civic.genome.wustl.edu/links/variants/1777	VHL	7428	E186* (c.556G>T)			3	10191563	10191563	G	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.556G>T,NP_000542.1:p.Glu186Ter,NC_000003.11:g.10191563G>T,ENST00000256474.2:c.556G>T	2019-03-21 22:08:50 UTC	15.0	CA16604432	381602	C.556G>T,E186X,GLU186TER,RS367545984		
1778	https://civic.genome.wustl.edu/links/variants/1778	VHL	7428	E186K (c.556G>A)			3	10191563	10191563	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.556G>A,NP_000542.1:p.Glu186Lys,NC_000003.11:g.10191563G>A,ENST00000256474.2:c.556G>A	2019-01-29 19:46:20 UTC	5.0	CA020480	161403	C.556G>A,GLU186LYS,RS367545984		
1780	https://civic.genome.wustl.edu/links/variants/1780	VHL	7428	R176fs (c.526del)			3	10191533	10191533	A		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.526delA,NC_000003.11:g.10191533del,NM_000551.3:c.526del,NP_000542.1:p.Arg176GlyfsTer26	2020-10-27 16:50:54 UTC	10.0	CA16602180	625257	C.526DELA,ARG176FS,RS1559429711,R176GFS*26 (C.526DEL)		
1782	https://civic.genome.wustl.edu/links/variants/1782	VHL	7428	P154L (c.461C>T)			3	10188318	10188318	C	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.461C>T,NC_000003.11:g.10188318C>T,NM_000551.3:c.461C>T,NP_000542.1:p.Pro154Leu	2020-08-13 06:15:01 UTC	30.0	CA351754410	NONE FOUND	C.461C>T,PRO154LEU		
1783	https://civic.genome.wustl.edu/links/variants/1783	VHL	7428	L158fs (c.471dupT)			3	10191478	10191479		T	ENST00000256474.2	75	GRCh37					frameshift_variant	NC_000003.11:g.10191478dup,NC_000003.12:g.10149794dup,NM_000551.3:c.471dup,NP_000542.1:p.Leu158SerfsTer16,ENST00000256474.2:c.471dup,ENSP00000256474.2:p.Leu158SerfsTer16	2020-10-24 00:00:16 UTC	5.0	CA357050	NONE FOUND	C.685INST		
1784	https://civic.genome.wustl.edu/links/variants/1784	VHL	7428	S183* (c.548C>A)			3	10191555	10191555	C	A	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.548C>A,NP_000542.1:p.Ser183Ter,NC_000003.11:g.10191555C>A,ENST00000256474.2:c.548C>A	2020-08-13 06:15:25 UTC	15.0	CA020473	2215	C.548C>A,S183X,SER183TER,RS5030823		
1785	https://civic.genome.wustl.edu/links/variants/1785	VHL	7428	A56fs (c.166_167insA)			3	10183697	10183698		A	ENST00000256474.2	75	GRCh37					frameshift_truncation	NC_000003.11:g.10183697_10183698insA,NC_000003.12:g.10142013_10142014insA,NM_000551.3:c.166_167insA,NP_000542.1:p.Ala56AspfsTer?,ENST00000256474.2:c.166_167insA	2020-05-20 14:36:28 UTC	5.0	CA432536366	NONE FOUND	L15409.1:380INSA,380INSA		
1787	https://civic.genome.wustl.edu/links/variants/1787	VHL	7428	S65W (c.194C>G)			3	10183725	10183725	C	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.194C>G,NM_000551.3:c.194C>G,NP_000542.1:p.Ser65Trp,NC_000003.11:g.10183725C>G	2020-11-02 18:35:16 UTC	105.0	CA020099	43597	C.194C>G,SER65TRP,RS5030826		
1788	https://civic.genome.wustl.edu/links/variants/1788	VHL	7428	S65L (c.194C>T)			3	10183725	10183725	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.194C>T,NP_000542.1:p.Ser65Leu,NC_000003.11:g.10183725C>T,ENST00000256474.2:c.194C>T	2019-02-11 16:41:56 UTC	75.5	CA020104	182975	C.194C>T,SER65LEU,RS5030826		
1791	https://civic.genome.wustl.edu/links/variants/1791	VHL	7428	R79P (c.236G>C)			3	10183767	10183767	G	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.236G>C,NC_000003.11:g.10183767G>C,NM_000551.3:c.236G>C,NP_000542.1:p.Arg79Pro	2019-01-29 20:06:01 UTC	7.5	CA351749311	NONE FOUND	C.236G>C,ARG79PRO		
1792	https://civic.genome.wustl.edu/links/variants/1792	VHL	7428	S80R (c.240T>G)			3	10183771	10183771	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.240T>G	2020-08-13 05:14:30 UTC	12.5	CA351750515	NONE FOUND	C.240T>G,SER80ARG		
1793	https://civic.genome.wustl.edu/links/variants/1793	VHL	7428	L89P (c.266T>C)			3	10183797	10183797	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.266T>C,NP_000542.1:p.Leu89Pro,NC_000003.11:g.10183797T>C,ENST00000256474.2:c.266T>C	2020-08-13 05:33:28 UTC	32.5	CA020207	182979	C.266T>C,LEU89PRO,RS5030807		
1794	https://civic.genome.wustl.edu/links/variants/1794	VHL	7428	E94* (c.280G>T)			3	10183811	10183811	G	T	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.280G>T,NM_198156.2:c.280G>T,NP_000542.1:p.Glu94Ter,NC_000003.11:g.10183811G>T	2019-03-21 22:11:02 UTC	42.5	CA70046202	584477	C.280G>T,E94X,GLU94TER,RS5030829		
1795	https://civic.genome.wustl.edu/links/variants/1795	VHL	7428	P103FS (c.309_310delTG)			3	10183840	10183841	TG		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.309_310delTG,NC_000003.11:g.10183840_10183841del,NM_000551.3:c.309_310del,NP_000542.1:p.Gly104HisfsTer27	2018-11-30 14:44:17 UTC	7.5	CA658795178	NONE FOUND	C.309_310DELTG,PRO103FS		
1796	https://civic.genome.wustl.edu/links/variants/1796	VHL	7428	R113* (c.337C>T)			3	10183868	10183868	C	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.337C>T,NP_000542.1:p.Arg113Ter,NC_000003.11:g.10183868C>T,ENST00000256474.2:c.337C>T	2020-05-12 19:27:05 UTC	37.5	CA348491	220414	C.337C>T,R113X,ARG113TER,RS5030810		
1797	https://civic.genome.wustl.edu/links/variants/1797	VHL	7428	G114C (c.340G>T)			3	10183871	10183871	G	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.340G>T,NC_000003.11:g.10183871G>T,NM_000551.3:c.340G>T,NP_000542.1:p.Gly114Cys	2018-11-30 14:45:20 UTC	12.5	CA351751376	NONE FOUND	C.340G>T,GLY114CYS		
1798	https://civic.genome.wustl.edu/links/variants/1798	VHL	7428	L118P (c.353T>C)			3	10188210	10188210	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.353T>C,NM_000551.3:c.353T>C,NP_000542.1:p.Leu118Pro,NC_000003.11:g.10188210T>C	2021-01-16 22:01:08 UTC	42.5	CA70049399	428807	C.353T>C,LEU118PRO,RS5030830		
1800	https://civic.genome.wustl.edu/links/variants/1800	VHL	7428	N131fs (c.390_391del)			3	10188247	10188248	TA		ENST00000256474.2	75	GRCh37					minus_2_frameshift_variant	ENST00000256474.2:c.390_391delTA,NC_000003.11:g.10188247_10188248del,NC_000003.12:g.10146563_10146564del,NM_000551.3:c.390_391delTA,NP_000542.1:p.Asn131fs,NP_000542.1:p.Asn131ProfsTer3	2020-10-29 00:11:30 UTC	15.0	CA658795179	NONE FOUND	C.390_391DELTA,ASN131PRO,N131PFS*3,ASN131PROFSTER3		
1801	https://civic.genome.wustl.edu/links/variants/1801	VHL	7428	F136S (c.407T>C)			3	10188264	10188264	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.407T>C,NC_000003.11:g.10188264T>C,NM_000551.3:c.407T>C,NP_000542.1:p.Phe136Ser	2020-08-13 05:21:19 UTC	47.5	CA040847	496064	C.407T>C,PHE136SER,RS5030833		
1802	https://civic.genome.wustl.edu/links/variants/1802	VHL	7428	L153fs (c.457delC)	There are two similar variants in ClinVar at this exact genomic location with ClinVar IDs: 526670 and 486714.		3	10188317	10188317	C		ENST00000256474.2	75	GRCh37					deletion	NM_000551.3:c.457delC	2020-11-03 00:00:35 UTC	17.5	CA432421924	NONE FOUND	C.457DELC,LEU153FS		
1803	https://civic.genome.wustl.edu/links/variants/1803	VHL	7428	L158V (c.472C>G)			3	10191479	10191479	C	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.472C>G,NC_000003.11:g.10191479C>G,NM_000551.3:c.472C>G,NP_000542.1:p.Leu158Val	2020-08-13 05:29:58 UTC	22.5	CA351756068	NONE FOUND	C.472C>G,LEU158VAL		
1804	https://civic.genome.wustl.edu/links/variants/1804	VHL	7428	R161* (c.481C>T)			3	10191488	10191488	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.481C>T,NP_000542.1:p.Arg161Ter,NC_000003.11:g.10191488C>T,ENST00000256474.2:c.481C>T	2020-12-17 16:43:41 UTC	52.5	CA020408	2217	C.481C>T,R161X,ARG161TER,RS5030818		
1806	https://civic.genome.wustl.edu/links/variants/1806	VHL	7428	V170F (c.508G>T)			3	10191515	10191515	G	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.508G>T,NC_000003.11:g.10191515G>T,NM_000551.3:c.508G>T,NP_000542.1:p.Val170Phe	2018-11-30 14:44:28 UTC	7.5	CA351756193	NONE FOUND	C.508G>T,VAL170PHE		
1807	https://civic.genome.wustl.edu/links/variants/1807	VHL	7428	I180V (c.538A>G)			3	10191545	10191545	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.538A>G,NP_000542.1:p.Ile180Val,NC_000003.11:g.10191545A>G,ENST00000256474.2:c.538A>G	2020-08-13 05:28:30 UTC	7.5	CA020469	161401	C.538A>G,ILE180VAL,RS377715747		
1808	https://civic.genome.wustl.edu/links/variants/1808	VHL	7428	L184R (c.551T>G)			3	10191558	10191558	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.551T>G,NC_000003.11:g.10191558T>G,NM_000551.3:c.551T>G,NP_000542.1:p.Leu184Arg	2020-08-13 05:24:35 UTC	7.5	CA351756355	NONE FOUND	C.551T>G,LEU184ARG		
1809	https://civic.genome.wustl.edu/links/variants/1809	VHL	7428	Y185* (c.555C>G)			3	10191562	10191562	C	G	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.555C>G,NP_000542.1:p.Tyr185Ter,NC_000003.11:g.10191562C>G,ENST00000256474.2:c.555C>G	2018-11-30 14:45:10 UTC	15.0	CA357075	223233	C.555C>G,Y185X,TYR185TER,RS864622109		
1810	https://civic.genome.wustl.edu/links/variants/1810	VHL	7428	Q195* (c.583C>T)			3	10191590	10191590	C	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.583C>T,NP_000542.1:p.Gln195Ter,NC_000003.11:g.10191590C>T,ENST00000256474.2:c.583C>T	2020-08-13 05:23:53 UTC	60.0	CA70052558	428794	C.583C>T,Q195X,GLN195TER,RS5030825	18	https://civic.genome.wustl.edu/links/assertions/18
1811	https://civic.genome.wustl.edu/links/variants/1811	VHL	7428	S65* (c.194C>A)			3	10183725	10183725	C	A	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.194C>A,NP_000542.1:p.Ser65Ter,NC_000003.11:g.10183725C>A,ENST00000256474.2:c.194C>A	2020-08-13 05:21:59 UTC	15.0	CA357085	223161	C.194C>A,S65X,SER65TER,RS5030826		
1813	https://civic.genome.wustl.edu/links/variants/1813	VHL	7428	D121G (c.362A>G)			3	10188219	10188219	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.362A>G,NP_000542.1:p.Asp121Gly,NC_000003.11:g.10188219A>G,ENST00000256474.2:c.362A>G	2018-11-30 14:44:31 UTC	10.0	CA357083	223200	C.362A>G,ASP121GLY,RS5030832		
1814	https://civic.genome.wustl.edu/links/variants/1814	VHL	7428	F136C (c.407T>G)			3	10188264	10188264	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.407T>G,NC_000003.11:g.10188264T>G,NM_000551.3:c.407T>G,NP_000542.1:p.Phe136Cys	2020-08-13 05:21:00 UTC	12.5	CA70049495	496065	C.407T>G,PHE136CYS,RS5030833		
1815	https://civic.genome.wustl.edu/links/variants/1815	VHL	7428	V84L (c.250G>T)			3	10183781	10183781	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.250G>T,NP_000542.1:p.Val84Leu,NC_000003.11:g.10183781G>T,ENST00000256474.2:c.250G>T	2021-01-11 20:46:10 UTC	10.0	CA020170	2236	C.250G>T,VAL84LEU,RS5030827		
1816	https://civic.genome.wustl.edu/links/variants/1816	VHL	7428	S72fs (c.214del)			3	10183745	10183745	T		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	ENST00000256474.2:c.214delT,NC_000003.12:g.10142061del,NM_000551.4:c.214del,NP_000542.1:p.Ser72ProfsTer?,NC_000003.11:g.10183745del	2020-11-03 20:49:38 UTC	10.0	CA658795180	NONE FOUND	C.214DELT,SER72FS,S72FS (C.214DELT)		
1820	https://civic.genome.wustl.edu/links/variants/1820	VHL	7428	L116V (c.346C>G)			3	10188203	10188203	C	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.346C>G,NC_000003.11:g.10188203C>G,NM_000551.3:c.346C>G,NP_000542.1:p.Leu116Val	2020-08-13 05:19:47 UTC	10.0	CA351753642	NONE FOUND	C.346C>G,LEU116VAL		
1824	https://civic.genome.wustl.edu/links/variants/1824	VHL	7428	C162Y (c.485G>A)			3	10191492	10191492	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.485G>A,NP_000542.1:p.Cys162Tyr,NC_000003.11:g.10191492G>A,ENST00000256474.2:c.485G>A	2021-01-16 22:00:18 UTC	20.0	CA357010	223225	C.485G>A,CYS162TYR,RS397516444		
1825	https://civic.genome.wustl.edu/links/variants/1825	VHL	7428	V166F (c.496G>T)			3	10191503	10191503	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.496G>T,NP_000542.1:p.Val166Phe,NC_000003.11:g.10191503G>T,ENST00000256474.2:c.496G>T	2019-03-21 20:04:31 UTC	7.5	CA020436	2224	C.496G>T,VAL166PHE,RS104893825		
1826	https://civic.genome.wustl.edu/links/variants/1826	VHL	7428	V170D (c.509T>A)			3	10191516	10191516	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.509T>A,NC_000003.11:g.10191516T>A,NM_000551.3:c.509T>A,NP_000542.1:p.Val170Asp	2020-06-29 17:16:22 UTC	40.0	CA351756195	625256	C.509T>A,VAL170ASP		
1827	https://civic.genome.wustl.edu/links/variants/1827	VHL	7428	R177* (c.529A>T)			3	10191536	10191536	A	T	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.529A>T,NC_000003.11:g.10191536A>T,NM_000551.3:c.529A>T,NP_000542.1:p.Arg177Ter	2018-11-30 14:44:30 UTC	7.5	CA351756239	625258	C.529A>T,R177X,ARG177TER,RS1559429717		
1830	https://civic.genome.wustl.edu/links/variants/1830	POLE	5426	P286R																	2017-12-01 14:40:42 UTC	15.0					
1831	https://civic.genome.wustl.edu/links/variants/1831	POLE	5426	V411L																	2017-12-01 14:40:42 UTC	15.0					
1832	https://civic.genome.wustl.edu/links/variants/1832	POLE	5426	S459F																	2017-12-01 14:40:42 UTC	15.0					
1834	https://civic.genome.wustl.edu/links/variants/1834	VHL	7428	E70* (c.208G>T)			3	10183739	10183739	G	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.208G>T,NP_000542.1:p.Glu70Ter,NC_000003.11:g.10183739G>T,ENST00000256474.2:c.208G>T	2018-11-30 14:44:58 UTC	27.5	CA16602179	428806	C.208G>T,E70X,GLU70TER,RS5030802		
1835	https://civic.genome.wustl.edu/links/variants/1835	VHL	7428	F76S (c.227T>C)			3	10183758	10183758	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.227T>C,NC_000003.11:g.10183758T>C,NM_000551.3:c.227T>C,NP_000542.1:p.Phe76Ser	2018-11-30 14:44:34 UTC	7.5	CA020125	182976	PHE76SER,C.277T>C,RS730882033		
1836	https://civic.genome.wustl.edu/links/variants/1836	VHL	7428	L188V (c.562C>G)			3	10191569	10191569	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.562C>G,NP_000542.1:p.Leu188Val,NC_000003.11:g.10191569C>G,ENST00000256474.2:c.562C>G	2020-06-17 14:31:58 UTC	15.0	CA020488	2225	C.562C>G,LEU188VAL,RS5030824		
1837	https://civic.genome.wustl.edu/links/variants/1837	VHL	7428	P81S (c.241C>T)			3	10183772	10183772	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.241C>T,NP_000542.1:p.Pro81Ser,NC_000003.11:g.10183772C>T,ENST00000256474.2:c.241C>T	2020-06-29 17:10:00 UTC	12.5	CA020148	2233	C.241C>T,PRO81SER,RS104893829		
1838	https://civic.genome.wustl.edu/links/variants/1838	VHL	7428	L101G (c.301_302delinsGG)	Note that there is a different variant reported at this amino acid position of VHL in ClinVar: NM_000551.3(VHL):c.302T>C (p.Leu101Pro; L101P) (https://www.ncbi.nlm.nih.gov/clinvar/variation/480963/)		3	10183832	10183833	CT	GG	ENST00000256474.2	75	GRCh37					delins	NM_000551.3:c.301_302delinsGG,NP_000542.1:p.Leu101Gly,ENST00000256474.2:c.301_302delinsGG,ENSP00000256474.2:p.Leu101Gly,NC_000003.11:g.10183832_10183833delinsGG,NC_000003.12:g.10142148_10142149delinsGG	2020-10-30 00:00:11 UTC	5.0	CA915940707	NONE FOUND	C.301_302CT>GG		
1839	https://civic.genome.wustl.edu/links/variants/1839	VHL	7428	T105P (c.313A>C)			3	10183844	10183844	A	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.313A>C,NC_000003.11:g.10183844A>C,NM_000551.3:c.313A>C,NP_000542.1:p.Thr105Pro	2018-11-30 14:45:20 UTC	12.5	CA351751116	496055	C.313A>C,THR105PRO,RS1553619461		
1840	https://civic.genome.wustl.edu/links/variants/1840	VHL	7428	R107P (c.320G>C)			3	10183851	10183851	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.320G>C,NP_000542.1:p.Arg107Pro,NC_000003.11:g.10183851G>C,ENST00000256474.2:c.320G>C	2020-08-13 05:18:09 UTC	7.5	CA020262	36900	C.320G>C,ARG107PRO,RS193922609		
1841	https://civic.genome.wustl.edu/links/variants/1841	VHL	7428	L118fs (c.352_353insA)			3	10188209	10188210		A	ENST00000256474.2	75	GRCh37					plus_1_frameshift_variant	NC_000003.11:g.10188209_10188210insA,NC_000003.12:g.10146525_10146526insA,NM_000551.3:c.352_353insA,NP_000542.1:p.Leu118fs	2020-10-30 00:00:11 UTC	7.5	CA357125	223198	LEU118FS,RS869025641		
1843	https://civic.genome.wustl.edu/links/variants/1843	VHL	7428	T133fs (c.397del)			3	10188252	10188252	A		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10188254del,NP_000542.1:p.Thr133LeufsTer26,NP_000542.1:p.Thr133fs,NC_000003.12:g.10146570del,NM_000551.4:c.397del	2020-11-14 06:11:39 UTC	7.5	CA432421843	625244	Q132FS (C.395DELA),T133LFS*26		
1844	https://civic.genome.wustl.edu/links/variants/1844	VHL	7428	D143fs (c.430delG)																	2018-03-29 18:32:43 UTC	7.5					
1845	https://civic.genome.wustl.edu/links/variants/1845	VHL	7428	Q164* (c.490C>T)			3	10191497	10191497	C	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.490C>T,NP_000542.1:p.Gln164Ter,NC_000003.11:g.10191497C>T,ENST00000256474.2:c.490C>T	2020-08-13 05:17:18 UTC	27.5	CA357060	223228	C.490C>T,Q164X,GLN164TER,RS5030819		
1846	https://civic.genome.wustl.edu/links/variants/1846	VHL	7428	Y175D (c.523T>G)			3	10191530	10191530	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.523T>G,NC_000003.11:g.10191530T>G,NM_000551.3:c.523T>G,NP_000542.1:p.Tyr175Asp	2018-11-30 14:45:10 UTC	7.5	CA351756228	NONE FOUND	C.523T>G,TYR175ASP		
1847	https://civic.genome.wustl.edu/links/variants/1847	VHL	7428	V181fs (c.540_543del)			3	10191547	10191550	CGTC		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10191547_10191550del,NC_000003.12:g.10149863_10149866del,NM_000551.3:c.540_543del,NP_000542.1:p.Val181fs	2020-12-17 07:17:18 UTC	7.5	CA357022	223230	VAL181FS,C.540_543DELCGTC,RS869025664		
1848	https://civic.genome.wustl.edu/links/variants/1848	VHL	7428	Q96* (c.286C>T)			3	10183817	10183817	C	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.286C>T,NP_000542.1:p.Gln96Ter,NC_000003.11:g.10183817C>T,ENST00000256474.2:c.286C>T	2020-08-13 05:16:41 UTC	15.0	CA351750811	428804	C.286C>T,Q96X,GLN96TER,RS1131690959		
1849	https://civic.genome.wustl.edu/links/variants/1849	VHL	7428	P86R (c.257C>G)			3	10183788	10183788	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.257C>G,NP_000542.1:p.Pro86Arg,NC_000003.11:g.10183788C>G,ENST00000256474.2:c.257C>G	2020-08-20 05:13:14 UTC	17.5	CA357142	223170	C.257C>G,PRO86ARG,RS730882034		
1850	https://civic.genome.wustl.edu/links/variants/1850	VHL	7428	G144* (c.430G>T)			3	10188287	10188287	G	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.430G>T,NP_000542.1:p.Gly144Ter,NC_000003.11:g.10188287G>T,ENST00000256474.2:c.430G>T	2020-08-20 05:10:44 UTC	7.5	CA357109	223208	C.430G>T,G144X,GLY144TER,RS869025650		
1852	https://civic.genome.wustl.edu/links/variants/1852	VHL	7428	L188P (c.563T>C)			3	10191570	10191570	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.563T>C,NC_000003.11:g.10191570T>C,NM_000551.3:c.563T>C,NP_000542.1:p.Leu188Pro	2018-11-30 14:44:36 UTC	15.0	CA351756399	625266	C.563T>C,LEU188PRO		
1853	https://civic.genome.wustl.edu/links/variants/1853	VHL	7428	S111C (c.330_331delinsTT)	Note that there is a different variant reported at this amino acid position of VHL in ClinVar. Clinvar ID: 565557		3	10183861	10183862	CA	TT	ENST00000256474.2	75	GRCh37					delins	NP_000542.1:p.Ser111Cys,NP_001341652.1:p.Ser111Cys,NC_000003.11:g.10183861_10183862delinsTT,NC_000003.12:g.10142177_10142178delinsTT	2020-10-26 23:41:01 UTC	7.5	unregistered	NONE FOUND	S111C (C.330_331CA>TT)		
1854	https://civic.genome.wustl.edu/links/variants/1854	EGFR	1956	Ex19 del L858R															missense_variant,inframe_deletion		2017-12-01 14:40:43 UTC	50.0					
1855	https://civic.genome.wustl.edu/links/variants/1855	VHL	7428	R161P (c.482G>C)			3	10191489	10191489	G	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.482G>C,NC_000003.11:g.10191489G>C,NM_000551.3:c.482G>C,NP_000542.1:p.Arg161Pro	2019-03-21 17:24:39 UTC	7.5	CA351756111	NONE FOUND	C.482G>C,ARG161PRO		
1856	https://civic.genome.wustl.edu/links/variants/1856	VHL	7428	Q164R (c.491A>G)			3	10191498	10191498	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.491A>G,NP_000542.1:p.Gln164Arg,NC_000003.11:g.10191498A>G,ENST00000256474.2:c.491A>G	2020-08-20 05:07:51 UTC	10.0	CA020429	2238	C.491A>G,GLN164ARG,RS267607170		
1857	https://civic.genome.wustl.edu/links/variants/1857	VHL	7428	G114R (c.340G>C)			3	10183871	10183871	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.340G>C,NP_000542.1:p.Gly114Arg,NC_000003.11:g.10183871G>C,ENST00000256474.2:c.340G>C	2020-08-20 05:06:49 UTC	12.5	CA357101	223193	C.340G>C,GLY114ARG,RS869025636		
1859	https://civic.genome.wustl.edu/links/variants/1859	VHL	7428	G93S (c.277G>A)			3	10183808	10183808	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.277G>A,NP_000542.1:p.Gly93Ser,NC_000003.11:g.10183808G>A,ENST00000256474.2:c.277G>A	2020-04-11 04:29:28 UTC	22.5	CA020230	2237	C.277G>A,GLY93SER,RS5030808		
1861	https://civic.genome.wustl.edu/links/variants/1861	VHL	7428	L188Q (c.563T>A)			3	10191570	10191570	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.563T>A,NC_000003.11:g.10191570T>A,NM_000551.3:c.563T>A,NP_000542.1:p.Leu188Gln	2018-11-30 14:45:13 UTC	10.0	CA351756398	625265	C.563T>A,LEU188GLN		
1863	https://civic.genome.wustl.edu/links/variants/1863	EGFR	1956	RARE Exon 18-21 Mutation	Rare exon 18-21 mutations in EGFR consist of all EGFR mutations excluding sensitizing L858R substitutions and exon 19 deletions, as well as resistance mutation T790M.														exon_variant		2020-06-06 18:12:03 UTC	30.0					
1865	https://civic.genome.wustl.edu/links/variants/1865	VHL	7428	Y112H (c.334T>C)			3	10183865	10183865	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.334T>C,NP_000542.1:p.Tyr112His,NC_000003.11:g.10183865T>C,ENST00000256474.2:c.334T>C	2019-01-29 20:03:32 UTC	5.0	CA020277	2222	C.334T>C,TYR112HIS,RS104893824		
1866	https://civic.genome.wustl.edu/links/variants/1866	EGFR	1956	L861																	2017-12-01 14:40:43 UTC	15.0					
1867	https://civic.genome.wustl.edu/links/variants/1867	VHL	7428	R64P (c.191G>C)			3	10183722	10183722	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.191G>C,NP_000542.1:p.Arg64Pro,NC_000003.11:g.10183722G>C,ENST00000256474.2:c.191G>C	2019-03-21 17:21:02 UTC	7.5	CA020089	2226	C.191G>C,ARG64PRO,RS104893826		
1869	https://civic.genome.wustl.edu/links/variants/1869	VHL	7428	E189fs (c.565del)			3	10191572	10191572	G		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10191572del,NC_000003.12:g.10149888del,NM_000551.4:c.565del,NP_000542.1:p.Glu189fs	2020-10-28 00:00:39 UTC	15.0	CA432423686	625267	E189FS (C.565DELG),E189KFS*13 (C.565DEL),GLU189LYSFS*13		
1871	https://civic.genome.wustl.edu/links/variants/1871	VHL	7428	I151T (c.452T>C)			3	10188309	10188309	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.452T>C,NP_000542.1:p.Ile151Thr,NC_000003.11:g.10188309T>C,ENST00000256474.2:c.452T>C	2019-03-21 22:22:50 UTC	17.5	CA351754359	428803	C.452T>C,ILE151THR,RS869025655		
1872	https://civic.genome.wustl.edu/links/variants/1872	VHL	7428	K159fs (c.473dup)			3	10191480	10191480		T	ENST00000256474.2	75	GRCh37					frameshift_variant	NM_000551.3:c.473dup,NP_000542.1:p.Lys159GlufsTer15,ENST00000256474.2:c.473dup,ENSP00000256474.2:p.Lys159GlufsTer15,NC_000003.11:g.10191480dup,NC_000003.12:g.10149796dup	2020-10-23 16:21:22 UTC	7.5		NONE FOUND	C.473INST,C.473DUPT		
1873	https://civic.genome.wustl.edu/links/variants/1873	VHL	7428	S68P (c.202T>C)			3	10183733	10183733	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.202T>C,NC_000003.11:g.10183733T>C,NM_000551.3:c.202T>C,NP_000542.1:p.Ser68Pro	2018-11-30 14:44:35 UTC	7.5	CA16621912	NONE FOUND	C.202T>C,SER68PRO		
1874	https://civic.genome.wustl.edu/links/variants/1874	VHL	7428	S80N (c.239G>A)			3	10183770	10183770	G	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.239G>A,NC_000003.11:g.10183770G>A,NM_000551.3:c.239G>A,NP_000542.1:p.Ser80Asn	2018-11-30 14:44:36 UTC	25.0	CA70046108	NONE FOUND	C.239G>A,SER80ASN,RS5030805		
1883	https://civic.genome.wustl.edu/links/variants/1883	VHL	7428	Q145* (c.433C>T)			3	10188290	10188290	C	T	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.433C>T,NC_000003.11:g.10188290C>T,NM_000551.3:c.433C>T,NP_000542.1:p.Gln145Ter	2018-11-30 14:45:30 UTC	10.0	CA351754219	625249	C.433C>T,Q145X,GLN145TER		
1885	https://civic.genome.wustl.edu/links/variants/1885	VHL	7428	H115P (c.344A>C)			3	10188201	10188201	A	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.344A>C,NC_000003.11:g.10188201A>C,NM_000551.3:c.344A>C,NP_000542.1:p.His115Pro	2018-11-30 14:45:09 UTC	10.0	CA351753626	560744	C.344A>C,HIS115PRO,RS5030812		
1886	https://civic.genome.wustl.edu/links/variants/1886	VHL	7428	L128R (c.383T>G)			3	10188240	10188240	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.383T>G,NC_000003.11:g.10188240T>G,NM_000551.3:c.383T>G,NP_000542.1:p.Leu128Arg	2018-11-30 14:44:31 UTC	10.0	CA351753891	NONE FOUND	C.383T>G,LEU128ARG		
1887	https://civic.genome.wustl.edu/links/variants/1887	VHL	7428	L169P (c.506T>C)			3	10191513	10191513	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.506T>C,NP_000542.1:p.Leu169Pro,NC_000003.11:g.10191513T>C,ENST00000256474.2:c.506T>C	2019-03-21 17:39:34 UTC	17.5	CA351756191	428809	C.506T>C,LEU169PRO,RS1131690962		
1888	https://civic.genome.wustl.edu/links/variants/1888	VHL	7428	L178R (c.533T>G)			3	10191540	10191540	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.533T>G,NC_000003.11:g.10191540T>G,NM_000551.3:c.533T>G,NP_000542.1:p.Leu178Arg	2018-11-30 14:44:36 UTC	15.0	CA351756248	625261	C.533T>G,LEU178ARG		
1889	https://civic.genome.wustl.edu/links/variants/1889	VHL	7428	M54fs (c.161dup)			3	10183691	10183692	T		ENST00000256474.2	75	GRCh37					plus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10183692dup,NM_000551.3:c.161dup,NP_000542.1:p.Met54IlefsTer?,NC_000003.12:g.10142008dup	2020-10-28 00:00:39 UTC	10.0	unregistered	NONE FOUND	M54IFS*78 (C.161DUP),M54FS (C.161INST),M54FS (C.161DUPT)		
1891	https://civic.genome.wustl.edu/links/variants/1891	EGFR	1956	L747P																	2017-12-01 14:40:43 UTC	5.0					
1892	https://civic.genome.wustl.edu/links/variants/1892	EGFR	1956	V774A																	2017-12-01 14:40:43 UTC	7.5					
1893	https://civic.genome.wustl.edu/links/variants/1893	VHL	7428	F91* (c.272_273delinsAA)																	2020-10-28 23:04:48 UTC	10.0			C.272TC>AA		
1894	https://civic.genome.wustl.edu/links/variants/1894	EGFR	1956	V774M																	2017-12-01 14:40:43 UTC	5.0					
1895	https://civic.genome.wustl.edu/links/variants/1895	EGFR	1956	K806E			7	55249118	55249118	A	G	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2416A>G	2018-11-30 14:44:54 UTC	5.0	CA4266068	NONE FOUND	LYS806GLU		
1896	https://civic.genome.wustl.edu/links/variants/1896	EGFR	1956	N826Y			7	55259418	55259418	A	T	ENST00000275493.2	75	GRCh37					missense_variant	ENST00000275493.2:c.2476A>T	2020-04-24 00:05:52 UTC	5.0	CA367580076	NONE FOUND	ASN826TYR		
1897	https://civic.genome.wustl.edu/links/variants/1897	EGFR	1956	V834I																	2017-12-01 14:40:43 UTC	7.5					
1899	https://civic.genome.wustl.edu/links/variants/1899	EGFR	1956	N842S																	2017-12-01 14:40:43 UTC	5.0					
1902	https://civic.genome.wustl.edu/links/variants/1902	VHL	7428	P86S (c.256C>T)			3	10183787	10183787	C	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.256C>T,NP_000542.1:p.Pro86Ser,NC_000003.11:g.10183787C>T,ENST00000256474.2:c.256C>T	2021-01-18 08:42:59 UTC	42.5	CA020180	178692	C.256C>T,PRO86SER,RS398123481		
1903	https://civic.genome.wustl.edu/links/variants/1903	VHL	7428	S65P (c.193T>C)			3	10183724	10183724	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.193T>C,NC_000003.11:g.10183724T>C,NM_000551.3:c.193T>C,NP_000542.1:p.Ser65Pro	2018-11-30 14:45:06 UTC	10.0	CA351748798	547829	C.193T>C,SER65PRO,RS869025616		
1904	https://civic.genome.wustl.edu/links/variants/1904	VHL	7428	S72P (c.214T>C)			3	10183745	10183745	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.214T>C,NP_000542.1:p.Ser72Pro,NC_000003.11:g.10183745T>C,ENST00000256474.2:c.214T>C	2020-07-24 02:16:59 UTC	10.0	CA357006	223163	C.214T>C,SER72PRO,RS869025618		
1905	https://civic.genome.wustl.edu/links/variants/1905	VHL	7428	T124fs (c.369del)			3	10188224	10188224	G		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	ENST00000256474.2:c.367del,NC_000003.11:g.10188226del,NC_000003.12:g.10146542del,NM_000551.3:c.369del,NP_000542.1:p.Thr124HisfsTer?,NM_000551.4:c.369del	2020-11-03 03:17:45 UTC	10.0	CA432421810	NONE FOUND	C.367DELG,GLY123FS,C.369DELG,T124HFS*35		
1906	https://civic.genome.wustl.edu/links/variants/1906	VHL	7428	L135FS (c.404delT)			3	10188261	10188261	T		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.404delT,NC_000003.11:g.10188261del,NM_000551.3:c.404delT,NP_000542.1:p.Leu135TyrfsTer24	2018-11-30 14:44:40 UTC	10.0	CA432421852	NONE FOUND	C.404DELT,LEU135FS		
1907	https://civic.genome.wustl.edu/links/variants/1907	VHL	7428	R177fs (c.528del)			3	10191535	10191535	G		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	ENST00000256474.2:c.528delG,NC_000003.11:g.10191535del,NM_000551.3:c.528del,NP_000542.1:p.Arg177AspfsTer25	2020-10-22 01:48:40 UTC	17.5	CA432423454	NONE FOUND	ARG176FS,C.528DELG,R177DFS*25 (C.528DELG),R176FS (C.528DELG),R176FS (C.528DEL)		
1908	https://civic.genome.wustl.edu/links/variants/1908	VHL	7428	W88* (c.264G>A)			3	10183795	10183795	G	A	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.264G>A,NP_000542.1:p.Trp88Ter,NC_000003.11:g.10183795G>A,NM_000551.3:c.264G>A	2019-03-21 20:19:14 UTC	10.0	CA351750677	936684	C.264G>A,W88X,TRP88TER		
1909	https://civic.genome.wustl.edu/links/variants/1909	VHL	7428	V155E (c.464T>A)			3	10191471	10191471	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.464T>A,NC_000003.11:g.10191471T>A,NM_000551.3:c.464T>A,NP_000542.1:p.Val155Glu	2018-11-30 14:45:01 UTC	10.0	CA351756032	NONE FOUND	C.464T>A,VAL155GLU		
1912	https://civic.genome.wustl.edu/links/variants/1912	VHL	7428	F76fs (c.223_224insT)			3	10183754	10183755		T	ENST00000256474.2	75	GRCh37					frameshift_truncation	NC_000003.11:g.10183755dupT,NM_000551.3:c.224dupT,NP_000542.1:p.F76Lfs*56,NC_000003.12:g.10142071dupT,NP_937799.1:p.Phe76LeufsTer?,NP_001341652.1:p.Phe76LeufsTer?	2019-07-30 00:02:55 UTC	7.5	CA913189239		ILE75FS,C.224DUPT,C.223_224INST		
1913	https://civic.genome.wustl.edu/links/variants/1913	VHL	7428	K196* (c.586A>T)			3	10191593	10191593	A	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.586A>T,NP_000542.1:p.Lys196Ter,NC_000003.11:g.10191593A>T,ENST00000256474.2:c.586A>T	2018-11-30 14:44:32 UTC	5.0	CA020507	196284	C.586A>T,K196X,LYS196TER,RS281860296		
1914	https://civic.genome.wustl.edu/links/variants/1914	VHL	7428	R120G (c.358A>G)			3	10188215	10188215	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.358A>G,NP_000542.1:p.Arg120Gly,NC_000003.11:g.10188215A>G,ENST00000256474.2:c.358A>G	2020-07-09 19:07:05 UTC	22.5	CA357028	223199	C.358A>G,ARG120GLY,RS869025642		
1915	https://civic.genome.wustl.edu/links/variants/1915	VHL	7428	R161G (c.481C>G)			3	10191488	10191488	C	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.481C>G,NC_000003.11:g.10191488C>G,NM_000551.3:c.481C>G,NP_000542.1:p.Arg161Gly	2020-08-20 05:05:03 UTC	7.5	CA16621941	NONE FOUND	C.481C>G,ARG161GLY,RS5030818		
1916	https://civic.genome.wustl.edu/links/variants/1916	VHL	7428	R167L (c.500G>T)			3	10191507	10191507	G	T	ENST00000256474.2	75	GRCh37					missense_variant	NC_000003.11:g.10191507G>T,NM_000551.3:c.500G>T,NP_000542.1:p.Arg167Leu,ENST00000256474.2:c.500G>T	2019-02-18 10:39:31 UTC	7.5	CA351756178	526685	RS5030821,C.500G>T,ARG167LEU		
1918	https://civic.genome.wustl.edu/links/variants/1918	VHL	7428	D126FS (c.375_376insC)			3	10188232	10188233		C	ENST00000256474.2	75	GRCh37					inframe_insertion	ENST00000256474.2:c.375_376insC	2018-11-30 14:44:32 UTC	5.0	CA16621931	NONE FOUND	C.375_376INSC,ASP126FS		
1919	https://civic.genome.wustl.edu/links/variants/1919	VHL	7428	E160FS (c.479_480delAG)			3	10191486	10191487	AG		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.479_480delAG,NC_000003.11:g.10191486_10191487delAG,NM_000551.3:c.479_480delAG,NP_000542.1:p.Glu160AlafsTer13	2018-11-30 14:43:03 UTC	5.0	CA16621940	NONE FOUND	GLU160FS,C.479_480DELAG		
1920	https://civic.genome.wustl.edu/links/variants/1920	VHL	7428	G93R (c.277G>C)			3	10183808	10183808	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.277G>C,NP_000542.1:p.Gly93Arg,NC_000003.11:g.10183808G>C,ENST00000256474.2:c.277G>C	2018-11-30 14:44:41 UTC	10.0	CA357130	223174	C.277G>C,GLY93ARG,RS5030808		
1921	https://civic.genome.wustl.edu/links/variants/1921	VHL	7428	H115Y (c.343C>T)			3	10188200	10188200	C	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.343C>T,NC_000003.11:g.10188200C>T,NM_000551.3:c.343C>T,NP_000542.1:p.His115Tyr	2018-11-30 14:44:37 UTC	10.0	CA16621930	NONE FOUND	C.343C>T,HIS115TYR,RS5030811		
1923	https://civic.genome.wustl.edu/links/variants/1923	VHL	7428	L153P (c.458T>C)			3	10188315	10188315	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.458T>C,NC_000003.11:g.10188315T>C,NM_000551.3:c.458T>C,NP_000542.1:p.Leu153Pro	2019-02-18 11:11:30 UTC	7.5	CA16621942	NONE FOUND	C.458T>C,LEU153PRO		
1924	https://civic.genome.wustl.edu/links/variants/1924	VHL	7428	L188R (c.563T>G)			3	10191570	10191570	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.563T>G,NC_000003.11:g.10191570T>G,NM_000551.3:c.563T>G,NP_000542.1:p.Leu188Arg	2019-02-18 10:23:54 UTC	7.5	CA351756400	NONE FOUND	C.563T>G,LEU188ARG		
1928	https://civic.genome.wustl.edu/links/variants/1928	VHL	7428	P138T (c.412C>A)			3	10188269	10188269	C	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.412C>A,NC_000003.11:g.10188269C>A,NM_000551.3:c.412C>A,NP_000542.1:p.Pro138Thr	2019-02-18 11:13:37 UTC	10.0	CA16621932	NONE FOUND	PRO138THR,C.412C>A		
1929	https://civic.genome.wustl.edu/links/variants/1929	VHL	7428	P59fs (c.176delC)			3	10183707	10183707	C		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	ENST00000256474.2:c.176delC,NC_000003.11:g.10183707del,NM_000551.3:c.176del,NP_000542.1:p.Pro59ArgfsTer8	2018-11-30 14:44:40 UTC	0.0	CA432536374	NONE FOUND	PRO59FS,C.176DELC,P59RFS*8 (C.176DELC)		
1932	https://civic.genome.wustl.edu/links/variants/1932	VHL	7428	Y175* (c.525C>A)			3	10191532	10191532	C	A	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.525C>A,NP_000542.1:p.Tyr175Ter,NC_000003.11:g.10191532C>A,NM_000551.3:c.525C>A	2020-07-24 18:34:03 UTC	0.0	CA351756231	NONE FOUND	Y175X,TYR175TER,C.525C>A		
1933	https://civic.genome.wustl.edu/links/variants/1933	VHL	7428	Y98C  (c.293A>G)			3	10183824	10183824	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.293A>G,NP_000542.1:p.Tyr98Cys,NC_000003.11:g.10183824A>G,ENST00000256474.2:c.293A>G	2019-01-28 00:23:17 UTC	5.0	CA357072	223176	C.293A>G,TYR98CYS,RS864321643		
1934	https://civic.genome.wustl.edu/links/variants/1934	VHL	7428	V155G (c.464T>G)			3	10191471	10191471	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.464T>G,NC_000003.11:g.10191471T>G,NM_000551.3:c.464T>G,NP_000542.1:p.Val155Gly	2019-02-18 11:07:45 UTC	2.5	CA16621938	NONE FOUND	C.464T>G,VAL155GLY		
1935	https://civic.genome.wustl.edu/links/variants/1935	VHL	7428	V170G (c.509T>G)			3	10191516	10191516	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.509T>G,NC_000003.11:g.10191516T>G,NM_000551.3:c.509T>G,NP_000542.1:p.Val170Gly	2019-03-21 20:05:06 UTC	15.0	CA351756196	NONE FOUND	C.509T>G,VAL170GLY		
1938	https://civic.genome.wustl.edu/links/variants/1938	VHL	7428	EXON 2 DELETION																	2018-12-14 19:03:58 UTC	7.5					
1939	https://civic.genome.wustl.edu/links/variants/1939	VHL	7428	EXON 3 DELETION																	2020-12-11 19:18:04 UTC	17.5					
1940	https://civic.genome.wustl.edu/links/variants/1940	VHL	7428	EXON 2-3 DELETION																	2018-12-14 19:03:57 UTC	7.5					
1946	https://civic.genome.wustl.edu/links/variants/1946	VHL	7428	Y156C (c.467A>G)			3	10191474	10191474	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.467A>G,NP_000542.1:p.Tyr156Cys,NC_000003.11:g.10191474A>G,ENST00000256474.2:c.467A>G	2020-06-29 16:50:12 UTC	27.5	CA020394	43600	C.467A>G,TYR156CYS,RS397516441		
1948	https://civic.genome.wustl.edu/links/variants/1948	VHL	7428	R69fs (c.204insG)																	2018-07-25 18:44:09 UTC	5.0			C.204DUPG		
1949	https://civic.genome.wustl.edu/links/variants/1949	VHL	7428	G144fs (c.432insG)																	2018-07-25 18:35:14 UTC	5.0					
1953	https://civic.genome.wustl.edu/links/variants/1953	VHL	7428	N131K (c.393C>A)			3	10188250	10188250	C	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.393C>A,NP_000542.1:p.Asn131Lys,NC_000003.11:g.10188250C>A,ENST00000256474.2:c.393C>A	2020-06-30 19:25:37 UTC	10.0	CA16617789	420074	C.393C>A,ASN131LYS,RS1064794272		
1954	https://civic.genome.wustl.edu/links/variants/1954	VHL	7428	T105fs (c.315insAC)																	2017-12-01 14:40:43 UTC	7.5					
1955	https://civic.genome.wustl.edu/links/variants/1955	VHL	7428	P71fs (c.211insT)																	2017-12-01 14:40:43 UTC	7.5					
1956	https://civic.genome.wustl.edu/links/variants/1956	VHL	7428	E70K (c.208G>A)	The VHL gene has a low rate of benign missense variation and is known to be definitively associated with VHL disease. The E70K missense mutation, located in the Beta-domain of VHL, is rare in open-source genome databases (0.00001489 allele frequency in ExAC, 4.365e-6 allele frequency in gnomAD) and was identified in several individuals with VHL disease symptoms (see evidence statements). Thus, this variant could be assigned ACMG code 'PP2' - Missense mutation in a gene with a low rate of benign missense variation where missense variants are a common mechanism of disease. Although this variant is registered once in ExAC and gnomAD, 'PM2' could be applied (Absent from controls in ESP, 1000 Genomes or ExAC) because VHL manifestations sometimes emerge later in adulthood. Thus, the allele may have been detected in a proband who was not yet affected by symptoms.		3	10183739	10183739	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.208G>A,NP_000542.1:p.Glu70Lys,NC_000003.11:g.10183739G>A,ENST00000256474.2:c.208G>A	2019-05-16 23:33:44 UTC	45.0	CA020108	43598	C.208G>A,GLU70LYS,RS5030802	14	https://civic.genome.wustl.edu/links/assertions/14
1957	https://civic.genome.wustl.edu/links/variants/1957	VHL	7428	H115Q (c.345C>G)			3	10188202	10188202	C	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.345C>G,NC_000003.11:g.10188202C>G,NM_000551.3:c.345C>G,NP_000542.1:p.His115Gln	2018-12-14 19:04:40 UTC	12.5	CA351753634	496058	HIS115GLN,C.345C>G,RS864622646		
1958	https://civic.genome.wustl.edu/links/variants/1958	VHL	7428	H191FS (c.571delC)			3	10191578	10191578	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.571delC,NC_000003.11:g.10191578del,NM_000551.3:c.571delC,NP_000542.1:p.His191ThrfsTer11	2018-11-30 14:44:32 UTC	7.5	CA658795182	NONE FOUND	C.571DELC,HIS191FS		
1960	https://civic.genome.wustl.edu/links/variants/1960	VHL	7428	L140fs (c.417_418delTC)																	2020-08-18 04:58:37 UTC	7.5					
1962	https://civic.genome.wustl.edu/links/variants/1962	VHL	7428	P154= (c.462A>C)	Note that there is a different variant reported at this amino acid position of VHL in ClinVar: NM_000551.3(VHL):c.462A>G (p.Pro154=).(https://www.ncbi.nlm.nih.gov/clinvar/variation/411977/)		3	10188319	10188319	A	C	ENST00000256474.2	75	GRCh37					synonymous_variant	ENST00000256474.2:c.462A>C,NC_000003.11:g.10188319A>C,NM_000551.3:c.462A>C,NP_000542.1:p.Pro154=	2020-10-29 00:46:33 UTC	15.0	CA16621934	NONE FOUND	C.462A>C,PRO154PRO,P154P (C.462A>C)		
1963	https://civic.genome.wustl.edu/links/variants/1963	VHL	7428	S80R (c.238A>C)			3	10183769	10183769	A	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.238A>C,NC_000003.11:g.10183769A>C,NM_000551.3:c.238A>C,NP_000542.1:p.Ser80Arg	2018-11-30 14:45:16 UTC	22.5	CA16621913	496052	SER80ARG,C.238A>C,RS786202787		
1964	https://civic.genome.wustl.edu/links/variants/1964	VHL	7428	R60FS (c.179delG)			3	10183710	10183710	G		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.179delG	2019-01-29 19:58:59 UTC	7.5	CA020069	NONE FOUND	C.179DELG,ARG60FS		
1966	https://civic.genome.wustl.edu/links/variants/1966	VHL	7428	W88S (c.263G>C)			3	10183794	10183794	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.263G>C,NP_000542.1:p.Trp88Ser,NC_000003.11:g.10183794G>C,ENST00000256474.2:c.263G>C	2020-06-30 20:30:14 UTC	5.0	CA020202	2220	C.263G>C,TRP88SER,RS119103277		
1967	https://civic.genome.wustl.edu/links/variants/1967	VHL	7428	Y156D (c.466T>G)			3	10191473	10191473	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.466T>G,NC_000003.11:g.10191473T>G,NM_000551.3:c.466T>G,NP_000542.1:p.Tyr156Asp	2018-11-30 14:44:39 UTC	7.5	CA351756043	NONE FOUND	C.466T>G,TYR156ASP		
1968	https://civic.genome.wustl.edu/links/variants/1968	VHL	7428	Y156* (c.468T>G)			3	10191475	10191475	T	G	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.468T>G,NC_000003.11:g.10191475T>G,NM_000551.3:c.468T>G,NP_000542.1:p.Tyr156Ter	2018-11-30 14:45:14 UTC	7.5	CA351756053	NONE FOUND	C.468T>G,Y156X,TYR156TER		
1969	https://civic.genome.wustl.edu/links/variants/1969	VHL	7428	Y175* (c.525C>G)			3	10191532	10191532	C	G	ENST00000256474.2	75	GRCh37					stop_gained	ENST00000256474.2:c.525C>G,NC_000003.11:g.10191532C>G,NM_000551.3:c.525C>G,NP_000542.1:p.Tyr175Ter	2018-11-30 14:45:13 UTC	15.0	CA020466	182974	C.525C>G,Y175X,TYR175TER,RS5030835		
1970	https://civic.genome.wustl.edu/links/variants/1970	VHL	7428	V130L (c.388G>C)			3	10188245	10188245	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.388G>C,NP_000542.1:p.Val130Leu,NC_000003.11:g.10188245G>C,ENST00000256474.2:c.388G>C	2020-07-07 17:47:49 UTC	5.0	CA020325	2229	C.388G>C,VAL130LEU,RS104893830		
1974	https://civic.genome.wustl.edu/links/variants/1974	VHL	7428	Splicing alteration (c.464-1G>A)			3	10191470	10191470	G	A	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-1G>A,NC_000003.11:g.10191470G>A,ENST00000256474.2:c.464-1G>A	2018-11-30 14:45:01 UTC	5.0	CA020389	43603	C.464-1G>A,RS5030817		
1977	https://civic.genome.wustl.edu/links/variants/1977	VHL	7428	V194fs (c.581_582del)			3	10191587	10191588	TG		ENST00000256474.2	75	GRCh37					minus_2_frameshift_variant	ENST00000256474.2:c.579_580delTG	2020-10-27 18:47:17 UTC	0.0	CA70052556	NONE FOUND	C.579_580DELTG,VAL194FSX39,C.581_582DELTG,V153FS,V194FS (C.581_582DELTG)		
1980	https://civic.genome.wustl.edu/links/variants/1980	VHL	7428	R82P (c.245G>C)			3	10183776	10183776	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.245G>C,NP_000542.1:p.Arg82Pro,NC_000003.11:g.10183776G>C,ENST00000256474.2:c.245G>C	2020-09-25 17:46:30 UTC	7.5	CA020159	193118	C.245G>C,ARG82PRO,RS794726890		
1986	https://civic.genome.wustl.edu/links/variants/1986	VHL	7428	*214L (c.641G>T)			3	10191648	10191648	G	T	ENST00000256474.2	75	GRCh37					stop_lost	NM_000551:c.641G>T,ENST00000256474.2:c.641G>T,NP_000542.1:p.Ter214Leu,NC_000003.11:g.10191648G>T	2018-11-30 14:45:14 UTC	10.0	CA357103	223236	X214L,*214LEXT*15,RS869025668		
1987	https://civic.genome.wustl.edu/links/variants/1987	VHL	7428	*214W (c.642A>G)			3	10191649	10191649	A	G	ENST00000256474.2	75	GRCh37					stop_lost	NM_000551.3:c.642A>G,NP_000542.1:p.Ter214Trp,ENST00000256474.2:c.642A>G,NC_000003.11:g.10191649A>G	2018-11-30 14:44:42 UTC	5.0	CA351756723	36907,625269	C.642A>G,TER214TRP,NM_000551:*214WEXT*14		
1988	https://civic.genome.wustl.edu/links/variants/1988	VHL	7428	*214C (c.642A>T)			3	10191649	10191649	A	T	ENST00000256474.2	75	GRCh37					stop_lost	ENST00000256474.2:c.642A>T,NC_000003.11:g.10191649A>T,NM_000551.3:c.642A>T,NP_000542.1:p.Ter214Cys	2018-11-30 14:44:44 UTC	5.0	CA351756724	625270	C.642A>T,X214C,TER214CYS,RS1559430011		
1990	https://civic.genome.wustl.edu/links/variants/1990	VHL	7428	Splicing alteration (c.464-1G>T)			3	10191470	10191470	G	T	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NC_000003.11:g.10191470G>T,NM_000551.3:c.464-1G>T,ENST00000256474.2:c.464-1G>T	2018-11-30 14:44:38 UTC	12.5	CA357144	223221	C.464-1G>T,RS5030817		
1991	https://civic.genome.wustl.edu/links/variants/1991	PIK3CA	5290	Exon 10 and Exon 21 Mutation	PIK3CA exon 10 and exon 21 mutations occasionally co-occur in the same tumor, same cell line, or same clone (if clonality information is available). Note that exons 10 and 21 are sometimes listed as exons 9 and 20 in publications, as it was once common to exclude non-coding exon 1.																2021-02-02 23:02:16 UTC	10.0			EXON 9 AND EXON 20 MUTATION		
1992	https://civic.genome.wustl.edu/links/variants/1992	VHL	7428	Splicing alteration (c.464-2A>T)			3	10191469	10191469	A	T	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-2A>T,NC_000003.11:g.10191469A>T,ENST00000256474.2:c.464-2A>T,NP_000542.1:p.=	2018-11-30 14:44:42 UTC	5.0	CA70052157	NONE FOUND	C.464-2A>T,RS5030816		
1994	https://civic.genome.wustl.edu/links/variants/1994	VHL	7428	Q132* (c.394C>T)			3	10188251	10188251	C	T	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.394C>T,NP_000542.1:p.Gln132Ter,NC_000003.11:g.10188251C>T,ENST00000256474.2:c.394C>T	2018-11-30 14:44:46 UTC	10.0	CA10606205	288749	C.394C>T,Q132X,GLN132TER,RS5030813		
1996	https://civic.genome.wustl.edu/links/variants/1996	VHL	7428	L129fs (c.384delT)			3	10188241	10188241	T		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.384delT	2018-11-30 14:44:52 UTC	7.5	CA70049452	NONE FOUND	C.384DELT,LEU129FS		
1997	https://civic.genome.wustl.edu/links/variants/1997	VHL	7428	L178Q (c.533T>A)			3	10191540	10191540	T	A	ENST00000256474.2	75	GRCh37					missense_variant	NC_000003.11:g.10191540T>A,NM_000551.3:c.533T>A,NP_000542.1:p.Leu178Gln,ENST00000256474.2:c.533T>A	2020-12-16 18:59:37 UTC	12.5	CA70052370	625260	C.533T>A,LEU178GLN,RS5030822		
1998	https://civic.genome.wustl.edu/links/variants/1998	VHL	7428	Splicing alteration (c.463+1G>C)			3	10188321	10188321	G	C	ENST00000256474.2	75	GRCh37					splice_donor_variant	NM_000551.3:c.463+1G>C,NC_000003.11:g.10188321G>C,ENST00000256474.2:c.463+1G>C	2018-11-30 14:44:43 UTC	5.0	CA357023	223217	C.463+1G>C,RS869025657		
1999	https://civic.genome.wustl.edu/links/variants/1999	VHL	7428	V74G (c.221T>G)			3	10183752	10183752	T	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.221T>G,NM_000551.3:c.221T>G,NP_000542.1:p.Val74Gly,NC_000003.11:g.10183752T>G	2019-03-21 20:07:39 UTC	15.0	CA70042528	NONE FOUND	C.221T>G,VAL74GLY,RS5030803		
2000	https://civic.genome.wustl.edu/links/variants/2000	VHL	7428	H115R (c.344A>G)			3	10188201	10188201	A	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.344A>G,NC_000003.11:g.10188201A>G,NM_000551.3:c.344A>G,NP_000542.1:p.His115Arg	2018-11-30 14:44:45 UTC	10.0	CA70049376	664415	C.344A>G,HIS115ARG,RS5030812		
2007	https://civic.genome.wustl.edu/links/variants/2007	VHL	7428	R107G  (c.319C>G)			3	10183850	10183850	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.319C>G,NP_000542.1:p.Arg107Gly,NC_000003.11:g.10183850C>G,ENST00000256474.2:c.319C>G	2020-08-20 05:00:15 UTC	7.5	CA020257	43599	C.319C>G,ARG107GLY,RS397516440		
2008	https://civic.genome.wustl.edu/links/variants/2008	VHL	7428	G93C (c.277G>T)			3	10183808	10183808	G	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.277G>T,NM_000551.3:c.277G>T,NP_000542.1:p.Gly93Cys,NC_000003.11:g.10183808G>T	2018-11-30 14:44:45 UTC	7.5	CA357106	223175	C.277G>T,GLY93CYS,RS5030808		
2009	https://civic.genome.wustl.edu/links/variants/2009	VHL	7428	G93V (c.278G>T)			3	10183809	10183809	G	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.278G>T,NC_000003.11:g.10183809G>T,NM_000551.3:c.278G>T,NP_000542.1:p.Gly93Val	2018-11-30 14:44:44 UTC	7.5	CA351750779	625232	C.278G>T,GLY93VAL		
2010	https://civic.genome.wustl.edu/links/variants/2010	VHL	7428	L198Q  (c.593T>A)			3	10191600	10191600	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.593T>A,NC_000003.11:g.10191600T>A,NM_000551.3:c.593T>A,NP_000542.1:p.Leu198Gln	2018-11-30 14:44:47 UTC	12.5	CA351756548	NONE FOUND	C.593T>A,LEU198GLN		
2011	https://civic.genome.wustl.edu/links/variants/2011	VHL	7428	S65A (c.193T>G)			3	10183724	10183724	T	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.193T>G,NP_000542.1:p.Ser65Ala,NC_000003.11:g.10183724T>G,ENST00000256474.2:c.193T>G	2018-11-30 14:44:45 UTC	7.5	CA357048	223160	C.193T>G,SER65ALA,RS869025616		
2012	https://civic.genome.wustl.edu/links/variants/2012	VHL	7428	S68W (c.203C>G)	One similar submission at this exact genomic location has been entered into ClinVar (ClinVar ID: 625222 C>T).		3	10183734	10183734	C	G	ENST00000256474.2		GRCh37					missense_variant	NP_000542.1:p.Ser68Trp,NC_000003.11:g.10183734C>G,NC_000003.12:g.10142050C>G,NM_000551.3:c.203C>G	2020-10-27 00:32:09 UTC	7.5	CA351748895	NONE FOUND			
2013	https://civic.genome.wustl.edu/links/variants/2013	VHL	7428	Y156N (c.466T>A)			3	10191473	10191473	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.466T>A,NC_000003.11:g.10191473T>A,NM_000551.3:c.466T>A,NP_000542.1:p.Tyr156Asn	2018-11-30 14:45:19 UTC	7.5	CA351756038	NONE FOUND	C.466T>A,TYR156ASN		
2014	https://civic.genome.wustl.edu/links/variants/2014	VHL	7428	P61fs (c.183insC)																	2018-10-25 19:50:17 UTC	7.5					
2016	https://civic.genome.wustl.edu/links/variants/2016	VHL	7428	Null (Complete deletion)																	2019-02-18 10:22:44 UTC	5.0					
2020	https://civic.genome.wustl.edu/links/variants/2020	VHL	7428	L85P (c.254T>C)			3	10183785	10183785	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.254T>C,NP_000542.1:p.Leu85Pro,NC_000003.11:g.10183785T>C,ENST00000256474.2:c.254T>C	2018-11-30 14:44:47 UTC	5.0	CA16602675	376222	C.254T>C,LEU85PRO,RS5030828		
2021	https://civic.genome.wustl.edu/links/variants/2021	VHL	7428	R108dup (c.322_324dup)			3	10183849	10183850		CGC	ENST00000256474.2	75	GRCh37					conservative_inframe_insertion	NC_000003.11:g.10183853_10183855dup,NC_000003.12:g.10142169_10142171dup,NP_000542.1:p.Arg108dup,NM_000551.4:c.322_324dup,NM_000551.3:c.322_324dup	2020-11-03 05:13:33 UTC	5.0	CA916832608	NONE FOUND	R107DUP,R108INS (C.324INSCGC)		
2023	https://civic.genome.wustl.edu/links/variants/2023	VHL	7428	A149fs (c.449del14-nt)																	2017-12-01 14:40:44 UTC	5.0					
2024	https://civic.genome.wustl.edu/links/variants/2024	VHL	7428	3'UTR alteration (c.639+10C>G)			3	10191656	10191656	C	G	ENST00000256474.2	75	GRCh37					3_prime_UTR_variant	ENST00000256474.2:c.639+10C>G	2019-01-11 13:07:04 UTC	5.0	CA16042064	NONE FOUND	C.639+10C>G		
2026	https://civic.genome.wustl.edu/links/variants/2026	VHL	7428	G114S (c.340G>A)			3	10183871	10183871	G	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.340G>A,NC_000003.11:g.10183871G>A,NM_000551.3:c.340G>A,NP_000542.1:p.Gly114Ser	2018-11-30 14:44:50 UTC	5.0	CA351751372	583094	C.340G>A,GLY114SER		
2027	https://civic.genome.wustl.edu/links/variants/2027	VHL	7428	W117fs (c.349dup)			3	10188206	10188207		T	ENST00000256474.2	75	GRCh37					plus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10188206dup,ENST00000256474.2:c.349dupT,NM_000551.3:c.349dup,NP_000542.1:p.cTrp117LeufsTer15	2020-11-03 20:54:23 UTC	5.0	CA432421788	NONE FOUND	TRP117LEUFS,C.349DUPT		
2028	https://civic.genome.wustl.edu/links/variants/2028	VHL	7428	A122I (c.364_365GC>AT)			3	10188221	10188222	GC	AT	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.364_365delinsAT,ENST00000256474.2:c.364_365delinsAT,NC_000003.11:g.10188221_10188222delinsAT,NC_000003.12:g.10146537_10146538delinsAT	2018-11-30 14:44:47 UTC	12.5	CA658820874	NONE FOUND	C.364_365GC>AT,ALA122ILE		
2029	https://civic.genome.wustl.edu/links/variants/2029	VHL	7428	N150fs (c.445_458del)			3	10188302	10188315	GCCAATATCACACT		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.445_458delGCCAATATCACACT	2018-11-30 14:45:31 UTC	5.0	CA658820719	NONE FOUND	C.445_458DEL,ASN150FS		
2030	https://civic.genome.wustl.edu/links/variants/2030	VHL	7428	I151M (c.453C>G)			3	10188310	10188310	C	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.453C>G,NC_000003.11:g.10188310C>G,NM_000551.3:c.453C>G,NP_000542.1:p.Ile151Met	2018-11-30 14:44:50 UTC	5.0	CA351754364	NONE FOUND	C.453C>G,ILE151MET		
2033	https://civic.genome.wustl.edu/links/variants/2033	VHL	7428	L163H (c.488T>A)			3	10191495	10191495	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.488T>A,NC_000003.11:g.10191495T>A,NM_000551.3:c.488T>A,NP_000542.1:p.Leu163His	2018-11-30 14:44:51 UTC	5.0	CA351756137	NONE FOUND	C.488T>A,LEU163HIS		
2035	https://civic.genome.wustl.edu/links/variants/2035	VHL	7428	C162fs (c.483del)			3	10191490	10191490	A		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10191490del,NP_000542.1:p.Cys162AlafsTer8,ENST00000256474.2:c.483del,NM_000551.3:c.483del,NC_000003.12:g.10149806del	2020-11-14 05:04:01 UTC	5.0	CA658795183	928822	C.483DELA,CYS162FS,C162AFS*8		
2036	https://civic.genome.wustl.edu/links/variants/2036	VHL	7428	Null (Partial deletion of Exons 2 & 3)																	2019-02-17 14:04:47 UTC	7.5					
2037	https://civic.genome.wustl.edu/links/variants/2037	VHL	7428	N78I (c.233A>T)			3	10183764	10183764	A	T	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.233A>T,NP_000542.1:p.Asn78Ile,NC_000003.11:g.10183764A>T,ENST00000256474.2:c.233A>T	2018-11-30 14:44:46 UTC	5.0	CA357063	223169	C.233A>T,ASN78ILE,RS5030804		
2039	https://civic.genome.wustl.edu/links/variants/2039	VHL	7428	W88FS (c.263_265delGGCinsTT)			3	10183794	10183796	GGC	TT	ENST00000256474.2	75	GRCh37					frameshift_variant,delins	ENST00000256474.2:c.263_265delGGCinsTT,NC_000003.11:g.10183794_10183796delinsTT,NM_000551.3:c.263_265delinsTT,NP_000542.1:p.Trp88PhefsTer?	2019-03-12 02:34:05 UTC	5.0	CA658683075	NONE FOUND	C.263_265DELGGCINSTT,TRP88FS		
2040	https://civic.genome.wustl.edu/links/variants/2040	VHL	7428	K159fs (c.477_478insCA)			3	10191484	10191485		CA	ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.477_478insCA	2018-11-30 14:44:46 UTC	5.0	CA645525053	NONE FOUND	LYS159FS,C.477_478INSCA		
2041	https://civic.genome.wustl.edu/links/variants/2041	VHL	7428	Q73FS (c.217delC)			3	10183748	10183748	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.217delC,NC_000003.11:g.10183748del,NM_000551.3:c.217del,NP_000542.1:p.Gln73ArgfsTer?	2019-03-21 17:29:30 UTC	5.0	CA432536422	NONE FOUND	C.217DELC,GLN73FS		
2042	https://civic.genome.wustl.edu/links/variants/2042	VHL	7428	A149fs (c.445delG)			3	10188302	10188302	G		ENST00000256474.2	75	GRCh37					frameshift_variant,minus_1_frameshift_variant	ENST00000256474.2:c.445delG,NC_000003.11:g.10188302delG,NM_000551.3:c.445delG,NP_000542.1:p.Ala149ProfsTer10	2018-11-30 14:44:47 UTC	5.0	CA432421902	NONE FOUND	C.445DELG,ALA149FS		
2043	https://civic.genome.wustl.edu/links/variants/2043	VHL	7428	G104A (c.311G>C)			3	10183842	10183842	G	C	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.311G>C,NP_000542.1:p.Gly104Ala,NC_000003.11:g.10183842G>C,ENST00000256474.2:c.311G>C	2018-11-30 14:45:18 UTC	0.0	CA16611067	411966	C.311G>C,GLY104ALA,RS869025630		
2045	https://civic.genome.wustl.edu/links/variants/2045	VHL	7428	S111C (c.331A>T)			3	10183862	10183862	A	T	ENST00000256474.2	75	GRCh37					missense_variant	NC_000003.11:g.10183862A>T,NM_000551.3:c.331A>T,NP_000542.1:p.Ser111Cys	2020-01-17 00:06:29 UTC	7.5	CA351751322	565557	SER111CYS,RS1559426203,C.331A>T		
2050	https://civic.genome.wustl.edu/links/variants/2050	DICER1	23405	E1705K			14	95560476	95560476	C	T	ENST00000526495.1	75	GRCh37					missense_variant	ENST00000526495.1:c.5113G>A	2019-03-13 00:00:06 UTC	20.0	CA390865421	NONE FOUND	GLU1705LYS		
2051	https://civic.genome.wustl.edu/links/variants/2051	DICER1	23405	D1709N																	2018-07-06 21:36:36 UTC	40.0					
2052	https://civic.genome.wustl.edu/links/variants/2052	DICER1	23405	E1813Q			14	95557630	95557630	C	G	ENST00000526495.1	75	GRCh37					missense_variant	ENST00000526495.1:c.5437G>C	2019-03-13 00:00:08 UTC	25.0	CA390864655	NONE FOUND	GLU1813GLN		
2055	https://civic.genome.wustl.edu/links/variants/2055	VHL	7428	P146fs (c.437del)			3	10188293	10188293	C		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NC_000003.12:g.10146610del,ENST00000256474.2:c.437del,NC_000003.11:g.10188294del,NM_000551.3:c.437del,NP_000542.1:p.Pro146LeufsTer13	2020-11-03 02:59:55 UTC	7.5	CA432421892	NONE FOUND	C.436DELC,PRO146FS,C.437DELC,P146LFS*13		
2056	https://civic.genome.wustl.edu/links/variants/2056	VHL	7428	W88R (c.262T>C)			3	10183793	10183793	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.262T>C,NC_000003.11:g.10183793T>C,NM_000551.3:c.262T>C,NP_000542.1:p.Trp88Arg	2018-11-30 14:44:38 UTC	7.5	CA351750667	496053	TRP88ARG,C.262T>C,RS1553619431		
2057	https://civic.genome.wustl.edu/links/variants/2057	VHL	7428	H115fs (c.344del)			3	10188201	10188201	A		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10188201del,NM_000551.3:c.344delA,ENST00000256474.2:c.344del,NP_000542.1:p.His115ProfsTer44	2020-10-29 00:45:36 UTC	7.5	CA70049370	NONE FOUND	C.344DELA,HIS115FS,RS1553619937,HIS115PROFSTER44 (C.344DEL),H115FS (C.344DELA),H115PFS*44 (C.344DEL)		
2058	https://civic.genome.wustl.edu/links/variants/2058	VHL	7428	P102fs (c.305delC)			3	10183836	10183836	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.305delC,NC_000003.11:g.10183836del,NM_000551.3:c.305del,NP_000542.1:p.Pro102ArgfsTer?	2018-11-30 14:44:41 UTC	7.5	CA658820710	NONE FOUND	C.305DELC,PRO102FS		
2061	https://civic.genome.wustl.edu/links/variants/2061	ACVR1	90	Gain-of-Function																	2017-12-01 14:40:44 UTC	15.0					
2066	https://civic.genome.wustl.edu/links/variants/2066	VHL	7428	Y175N (c.523T>A)			3	10191530	10191530	T	A	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.523T>A,NC_000003.11:g.10191530T>A,NM_000551.3:c.523T>A,NP_000542.1:p.Tyr175Asn	2018-11-30 14:44:42 UTC	0.0	CA351756226	NONE FOUND	C.523T>A,TYR175ASN		
2067	https://civic.genome.wustl.edu/links/variants/2067	VHL	7428	Y175C (c.524A>G)			3	10191531	10191531	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.524A>G,NP_000542.1:p.Tyr175Cys,NC_000003.11:g.10191531A>G,ENST00000256474.2:c.524A>G	2018-11-30 14:44:58 UTC	0.0	CA020462	36905	C.524A>G,TYR175CYS,RS193922613		
2075	https://civic.genome.wustl.edu/links/variants/2075	VHL	7428	Splicing alteration (c.463+2T>C)			3	10188322	10188322	T	C	ENST00000256474.2	75	GRCh37					splice_donor_variant	NM_000551.3:c.463+2T>C,NC_000003.11:g.10188322T>C,ENST00000256474.2:c.463+2T>C,NP_000542.1:p.?,NC_000003.12:g.10146638T>C	2018-11-30 14:44:49 UTC	0.0	CA16621936	569414	C.463+2T>C,RS5030814		
2077	https://civic.genome.wustl.edu/links/variants/2077	VHL	7428	Splicing alteration (c.464-1G>C)	There are three variants in ClinVar at this exact position: (ClinVar ID: 223220, ClinVar ID:223221, and ClinVar ID:43603). ClinVar ID: 223220 is an exact match.		3	10191470	10191470	G	C	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-1G>C,NC_000003.11:g.10191470G>C,ENST00000256474.2:c.464-1G>C,NP_000542.1:p.=,NC_000003.12:g.10149786G>C	2020-07-23 20:30:10 UTC	10.0	CA357081	223220	C.464-1G>C,RS5030817,IVS2-1G>C		
2078	https://civic.genome.wustl.edu/links/variants/2078	VHL	7428	Splicing alteration (c.464-2A>G)			3	10191469	10191469	A	G	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NM_000551.3:c.464-2A>G,NC_000003.11:g.10191469A>G,ENST00000256474.2:c.464-2A>G	2018-11-30 14:44:59 UTC	20.0	CA357046	223222	C.464-2A>G,RS5030816		
2079	https://civic.genome.wustl.edu/links/variants/2079	VHL	7428	Q164L (c.491A>T)			3	10191498	10191498	A	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.491A>T,NC_000003.11:g.10191498A>T,NM_000551.3:c.491A>T,NP_000542.1:p.Gln164Leu	2018-12-14 19:04:25 UTC	7.5	CA351756149	NONE FOUND	C.491A>T,GLN164LEU		
2088	https://civic.genome.wustl.edu/links/variants/2088	VHL	7428	F76del (c.224_226delTCT)	Note that this variant occurs within a short TCT repeat and there are several variant notations that resolve to the same sequence when they are shifted or justified. Each results in the same in-frame single amino acid deletion (Phe76del aka F76del).		3	10183755	10183757	TCT		ENST00000256474.2	75	GRCh37					inframe_deletion	NP_000542.1:p.Phe76del,ENST00000256474.2:c.224_226delTCT,NC_000003.11:g.10183758_10183760del,NC_000003.12:g.10142074_10142076del,NM_000551.3:c.227_229del,ENSP00000256474.2:p.Phe76del	2020-07-17 16:11:50 UTC	120.0	CA357012	223166	PHE76DEL,C.224_226DELTCT,C.226_228DELTTC,C.227_229DELTCT,DELPHE76	17	https://civic.genome.wustl.edu/links/assertions/17
2089	https://civic.genome.wustl.edu/links/variants/2089	VHL	7428	R82_V84del (c.243_251del)			3	10183774	10183782	GCGCGTCGT		ENST00000256474.2	75	GRCh37					inframe_deletion	NC_000003.11:g.10183774_10183782del,NC_000003.12:g.10142092_10142100del,NM_000551.4:c.245_253del,NP_000542.1:p.Arg82_Val84del	2020-12-17 16:54:36 UTC	17.5	CA658820713	NONE FOUND	P81DELRVV (C.243_251DELGCGCGTCGT),ARG82_VAL84DEL		
2090	https://civic.genome.wustl.edu/links/variants/2090	VHL	7428	P40fs (c.118ins)																	2018-02-04 21:59:17 UTC	7.5					
2091	https://civic.genome.wustl.edu/links/variants/2091	VHL	7428	T152fs (c.455insA)																	2018-02-04 21:56:24 UTC	17.5					
2092	https://civic.genome.wustl.edu/links/variants/2092	VHL	7428	T157fs (c.472ins)																	2018-02-04 21:54:01 UTC	7.5					
2097	https://civic.genome.wustl.edu/links/variants/2097	VHL	7428	D92_Y98del (c.275_292del)																	2020-08-15 05:03:36 UTC	7.5					
2098	https://civic.genome.wustl.edu/links/variants/2098	VHL	7428	E160fs (c.477del)			3	10191482	10191482	A		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	ENST00000256474.2:c.475del,NP_000542.1:p.Glu160SerfsTer10,NM_000551.3:c.477del,NC_000003.12:g.10149800del,NC_000003.11:g.10191484del	2020-11-03 02:53:05 UTC	7.5	CA020404	182959	C.475DELA,LYS159FS,E160SFS*10		
2099	https://civic.genome.wustl.edu/links/variants/2099	VHL	7428	V66del (c.197_220del)															inframe_deletion		2018-03-29 18:30:42 UTC	5.0					
2101	https://civic.genome.wustl.edu/links/variants/2101	VHL	7428	V84M (c.250G>A)			3	10183781	10183781	G	A	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.250G>A,NP_000542.1:p.Val84Met,NC_000003.11:g.10183781G>A,ENST00000256474.2:c.250G>A	2018-11-30 14:44:54 UTC	0.0	CA351750580	428813	C.250G>A,VAL84MET,RS5030827		
2104	https://civic.genome.wustl.edu/links/variants/2104	VHL	7428	Splicing alteration (c.340+5G>C)			3	10183876	10183876	G	C	ENST00000256474.2	75	GRCh37					intron_variant	NM_000551.3:c.340+5G>C,NC_000003.11:g.10183876G>C,ENST00000256474.2:c.340+5G>C,NP_000542.1:p.?,NC_000003.12:g.10142192G>C	2021-01-31 17:44:23 UTC	5.0	CA020288	36901	C.340+5G>C,C.533+5G>C,IVS1+5G>C		
2108	https://civic.genome.wustl.edu/links/variants/2108	ARID1A	8289	UNDEREXPRESSION			1	27022524	27108595			ENST00000324856.7	75	GRCh37					N/A		2018-07-06 20:40:09 UTC	34.0		N/A			
2114	https://civic.genome.wustl.edu/links/variants/2114	VHL	7428	Splicing alteration (c.340+1G>A)			3	10183872	10183872	G	A	ENST00000256474.2	75	GRCh37					splice_donor_variant	NM_000551.3:c.340+1G>A,NC_000003.11:g.10183872G>A,ENST00000256474.2:c.340+1G>A	2018-11-30 14:44:56 UTC	35.0	CA357042	223190	C.340+1G>A,C.553+1G>A		
2125	https://civic.genome.wustl.edu/links/variants/2125	VHL	7428	Q132P (c.395A>C)			3	10188252	10188252	A	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.395A>C,NC_000003.11:g.10188252A>C,NM_000551.3:c.395A>C,NP_000542.1:p.Gln132Pro	2018-11-30 14:44:56 UTC	10.0	CA351753958	496063	C.395A>C,GLN132PRO,RS1347416980		
2127	https://civic.genome.wustl.edu/links/variants/2127	VHL	7428	E94FS (c.279delC)			3	10183810	10183810	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.279delC,NC_000003.11:g.10183810del,NM_000551.3:c.279del,NP_000542.1:p.Glu94SerfsTer?	2020-10-28 23:48:27 UTC	0.0	CA658820711	NONE FOUND	C.279DELC,GLY93FS,GLU94FS		
2129	https://civic.genome.wustl.edu/links/variants/2129	VHL	7428	G114dup (c.342dupGGT)																	2017-12-01 14:40:45 UTC	10.0					
2130	https://civic.genome.wustl.edu/links/variants/2130	VHL	7428	S65FS (c.194delC)			3	10183725	10183725	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.194delC,NC_000003.11:g.10183725delC,NM_000551.3:c.194delC,NP_000542.1:p.Ser65TrpfsTer2	2018-11-30 14:44:55 UTC	10.0	CA432536395	NONE FOUND	C.194DELC,SER65FS		
2131	https://civic.genome.wustl.edu/links/variants/2131	VHL	7428	Q73fs (c.214insGCCC)																	2017-12-01 14:40:45 UTC	10.0					
2132	https://civic.genome.wustl.edu/links/variants/2132	VHL	7428	C77fs (c.228dup)			3	10183758	10183759		C	ENST00000256474.2	75	GRCh37						NC_000003.11:g.10183759dup,NC_000003.12:g.10142075dup,NM_000551.3:c.228dup,ENST00000256474.2:c.228dup,NP_000542.1:p.Cys77LeufsTer?,ENSP00000256474.2:p.Cys77LeufsTer?	2020-10-27 00:00:33 UTC	10.0	CA658795177	NONE FOUND	440_441INSC,C.227_228INSC,F76FS,C.227INSC		
2133	https://civic.genome.wustl.edu/links/variants/2133	VHL	7428	Splicing alteration (c.341-2A>C)			3	10188196	10188196	A	C	ENST00000256474.2	75	GRCh37					splice_acceptor_variant	NC_000003.11:g.10188196A>C,NM_000551.3:c.341-2A>C,ENST00000256474.2:c.341-2A>C	2018-11-30 14:45:26 UTC	17.5	CA351753579	NONE FOUND	C.341-2A>C		
2134	https://civic.genome.wustl.edu/links/variants/2134	VHL	7428	Intronic deletion (c.341-13delCGTTTCCAACAATTTCTCGGTGT)																	2021-01-21 18:16:01 UTC	5.0					
2136	https://civic.genome.wustl.edu/links/variants/2136	VHL	7428	H125fs (c.374insA)																	2017-12-01 14:40:45 UTC	10.0					
2137	https://civic.genome.wustl.edu/links/variants/2137	VHL	7428	K159fs (c.474_476delGAAinsC)			3	10191481	10191483	GAA	C	ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.474_476delGAAinsC	2020-11-02 22:00:46 UTC	10.0		NONE FOUND	C.474_476DELGAAINSC,LEU158FS,LYS159FS,K159FS		
2138	https://civic.genome.wustl.edu/links/variants/2138	VHL	7428	Y175* (c.525delC)			3	10191532	10191532	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.525delC,NP_000542.1:p.Tyr175Ter,NC_000003.11:g.10191532del,NM_000551.3:c.525del	2020-11-03 19:19:08 UTC	7.5	CA913185019	NONE FOUND	TYR175FS,C.525DELC		
2139	https://civic.genome.wustl.edu/links/variants/2139	VHL	7428	L188fs (c.562delC)			3	10191569	10191569	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.562delC,NC_000003.11:g.10191569del,NM_000551.3:c.562delC,NP_000542.1:p.Leu188TrpfsTer14	2018-11-30 14:44:57 UTC	10.0	CA432423671	NONE FOUND	C.562DELC,LEU188FS		
2140	https://civic.genome.wustl.edu/links/variants/2140	VHL	7428	K196fs (c.584_585delAG)			3	10191591	10191592	AG		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.584_585delAG	2020-11-03 19:37:04 UTC	10.0	CA645529570	NONE FOUND	C.584_585DELAG,GLN195FS		
2141	https://civic.genome.wustl.edu/links/variants/2141	VHL	7428	D197FS (c.589delG)			3	10191596	10191596	G		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.589delG,NC_000003.11:g.10191596del,NM_000551.3:c.589del,NP_000542.1:p.Asp197ThrfsTer5	2019-07-30 00:02:51 UTC	10.0	CA913189233	NONE FOUND	C.589DELG,ASP197FS		
2142	https://civic.genome.wustl.edu/links/variants/2142	VHL	7428	T202fs (c.606insA)																	2018-04-15 14:12:40 UTC	7.5			T202FS (C.606DUPA)		
2143	https://civic.genome.wustl.edu/links/variants/2143	VHL	7428	R113FS (c.337delC)			3	10183868	10183868	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.337delC,NC_000003.11:g.10183868delC,NM_000551.3:c.337delC,NP_000542.1:p.Arg113GlufsTer?	2018-11-30 14:45:02 UTC	10.0	CA432420675	NONE FOUND	C.337DELC,ARG113FS		
2144	https://civic.genome.wustl.edu/links/variants/2144	VHL	7428	A56fs (c.166dup)			3	10183696	10183697		G	ENST00000256474.2	75	GRCh37					plus_1_frameshift_variant	NP_000542.1:p.Ala56fs,NC_000003.11:g.10183697dup,NC_000003.12:g.10142013dup,NM_000551.3:c.166dup	2020-10-30 00:00:12 UTC	10.0	CA645524645	NONE FOUND	C.165DUP,C.165_166DUPG,A56GFS*76 (C.166DUP)		
2145	https://civic.genome.wustl.edu/links/variants/2145	VHL	7428	P61FS (c.182_185delCCGT)			3	10183713	10183716	CCGT		ENST00000256474.2	75	GRCh37					frameshift_variant	ENST00000256474.2:c.182_185delCCGT,NC_000003.11:g.10183713_10183716del,NM_000551.3:c.182_185delCCGT,NP_000542.1:p.Pro61ArgfsTer5	2018-11-30 14:44:58 UTC	10.0	CA658820712	NONE FOUND	C.182_185DELCCGT,PRO61FS		
2148	https://civic.genome.wustl.edu/links/variants/2148	VHL	7428	R161= (c.481C>A)			3	10191488	10191488	C	A	ENST00000256474.2	75	GRCh37					synonymous_variant	NC_000003.11:g.10191488C>A,NC_000003.12:g.10149804C>A,NP_000542.1:p.Arg161=	2020-10-24 00:00:16 UTC	5.0	CA432423146	NONE FOUND	R161R (C.481C>A)		
2150	https://civic.genome.wustl.edu/links/variants/2150	VHL	7428	I151F (c.451A>T)			3	10188308	10188308	A	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.451A>T,NC_000003.11:g.10188308A>T,NM_000551.3:c.451A>T,NP_000542.1:p.Ile151Phe	2019-03-22 00:00:07 UTC	5.0	CA351754353	NONE FOUND	C.451A>T,ILE151PHE		
2151	https://civic.genome.wustl.edu/links/variants/2151	VHL	7428	W88* (c.263G>A)			3	10183794	10183794	G	A	ENST00000256474.2	75	GRCh37					stop_gained	NM_000551.3:c.263G>A,NP_000542.1:p.Trp88Ter,NC_000003.11:g.10183794G>A,ENST00000256474.2:c.263G>A	2021-02-01 20:16:49 UTC	7.5	CA020197	182978	W88X,TRP88TER,C.263G>A,RS119103277		
2152	https://civic.genome.wustl.edu/links/variants/2152	VHL	7428	3'UTR alteration (c.642+70C>A)			3	10191719	10191719	C	A			GRCh37					3_prime_UTR_variant	NC_000003.11:g.10191719C>A,ENST00000256474.2:c.*70C>A,NM_000551.3:c.*70C>A,NP_000542.1:p.=	2018-11-30 14:45:01 UTC	5.0	CA658820858	NONE FOUND	C.*70C>A		
2160	https://civic.genome.wustl.edu/links/variants/2160	VHL	7428	Y98FS (c.291delC)			3	10183822	10183822	C		ENST00000256474.2	75	GRCh37					frameshift_truncation	ENST00000256474.2:c.291delC,NC_000003.11:g.10183822delC,NM_000551.3:c.291delC,NP_000542.1:p.Tyr98ThrfsTer	2018-11-30 14:44:54 UTC	10.0	CA432420512	NONE FOUND	TYR98FS,C.291DELC		
2162	https://civic.genome.wustl.edu/links/variants/2162	VHL	7428	N150S (c.449A>G)			3	10188306	10188306	A	G	ENST00000256474.2	75	GRCh37					missense_variant	NM_000551.3:c.449A>G,NP_000542.1:p.Asn150Ser,NC_000003.11:g.10188306A>G,ENST00000256474.2:c.449A>G	2018-11-30 14:45:00 UTC	5.0	CA041030	371992	C.449A>G,ASN150SER,RS760184234		
2166	https://civic.genome.wustl.edu/links/variants/2166	NRG1	3084	SLC3A2-NRG1		NRG1 gene fusions															2017-12-01 14:40:45 UTC	0.0					
2168	https://civic.genome.wustl.edu/links/variants/2168	RAD50	10111	L1237F																	2017-12-01 14:40:45 UTC	10.0					
2169	https://civic.genome.wustl.edu/links/variants/2169	BTK	695	MUTATION																	2018-07-12 18:19:47 UTC	20.0					
2170	https://civic.genome.wustl.edu/links/variants/2170	PLCG2	5336	MUTATION																	2018-07-10 18:15:10 UTC	25.0					
2174	https://civic.genome.wustl.edu/links/variants/2174	EGFR	1956	WILDTYPE			7	55086794	55279321			ENST00000275493.2	75	GRCh37					wild_type		2020-10-07 23:43:59 UTC	20.0		N/A			
2178	https://civic.genome.wustl.edu/links/variants/2178	NRG1	3084	ATP1B1-NRG1		NRG1 gene fusions													transcript_fusion		2020-05-11 17:26:45 UTC	15.0					
2179	https://civic.genome.wustl.edu/links/variants/2179	NRG1	3084	SDC4-NRG1		NRG1 gene fusions															2018-07-19 10:36:27 UTC	7.5					
2181	https://civic.genome.wustl.edu/links/variants/2181	VHL	7428	R177ins (c.531insCTGAGAGTAAAGCCTGAA)																	2017-12-01 14:40:45 UTC	0.0					
2182	https://civic.genome.wustl.edu/links/variants/2182	VHL	7428	Null (Large deletion)																	2021-02-01 18:57:59 UTC	7.5					
2195	https://civic.genome.wustl.edu/links/variants/2195	DICER1	23405	D1709G																	2018-07-06 21:41:17 UTC	12.5					
2196	https://civic.genome.wustl.edu/links/variants/2196	DICER1	23405	D1709E																	2018-07-06 21:30:14 UTC	10.0					
2202	https://civic.genome.wustl.edu/links/variants/2202	FGFR2	2263	FGFR2 fusions																	2020-12-03 18:33:04 UTC	20.0					
2203	https://civic.genome.wustl.edu/links/variants/2203	EGFR	1956	EGFR-RAD51															transcript_fusion		2020-06-12 15:44:20 UTC	12.5					
2206	https://civic.genome.wustl.edu/links/variants/2206	FGFR2	2263	FGFR2 mutations																	2018-07-12 18:36:08 UTC	20.0					
2211	https://civic.genome.wustl.edu/links/variants/2211	BAP1	8314	ALTERNATIVE TRANSCRIPT (ATI)																	2018-02-15 13:05:54 UTC	3.0					
2218	https://civic.genome.wustl.edu/links/variants/2218	ALK	238	STRN-ALK																	2018-04-20 18:27:41 UTC	0.0					
2219	https://civic.genome.wustl.edu/links/variants/2219	BARD1	580	LOSS-OF-FUNCTION																	2018-02-15 13:11:25 UTC	3.0					
2221	https://civic.genome.wustl.edu/links/variants/2221	BRAF	673	G496A																	2018-02-16 01:08:01 UTC	5.0					
2222	https://civic.genome.wustl.edu/links/variants/2222	BRAF	673	G466V			7	140481411	140481411	C	A	ENST00000288602.6	75	GRCh37					missense_variant	NC_000007.13:g.140481411C>A,NM_004333.4:c.1397G>T,NP_004324.2:p.Gly466Val,ENST00000288602.6:c.1397G>T	2019-11-22 16:19:53 UTC	14.0	CA123647	13967	GLY466VAL,RS121913351		
2223	https://civic.genome.wustl.edu/links/variants/2223	BRAF	673	G606E			7	140453118	140453118	C	T	ENST00000288602.6	75	GRCh37					missense_variant		2018-11-30 14:43:12 UTC	5.0	CA369542941	NONE FOUND	GLY606GLU		
2224	https://civic.genome.wustl.edu/links/variants/2224	BRAF	673	P731T			7	140434507	140434507	G	T	ENST00000288602.6	75	GRCh37					missense_variant	ENST00000288602.6:c.2193G>T	2018-11-30 14:43:14 UTC	5.0	CA369537254	NONE FOUND	PRO731THR		
2225	https://civic.genome.wustl.edu/links/variants/2225	BRAF	673	intron 9 rearrangement																	2018-07-19 23:10:54 UTC	20.0					
2226	https://civic.genome.wustl.edu/links/variants/2226	BRAF	673	intron 10 rearrangement																	2018-07-19 23:10:19 UTC	20.0					
2227	https://civic.genome.wustl.edu/links/variants/2227	BRAF	673	MACF1-BRAF																	2020-05-11 17:28:17 UTC	5.0					
2228	https://civic.genome.wustl.edu/links/variants/2228	BRAF	673	WASFL-BRAF															transcript_fusion		2020-06-12 16:43:38 UTC	5.0					
2229	https://civic.genome.wustl.edu/links/variants/2229	BRAF	673	CUX1-BRAF		BRAF Fusions													transcript_fusion		2018-07-24 15:01:00 UTC	5.0					
2230	https://civic.genome.wustl.edu/links/variants/2230	ASS1	445	LOSS																	2018-07-06 21:28:33 UTC	6.0					
2233	https://civic.genome.wustl.edu/links/variants/2233	BCL2	596	MUTATION																	2018-02-15 14:43:31 UTC	15.0					
2235	https://civic.genome.wustl.edu/links/variants/2235	RASA1	5921	LOSS-OF-FUNCTION																	2018-03-23 12:14:33 UTC	3.0					
2240	https://civic.genome.wustl.edu/links/variants/2240	TLK2	11011	AMPLIFICATION																	2018-02-15 14:19:56 UTC	3.0					
2264	https://civic.genome.wustl.edu/links/variants/2264	VHL	7428	R82_V84del (c.244_252del)			3	10183775	10183783	CGCGTCGTG		ENST00000256474.2	75	GRCh37					inframe_deletion		2018-11-30 14:45:30 UTC	10.0	CA658820713	NONE FOUND	C.244_252DEL,C.245_253DEL		
2265	https://civic.genome.wustl.edu/links/variants/2265	VHL	7428	A56_P59del (c.166_178del)																	2018-07-10 18:10:04 UTC	7.5					
2283	https://civic.genome.wustl.edu/links/variants/2283	ACVR1	90	G328E	This mutation occurs within the kinase domain of ACVR1 and has been shown to be activating of downstream BMP signaling with increased cell proliferation in cells overexpressing this variant.	ACVR1 kinase domain mutation													missense_variant,gain_of_function_variant		2018-10-15 23:19:04 UTC	7.5					
2286	https://civic.genome.wustl.edu/links/variants/2286	NRG1	3084	NRG1 FUSIONS	NRG1 fusions have been described in cases of invasive mucinous adenocarcinoma of the lung, pancreatic ductal adenocarcinoma, cholangiocarcinoma and lung adenocarcinoma. In many cases these tumors were negative for the more common known driver genes of these diseases (e.g., KRAS wild-type pancreatic ductal adenocarcinoma). These events have been proposed as an attractive therapeutic target and some promising results have been observed with pan-HER inhibitors such as afatinib.																2020-04-17 00:24:27 UTC	10.0					
2287	https://civic.genome.wustl.edu/links/variants/2287	NTRK2	4915	STRN-NTRK2															transcript_fusion		2020-06-12 16:19:38 UTC	7.5					
2289	https://civic.genome.wustl.edu/links/variants/2289	NTRK1	4914	PDE4DIP-NTRK1																	2020-09-15 16:45:07 UTC	12.5					
2290	https://civic.genome.wustl.edu/links/variants/2290	VHL	7428	G144E (c.431G>A)			3	10188288	10188288	G	A	ENST00000256474.2	75	GRCh37							2020-10-13 00:02:36 UTC	5.0	CA351754206				
2292	https://civic.genome.wustl.edu/links/variants/2292	VHL	7428	Splicing alteration (c.463+8C>T)			3	10188328	10188328	C	T	ENST00000256474.2	75	GRCh37					splicing_variant	NC_000003.11:g.10188328C>T,ENST00000256474.2:c.463+8C>T,NM_000551.3:c.463+8C>T	2020-12-03 18:33:04 UTC	5.0	CA020379	127830			
2294	https://civic.genome.wustl.edu/links/variants/2294	VHL	7428	F91L (c.273C>G)	Note that there is a different variant reported at this amino acid position of VHL in ClinVar: NM_000551.3(VHL):c.273C>A (p.Phe91Leu; F91L) (https://www-ncbi-nlm-nih-gov/clinvar/variation/411978/)		3	10183804	10183804	C	G	ENST00000256474.2	75	GRCh37					missense_variant	NC_000003.11:g.10183804C>G,NC_000003.12:g.10142120C>G,NP_000542.1:p.Phe91Leu	2020-10-17 00:00:11 UTC	0.0	CA351750747	NONE FOUND	C.273C>G,PHE91LEU		
2299	https://civic.genome.wustl.edu/links/variants/2299	VHL	7428	W88fs (c.261dup)			3	10183791	10183792		A	ENST00000256474.3	75	GRCh37					plus_1_frameshift_variant,frameshift_truncation	NC_000003.11:g.10183792dup,NM_000551.3:c.261dup,NP_000542.1:p.Trp88MetfsTer44,ENST00000256474.3:c.261dup,NC_000003.12:g.10142108dup	2020-11-20 18:12:38 UTC	7.5	unregistered	NONE FOUND	C.261DUP,C.261INSA,TRP88METFSTER44,W88MFS*44		
2331	https://civic.genome.wustl.edu/links/variants/2331	ERBB2	2064	T798I			17	37881064	37881064	C	T	ENST00000269571.5	75	GRCh37					missense_variant	ENST00000269571.5:c.2393C>T,NC_000017.10:g.37881064C>T,NM_001289937.1:c.2393C>T,NP_001276866.1:p.Thr798Ile	2020-07-25 00:00:13 UTC	0.0	CA399303242	NONE FOUND	THR798ILE		
2333	https://civic.genome.wustl.edu/links/variants/2333	EGFR	1956	R705K																	2018-05-31 19:59:12 UTC	5.0					
2334	https://civic.genome.wustl.edu/links/variants/2334	EGFR	1956	RARE EGRF MUT																	2018-06-04 15:39:12 UTC	5.0					
2335	https://civic.genome.wustl.edu/links/variants/2335	ABL1	25	BCR-ABL T315A			9	133748282	133748282	A	G	ENST00000318560.5	75	GRCh37					missense_variant	NM_005157.5:c.943A>G,NP_005148.2:p.Thr315Ala,NC_000009.11:g.133748282A>G,ENST00000318560.5:c.943A>G	2019-12-30 03:32:59 UTC	5.0	CA16602576	376118	THR315ALA,T334A,RS1057519772		
2340	https://civic.genome.wustl.edu/links/variants/2340	ABL1	25	BCR-ABL L248R			9	133738343	133738343	T	G	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.743T>G	2019-12-30 03:58:29 UTC	7.0	CA375263224	NONE FOUND	LEU248ARG		
2343	https://civic.genome.wustl.edu/links/variants/2343	ABL1	25	BCR-ABL F317S			9	133748289	133748289	T	C	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560.5:c.950T>C	2019-03-13 00:00:07 UTC	1.0	CA375249431	NONE FOUND	PHE317SER		
2359	https://civic.genome.wustl.edu/links/variants/2359	ABL1	25	BCR-ABL F317C			9	133748289	133748289	T	G	ENST00000318560.5	75	GRCh37					missense_variant	ENST00000318560:c.950T>G	2019-03-13 00:00:07 UTC	2.0	CA16602579	376121	PHE317CYS,F336C		
2360	https://civic.genome.wustl.edu/links/variants/2360	AKT1	207	Overexpression																	2021-02-02 02:14:53 UTC	3.0					
2361	https://civic.genome.wustl.edu/links/variants/2361	BRAF	673	V600E/K and AMPLIFICATION																	2020-05-28 21:35:25 UTC	10.0					
2363	https://civic.genome.wustl.edu/links/variants/2363	PIK3R2	5296	OVEREXPRESSION																	2018-07-19 20:32:47 UTC	2.0					
2364	https://civic.genome.wustl.edu/links/variants/2364	PREX2	80243	R172I			8	68939530	68939530	G	T	ENST00000288368.4	75	GRCh37					missense_variant		2021-01-27 00:00:15 UTC	10.0	CA371196220	NONE FOUND	ARG172ILE		
2367	https://civic.genome.wustl.edu/links/variants/2367	VHL	7428	3p26.3-25.3 11Mb del																	2018-07-10 18:06:35 UTC	7.5					
2370	https://civic.genome.wustl.edu/links/variants/2370	ABL1	25	BCR-ABL E459K			9	133753906	133753906	G	A	ENST00000318560.5	75	GRCh37					missense_variant,transcript_fusion	ENST00000318560.5:c.1375G>A,NC_000009.11:g.133753906G>A,NM_005157.5:c.1375G>A,NP_005148.2:p.Glu459Lys	2019-01-31 10:31:50 UTC	20.0	CA200648598	NONE FOUND	BCR-ABL GLU459LYS,RS1064156,BCR-ABL1 E459K,BCR-ABL1 GLU459LYS		
2371	https://civic.genome.wustl.edu/links/variants/2371	ABL1	25	TKD MUTATION																	2018-12-21 19:56:23 UTC	60.0					
2373	https://civic.genome.wustl.edu/links/variants/2373	VHL	7428	c.128-?_250+?																	2020-06-16 21:02:23 UTC	5.0					
2375	https://civic.genome.wustl.edu/links/variants/2375	ABL1	25	P-Loop Mutation																	2018-12-21 19:53:04 UTC	25.0					
2376	https://civic.genome.wustl.edu/links/variants/2376	ABL1	25	Non-P-Loop Mutation																	2018-12-21 19:54:35 UTC	30.0					
2387	https://civic.genome.wustl.edu/links/variants/2387	CSF3R	1441	T618I																	2018-07-13 13:56:25 UTC	14.0					
2388	https://civic.genome.wustl.edu/links/variants/2388	CALR	811	MUTATION																	2018-07-13 13:54:15 UTC	50.0					
2393	https://civic.genome.wustl.edu/links/variants/2393	NTRK1	4914	NTRK1-TRIM63																	2018-10-02 14:58:42 UTC	0.5					
2394	https://civic.genome.wustl.edu/links/variants/2394	NTRK1	4914	NTRK1-DDR2																	2018-10-15 03:27:57 UTC	0.5					
2395	https://civic.genome.wustl.edu/links/variants/2395	NTRK1	4914	NTRK1-GON4L																	2018-10-02 14:58:42 UTC	0.5					
2396	https://civic.genome.wustl.edu/links/variants/2396	NTRK2	4915	ETV6-NTRK2																	2020-03-24 22:58:17 UTC	10.0					
2398	https://civic.genome.wustl.edu/links/variants/2398	BRAF	673	D594K																	2018-07-19 23:01:51 UTC	30.0					
2408	https://civic.genome.wustl.edu/links/variants/2408	BRAF	673	Non-V600															protein_altering_variant		2018-10-02 14:58:42 UTC	25.0					
2411	https://civic.genome.wustl.edu/links/variants/2411	SDHB	6390	p.193_196dupSTSC (c.577_588dupAGCACCAGCTGC)	ClinGen Canonical Allele Identifier: CA658820851		1	17350521	17350522		GCAGCTGGTGCT	ENST00000375499.3	75	GRCh37					inframe_insertion	NM_003000.2:c.577_588dupAGCACCAGCTGC,NP_002991.2:p.193_196dupSTSC,NC_000001.10:g.17350522_17350533dup	2020-02-03 00:08:00 UTC	5.0	CA658820851		C.589_600DUP		
2416	https://civic.genome.wustl.edu/links/variants/2416	H3-3A	3020	K27M																	2020-12-10 18:37:06 UTC	50.0					
2420	https://civic.genome.wustl.edu/links/variants/2420	H3-3B	3021	K36M																	2019-11-20 00:04:34 UTC	20.0					
2421	https://civic.genome.wustl.edu/links/variants/2421	H3-3A	3020	G34W																	2019-11-20 00:00:50 UTC	20.0					
2428	https://civic.genome.wustl.edu/links/variants/2428	VHL	7428	G104V (c.311G>T)			3	10183842	10183842	G	T	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.311G>T,NM_000551.3:c.311G>T,NP_000542.1:p.Gly104Val,NC_000003.11:g.10183842G>T	2019-03-22 00:00:04 UTC	0.0	CA357033	223183	C.311G>T,GLY104VAL,RS869025630		
2431	https://civic.genome.wustl.edu/links/variants/2431	VHL	7428	c.213 ?_463 ?del																	2018-10-02 14:58:42 UTC	0.0					
2432	https://civic.genome.wustl.edu/links/variants/2432	VHL	7428	V87fs (c.259_260insA)			3	10183790	10183791		A	ENST00000256474.2	75	GRCh37					plus_1_frameshift_variant,frameshift_truncation	ENST00000256474.2:c.259_260insA,NC_000003.11:g.10183790_10183791insA,NM_000551.3:c.259_260insA,NP_000542.1:p.Val87AspfsTer?,NC_000003.12:g.10142106_10142107insA	2019-07-30 00:00:32 UTC	0.0	CA913189242	NONE FOUND	C.259_260INSA,VAL87FS,V87DFS*45		
2435	https://civic.genome.wustl.edu/links/variants/2435	VHL	7428	c.341-59_341-14del																	2018-10-02 14:58:42 UTC	0.0					
2437	https://civic.genome.wustl.edu/links/variants/2437	VHL	7428	V166A (c.497T>C)			3	10191504	10191504	T	C	ENST00000256474.2	75	GRCh37					missense_variant	NC_000003.11:g.10191504T>C,NM_000551.3:c.497T>C,NP_000542.1:p.Val166Ala,ENST00000256474.2:c.497T>C	2020-10-24 00:00:18 UTC	0.0	CA020442	43605	VAL166ALA		
2439	https://civic.genome.wustl.edu/links/variants/2439	VHL	7428	REARRANGEMENT																	2020-06-29 18:06:14 UTC	10.0					
2447	https://civic.genome.wustl.edu/links/variants/2447	VHL	7428	V66Gfs*89 (c.197_209del)																	2018-12-14 19:04:46 UTC	5.0					
2448	https://civic.genome.wustl.edu/links/variants/2448	VHL	7428	R79_S80del (c.236_241delGCAGTC)																	2018-12-14 19:04:46 UTC	5.0					
2449	https://civic.genome.wustl.edu/links/variants/2449	VHL	7428	D92G (c.275A>G)			3	10183806	10183806	A	G	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.275A>G,NC_000003.11:g.10183806A>G,NM_000551.3:c.275A>G,NP_000542.1:p.Asp92Gly	2019-03-22 00:00:05 UTC	5.0	CA351750765	NONE FOUND	C.275A>G,ASP92GLY		
2455	https://civic.genome.wustl.edu/links/variants/2455	VHL	7428	G114Vfs*45 (c.339delA)																	2018-12-14 19:04:41 UTC	7.5					
2457	https://civic.genome.wustl.edu/links/variants/2457	VHL	7428	Splicing alteration (c.464-2G>A)																	2020-12-03 18:33:04 UTC	7.5					
2458	https://civic.genome.wustl.edu/links/variants/2458	VHL	7428	R167P (c.500G>C)			3	10191507	10191507	G	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.500G>C,NM_000551.3:c.500G>C,NP_000542.1:p.Arg167Pro,NC_000003.11:g.10191507G>C	2019-03-22 00:00:05 UTC	7.5	CA351756177	428799	RS5030821,C.500G>C,ARG167PRO		
2459	https://civic.genome.wustl.edu/links/variants/2459	VHL	7428	L178P (c.532C>T)																	2020-12-18 19:39:29 UTC	7.5					
2468	https://civic.genome.wustl.edu/links/variants/2468	PRKCB	5579	D427N																	2018-10-02 14:58:43 UTC	3.0					
2488	https://civic.genome.wustl.edu/links/variants/2488	VHL	7428	*214G (c.640T>G)			3	10191647	10191647	T	G	ENST00000256474.2	75	GRCh37					stop_lost	ENST00000256474.2:c.640T>G,NM_000551.3:c.640T>G,NP_000542.1:p.Ter214Gly,ENSP00000256474.2:p.Ter214Gly	2018-11-30 14:45:33 UTC	5.0	CA351756720	NONE FOUND	X214G,TER214GLY,C.640T>G,X > GLY + 14AA		
2489	https://civic.genome.wustl.edu/links/variants/2489	VHL	7428	*214C (c.641_642insC)			3	10191648	10191649		C	ENST00000256474.2	75	GRCh37					stop_lost	ENST00000256474.2:c.641_642insC,NC_000003.11:g.10191648_10191649insC,NM_000551.3:c.641_642insC,NP_000542.1:p.Ter214CysextTer?	2020-06-29 18:57:14 UTC	5.0	CA913189243	NONE FOUND	X214C,TER214CYS,C.641INSC		
2508	https://civic.genome.wustl.edu/links/variants/2508	VHL	7428	L129P (c.386T>C)			3	10188243	10188243	T	C	ENST00000256474.2	75	GRCh37					missense_variant	ENST00000256474.2:c.386T>C,NC_000003.11:g.10188243T>C,NM_000551.3:c.386T>C,NP_000542.1:p.Leu129Pro,ENSP00000256474.2:p.Leu129Pro,NC_000003.12:g.10146559T>C	2020-10-28 00:00:40 UTC	0.0	CA351753904	625242	L129P (C.386T>G)		
2511	https://civic.genome.wustl.edu/links/variants/2511	VHL	7428	S80fs (c.239del)			3	10183770	10183770	G		ENST00000256474.2	75	GRCh37					minus_1_frameshift_variant,frameshift_truncation	NP_000542.1:p.Ser80IlefsTer,ENST00000256474.2:c.239del,NC_000003.11:g.10183770del,NM_000551.3:c.239del	2021-01-16 22:18:34 UTC	7.5	CA913189245	NONE FOUND	C.239DELG,SER80ILEFS*79,S80IFS*79 (C.239DELG)		
2570	https://civic.genome.wustl.edu/links/variants/2570	HRAS	3265	Q61																	2019-02-10 01:56:21 UTC	10.0					
2571	https://civic.genome.wustl.edu/links/variants/2571	ABL2	27	ABL2 fusions																	2019-12-17 14:27:53 UTC	3.0					
2575	https://civic.genome.wustl.edu/links/variants/2575	ABL1	25	ETV6-ABL1															transcript_fusion		2019-12-17 16:48:38 UTC	5.0					
2580	https://civic.genome.wustl.edu/links/variants/2580	VHL	7428	N131T (c.392A>C)	A similar but distinct variant the same position has been reported in ClinVar (c.392A>G (p.Asn131Ser); https://www.ncbi.nlm.nih.gov/clinvar/variation/496062/). It involves the same base position but a different nucleotide change leading to a different amino acid change.		3	10188249	10188249	A	C	ENST00000256474.2	75	GRCh37					non_conservative_missense_variant	NC_000003.11:g.10188249A>C,CM000665.1:g.10188249A>C,NP_000542.1:p.Asn131Thr,NM_000551.3:c.392A>C	2020-08-20 05:29:35 UTC	7.5	CA351753944	NONE FOUND			
2581	https://civic.genome.wustl.edu/links/variants/2581	NCOA2	10499	HEY1-NCOA2	HEY1-NCOA2 is a specific and recurrent translocation in mesenchymal chondrosarcoma.  The resulting chimeric transcription factor consists of the HEY1 DNA binding domain (exons 1-4) and two activating domains and a histone methyltransferase-interacting domain from NCOA2 (exon 13-23).		8	80	80			ENST00000337919.9	94	GRCh37	8	71	71	ENST00000452400.6	transcript_fusion		2019-07-22 14:10:31 UTC	70.0				21	https://civic.genome.wustl.edu/links/assertions/21
2582	https://civic.genome.wustl.edu/links/variants/2582	FOXO1	2308	PAX3-FOXO1																	2020-10-12 23:17:30 UTC	35.0					
2583	https://civic.genome.wustl.edu/links/variants/2583	FOXO1	2308	PAX7-FOXO1															transcript_fusion		2020-10-12 23:17:31 UTC	35.0					
2586	https://civic.genome.wustl.edu/links/variants/2586	PARP1	142	OVEREXPRESSION																	2019-12-16 22:01:48 UTC	3.0					
2587	https://civic.genome.wustl.edu/links/variants/2587	JAK2	3717	JAK2 F694L																	2019-01-11 13:39:02 UTC	5.0					
2590	https://civic.genome.wustl.edu/links/variants/2590	PIK3CA	5290	Wildtype			3	178866311	178957881			ENST00000263967.3	75	GRCh37					wild_type		2021-02-02 23:04:09 UTC	15.0					
2613	https://civic.genome.wustl.edu/links/variants/2613	EGFR	1956	V441F		ECD MUTATION															2019-02-08 15:40:33 UTC	0.0					
2620	https://civic.genome.wustl.edu/links/variants/2620	KIT	3815	T417_D419delinsY																	2019-02-08 17:40:27 UTC	5.0					
2621	https://civic.genome.wustl.edu/links/variants/2621	KIT	3815	F506_F508DUP																	2019-02-08 17:46:02 UTC	2.5					
2622	https://civic.genome.wustl.edu/links/variants/2622	KIT	3815	K484_G487DEL																	2019-02-08 17:50:51 UTC	2.5					
2623	https://civic.genome.wustl.edu/links/variants/2623	PDGFRA	5156	EXON 18 MUTATION																	2019-02-08 18:22:13 UTC	2.5					
2643	https://civic.genome.wustl.edu/links/variants/2643	KIT	3815	EXON 13 MUTATION																	2019-02-26 18:17:04 UTC	5.0					
2644	https://civic.genome.wustl.edu/links/variants/2644	SMARCA4	6597	LOSS																	2020-08-25 00:31:02 UTC	4.0				35	https://civic.genome.wustl.edu/links/assertions/35
2648	https://civic.genome.wustl.edu/links/variants/2648	TP53	7157	C238Y			17	7577568	7577568	C	T	ENST00000269305.4	75	GRCh37					missense_variant	NC_000017.10:g.7577568C>T,NM_000546.5:c.713G>A,NP_000537.3:p.Cys238Tyr,ENST00000269305.4:c.713G>A	2020-12-12 22:27:46 UTC	0.75	CA000351	182935	CYS238TYR		
2650	https://civic.genome.wustl.edu/links/variants/2650	BRAF	673	EXON 15 MUTATION																	2019-03-21 20:35:52 UTC	7.5					
2651	https://civic.genome.wustl.edu/links/variants/2651	KIT	3815	WILDTYPE																	2019-03-11 22:19:30 UTC	10.0		N/A			
2652	https://civic.genome.wustl.edu/links/variants/2652	H3-3A	3020	MUTATION																	2020-02-16 23:56:30 UTC	20.0					
2654	https://civic.genome.wustl.edu/links/variants/2654	CDKN2A	1029	DELETION																	2020-02-16 23:55:55 UTC	20.0					
2655	https://civic.genome.wustl.edu/links/variants/2655	MYB	4602	AMPLIFICATION																	2020-02-16 23:55:14 UTC	20.0					
2659	https://civic.genome.wustl.edu/links/variants/2659	FGFR1	2260	INTERNAL DUPLICATION																	2019-03-19 03:22:54 UTC	0.0					
2661	https://civic.genome.wustl.edu/links/variants/2661	JAK2	3717	SSBP2-JAK2		JAK2 fusions in B-ALL															2020-10-19 20:11:28 UTC	25.0					
2663	https://civic.genome.wustl.edu/links/variants/2663	CRLF2	64109	IGH-CRLF2															transcript_fusion		2021-01-27 01:12:49 UTC	20.0					
2678	https://civic.genome.wustl.edu/links/variants/2678	ABL1	25	SNX2-ABL1															transcript_fusion		2020-06-11 20:16:05 UTC	13.0					
2680	https://civic.genome.wustl.edu/links/variants/2680	ABL1	25	ABL1-RCSD																	2019-12-17 16:55:57 UTC	7.5					
2681	https://civic.genome.wustl.edu/links/variants/2681	ABL1	25	ABL1-RCSD1																	2019-12-20 09:47:33 UTC	10.5					
2682	https://civic.genome.wustl.edu/links/variants/2682	ABL1	25	FOXP1-ABL1															transcript_fusion		2020-06-11 20:12:10 UTC	0.0					
2693	https://civic.genome.wustl.edu/links/variants/2693	ROS1	6098	FUSION																	2019-05-02 21:35:38 UTC	0.0				37	https://civic.genome.wustl.edu/links/assertions/37
2695	https://civic.genome.wustl.edu/links/variants/2695	KIT	3815	V555_V559DEL																	2019-05-03 23:45:42 UTC	5.0					
2696	https://civic.genome.wustl.edu/links/variants/2696	KIT	3815	K550_K559DEL			4	55593582	55593611	AAACCCATGTATGAAGTACAGTGGAAGGTT		ENST00000288135.5	75	GRCh37							2020-05-20 14:36:10 UTC	5.0	CA645516734				
2704	https://civic.genome.wustl.edu/links/variants/2704	CDKN2A	1029	MUTATION																	2019-05-09 11:19:48 UTC	40.0					
2743	https://civic.genome.wustl.edu/links/variants/2743	FGFR1	2260	FGFR1OP2-FGFR1																	2019-06-21 22:45:55 UTC	2.0					
2744	https://civic.genome.wustl.edu/links/variants/2744	IKZF1	10320	IKZF1 deletion and mutation																	2019-06-26 19:41:08 UTC	0.0					
2749	https://civic.genome.wustl.edu/links/variants/2749	NFE2L2	4780	MUTATION																	2019-11-04 16:35:20 UTC	15.0					
2769	https://civic.genome.wustl.edu/links/variants/2769	ALK	238	CAD-ALK																	2019-11-08 22:32:55 UTC	7.5					
2770	https://civic.genome.wustl.edu/links/variants/2770	ROS1	6098	GOPC-ROS1																	2020-06-08 17:28:15 UTC	3.0					
2772	https://civic.genome.wustl.edu/links/variants/2772	NRG1	3084	APP-NRG1															transcript_fusion		2020-05-11 17:26:55 UTC	0.0					
2774	https://civic.genome.wustl.edu/links/variants/2774	MET	4233	R1004G																	2019-10-10 14:07:11 UTC	7.5					
2794	https://civic.genome.wustl.edu/links/variants/2794	BRAF	673	N486_P490del																	2019-11-14 10:41:28 UTC	7.5					
2820	https://civic.genome.wustl.edu/links/variants/2820	BRAF	673	V600_K601>E																	2020-07-10 19:32:56 UTC	7.5					
2822	https://civic.genome.wustl.edu/links/variants/2822	BRAF	673	G469																	2020-03-17 16:21:16 UTC	15.0					
2826	https://civic.genome.wustl.edu/links/variants/2826	BRAF	673	A598V			7	140453142	140453142	G	A	ENST00000288602.6	75	GRCh37					missense_variant		2020-06-08 17:22:07 UTC	7.5	CA369543099	NONE FOUND	ALA598VAL		
2827	https://civic.genome.wustl.edu/links/variants/2827	FGF19	9965	EXPRESSION																	2019-12-04 19:31:36 UTC	20.0					
2846	https://civic.genome.wustl.edu/links/variants/2846	JAK2	3717	ATF7IP-JAK2	The ATF7IP-JAK2 fusion is composed of part of the ATF7IP (Activating Transcription Factor 7 Interacting Protein) gene at the 5 end (N-terminus of the fusion protein), and a part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion. Known breakpoint/splice variants join exon 10 of ATF7IP to exon 8 of JAK2 (ATF7IP-JAK2 10-8), exon 13 of ATF7IP to exon 16 of JAK2 (ATF7IP-JAK2 13-16), or exon 13 of ATF7IP to exon 17 of JAK2 (ATF7IP-JAK2 13-17). The fusion is predicted to result from a reciprocal translocation t(9;12) (p24;p13.1), and has been identified by RNA sequencing and Sanger sequencing in three adult patients with BCR-ABL1-like B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the coiled coil and MDN1 domains from ATF7IP and the JH2 pseudokinase and JH1 kinase domains from JAK2. The coiled coil domain is hypothesized to constitutively activate the JAK2 kinase domain, thereby upregulating the pathway shared with signal transducers and activators of transcription (STATs). Clinical significance: The novel ATF7IP-JAK2 fusion has been documented in three cases for which specific clinical information is unavailable. A pre-clinical xenograft model containing the fusion was sensitive to exposure to the JAK2 inhibitor, ruxolitinib. Therefore, the presence of the JAK2 JH1 kinase domain in the fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).	JAK2 fusions in B-ALL															2020-12-16 21:08:57 UTC	15.0					
2847	https://civic.genome.wustl.edu/links/variants/2847	JAK2	3717	EBF1-JAK2	The EBF1-JAK2 fusion is composed of part of the EBF1 (Early B-Cell Factor Transcription Factor 1) gene at the 5 end (N-terminus of the fusion protein), and part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion protein. The published breakpoint joins exon 14 of EBF1 to exon 17 of JAK2 (EBF1-JAK2 14-17). The fusion is predicted to result from a reciprocal translocation t(5;9) (q33.3;p24), and has been identified by RNA sequencing in one adolescent patient with BCR-ABL1-like B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the DNA binding, immunoglobulin-life fold, and helix-loop-helix domains from EBF1 and an intact JH1 kinase domain from JAK2, as confirmed by RT-PCR and Sanger sequencing. The inclusion of the JH1 kinase domain is hypothesized to upregulate the pathway shared with signal transducers and activators of transcription (STATs). Functional analysis of the EBF1-JAK2 fusion protein has not been performed. Clinical significance: The novel EBF1-JAK2 fusion has been documented in one case for which specific clinical information is unavailable. However, the presence of the JAK2 JH1 kinase domain in the fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).																2020-12-16 21:04:43 UTC	0.0					
2848	https://civic.genome.wustl.edu/links/variants/2848	JAK2	3717	PPFIBP1-JAK2		JAK2 fusions in B-ALL															2020-09-30 21:47:29 UTC	7.5					
2849	https://civic.genome.wustl.edu/links/variants/2849	JAK2	3717	STRN3-JAK2	The STRN3-JAK2 fusion is composed of part of the STRN3 (Striatin 3) gene at the 5 end (N-terminus of the fusion protein), and a part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion. The published breakpoint joins exon 9 of STRN3 to exon 17 of JAK2 (STRN3 -JAK2 9-17). The fusion is predicted to result from a reciprocal translocation t(9;14) (p24;q12), and has been identified by RNA sequencing in one pediatric patient with BCR-ABL1-like B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the Striatin domain from STRN3 and the JH2 pseudokinase domain and intact JH1 kinase domain from JAK2, as confirmed by RT-PCR and Sanger sequencing. The inclusion of the JH1 kinase domain is hypothesized to upregulate the pathway shared with signal transducers and activators of transcription (STATs). Functional analysis of the STRN3-JAK2 fusion protein has not been performed. Clinical significance: The novel STRN3-JAK2 fusion has been documented in a single case for which specific clinical information is unavailable. However, the presence of the JAK2 JH1 kinase domain in the fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).	JAK2 fusions in B-ALL															2020-12-16 21:47:40 UTC	0.0					
2850	https://civic.genome.wustl.edu/links/variants/2850	JAK2	3717	TPR-JAK2	The TPR-JAK2 fusion is composed of part of the TPR (Translocated Promoter Region, Nuclear Basket Protein) gene at the 5 end (N-terminus of the fusion protein), and a part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion. The published breakpoint joins exon 39 of TPR to exon 17 of JAK2 (TPR -JAK2 39-17). The fusion stems from a reciprocal translocation t(1;9) (q31.1;p24), and has been identified by FISH and RNA sequencing in one young adult patient with BCR-ABL1-like B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the TPR/MLP1/MLP2-like protein domain from TERF2 and the JH2 pseudokinase domain and intact JH1 kinase domain from JAK2, as confirmed by RT-PCR and Sanger sequencing. The inclusion of the JH1 kinase domain is hypothesized to upregulate the pathway shared with signal transducers and activators of transcription (STATs). Functional analysis of the TPR-JAK2 fusion protein has not been performed. Clinical significance: The novel TPR-JAK2 fusion has been documented in one case for which specific clinical information is unavailable. However, the presence of the JAK2 JH1 kinase domain in the fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).	JAK2 fusions in B-ALL															2020-12-16 21:35:15 UTC	0.0					
2859	https://civic.genome.wustl.edu/links/variants/2859	JAK2	3717	ETV6-JAK2		JAK2 fusions in B-ALL															2020-10-12 23:14:39 UTC	25.0					
2860	https://civic.genome.wustl.edu/links/variants/2860	JAK2	3717	BCR-JAK2	The BCR-JAK2 fusion is composed of part of the BCR (Breakpoint Cluster Region) gene at the 5 end (N-terminus of the fusion protein), and part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion. Known breakpoint/splice variants join exon 14 of BCR to exon 17 of JAK2 (BCR-JAK2 4-17) and exon 1 of BCR to exons 15 (BCR-JAK2 1-15), 17 (BCR-JAK2 1-17), or 19 (BCR-JAK2 1-19). The fusion results from the reciprocal translocation t(9;22)(p24;p11.2), and has been identified by karyotype analysis, FISH, RT-PCR, targeted ligation amplification (TLA), and RNA sequencing. The fusion gene is expressed from the der(9) chromosome. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the coiled coil domain from BCR and the JH1 kinase domain from JAK2. Depending on the breakpoint variant, the fusion protein may also contain the JAK2 JH2 pseudokinase domain. In pre-clinical studies, the coiled coil domain of BCR has been shown to mediate oligomeric activation of the JAK2 kinase domain, thereby promoting downstream signaling by signal transducers and activators of transcription (STATs). The BCR-JAK2 fusion is associated with hematologic malignancies and has been observed in myeloproliferative neoplasms with eosinophilia (multiple cases), B-lymphoblastic leukemia (multiple cases), acute myeloid leukemia (a rare case), and B-cell lymphoma (rare case of Burkitt lymphoma). Clinical significance: As a diagnostic biomarker in B-lymphoblastic leukemia, the BCR-JAK2 fusion is frequently observed in the BCR-ABL1-like subtype. As a prognostic marker, the fusion appears to be associated with high-risk disease in pediatric and adult populations. As a predictive marker, patients whose diseases exhibit the BCR-JAK2 fusion have experienced partial responses or even complete remission with hydroxyurea and/or interferon alfa. Case reports have demonstrated the limited utility of tyrosine kinase inhibitors. One patient diagnosed with a myeloid neoplasm initially responded to the JAK2 inhibitor ruxolitinib, but relapsed after 18 months. Current research has suggested a survival advantage following allogeneic or autologous stem cell transplantation.	JAK2 fusions in B-ALL															2020-12-16 21:02:25 UTC	35.0					
2861	https://civic.genome.wustl.edu/links/variants/2861	JAK2	3717	PAX5-JAK2	The PAX5-JAK2 fusion is composed of part of the PAX5 (Paired Box 5) gene at the 5 end (N-terminus of the fusion protein), and part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion protein. The published breakpoint joins exon 5 of PAX5 to exon 19 of JAK2 (PAX5-JAK2 5-19). The fusion is hypothesized to result from an intrachromosomal translocation, inversion, or deletion of chromosome 9 (involving loci p13 and p24), and has been identified by RNA sequencing, RT-PCR, Sanger sequencing, and FISH in patients B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the DNA-binding paired domain from PAX5 and the JH1 kinase domain from JAK2. A pre-clinical study has revealed that this fusion protein deregulates the PAX5 transcriptional pathway while also autophosphorylating the JAK2 kinase domain, thereby promoting downstream signaling by signal transducers and activators of transcription (STATs). Clinical significance: As a diagnostic biomarker, the PAX5-JAK2 fusion in B-lymphoblastic leukemia is frequently associated with the BCR-ABL1-like subtype. As a prognostic marker, the fusion has been associated with intermediate to high-risk disease. As a predictive marker, the PAX5-JAK2 fusion has been shown in pre-clinical data to predict response to treatment with JAK2 inhibitors. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to treatment of B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).																2020-12-16 21:28:12 UTC	30.0					
2862	https://civic.genome.wustl.edu/links/variants/2862	JAK2	3717	TERF2-JAK2		JAK2 fusions in B-ALL															2019-10-24 01:04:51 UTC	0.0					
2864	https://civic.genome.wustl.edu/links/variants/2864	JAK2	3717	ZNF274-JAK2		JAK2 fusions in B-ALL															2020-10-20 18:17:56 UTC	7.5					
2865	https://civic.genome.wustl.edu/links/variants/2865	JAK2	3717	RFX3-JAK2		JAK2 fusions in B-ALL															2020-10-20 18:17:04 UTC	7.5					
2871	https://civic.genome.wustl.edu/links/variants/2871	BRCA2	675	K3226*																	2019-10-26 22:03:29 UTC	0.0					
2883	https://civic.genome.wustl.edu/links/variants/2883	BRAF	673	NRF1-BRAF															transcript_fusion		2019-12-05 18:38:43 UTC	7.5					
2885	https://civic.genome.wustl.edu/links/variants/2885	ABL1	25	BCR-ABL T315V															missense_variant,transcript_fusion		2019-12-30 03:30:13 UTC	2.0			BCR-ABL THR315VAL,BCR-ABL1 T315V,BCR-ABL1 THR315VAL		
2886	https://civic.genome.wustl.edu/links/variants/2886	ABL1	25	BCR-ABL E279K															missense_variant,transcript_fusion		2019-12-30 03:51:28 UTC	2.0			BCR-ABL1 E279K,BCR-ABL GLU279LYS,BCR-ABL1 GLU279LYS		
2887	https://civic.genome.wustl.edu/links/variants/2887	ABL1	25	BCR-ABL E292L															missense_variant,transcript_fusion		2019-12-30 03:52:38 UTC	2.0			BCR-ABL1 E292L,BCR-ABL GLY292LEU,BCR-ABL1 GLY292LEU		
2888	https://civic.genome.wustl.edu/links/variants/2888	ABL1	25	BCR-ABL F317R															missense_variant,transcript_fusion		2019-12-30 03:53:49 UTC	2.0			BCR-ABL1 F317R,BCR-ABL PHE317ARG,BCR-ABL1 PHE317ARG		
2889	https://civic.genome.wustl.edu/links/variants/2889	ABL1	25	BCR-ABL L248R F359I																	2019-12-30 04:53:14 UTC	2.0			BCR-ABL1 L248R F359I		
2890	https://civic.genome.wustl.edu/links/variants/2890	ABL1	25	BCR-ABL E255K V299L																	2019-12-30 04:45:35 UTC	2.0			BCR-ABL1 E255K V299L		
2892	https://civic.genome.wustl.edu/links/variants/2892	CTNNB1	1499	Exon 3 Mutation			3	41266017	41266244			ENST00000349496.5	75	GRCh37							2021-01-26 21:27:07 UTC	55.0				31	https://civic.genome.wustl.edu/links/assertions/31
2893	https://civic.genome.wustl.edu/links/variants/2893	DPYD	1806	EXON 11-19 DELETION			1	97700408	98039526			ENST00000370192.3	75	GRCh37					inframe_deletion		2020-01-03 22:58:08 UTC	10.0					
2894	https://civic.genome.wustl.edu/links/variants/2894	MET	4233	MET-ATXN7L1															transcript_fusion		2020-06-12 16:23:19 UTC	0.0					
2896	https://civic.genome.wustl.edu/links/variants/2896	NT5C2	22978	R238W			10	104857107	104857107	G	A	ENST00000343289.5	75	GRCh37							2020-03-27 08:57:54 UTC	9.0	CA377975023				
2897	https://civic.genome.wustl.edu/links/variants/2897	NT5C2	22978	S445F			10	104850483	104850483	G	A	ENST00000343289.5	75	GRCh37					gain_of_function_variant,sequence_variant_causing_missense_codon_change_in_transcript		2020-03-27 08:58:14 UTC	9.0	CA377969059	NONE FOUND			
2898	https://civic.genome.wustl.edu/links/variants/2898	NT5C2	22978	NT5C2 MUTATION																	2020-01-23 22:38:43 UTC	20.0					
2900	https://civic.genome.wustl.edu/links/variants/2900	ABL1	25	BCR-ABL D363G															missense_variant,transcript_fusion		2020-02-18 04:28:43 UTC	2.5			BCR-ABL1 D363G		
2901	https://civic.genome.wustl.edu/links/variants/2901	ABL1	25	BCR-ABL E98G															missense_variant,transcript_fusion		2020-02-18 05:54:38 UTC	2.5			BCR-ABL1 E98G,BCR-ABL GLU98GLY,BCR-ABL1 GLU98GLY		
2902	https://civic.genome.wustl.edu/links/variants/2902	ABL1	25	BCR-ABL L364I															missense_variant,transcript_fusion		2020-07-31 22:08:28 UTC	2.5			BCR-ABL1 L364I,BCR-ABL LEU364ILE,BCR-ABL1 LEU364ILE		
2909	https://civic.genome.wustl.edu/links/variants/2909	ABL1	25	BCR-ABL Y253F															missense_variant,transcript_fusion		2020-01-16 21:21:55 UTC	0.0			BCR-ABL TYR253PHE,BCR-ABL1 Y253F,BCR-ABL1 TYR253PHE		
2911	https://civic.genome.wustl.edu/links/variants/2911	IL6	3569	OVEREXPRESSION																	2020-01-16 22:05:57 UTC	0.0					
2916	https://civic.genome.wustl.edu/links/variants/2916	PRPS1	5631	PRPS1 MUTATION																	2020-02-03 22:34:33 UTC	20.0					
2918	https://civic.genome.wustl.edu/links/variants/2918	PRPS1	5631	T303S																	2020-03-25 01:50:47 UTC	4.0					
2919	https://civic.genome.wustl.edu/links/variants/2919	PRPS1	5631	L191F																	2020-03-25 01:44:51 UTC	6.0					
2920	https://civic.genome.wustl.edu/links/variants/2920	PRPS1	5631	D183E																	2020-03-25 01:50:00 UTC	4.0					
2921	https://civic.genome.wustl.edu/links/variants/2921	PRPS1	5631	K176N																	2020-03-25 01:49:32 UTC	4.0					
2923	https://civic.genome.wustl.edu/links/variants/2923	PRPS1	5631	N144S																	2020-03-25 01:51:34 UTC	7.0					
2925	https://civic.genome.wustl.edu/links/variants/2925	PRPS1	5631	S103I																	2020-01-31 17:01:25 UTC	0.0					
2926	https://civic.genome.wustl.edu/links/variants/2926	PRPS1	5631	S103N																	2020-03-25 01:49:02 UTC	4.0					
2927	https://civic.genome.wustl.edu/links/variants/2927	PRPS1	5631	S103T																	2020-03-25 01:48:09 UTC	5.0					
2929	https://civic.genome.wustl.edu/links/variants/2929	PRPS1	5631	A190T																	2020-03-25 01:50:29 UTC	23.0					
2930	https://civic.genome.wustl.edu/links/variants/2930	VHL	7428	106insR (c.316insGCC)																	2020-06-17 05:29:14 UTC	7.5					
2935	https://civic.genome.wustl.edu/links/variants/2935	PRPS1	5631	D139G																	2020-01-31 21:37:50 UTC	0.0					
2936	https://civic.genome.wustl.edu/links/variants/2936	PRPS1	5631	C77S																	2020-01-31 21:38:07 UTC	0.0					
2937	https://civic.genome.wustl.edu/links/variants/2937	PRPS1	5631	I72V																	2020-01-31 21:38:21 UTC	0.0					
2938	https://civic.genome.wustl.edu/links/variants/2938	PRPS1	5631	V53A																	2020-01-31 21:38:28 UTC	0.0					
2939	https://civic.genome.wustl.edu/links/variants/2939	PRPS1	5631	A87T																	2020-01-31 23:12:45 UTC	0.0					
2940	https://civic.genome.wustl.edu/links/variants/2940	PRPS1	5631	M115T																	2020-01-31 23:12:55 UTC	0.0					
2944	https://civic.genome.wustl.edu/links/variants/2944	PDGFRA	5156	OVEREXPRESSION																	2020-06-08 16:54:46 UTC	3.0					
2948	https://civic.genome.wustl.edu/links/variants/2948	ABL1	25	BCR-ABL E450Q															missense_variant,transcript_fusion		2020-03-16 21:50:56 UTC	10.0			BCR-ABL1 E450Q,BCR-ABL GLU450GLN,BCR-ABL1 GLU450GLN		
2949	https://civic.genome.wustl.edu/links/variants/2949	ABL1	25	BCR-ABL M244V and L364I																	2020-06-03 20:10:18 UTC	0.0					
2951	https://civic.genome.wustl.edu/links/variants/2951	ABL1	25	BCR-ABL N146S															missense_variant,transcript_fusion		2020-02-07 05:10:44 UTC	0.0			BCR-ABL ASN146SER,BCR-ABL1 N146S,BCR-ABL1 ASN146SER		
2952	https://civic.genome.wustl.edu/links/variants/2952	ABL1	25	BCR-ABL V298I															missense_variant,transcript_fusion		2020-02-07 05:20:50 UTC	0.0			BCR-ABL VAL298ILE,BCR-ABL1 V298I,BCR-ABL1 VAL298ILE		
2953	https://civic.genome.wustl.edu/links/variants/2953	ABL1	25	BCR-ABL S438C															missense_variant,transcript_fusion		2020-07-31 22:59:10 UTC	7.5			BCR-ABL SER438CYS,BCR-ABL1 SER438CYS,BCR-ABL1 S438C		
2954	https://civic.genome.wustl.edu/links/variants/2954	ABL1	25	BCR-ABL M388L															missense_variant,transcript_fusion		2020-02-08 04:03:29 UTC	0.0			BCR-ABL1 M388L,BCR-ABL MET388LEU,BCR-ABL1 MET388LEU		
2959	https://civic.genome.wustl.edu/links/variants/2959	CHEK2	11200	R474C c.1420C>T																	2020-06-17 05:20:13 UTC	7.5					
2960	https://civic.genome.wustl.edu/links/variants/2960	BCL2	596	G101V																	2020-09-04 15:20:22 UTC	3.0					
2971	https://civic.genome.wustl.edu/links/variants/2971	PDGFRA	5156	BCR-PDGFRA																	2020-02-27 17:42:21 UTC	0.0					
2972	https://civic.genome.wustl.edu/links/variants/2972	PDGFB	5155	COL1A1-PDGFB																	2020-06-08 16:54:46 UTC	7.5					
2973	https://civic.genome.wustl.edu/links/variants/2973	PDGFRB	5159	OVEREXPRESSION																	2020-06-08 16:54:46 UTC	7.5					
2974	https://civic.genome.wustl.edu/links/variants/2974	JAK2	3717	OFD1-JAK2	The OFD1-JAK2 fusion is composed of part of the OFD1 (Oral-Facial-Digital Syndrome 1) gene at the 5 end (N-terminus of the fusion protein), and part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion protein. OFD1 is a centrosomal protein of primary cilia implicated in Oral-Facial-Digital Syndrome type 1, but it has not been previously described in hematologic malignancies. The published breakpoint joins exon 22 of OFD1 to exon 13 of JAK2 (OFD1-JAK2 22-13). This fusion is predicted to result from a reciprocal translocation t(X;9)(p22;p24), and has been identified in two patients by RNA sequencing, one of which demonstrated the abnormal karyotype 46,XY,-17+mar[11]/46,XY[9]. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the FERM and SH2 domains from OFD1 and the JH2 pseudokinase and JH1 kinase domains from JAK2. The inclusion of the JH1 kinase domain is hypothesized to upregulate the pathway shared with signal transducers and activators of transcription (STATs). Functional analysis of the OFD1-JAK2 fusion protein is reportedly underway. Clinical significance: The novel OFD1-JAK2 fusion has been documented in one 3-year-old and one 11-year-old boy with BCR-ABL1-like B-lymphoblastic leukemia. Both children successfully maintained first complete remission following induction chemotherapy and allogeneic hematopoietic stem cell transplantation, with as long as 6 years of follow up. While neither patient was treated with a JAK2 inhibitor, the JH1 kinase domain present within the OFD1-JAK2 fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of pediatric B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).																2020-12-16 21:51:26 UTC	12.5					
2975	https://civic.genome.wustl.edu/links/variants/2975	JAK2	3717	SMU1-JAK2	The SMU1-JAK2 fusion is composed of part of the SMU1 (SMU1 DNA Replication Regulator and Splicesomal Factor) gene at the 5 end (N-terminus of the fusion protein), and part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion protein. The published breakpoint joins exon 18 of SMU1 to exon 12 of JAK2 (SMU1-JAK2 18-12). The fusion is hypothesized to result from an intrachromosomal translocation, inversion, or deletion of chromosome 9 (involving loci p21 and p24), and has been identified by RNA sequencing in an older adult patient with BCR-ABL1-like B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the LisH, CTLH, HisP, and Wd40 domains from SMU1 and the JH2 pseudokinase and JH1 kinase domains from JAK2. Pre-clinical data demonstrates increased JH1 kinase expression as a result of the SMU1-JAK2 fusion event, which is hypothesized to upregulate the pathway shared with signal transducers and activators of transcription (STATs). Clinical significance: The novel SMU1-JAK2 fusion has been documented in one case for which specific clinical information is unavailable. However, the presence of the JAK2 JH1 kinase domain in the fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).																2020-12-16 20:46:31 UTC	0.0					
2976	https://civic.genome.wustl.edu/links/variants/2976	JAK2	3717	SNX29-JAK2	The SNX29-JAK2 fusion is composed of part of the SNX29 (Sorting Nexin 29) gene at the 5 end (N-terminus of the fusion protein), and a part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion. The published breakpoint joins exon 18 of SNX29 to exon 13 of JAK2 (SNX29 -JAK2 18-13). It is predicted to result from a reciprocal translocation t(9;16) (p24;q13.13), and has been identified by RNA sequencing in one normal-karyotype adult patient with BCR-ABL1-like B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the RUN and PX_RUN domains from SNX29 and the JH2 pseudokinase and JH1 kinase domains from JAK2. The inclusion of the JH1 kinase domain is hypothesized to upregulate the pathway shared with signal transducers and activators of transcription (STATs). Functional analysis of the SNX29-JAK2 fusion protein has not been performed. Clinical significance: The novel SNX29-JAK2 fusion has been documented in a single case that successfully maintained complete remission without relapse following induction chemotherapy. While the patient was not treated with a JAK2 inhibitor, the JH1 kinase domain present within the SNX29-JAK2 fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).																2020-12-16 21:13:22 UTC	0.0					
2977	https://civic.genome.wustl.edu/links/variants/2977	JAK2	3717	ZNF430-JAK2	The ZNF430-JAK2 fusion is composed of part of the ZNF430 (Zinc Finger Protein 430) gene at the 5 end (N-terminus of the fusion protein), and part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion protein. The published breakpoint joins exon 4 of ZNF430 to exon 19 of JAK2 (ZNF430-JAK2 4-19). The fusion is predicted to result from a reciprocal translocation t(9;19)(p24;p12), and has been identified by RNA sequencing in one adult patient with BCR-ABL1-like B-lymphoblastic leukemia. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the KRAB_A-box domain from ZNF430 and the JH1 kinase domain from JAK2. The inclusion of the JH1 kinase domain is hypothesized to upregulate the pathway shared with signal transducers and activators of transcription (STATs). Functional analysis of the ZNF430-JAK2 fusion protein has not been performed. Clinical significance: The novel ZNF430-JAK2 fusion has been documented in one case for which clinical information is unavailable. However, the presence of the JAK2 JH1 kinase domain in the fusion protein may offer a target for therapeutic inhibition. Prospective clinical trials are ongoing to evaluate the efficacy of adding JAK2 inhibitors to the treatment of pediatric B-lymphoblastic leukemia patients with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).																2020-12-16 19:46:20 UTC	7.5					
2979	https://civic.genome.wustl.edu/links/variants/2979	KRAS	3845	A146																	2020-03-16 21:09:48 UTC	15.0					
2992	https://civic.genome.wustl.edu/links/variants/2992	NTRK1	4914	TPM3-NTRK1																	2020-09-11 19:52:16 UTC	17.5					
3001	https://civic.genome.wustl.edu/links/variants/3001	PIK3CA	5290	V955I			3	178948091	178948091	G	A	ENST00000263967.3	75	GRCh37					missense_variant		2021-01-06 19:13:42 UTC	10.0	CA355281422		VAL955ILE		
3009	https://civic.genome.wustl.edu/links/variants/3009	ABL1	25	Double Ph																	2020-07-24 22:20:24 UTC	10.0			DOUBLE PHILADELPHIA CHROMOSOME		
3011	https://civic.genome.wustl.edu/links/variants/3011	FLT3	2322	D835Y																	2020-12-03 18:41:17 UTC	6.0					
3032	https://civic.genome.wustl.edu/links/variants/3032	MYOD1	4654	L122R			11	17741694	17741694	T	G	ENST00000250003.3	75	GRCh37					missense_variant		2021-01-28 00:00:28 UTC	45.0	CA379790889	NONE FOUND	LEU122ARG		
3042	https://civic.genome.wustl.edu/links/variants/3042	CDK6	1021	EXPRESSION																	2020-12-10 20:17:06 UTC	2.0					
3049	https://civic.genome.wustl.edu/links/variants/3049	ATM	472	c.902-1G>T																	2020-06-08 17:30:51 UTC	3.0					
3050	https://civic.genome.wustl.edu/links/variants/3050	ATM	472	c.7089+1del																	2020-06-08 17:30:52 UTC	3.0					
3051	https://civic.genome.wustl.edu/links/variants/3051	ATM	472	c.7515+1_2del																	2020-06-08 17:30:52 UTC	3.0					
3066	https://civic.genome.wustl.edu/links/variants/3066	VHL	7428	L128F (c.382C>T)			3	10188239	10188239	C	T	ENST00000256474.2	75	GRCh37					missense_variant		2020-10-14 00:00:11 UTC	0.0	CA351753886				
3070	https://civic.genome.wustl.edu/links/variants/3070	FLT3	2322	Y842C																	2020-08-13 05:07:50 UTC	14.0					
3071	https://civic.genome.wustl.edu/links/variants/3071	FLT3	2322	F691L																	2020-09-04 15:18:15 UTC	6.0					
3075	https://civic.genome.wustl.edu/links/variants/3075	FLT3	2322	D835I																	2020-06-17 02:13:04 UTC	0.0					
3082	https://civic.genome.wustl.edu/links/variants/3082	BCL2	596	F104I																	2020-09-04 15:15:54 UTC	8.0					
3096	https://civic.genome.wustl.edu/links/variants/3096	VHL	7428	C77_N78insL (c.230_231insTCT)			3	10183761	10183762		TCT	ENST00000256474.2	75	GRCh37					disruptive_inframe_insertion	NC_000003.12:g.10142077_10142078insTCT,NC_000003.11:g.10183761_10183762insTCT,NM_000551.3:c.230_231insTCT,NP_000542.1:p.Cys77_Asn78insLeu	2020-11-05 00:00:25 UTC	0.0	unregistered	NONE FOUND	77INSL		
3157	https://civic.genome.wustl.edu/links/variants/3157	VHL	7428	F76del (c.227_229del)																	2021-01-19 19:30:56 UTC	7.5					
3158	https://civic.genome.wustl.edu/links/variants/3158	NTRK2	4915	KANK1-NTRK2																	2020-08-11 16:37:51 UTC	5.0					
3200	https://civic.genome.wustl.edu/links/variants/3200	KRAS	3845	Wildtype																	2020-08-30 21:35:20 UTC	2.0					
3202	https://civic.genome.wustl.edu/links/variants/3202	SMARCB1	6598	LOSS																	2020-12-15 14:24:54 UTC	20.0					
3203	https://civic.genome.wustl.edu/links/variants/3203	ATRX	546	Mutation			X	76760356	77041702			ENST00000373344.5	75	GRCh37							2021-01-11 17:19:09 UTC	15.0		N/A			
3214	https://civic.genome.wustl.edu/links/variants/3214	JAK2	3717	GOLGA5-JAK2	The GOLGA5-JAK2 fusion is composed of part of the GOLGA5 (Golgin A5) gene at the 5 end (N-terminus of the fusion protein), and part of the JAK2 (Janus Kinase 2) gene at the 3 end (C-terminus of the fusion protein). JAK2 is considered as the key partner that defines the functional/oncogenic effects of the fusion protein. The published breakpoint joins exon 10 of GOLGA5 to exon 12 of JAK2 (GOLGA5-JAK2 10-12). The fusion is predicted to result from a reciprocal translocation t(9;14)(p24;q32), and has been identified in one patient by RNA sequencing. The fusion is in-frame and results in production of an abnormal hybrid protein, containing the coiled coil domain from GOLGA5 and an aberrantly activated JH1 kinase domain from JAK2, which is thought to upregulate the pathway shared with signal transducers and activators of transcription (STATs). The inclusion of the JH1 domain may affect functionality and offer a target for therapeutic inhibition. Clinical significance: The novel GOLGA5-JAK2 fusion has been documented in one 10-year-old boy with BCR-ABL1-like B-lymphoblastic leukemia with complex karyotype. The clinical details of this case could predict response to treatment with JAK2 inhibitors. A xenograft model created from the patient's malignant cells demonstrated clearance of the leukemic clone in murine peripheral blood upon exposure to ruxolitinib. Moreover, this drug was added to the child's treatment regimen, resulting in nearly undetectable levels of the GOLGA5-JAK2 fusion measured after 64 days of therapy. The patient has reportedly remained in remission 20 months after CAR T-cell infusion and allogeneic hematopoietic stem cell transplantation. This child was included in the currently ongoing prospective clinical trial evaluating the efficacy of JAK2 inhibitors in treating pediatric B-lymphoblastic leukemia with JAK2 fusions (Clinicaltrials.gov Identifier: NCT02723994).																2020-12-16 21:53:24 UTC	0.0					
3222	https://civic.genome.wustl.edu/links/variants/3222	PIK3CA	5290	Rare Mutation			3	178866311	178957881			ENST00000263967.3	75	GRCh37							2021-02-02 23:05:30 UTC	0.0					
3224	https://civic.genome.wustl.edu/links/variants/3224	NTRK1	4914	LMNA-NTRK1 e2-e11																	2020-12-04 19:32:50 UTC	5.0					
3225	https://civic.genome.wustl.edu/links/variants/3225	NTRK1	4914	LMNA-NTRK1 e11-e10																	2020-12-04 19:32:09 UTC	7.5					
3244	https://civic.genome.wustl.edu/links/variants/3244	VHL	7428	R120fs (c.358_359insAC)			3	10188215	10188216		AC	ENST00000256474.2	75	GRCh37					frameshift_truncation,plus_2_frameshift_variant	NC_000003.12:g.10146531_10146532insAC,NC_000003.11:g.10188215_10188216insAC,NM_000551.3:c.358_359insAC,NP_000542.1:p.Arg120AsnfsTer?	2021-01-19 00:00:32 UTC	7.5	unregistered	NONE FOUND	R120NFS*40		
3245	https://civic.genome.wustl.edu/links/variants/3245	VHL	7428	C77fs (c.230del)																	2021-01-13 05:13:07 UTC	0.0					
3246	https://civic.genome.wustl.edu/links/variants/3246	VHL	7428	Q96_P97delinsH (c.288_290del)			3	10183819	10183821	GCC		ENST00000256474.2	75	GRCh37					disruptive_inframe_deletion	NC_000003.12:g.10142135_10142137del,NC_000003.11:g.10183819_10183821del,NM_000551.3:c.288_290del,NP_000542.1:p.Gln96_Pro97delinsHis	2021-01-17 00:00:25 UTC	7.5	unregistered	NONE FOUND	C.288DELGCC,C.288_290DELGCC		
3247	https://civic.genome.wustl.edu/links/variants/3247	VHL	7428	G144fs (c.429_439del)			3	10188285	10188295	ACGGACAGCCT		ENST00000256474.2	75	GRCh37					frameshift_truncation,minus_2_frameshift_variant	NC_000003.12:g.10146602_10146612del,NC_000003.11:g.10188286_10188296del,NM_000551.3:c.429_439del,NP_000542.1:p.Gly144PhefsTer26	2021-01-19 00:00:31 UTC	7.5	unregistered	NONE FOUND	G144FFS*26,C.428_438DEL		
3257	https://civic.genome.wustl.edu/links/variants/3257	AKT1	207	S473 Phosphorylation																	2021-02-02 23:38:11 UTC	0.0					
